1
As filed with the Securities and Exchange Commission on March 20, 2001
Registration No. 333-52304
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
AMENDMENT NO. 3
TO
FORM S-4
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AGCO CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 3523 58-1960019
(State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Identification Number)
Incorporation or Organization) Classification Code Number)
4205 RIVER GREEN PARKWAY
DULUTH, GA 30096
(770) 813-9200
(Address, Including Zip Code, and Telephone Number, Including
Area Code of Registrant's Principal Executive Offices)
STEPHEN D. LUPTON
SENIOR VICE PRESIDENT AND GENERAL COUNSEL
4205 RIVER GREEN PARKWAY
DULUTH, GA 30096
(770) 813-920
(Address, Including Zip Code, and Telephone Number, Including Area Codes of
Agent For Service)
With Copies to:
W. BRINKLEY DICKERSON, JR. MICHAEL W. SCHLEY
TROUTMAN SANDERS LLP LARKIN, HOFFMAN, DALY & LINDGREN, LTD.
600 PEACHTREE STREET NE, SUITE 5200 1500 WELLS FARGO PLAZA
ATLANTA, GEORGIA 30308 7900 XERXES AVENUE SOUTH
(404) 885-3000 BLOOMINGTON, MINNESOTA 55431
(952) 835-3800
Approximate date of commencement of proposed sale to the public: As soon as
possible after the effectiveness of this Registration Statement and the
satisfaction or waiver of all other conditions to the merger (the "merger") of
Agri Acquisition Corp., a wholly owned subsidiary of AGCO Corporation, and
Ag-Chem Equipment Co., Inc. pursuant to the Agreement and Plan of Merger dated
as of November 20, 2000, described in the proxy statement/prospectus.
If the securities being registered on this form are to be offered in connection
with the formation of a holding company and there is compliance with General
Instruction G, please check the following box. / /
If this form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. / / _________
If this form is a post-effective amendment filed pursuant to Rule 462(d) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / / _________
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES
AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE
A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT
SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE
SECURITIES ACT OF 1933, AS AMENDED, OR UNTIL THE REGISTRATION STATEMENT SHALL
BECOME EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING
PURSUANT TO SAID SECTION 8(A), MAY DETERMINE.
================================================================================
2
PROXY STATEMENT
FOR A
SPECIAL MEETING OF SHAREHOLDERS
AND
PROSPECTUS
MARCH 20, 2001
AG-CHEM LOGO
MERGER PROPOSED
To the Shareholders of Ag-Chem:
The board of directors of Ag-Chem has approved a merger agreement which
provides for the acquisition of Ag-Chem by AGCO Corporation. We are seeking your
vote on this important transaction. Accordingly, you are cordially invited to
attend a special meeting of shareholders of Ag-Chem Equipment Co., Inc. to be
held at Ag-Chem's corporate headquarters at 5720 Smetana Drive, Minnetonka,
Minnesota, 55343 on Friday, April 13, 2001, at 1:00 p.m., local time. This
document is the proxy statement of Ag-Chem for its special meeting and the
prospectus of AGCO for the AGCO common stock to be issued in the merger.
If the merger is completed, Ag-Chem shareholders will receive a
combination of AGCO common stock and cash for each share of Ag-Chem common stock
that they own. This combination may vary in composition, but will always total
in value $25.80 per share of Ag-Chem stock. The composition of cash and stock
that will make up this $25.80 in value could vary in a range from 100% cash with
0% stock, to 50% cash with 50% stock. The exact combination will ultimately be
determined based upon AGCO's share price, but in no event is AGCO obligated to
issue more than 11,800,000 shares. If the AGCO share price is less than $8.38
and AGCO issues less than 11,800,000 shares in the merger, Ag-Chem shareholders
will have the right to subscribe to purchase the difference between 11,800,000
shares and the number of shares actually issued.
Ag-Chem shareholders will, as a group, own approximately 15.8% of
AGCO's common stock once the merger is completed, assuming an AGCO per share
price of $11.00. AGCO stockholders will continue to own their existing shares
after the merger. AGCO common stock is traded on the New York Stock Exchange
under the symbol "AG." As of March 15, 2001, the closing price per share of AGCO
common stock was $11.06. We cannot complete the merger unless Ag-Chem
shareholders approve the merger agreement.
THE AG-CHEM BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE "FOR"
APPROVAL OF THE MERGER AGREEMENT.
I have signed an agreement with AGCO that I will vote a portion of my
Ag-Chem shares in favor of the merger and, although I am not contractually bound
to do so, I intend to vote all of my shares of Ag-Chem for the merger. If I do
so, the merger will be approved regardless of how you or other shareholders
vote.
Whether or not you plan to attend the special meeting, please take the
time to vote on the proposal to approve the merger agreement by completing and
mailing the enclosed proxy card to us.
Sincerely,
A. E. McQuinn
Chairman and Chief Executive Officer
3
NOTICE OF APPRAISAL RIGHTS
If the merger agreement is approved by the Ag-Chem shareholders at the
Ag-Chem special meeting and the merger is completed, any Ag-Chem shareholder who
files with Ag-Chem a written objection to the merger before the vote to approve
the merger agreement and who states in that objection that he or she intends to
demand payment for his or her shares if the merger is concluded, and does not
vote those shares in favor of the approval of the merger agreement will be
entitled to demand payment for his or her shares and an appraisal of the value
of those shares, in accordance with the provisions of Sections 302A.473 and
302A.471 of the Minnesota Business Corporation Act, a copy of which is attached
as Appendix C to the accompanying proxy statement/prospectus. Any signed proxy
returned by a shareholder that does not indicate a vote will be voted in favor
of the merger. See "Appraisal and Dissenters' Rights" in the proxy
statement/prospectus for more information concerning appraisal rights of
dissenting Ag-Chem shareholders.
PLEASE SEE "RISK FACTORS - FACTORS RELATING TO THE MERGER" BEGINNING ON
PAGE _____ OF THIS DOCUMENT FOR A DESCRIPTION OF SPECIFIC RISKS ASSOCIATED WITH
THE TRANSACTION.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
REGULATORS HAVE APPROVED THE TRANSACTION, THE COMMON STOCK TO BE ISSUED IN THE
TRANSACTION, OR THE FAIRNESS OF THE TRANSACTION, OR DETERMINED IF THIS DOCUMENT
IS ACCURATE OR ADEQUATE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
This proxy statement/prospectus is dated March 20, 2001, and is first
being mailed to shareholders on or about March 28, 2001.
4
AG-CHEM EQUIPMENT CO., INC.
---------------------
NOTICE OF SPECIAL MEETING OF AG-CHEM SHAREHOLDERS
---------------------
APRIL 13, 2001
AT 1:00 P.M.
To Ag-Chem Shareholders:
Notice is hereby given that a special meeting of shareholders of
Ag-Chem Equipment Co., Inc. will be held on April 13, 2001, at 1:00 p.m. local
time at Ag-Chem's corporate headquarters at 5720 Smetana Drive, Minnetonka,
Minnesota 55343, for the following purposes:
1. To consider and vote upon a proposal to adopt the Agreement
and Plan of Merger dated as of November 20, 2000, among
Ag-Chem Equipment Co. Inc., AGCO Corporation, and Agri
Acquisition Corp.
2. To transact any other business that properly comes before the
special meeting.
These items of business are described in the attached proxy
statement/prospectus. Only holders of record of Ag-Chem common stock at the
close of business on March 19, 2001, the record date, are entitled to vote at
the Special Meeting of Ag-Chem shareholders. You may vote in person at the
Ag-Chem special meeting even if you have returned a proxy.
By Order of the Board of Directors of
AG-CHEM EQUIPMENT CO., INC.
A.E. McQuinn
Chairman and Chief Executive Officer
Minnetonka, Minnesota
March 20, 2001
WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE COMPLETE, SIGN,
DATE AND RETURN THE ACCOMPANYING PROXY IN THE ENCLOSED SELF-ADDRESSED STAMPED
ENVELOPE.
Ag-Chem Equipment Co., Inc. AGCO Corporation
Proxy Statement Prospectus
5
TABLE OF CONTENTS
PAGE
----
QUESTIONS AND ANSWERS ABOUT THE MERGER..................................................................................II
SUMMARY..................................................................................................................1
RISK FACTORS............................................................................................................13
CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS.............................................................18
AG-CHEM SPECIAL MEETING.................................................................................................19
INFORMATION ABOUT OUR COMPANIES.........................................................................................20
THE MERGER..............................................................................................................21
MATERIAL PROVISIONS OF THE MERGER AGREEMENT AND RELATED AGREEMENTS......................................................45
UNAUDITED PRO FORMA CONSOLIDATED COMBINED FINANCIAL INFORMATION.........................................................56
UNAUDITED COMPARATIVE PER SHARE DATA....................................................................................62
DIRECTORS AND EXECUTIVE OFFICERS OF AGCO FOLLOWING THE MERGER...........................................................63
STOCK OWNERSHIP OF AGCO.................................................................................................63
COMPARISON OF SHAREHOLDER RIGHTS........................................................................................67
WHERE YOU CAN FIND MORE INFORMATION.....................................................................................73
EXPERTS.................................................................................................................75
LEGAL MATTERS...........................................................................................................75
FUTURE SHAREHOLDER PROPOSALS............................................................................................75
OTHER MATTERS...........................................................................................................75
APPENDICES..............................................................................................................76
APPENDICES
Appendix A - Agreement and Plan of Merger
Appendix B - Voting Agreement
Appendix C - Sections 302A.473 and 302A.471 of the Minnesota Business
Corporation Act
Appendix D - Opinion of Goldsmith, Agio, Helms Securities, Inc.
Appendix E - Form of Affiliate Letter
i
6
QUESTIONS AND ANSWERS ABOUT THE MERGER
Q: WHAT WILL I RECEIVE IN EXCHANGE FOR MY SHARES OF AG-CHEM COMMON STOCK?
A: You will receive a combination of cash and AGCO common stock valued at
$25.80 for each share of Ag-Chem common stock you own as of the closing
of the merger. The exact mix of stock and cash will not be determined
until just before the merger is completed. However, based upon an AGCO
price per share of $11.00 (AGCO's closing price per share on March 15,
2001 was $11.06), you would receive 1.17 shares of AGCO common stock
and $12.90 in cash. This amount will change if the stock price of AGCO
changes before we complete the merger. For a more detailed explanation,
please see page __.
Q: WHEN AND HOW CAN I LEARN THE FINAL FORM OF THE CONSIDERATION TO BE
PAID?
A: As soon as the final amount of cash and AGCO common stock is known,
AGCO and Ag-Chem will issue a press release. The final amount of cash
and AGCO common stock will be computed on the day of the merger.
Q: WILL THE RECEIPT BY ME OF AGCO COMMON STOCK AND CASH IN THE TRANSACTION
BE TAXABLE TO ME?
A: The exact tax consequences of the transaction will depend upon a number
of factors, particularly the price of AGCO common stock at the time of
the closing. For a typical individual Ag-Chem shareholder, if (1) the
closing price of AGCO common stock is $8.38 per share or more, the
receipt of AGCO common stock will not be taxable, and (2) the closing
price is less than $8.38 per share, the receipt of AGCO common stock
will be taxable. In either event, the receipt of cash will be taxable.
Since the tax consequences will not be known until closing, if you are
not willing to accept a fully taxable transaction, you should vote
AGAINST the transaction. See "The Merger--Material Federal Income Tax
Consequences."
Q: WHAT SHAREHOLDER APPROVALS ARE REQUIRED TO APPROVE THE MERGER?
A: A. E. McQuinn, Ag-Chem's Chairman and Chief Executive Officer, holds
approximately 58% of the outstanding shares of Ag-Chem and he
contractually has agreed to vote 19.9% of the total Ag-Chem shares
outstanding in favor of the merger. In addition, Mr. McQuinn has
indicated his intent to vote the rest of his shares for the merger.
If Mr. McQuinn votes all of his shares in favor of the merger, the
merger will be approved, regardless of how you or any other shareholder
may vote.
Q: DO I HAVE THE RIGHT TO DISSENT FROM THE MERGER?
A: Yes, the procedure for dissenting is set forth in the "Summary"
starting on page ___.
Q: WHAT DO I NEED TO DO TO GET MY CASH AND SHARES OF AGCO COMMON STOCK?
A: Promptly following the merger, AGCO will send you a letter of
transmittal and return envelope. The letter of transmittal will contain
instructions for exchanging your shares. Do not send in your stock
certificates until you are instructed to do so.
Q: WHEN DO THE COMPANIES EXPECT TO COMPLETE THE MERGER?
A: We hope to complete the merger on the same day as the shareholder
meeting. However, we cannot assure you that we will complete the merger
by then.
Q: WHAT DO I NEED TO DO NOW?
A: After carefully reading and considering the information contained in
this proxy statement/prospectus, please respond by completing, signing
and dating your proxy card and/or voting instructions and returning the
same in the enclosed postage-paid envelope. Please vote as soon as
possible.
Q: WHAT IF I DON'T VOTE?
A: If you are an Ag-Chem shareholder and you don't vote your shares or you
abstain, or if your shares are held by a brokerage firm, bank or other
nominee who abstains or does not vote them, your shares will have the
effect of a vote against the merger. If you respond and do not indicate
your voting preference, Ag-Chem will count your proxy as a vote in
favor of the merger.
ii
7
Q: CAN I CHANGE MY VOTE AFTER I HAVE DELIVERED MY PROXY OR VOTING
INSTRUCTIONS?
A: Yes. You can change your vote at any time before your proxy is voted at
the Ag-Chem special meeting. You can do this in one of three ways:
- You can revoke your proxy;
- You can submit a new proxy; or
- If you are a holder of record, you can attend the special
meeting and vote in person.
If you choose either of the first two methods, you must submit your
notice of revocation or your new proxy, as appropriate, to the
secretary of Ag-Chem before the special meeting. If you hold your
shares through an account at a brokerage firm or bank, you should
contact your brokerage firm or bank to change your vote.
Q: WHOM SHOULD I CALL IF I HAVE QUESTIONS?
A: If you have questions about the merger or how to submit your proxy, or
if you need additional copies of this joint proxy statement/prospectus
or the enclosed proxy card or voting instructions, you should contact:
Investor Relations Department
Ag-Chem Equipment Co., Inc.
5720 Smetana Drive
Minnetonka, Minnesota 55343
(952) 933-9006
Q: WHAT DIVIDENDS WILL I RECEIVE FROM MY AGCO STOCK IN THE FUTURE?
A: AGCO historically has paid a regular dividend of $.01 per share per
quarter. However, there can be no assurance that this dividend practice
will be continued.
iii
8
SUMMARY
Summarized below is selected basic information regarding the proposed
acquisition of Ag-Chem by AGCO. Because it is just a summary, it does not
contain all of the information regarding the merger. To understand the merger
more fully, and for a more complete description of the legal terms of the
merger, you should read carefully this entire document. The page references
included parenthetically will direct you to more complete descriptions of the
topics presented in this summary. The agreement and plan of merger is included
as Appendix A to this document. It is the legal document that governs the
merger, and you are encouraged to read it.
THE COMPANIES (SEE PAGE ___)
AGCO CORPORATION
4205 RIVER GREEN PARKWAY
DULUTH, GEORGIA 30096
- AGCO manufactures and distributes agricultural equipment and related
replacement parts throughout the world.
- AGCO sells a full range of agricultural equipment, including tractors,
combines, hay tools, sprayers, forage equipment and implements.
- AGCO's products are widely recognized in the agricultural equipment
industry and are marketed under the following brand names: AGCO(R)
Allis, Massey Ferguson(R), Hesston(R), White, GLEANER(R), New Idea(R),
AGCOSTAR(R), Tye(R), Farmhand(R), Glencoe(R), Fendt, Spra-Coupe(R) and
Willmar(R).
- AGCO distributes its products through a combination of approximately
8,200 independent dealers and distributors, associates and licensees.
- In addition, AGCO provides retail financing in North America, the
United Kingdom, France, Germany, Spain and Brazil through its finance
joint ventures with Cooperateive Centrale Raiffeisen-Boerenleenbank
B.A.
- AGCO had approximately $2.3 billion in assets as of December 31, 1999,
and in 1999 had revenues of $2.4 billion and had a net loss of $11.5
million.
AG-CHEM EQUIPMENT CO., INC.
5720 SMETANA DRIVE
MINNETONKA, MINNESOTA 55343
- Ag-Chem manufactures and distributes off-road equipment primarily for
use in fertilizing agricultural crops, the application of crop
protection chemicals to crops and, to a lesser extent, industrial waste
treatment applications and other industrial uses.
- Ag-Chem generates a majority of its consolidated revenues from the sale
of self-propelled, three- and four-wheeled vehicles and related
equipment for use in the application of liquid and dry fertilizers and
crop protection chemicals.
- Ag-Chem manufactures equipment for use both prior to planting crops
("pre-emergence") and after crops emerge from the ground
("post-emergence").
- Ag-Chem sells a majority of its products directly to the end-users of
the equipment, which include fertilizer dealers, farm cooperatives,
large growers, municipalities, waste disposal contractors and mining
and construction companies.
- Ag-Chem had approximately $156 million in assets as of September 30,
2000, and in fiscal 2000 had revenues of approximately $299 million and
had a net loss of $1.4 million.
1
9
THE MERGER (SEE PAGE ___)
The merger agreement provides that AGCO will acquire Ag-Chem and all of
the outstanding Ag-Chem common stock in exchange for a combination of cash and
shares of AGCO common stock. The value of this combination will be $25.80 per
share of Ag-Chem common stock.
The composition of the combination of AGCO common stock and cash that
you will receive will depend upon the closing price of AGCO common stock on the
trading day immediately prior to the merger. In addition, the transaction has
been designed to provide the most favorable tax results possible for Ag-Chem
shareholders depending upon the amount of AGCO common stock issued. As a result,
at some AGCO market prices, the merger is a "forward merger" for corporate law
purposes--and generally the receipt of the stock portion of the purchase price
will be tax free--and at others it is a "reverse merger" that is fully taxable.
These concepts are discussed more fully under "The Merger--Material Federal
Income Tax Consequences" beginning on page ___.
The following table shows the relative amounts of cash and stock, and
in general, the taxability of the receipt of the stock, depending upon the
market price of AGCO common stock:
If the AGCO Common Stock Ag-Chem Shareholders will Is AGCO Stock Portion
Price is: Receive: Structure of Transaction: Taxable to Ag-Chem Shareholders?
------------------------ ------------------------- ------------------------- --------------------------------
$10.48 or greater AGCO common stock with a "Forward merger" No
market value of $12.90 (Ag-Chem merges into
(1.2317 shares or fewer); subsidiary of AGCO).
$12.90 in cash.
$8.38 to $10.47 AGCO common stock with a "Forward merger." No
market value of between
$10.32 and $12.90 (1.2317
shares); remainder in cash
(between $12.90 and $15.48).
$6.10 to $8.37 AGCO common stock with a "Reverse merger" Yes
market value of between 0 (subsidiary of AGCO merges
and $10.31, as elected by into Ag-Chem).
AGCO in its discretion;
remainder in cash (between
$15.49 and $25.80).
$6.09 or below Same as for $6.10 to $8.37 "Reverse merger" unless Yes/No
except AGCO may elect to AGCO makes election in
------
obtain stockholder approval which event "forward
and issue AGCO common stock merger."
with a market value of
$10.32 and $15.48 in cash.
The price ranges listed above are subject to increase if Ag-Chem
shareholders exercise any dissenters' rights and for cash paid in lieu of
fractional AGCO shares. See "The Merger--What You Will Receive; The Merger
Consideration."
In the event that the AGCO common stock price is $6.09 per share or
less, AGCO may terminate the merger agreement or may seek to obtain approval of
its stockholders for issuing additional shares of common stock. In light of
AGCO's recent share price (as of March 15, 2001 the closing price was $11.06 per
share), its general price stability and its 52-week low of $9.43, AGCO believes
that the likelihood that AGCO's share price will fall to $6.09 is remote.
Accordingly, AGCO's board has not discussed what factors it would consider in
determining whether to seek stockholder approval if its stock price falls to
$6.09 or less. If AGCO elects to seek stockholder approval, which would
substantially delay the closing, Ag-Chem is entitled to terminate the merger
agreement. See "Material Provisions of the Merger Agreement and Related
Agreements--Termination of the Merger Agreement."
Because the value of the shares of AGCO common stock for purposes of
determining whether the merger will be a forward or reverse merger will not be
determined until the time of the merger, you will not know at the time of the
Ag-Chem special meeting whether the forward merger structure or the reverse
merger structure will be used. If AGCO shares continue to trade above $8.38, we
expect the closing to occur on the same day. If the price of AGCO's shares falls
below $6.10, the merger may be terminated by either AGCO or Ag-Chem or, at
AGCO's discretion, closing may be delayed, but no later than June 30, 2001.
With respect to each share of AGCO common stock that is issued, you
also will receive one preferred share purchase right under AGCO's shareholder
rights plan. In addition, to the extent that less than 11,800,000 shares are
issued in a reverse merger, Ag-Chem shareholders will have the right to
subscribe to purchase the shortfall. The subscription rights
2
10
may be exercised within thirty days from completion of the merger by indicating
the maximum number of shares that you want to subscribe to, if any, on the
transmittal letter that is sent to you following the merger. The subscription
price for the shares will be $8.38 per share or a per share price equal to 105%
of the average closing price of AGCO common stock on the ten-day period prior to
the merger (whichever is less). In the event that the rights are oversubscribed,
they will be allocated on a pro-rata basis among Ag-Chem shareholders. See
"Comparison of Shareholder Rights--Shareholder Rights Plans" and "The
Merger--What You Will Receive; The Merger Consideration--AGCO Subscription
Right."
The merger agreement is attached hereto as Appendix A. You should read
the merger agreement, as it is the legal document that governs the merger.
3
11
VOTING AGREEMENT (SEE PAGE ___)
When AGCO and Ag-Chem entered into the merger agreement, AGCO required
A. E. McQuinn, the founder, Chairman and Chief Executive Officer of Ag-Chem,
acting in his individual capacity as a shareholder, to enter into a voting
agreement, under which A. E. McQuinn and a trust controlled by Mr. McQuinn,
among other things:
- agreed to vote shares beneficially held by him representing 19.9% of
the total outstanding Ag-Chem common stock in favor of adoption of the
merger agreement, and although he is not obligated to vote the
remaining shares of Ag-Chem held by him in favor of adoption, he has
indicated he intends to do so (if he does so, the merger agreement will
be approved regardless of how you or other Ag-Chem shareholders vote);
- agreed to acquire up to an aggregate of 7,000,000 shares of AGCO common
stock, in connection with the AGCO subscription right made available to
Ag-Chem shareholders if the merger is a reverse merger; and
- if Ag-Chem terminates the merger agreement with AGCO and completes a
merger or other transaction with another party within one year, agreed
to pay AGCO an amount equal to the difference between $25.80 and any
higher price received for Ag-Chem shares in the transaction, multiplied
by 1,906,396 of the outstanding Ag-Chem shares.
The voting agreement terminates on the earlier of the effective date of
the merger or the termination of the merger agreement in accordance with its
terms. No party to the voting agreement can terminate the voting agreement
unless the merger is first completed or the merger agreement is terminated
according to its terms. The voting agreement is attached hereto as Appendix B.
LISTING OF AGCO COMMON STOCK (SEE PAGE ___)
The shares of AGCO common stock issued in connection with the merger
will be listed on the New York Stock Exchange under the ticker symbol "AG."
MATERIAL FEDERAL INCOME TAX CONSEQUENCES (SEE PAGE ___)
The tax consequences resulting from the acquisition will differ
depending on whether the forward merger structure or the reverse merger
structure is used. Since the structure of the merger will depend on the closing
price of AGCO common stock on the trading day immediately prior to the effective
date of the merger, you will not know at the time of the Ag-Chem special meeting
which structure will be used.
In order to view how the AGCO stock price will influence whether the
forward or reverse structure will be used see the table on page ___.
IF THE MERGER IS A FORWARD MERGER:
The merger is intended to be a forward merger and therefore partially
tax-free to Ag-Chem shareholders. In that case, generally:
- An Ag-Chem shareholder will not recognize loss, but will recognize gain
to the extent of the lesser of (1) the fair market value of AGCO common
stock plus the amount of cash received, less such shareholder's tax
basis in the Ag-Chem stock surrendered, or (2) the amount of cash
received. Ag-Chem shareholders will be taxed on cash received in lieu
of fractional shares and cash received pursuant to the exercise of
appraisal rights.
- The tax basis of AGCO common stock received by an Ag-Chem shareholder
in the merger will be the same as the tax basis of the Ag-Chem common
stock exchanged for the AGCO common stock, decreased by the amount of
cash received in the exchange for such Ag-Chem common stock and
increased by the amount of gain recognized by the Ag-Chem shareholder
upon such exchange.
- The holding period of the AGCO common stock received in the merger
generally will include the holding period of the Ag-Chem common stock
exchanged for the AGCO common stock assuming the Ag-Chem stock is held
as a capital asset at the effective time of the merger.
IF THE MERGER IS A REVERSE MERGER:
In the event the merger is a reverse merger, the merger will be treated
as a sale of Ag-Chem stock, fully taxable to Ag-Chem shareholders. In that case,
generally:
- An Ag-Chem shareholder will recognize gain or loss equal to the
difference between the sum of the fair market value of the AGCO stock
and the amount of cash received in the merger (including cash received
for fractional shares and pursuant to the exercise of
4
12
dissenters' rights), and the tax basis in the shares of Ag-Chem common
stock surrendered in the exchange.
- The tax basis of AGCO common stock received by Ag-Chem shareholders in
the merger will be equal to the fair market value of the AGCO common
stock at the time of the merger.
- The holding period of such stock will begin at the time such stock is
received.
OWNERSHIP OF AGCO FOLLOWING THE MERGER (SEE PAGE ___)
Assuming an AGCO price per share of $11.00 (the closing price per share
on March 15, 2001 was $11.06), Ag-Chem shareholders will own approximately 15.8%
of AGCO's outstanding shares of common stock following the merger. Also assuming
an AGCO price per share of $11.00, A.E. McQuinn will own approximately 9.2% of
AGCO's common stock following the merger.
EXECUTIVE OFFICERS AND DIRECTORS OF AGCO AND THE SURVIVING CORPORATION AFTER THE
MERGER (SEE PAGE ___)
The executive officers and directors of AGCO will not change as a
result of the merger, except that AGCO has agreed to use its reasonable best
efforts to appoint A. E. McQuinn to its board of directors if Mr. McQuinn
acquires 7,000,000 shares of AGCO common stock in connection with the merger
and/or any subscription right offered by AGCO to Ag-Chem shareholders. AGCO has
indicated its willingness to appoint Mr. McQuinn to its board of directors even
if the number of AGCO shares held by him is less than 7,000,000. The directors
and executive officers of the surviving corporation in the merger, whether it is
Ag-Chem or Agri Acquisition Corp., will be determined by AGCO.
AG-CHEM'S REASONS FOR THE MERGER
In reaching the decision to approve the merger, the special committee
of the Ag-Chem board of directors (and the Ag-Chem board of directors, in
reaching the decision to ratify the special committee's approval) consulted with
Goldsmith Agio Helms, its financial advisor and with Ag-Chem senior management,
and considered a number of factors, described more thoroughly elsewhere in this
proxy statement/prospectus, including the following:
- the fixed price per share to be paid by AGCO is higher than recent
market prices for Ag-Chem common stock;
- the probability that the merger will likely be partially tax free;
- the fairness opinion of Goldsmith Agio Helms;
- likely cost savings;
- likely increased purchasing power;
- likely increased marketing capabilities;
- better ability to finance sales;
- better parts and service distribution;
- better ability to finance development of site-specific agriculture; and
- the larger market capitalization of AGCO.
The Ag-Chem special committee and the Ag-Chem board of directors have
each unanimously determined that the merger agreement and the transactions
contemplated by the merger agreement, including the merger, are advisable and
fair to and in the best interests of Ag-Chem and its shareholders and both the
special committee and the board of directors recommend that Ag-Chem shareholders
vote to approve and adopt the merger agreement and the transactions contemplated
by the merger agreement, including the merger, at the Ag-Chem special meeting.
OPINION OF AG-CHEM'S FINANCIAL ADVISOR (SEE PAGE ____)
Goldsmith Agio Helms delivered an opinion to Ag-Chem's special
committee and board of directors that, as of the date thereof and subject to the
qualifications described in its opinion, the consideration to be received by the
Ag-Chem shareholders in the merger is fair, from a financial point of view, to
the Ag-Chem shareholders. The amount of consideration to be received was
determined through negotiations between Ag-Chem and AGCO and not pursuant to
recommendations of Goldsmith Agio Helms.
The complete opinion of Goldsmith Agio Helms is attached as Appendix D.
We urge you to read it in its entirety.
RISK FACTORS MERITING SPECIAL ATTENTION (SEE PAGE __)
Before you decide to vote for adoption of the merger agreement, you
should consider the following risk factors, which are more fully described (as
well as others set forth) in the "Risk Factors" section of this proxy
statement/prospectus:
- You will receive a number of shares of AGCO common stock in an amount
to be determined based
5
13
upon the closing price of the AGCO common stock on the trading day
immediately prior to the effective date of the merger;
- You will not know whether the issuance of AGCO common stock in the
merger will be a taxable event to you at the time you vote at the
Ag-Chem special meeting;
- The fairness opinion of Goldsmith Agio Helms did not take into
consideration potentially significant tax consequences;
- The management of Ag-Chem will receive benefits in the merger which
you will not receive;
- The merger is very likely to be approved because of a voting agreement
with A. E. McQuinn; and
- The expected benefits of the merger may not be realized.
INTERESTS OF PARTICULAR PERSONS IN THE MERGER (SEE PAGE ___)
When considering the recommendation of the board of directors of
Ag-Chem, you should be aware that some directors, officers and employees of
Ag-Chem have interests in the transaction that are different from, or in
addition to, your interests as shareholders, specifically the right to severance
benefits, the right to cash payments under Ag-Chem's phantom stock plan, cash
bonus payments and, in the case of A.E. McQuinn, the right to be appointed to
AGCO's board of directors.
ACCOUNTING TREATMENT OF THE MERGER (SEE PAGE ___)
The merger will be treated as a purchase for accounting and financial
reporting purposes, which means that AGCO will include Ag-Chem's operating
results in its financial statements only from the consummation of the merger.
TERMINATION OF THE MERGER AGREEMENT (SEE PAGE ___)
AGCO and Ag-Chem may agree by mutual consent at any time prior to the
merger to terminate the merger agreement, even if the Ag-Chem shareholders have
adopted the merger agreement. The merger agreement may also be terminated if it
is not approved by Ag-Chem's shareholders. Also, the merger agreement may be
terminated under other circumstances described elsewhere in this proxy
statement/prospectus.
TERMINATION FEE (SEE PAGE ___)
If the merger agreement is to be terminated, under the circumstances
described more thoroughly elsewhere in this proxy statement/prospectus, Ag-Chem
may be obligated to pay AGCO $10,000,000 in order to terminate the merger
agreement.
AG-CHEM'S RECOMMENDATION TO ITS SHAREHOLDERS (SEE PAGE ____)
The special committee of the board of directors has unanimously voted
to approve the merger and all related transactions. The full board unanimously
ratified this approval and both urge Ag-Chem shareholders to vote "FOR" the
merger.
THE SPECIAL MEETING OF AG-CHEM SHAREHOLDERS (SEE PAGE ____)
Record Date. The special meeting of Ag-Chem shareholders will be held
1:00 p.m. local time, at Ag-Chem's corporate headquarters at 5720 Smetana Drive,
Minnetonka, Minnesota, 55343 on April 13, 2001.
Vote Required. At the special meeting, Ag-Chem shareholders will be
asked to vote to adopt the merger agreement with AGCO. Adoption of the merger
agreement requires the favorable vote of a majority of the outstanding shares of
Ag-Chem common stock. It is not expected that the vote of AGCO shareholders will
be required to approve the merger.
Voting Procedure. You can vote at the special meeting if you owned
Ag-Chem common stock as of the close of business on March 19, 2001. As of that
date, directors and executive officers of Ag-Chem owned approximately 61% of the
outstanding shares of Ag-Chem common stock and have indicated that they will
vote in favor of the merger agreement and the merger. If you do not vote your
shares of Ag-Chem common stock and do not give instructions to your broker as to
how to vote, the effect will be the same as a vote against the merger agreement
and the merger.
DIVIDENDS (SEE PAGE ___)
AGCO historically has paid a regular dividend of $.01 per share per
quarter. However, there can be no assurance that this dividend practice will be
continued.
APPRAISAL AND DISSENTERS' RIGHTS (SEE PAGE ___)
Shareholders of Ag-Chem who follow the procedural requirements of
Minnesota law will be entitled to receive cash in the amount of the fair value
of
6
14
their shares instead of the cash and shares of AGCO common stock to be issued
pursuant to the merger agreement. The fair value of shares of Ag-Chem common
stock would be determined pursuant to Minnesota law.
Any Ag-Chem shareholder who wishes to exercise dissenters' rights must
not vote in favor of the merger agreement and must comply with all of the
procedural requirements provided by Minnesota law. A copy of the dissenters'
rights statute, sections 302A.473 and 302A.471, is attached as Appendix C to
this document. We encourage you to read the statute carefully and to consult
with your legal counsel if you desire to exercise your dissenters' rights.
FINANCING THE MERGER (SEE PAGE ___)
AGCO anticipates that the cash consideration to be paid in the merger
will be funded through its revolving credit facility.
DIFFERENCES IN THE RIGHTS OF SHAREHOLDERS (SEE PAGE ___)
The rights of AGCO stockholders are governed by Delaware corporate law,
AGCO's certificate of incorporation and AGCO's bylaws. The rights of Ag-Chem's
shareholders are governed by Minnesota corporate law, Ag-Chem's articles of
incorporation and Ag-Chem's bylaws. While the corporate laws of Delaware and
Minnesota are similar, significant differences exist between these corporate
laws and the governing documents of each company. These differences include
voting rights, rights of shareholders in a change of control situation such as a
merger, liquidation preferences and amendments to the articles and bylaws.
AGCO has a stockholder rights plan. AGCO adopted its stockholder rights
plan for the purpose of deterring coercive takeover tactics and otherwise to
encourage third parties interested in acquiring AGCO to negotiate with the AGCO
Board. Ag-Chem has not adopted a shareholder rights plan.
7
15
COMPARATIVE MARKET PRICES (SEE PAGES ___)
Ag-Chem's common stock trades on the Nasdaq National Market System
("Nasdaq") under the ticker symbol "AGCH." AGCO's common stock trades on the New
York Stock Exchange ("NYSE") under the ticker symbol "AG." The following table
sets forth, for the periods indicated, the high and low sales prices for
Ag-Chem's and AGCO's common stock for each quarter within the last two fiscal
years, as reported on the Nasdaq and the NYSE respectively.
At or for the Year Ended At or for the Year Ended For the Year Ending
September 30, 1999 September 30, 2000 September 30, 2001
(current through March 15,
2001)
High Low High Low High Low
---- --- ---- --- ---- ---
AG-CHEM
First Quarter 13 9-1/2 14-1/2 9-1/4 24 8
Second Quarter 15-5/8 10 10-5/8 8-5/16 25-5/8 23-15/16
Third Quarter 12-3/16 9-3/4 8-3/4 5-1/4 -- --
Fourth Quarter 10-3/4 8-1/2 12-3/4 6-3/4 -- --
At or for the Year Ended At or for the Year Ended For the Year Ending
December 31, 1999 December 31, 2000 December 31, 2001
(current through March 15,
2001)
High Low High Low High Low
---- --- ---- --- ---- ---
AGCO
First Quarter 8 9/16 6 1/16 13-7/8 10-1/16 12-7/16 10.04
Second Quarter 12 15/16 6 5/16 14-3/8 10-9/16
Third Quarter 13 1/2 8 11/16 13-1/16 10 -- --
Fourth Quarter 14 1/8 9 15/16 11-13/16 9-11/16 -- --
On November 17, 2000, the last full trading day prior to the public
announcement of the merger, the last reported sale price of AGCO common stock
was $10.1875 per share and of Ag-Chem common stock was $11.50 per share. On
March 15, 2001, the last reported sale price of AGCO common stock was $11.06 per
share and of Ag-Chem common stock was $25.25 per share.
8
16
AGCO CORPORATION
SELECTED HISTORICAL FINANCIAL DATA
The following selected historical financial data of AGCO Corporation as
of and for each of the years ended December 31, 1995 through 1999 set forth
below have been derived from AGCO's audited consolidated financial statements.
The financial data as of September 30, 2000 and 1999, and for the nine-month
periods then ended, have been derived from AGCO's unaudited condensed
consolidated financial statements which include, in management's opinion, all
adjustments, consisting of normal recurring adjustments, necessary to present
fairly the results of operations and financial position of AGCO for the periods
and dates presented. This data should be read in conjunction with the respective
audited and unaudited consolidated financial statements of AGCO, including the
notes to those financial statements and AGCO's "Management's Discussion and
Analysis of Financial Condition and Results of Operations" contained in its Form
10-K, as amended by Form 10-K/A (Amendment No. 1), for the year ended December
31, 1999, and Form 10-Q, as amended by Form 10-Q/A (Amendment No. 1), for the
quarter ended September 30, 2000, incorporated in this proxy
statement/prospectus by reference and enclosed with this document. All amounts
are in millions, except for per share data.
YEAR ENDED DECEMBER 31,
---------------------------------------------------------------
1999 1998 1997 1996 1995
---- ---- ---- ---- ----
OPERATING RESULTS
Net sales $ 2,413.3 $2,941.4 $3,224.4 $2,317.5 $2,125.0
Gross profit 356.4 537.3 666.8 470.3 440.7
Income from operations 42.9 157.3 307.0 206.1 216.6
Net income (loss) (11.5) 60.6 168.7 125.9 129.1
Net income (loss) per common share-diluted $ (0.20) $ 0.99 $ 2.71 $ 2.20 $ 2.31
Weighted average shares outstanding-diluted 58.7 61.2 62.1 57.4 56.6
Dividends declared per common share $ 0.04 $ 0.04 $ 0.04 $ 0.04 $ 0.02
NINE MONTHS ENDED
SEPTEMBER 30,
-----------------------
2000 1999
---- ----
Net sales $1,677.0 1,815.6
Gross profit 271.3 287.2
Income from operations 38.6 72.0
Net income (loss) (4.2) 15.8
Net income (loss) per common share-diluted $ (0.07) $ 0.27
Weighted average shares outstanding-diluted 59.1 59.6
Dividends declared per common share $ 0.03 $ 0.03
AS OF DECEMBER 31,
------------------------------------------------------------------
1999 1998 1997 1996 1995
---- ---- ---- ---- ----
BALANCE SHEET DATA
Working capital $ 733.9 $ 1,029.9 $ 884.3 $ 750.5 $ 485.5
Total assets 2,273.2 2,750.4 2,620.9 2,116.5 2,162.9
Long-term debt 691.7 924.2 727.4 567.1 568.9
Stockholders' equity 829.1 982.1 991.6 774.6 588.9
Book value per share 13.92 16.50 15.75 13.53 11.65
AS OF SEPTEMBER 30,
-------------------
2000 1999
---- ----
Working capital $ 584.2 $ 938.6
Total assets 2,056.3 2,470.7
Long-term debt 582.3 850.7
Stockholders' equity 774.8 868.5
Book value per share 13.00 14.59
9
17
The selected historical financial data for AGCO reflects the following
items which you should consider in making period to period comparisons:
- Amounts presented for Income from operations, Net income (loss) and Net
income (loss) per common share-diluted include restructuring and other
infrequent expenses of $24.5 million, $40.0 million, $18.2 million,
$22.3 million and $6.0 million for the years ended December 31, 1999,
1998, 1997, 1996 and 1995, respectively, and $19.5 for the nine months
ended September 30, 2000. The effect of these expenses reduced net
income per common share on a diluted basis by $0.26, $0.41, $0.19,
$0.25 and $0.07 for the years ended December 31, 1999, 1998, 1997, 1996
and 1995, respectively, and $0.05 for the nine months ended September
30, 2000. For additional information regarding these changes, see
"Management's Discussion and Analysis of Financial Condition and
Results of Operations - Restructuring and Other Infrequent Expenses"
contained in AGCO's Form 10-K, as amended by Form 10-K/A (Amendment No.
1), for the year ended December 31, 1999, and its Form 10-Q, as amended
by Form 10-Q/A (Amendment No. 1), for the quarter ended September 30,
2000.
- Amounts for the years ended December 31, 1996 and 1997 under Net income
(loss) per common share-diluted and Weighted average shares
outstanding-diluted include extraordinary losses for the write-off of
unamortized debt costs related to the refinancing of AGCO's revolving
credit facility, net of taxes, of $2.1 million, or $0.03 per share, in
1997 and $3.5 million, or $0.06 per share, in 1996.
- AGCO sold a 51% joint venture interest in its retail finance
subsidiary, Agricredit-North America, effective November 1, 1996.
Accordingly, Agricredit-North America is reflected on the equity basis
of accounting for the year ended December 31, 1996, and all subsequent
periods. The table includes the consolidated results of
Agricredit-North America for the year ended December 31, 1995. If the
Company's 100% interest in Agricredit-North America were reflected on
the equity basis of accounting for the year ended December 31, 1995,
total revenues would be $2,068.4 million, total assets would be
$1,628.6 million, and long-term debt would be $415.9 million. Gross
profit and income from operations for 1995 are for the equipment
operations only and exclude the results of Agricredit-North America.
- Net income per common share - diluted, Weighted average shares
outstanding - diluted and Dividends declared per common share have been
restated for all periods to reflect all stock splits.
- The amount under Long-term debt as of December 31, 1995, includes $37.6
million of AGCO's 6.5% Convertible Subordinated Debentures, which was
subsequently converted into common stock during 1996.
- Book value per share represents Stockholders' equity divided by common
shares outstanding as of the end of the period.
10
18
AG-CHEM EQUIPMENT CO., INC.
SELECTED HISTORICAL FINANCIAL DATA
The following selected historical financial data of Ag-Chem as of and
for each of the fiscal years ended September 30, 1996 through 2000 set forth
below have been derived from Ag-Chem's audited consolidated financial
statements. The financial data as of December 31, 2000 and for the three-month
periods ended December 31, 2000 and 1999, have been derived from Ag-Chem's
unaudited consolidated financial statements which include, in management's
opinion, all adjustments, consisting only of normal recurring adjustments,
necessary to present fairly the results of operations and financial position of
Ag-Chem for the periods and dates presented. This data should be read in
conjunction with the respective audited and unaudited consolidated financial
statements of Ag-Chem, including the notes to those financial statements and
Ag-Chem's "Management's Discussion and Analysis of Financial Condition and
Results of Operations" contained in its Form 10-K, as amended by Form 10-K/A
(Amendment No. 1), for the year ended September 30, 2000, and Form 10-Q for the
quarter ended December 31, 2000, incorporated in this proxy statement/prospectus
by reference. All amounts are in millions, except for per share data. Book value
per share represents shareholders' equity divided by common shares outstanding
as of the end of the period.
YEAR ENDED SEPTEMBER 30,
--------------------------------------------------
2000 1999 1998 1997 1996
---- ---- ---- ---- ----
OPERATING RESULTS
Net sales $ 298.8 $ 292.7 $ 322.1 $ 318.2 $ 280.2
Gross profit 66.4 78.0 87.2 85.6 79.8
Income (loss) from operations (0.1) 7.7 13.2 16.6 18.5
Net income (loss) $ (01.4) $ 3.4 $ 6.8 $ 7.6 $ 9.7
Net income (loss) per common share (0.15) 0.35 0.71 0.78 1.01
Weighted average shares outstanding 9.6 9.6 9.7 9.7 9.7
Dividends declared per common share $ 0 $ 0 $ 0 $ 0 $ 0
------------------------------------------------------
THREE MONTHS ENDED DECEMBER 31,
------------------------------------------------------
2000 1999
---- ----
Net sales $ 57.0 $ 58.7
Gross profit 12.1 14.1
(Loss) from operations (6.9) (2.1)
Net (loss) (4.2) (2.0)
Net (loss) per common share (0.44) (0.21)
Weighted average shares outstanding 9.6 9.6
Dividends declared per common share $ 0 $ 0
------------------------------------------------------
AS OF SEPTEMBER 30,
------------------------------------------------------
2000 1999 1998 1997 1996
---- ---- ---- ---- ----
BALANCE SHEET DATA
Working capital $ 52.8 $ 66.3 $ 76.2 $ 53.5 $ 47.9
Total assets 155.7 189.9 188.2 188.0 185.6
Long-term debt, net of current installments 23.9 44.3 59.9 45.4 43.3
Shareholders' equity 71.7 73.2 70.4 63.9 57.3
Book value per share 7.48 7.63 7.30 6.61 5.91
------------------------------------------------------
AS OF DECEMBER 31,
------------------------------------------------------
2000
----
Working capital $ 50.4
Total assets 129.1
Long-term debt, net of current installments 23.9
Shareholders' equity 67.5
Book value per share 7.04
------------------------------------------------------
11
19
SELECTED UNAUDITED PRO FORMA COMBINED FINANCIAL DATA
The following selected unaudited pro forma combined financial data is
based on the historical financial statements of AGCO and Ag-Chem, adjusted to
give effect to the merger of Ag-Chem with AGCO's wholly-owned subsidiary. The
pro forma combined financial data is derived from the unaudited pro forma
combined financial information included elsewhere in this prospectus. This pro
forma combined financial data should be read in conjunction with the notes to
the unaudited pro forma financial information. The pro forma combined financial
data was prepared to illustrate the estimated effects of the acquisition of
Ag-Chem, including acquisition-related debt and equity transactions and certain
assumptions. The pro forma results of operations data for the year ended
December 31, 1999 and the nine months ended September 30, 2000 give effect to
the acquisition of Ag-Chem as if the acquisition had occurred as of January 1,
1999. The pro forma balance sheet data give effect to the acquisition of Ag-Chem
as if the acquisition had occurred as of September 30, 2000. The pro forma
combined financial data does not purport to represent AGCO's results of
operations or financial position for any future period or as of any date. All
amounts are in millions, except for per share data.
PRO FORMA COMBINED
-----------------------------------------------
NINE MONTHS
ENDED YEAR ENDED
SEPTEMBER 30, DECEMBER 31,
2000 1999
--------------------- -------------------
OPERATING RESULTS
Net sales $ 1,917.1 $ 2,711.2
Gross profit 323.6 433.0
Income from operations 37.5 44.9
Net loss (12.0) (21.0)
Net loss per common share-diluted $ (0.17) $ (0.30)
Weighted average shares outstanding-diluted 70.9 70.5
Dividends declared per common share $ 0.03 $ 0.04
PRO FORMA COMBINED
----------------------
AS OF SEPTEMBER 30,
2000
----------------------
BALANCE SHEET DATA
Working capital $ 663.4
Total assets 2,423.2
Long-term debt 763.8
Shareholders' equity 892.1
Book value per share 12.50
12
20
RISK FACTORS
IN DECIDING WHETHER TO APPROVE THE MERGER, YOU SHOULD CONSIDER THE
FOLLOWING RISKS RELATED TO THE MERGER AND TO YOUR INVESTMENT IN AGCO FOLLOWING
THE MERGER. YOU SHOULD CONSIDER CAREFULLY THESE RISKS ALONG WITH THE OTHER
INFORMATION IN THIS DOCUMENT AND THE DOCUMENTS TO WHICH WE HAVE REFERRED YOU.
FACTORS RELATING TO THE MERGER
WHETHER YOU WILL RECEIVE SHARES OF AGCO COMMON STOCK AS PART OF THE
MERGER CONSIDERATION IS BASED ON THE MARKET PRICE OF AGCO COMMON STOCK. IN
ADDITION, IF THE MERGER IS STRUCTURED AS A REVERSE MERGER, THE RATIO OF SHARES
OF AGCO COMMON STOCK AND CASH THAT YOU WILL RECEIVE WILL BE DETERMINED SOLELY BY
AGCO.
If the closing price of AGCO's common stock on the trading day
immediately preceding the effective date of the merger is equal to or greater
than $8.38 per share, the merger will be a forward merger and you will receive
as part of the merger consideration AGCO common stock. If, however, the closing
price does not exceed $8.38 per share, the merger will be a reverse merger. In
the event of a reverse merger, AGCO in its sole discretion may determine the
number of shares of AGCO common stock, if any, not to exceed 11,800,000, to be
issued as part of the merger consideration.
We cannot predict market prices for AGCO common stock. Consequently, we
cannot predict whether and the extent to which you will receive shares of AGCO
common stock as part of the merger consideration. We encourage you to obtain
current market quotations of the AGCO common stock which is listed on the New
York Stock Exchange under the symbol "AG."
THE ISSUANCE OF AGCO COMMON STOCK TO YOU AS PART OF THE MERGER CONSIDERATION MAY
NOT BE TAX-FREE AND MAY REQUIRE YOU TO PAY SIGNIFICANT TAXES.
You will not know whether, for U.S. federal income tax purposes, any
issuance of AGCO common stock in the merger will be a taxable event to you at
the time you vote at the Ag-Chem special meeting. The receipt of the cash
portion of the merger consideration will be taxable to you in any case. The
opinion of Ag-Chem's financial advisor, discussed below, upon which the Ag-Chem
special committee and board of directors relied in making their decisions to
approve and ratify the merger agreement, did not consider the tax consequences
of the merger, including tax consequences to any holder of Ag-Chem common stock.
AGCO and Ag-Chem intend, if possible, for the merger to be a forward
merger and to qualify as a partially tax-free merger. If the merger so
qualifies, then any holders of Ag-Chem common stock who receive AGCO common
stock will not recognize a gain or loss for U.S. federal income tax purposes as
a result of the merger, except for gain to the extent of cash received as part
of the merger consideration, including cash received in lieu of fractional
shares or because of the exercise of appraisal or dissenters' rights.
There can be no assurance that the conditions will occur that are
necessary for the merger to be partially tax-free. One condition that must be
met in order for the merger to be partially tax-free is continuity of interest.
For a discussion of the continuity of interest requirement and whether the
merger will meet this requirement, see the discussion under the heading "The
Merger--Material Federal Income Tax Consequences."
If the merger is not tax-free in part or if the merger is structured as
a reverse merger, then any issuance of AGCO common stock to Ag-Chem shareholders
will be a taxable event for Ag-Chem shareholders. If the merger is taxable to
you, you will be taxed on the gain, if any, equal to the fair market value of
the shares of AGCO common stock plus the cash you receive, less your basis in
your shares of Ag-Chem common stock. For the following two examples, assume that
an Ag-Chem shareholder owns 100 shares of Ag-Chem common stock at the time of
the merger, entitling that shareholder to $2,580 in total merger consideration,
and that the Ag-Chem shareholder's tax basis in his or her Ag-Chem shares is
$10.00 per share, or $1,000 in the aggregate. Both of these examples reflect the
cash that the Ag-Chem shareholder would receive in lieu of fractional shares.
Example 1. Assume that the market value of AGCO common stock at the
time of the merger is $12.00 per share. In the merger, in exchange for his or
her Ag-Chem stock, the Ag-Chem shareholder would receive 107 shares of AGCO
common stock valued at $12.00, an aggregate value of $1,284, and $1,296 in cash.
Since the forward
13
21
merger structure is used (because of share price), the shareholder would
recognize taxable gain in the amount of $1,296, the amount of cash received. The
remaining $284 gain would be deferred.
Example 2. Assume that the market value of AGCO common stock at the
time of the merger is $8.00 per share and that AGCO elects to use the maximum
amount of stock possible to pay the merger consideration. The Ag-Chem
shareholder would receive 128 shares of AGCO common stock, having a value of
$1,024, and $1,556 in cash. The taxable gain would be $1580, all of which
currently would be recognized and none deferred.
The completion of the merger as a partially tax-free forward merger, is
conditioned on, among other things, the receipt by Ag-Chem of an opinion from
KPMG LLP, independent certified public accountants to Ag-Chem and the receipt by
AGCO of an opinion from Troutman Sanders LLP, counsel for AGCO, that the merger
will qualify as a partially tax-free merger. An opinion represents the
opinion-giver's best judgment and is not binding on the Internal Revenue
Service. There can be no assurance that following the merger the Internal
Revenue Service will not challenge the qualification of the merger as partially
tax-free.
See "The Merger - Material Federal Income Tax Consequences" on page
___.
AGCO MAY ENCOUNTER DIFFICULTIES IN INTEGRATING AG-CHEM AS A WHOLLY-OWNED
SUBSIDIARY AND MAY NOT FULLY ACHIEVE, OR ACHIEVE WITHIN THE ANTICIPATED TIME
FRAME, EXPECTED STRATEGIC OBJECTIVES, COST SAVINGS AND OTHER EXPECTED BENEFITS
OF THE MERGER.
The merger will convert Ag-Chem, which previously operated
independently, into a wholly-owned subsidiary of AGCO. AGCO expects to realize
strategic and other benefits as a result of the transaction, including, among
other things,
- expansion of AGCO's product line;
- access to Ag-Chem's advanced crop management technology;
- cost savings;
- operating efficiencies;
- cross-selling opportunities; and
- revenue enhancements.
However, it is impossible to predict with certainty whether, or to what extent,
these benefits will be realized or whether AGCO will be able to integrate
Ag-Chem in a timely and effective manner. In addition:
- the costs of integrating Ag-Chem may be higher than AGCO
expects;
- integration of Ag-Chem as a wholly-owned subsidiary of AGCO
will require significant attention from management. This
diversion of management attention and any other difficulties
associated with this integration could have a material adverse
effect on the revenues, the levels of expenses and the
operating results of AGCO after the transaction and cause the
value of AGCO's common stock to decline; and
- there are overlaps or redundancies in AGCO and Ag-Chem
products that may result in AGCO offering competing products.
For example, AGCO and Ag-Chem both manufacture a 1,000 gallon
sprayer. At this time, AGCO intends to pursue a multi-brand
marketing strategy for overlapping Ag-Chem products and does
not intend to discontinue production of any competing
products. Although AGCO has been successful with similar
multi-brand marketing strategies in the past and expects that
this multi-brand strategy will positively impact AGCO's
results of operations, AGCO may not be successful in achieving
these expectations.
The cash payments to be paid to Ag-Chem shareholders (with or without any
adjustment due to a possible low price of AGCO common stock), either alone or in
connection with other factors, might place AGCO at risk of not being in
compliance with restrictions pursuant to its debt covenants and therefore
negatively impact its ability to complete the merger.
Because the amount of cash to be paid by AGCO to Ag-Chem shareholders
is uncertain and is dependent, in part, upon the market price of AGCO's common
stock prior to closing, and because of the limitation on the number
14
22
of shares which AGCO can issue without being required to seek shareholder
approval, the amount of cash to be paid to Ag-Chem shareholders might be higher
than contemplated. The amount of cash required to complete the merger may place
AGCO out of compliance with its debt covenants and, therefore, AGCO may not be
able to raise sufficient cash to pay the cash portion of the merger price. If
this were to occur, there could be no assurance that AGCO would be able to
complete the merger.
DIRECTORS, OFFICERS AND EMPLOYEES OF AG-CHEM WILL HAVE INTERESTS THAT
ARE DIFFERENT FROM OR IN ADDITION TO YOUR INTERESTS AS A SHAREHOLDER, INCLUDING
SEVERANCE BENEFITS AND BONUS PAYMENTS.
When considering the recommendation of the board of directors of
Ag-Chem, you should be aware that some directors, officers and employees of
Ag-Chem have interests in the transaction that are different from, or in
addition to, your interests as a shareholder, specifically the right to
severance benefits, the right to bonus payments and payments under Ag-Chem's
phantom stock plan and, in the case of Mr. McQuinn, the right to be appointed to
AGCO's board of directors.
- Severance benefits. Some directors, officers and employees of
Ag-Chem are entitled to severance benefits pursuant to the
merger agreement. If those individuals are terminated without
cause or quit for good reason within one year following the
effective time of the merger, they will be entitled to cash
severance benefits equal to one or two times their annual base
salary. A. E. McQuinn is not entitled to any severance
benefits. If terminated, Mary M. Jetland, Steve M. Koep,
Donald D. Pottinger and John C. Retherford will receive
severance payments of $195,743, $264,481, $466,000, and
$122,450, respectively. Eight other persons would be entitled
to severance payments ranging from $114,400 to $170,000. The
amount of benefit received by these people has been limited by
so-called "golden parachute" provisions of the tax laws which
impose a higher tax on such payments and deny AGCO a deduction
for a portion of payments.
- Bonus payments. Some directors, officers, and employees of
Ag-Chem have been or are being paid bonuses. If the merger is
terminated for any reason, no bonuses that have not already
been paid will be given. These bonuses reflect Ag-Chem's
desire to compensate persons for either 1) prior service to
Ag-Chem or 2) efforts related to the merger. Ag-Chem has paid
or will pay an aggregate of $1.6 million to employees for
their past services to Ag-Chem. Of this amount, $50,000 was
paid to Steve M. Koep and $100,000 was paid to other who are
not executive officers. For their efforts related to
negotiating the merger, John Retherford has received
$1,000,000 and Mary Jetland has received $400,000. No bonus
for past services will be paid to any person receiving a bonus
related to the merger and A.E. McQuinn will not receive any
bonus whatsoever. The fact that Ag-Chem intends to make the
bonus payments led to a reduction of the total consideration
per Ag-Chem share from $26.00 to $25.80.
- Phantom stock plan payments. A number of Ag-Chem officers,
directors and employees are in possession of "phantom shares"
of Ag-Chem stock pursuant to the Ag-Chem Equipment Co., Inc.
1998 Key Employee Phantom Stock Bonus Plan. Prior to or upon
closing of the merger, Ag-Chem will terminate the Phantom
Stock Bonus Plan and make cash payments to its employees
aggregating $1,188,495 of which $55,440 has been or will be
paid to each of Mary M. Jetland, Donald D. Pottinger, and John
C. Retherford, and $41,580 has been or will be paid to Steve
M. Koep. No payments have been or will be paid to A.E. McQuinn
under this plan.
- Right to be appointed to AGCO's board of directors. If the
merger is consummated and A. E. McQuinn has acquired at least
7,000,000 shares of AGCO common stock, AGCO has agreed to use
its reasonable best efforts to increase the size of its board
of directors and appoint Mr. McQuinn as a member. AGCO has
indicated its willingness to appoint Mr. McQuinn to its board
of directors even if the number of AGCO shares held by him is
less than 7,000,000. See "The Merger--Interests of Ag-Chem
Directors, Executive Officers and Shareholders" on page __.
15
23
FACTORS RELATING TO AGCO AFTER THE TRANSACTION
A. E. MCQUINN WILL BECOME A SUBSTANTIAL STOCKHOLDER OF AGCO AND MAY NOT ACT
CONSISTENTLY WITH THE INTERESTS OF THE OTHER AGCO STOCKHOLDERS.
Following the merger, A. E. McQuinn will be AGCO's largest single
stockholder. If the merger is structured as a forward merger, as currently
contemplated, Mr. McQuinn would own approximately 6,515,903 shares, or 9.2%, of
AGCO's common stock based on a trading price of $11.00 (the AGCO closing price
per share was $11.06 on March 15, 2001). If the merger is structured as a
reverse merger and Mr. McQuinn exercises all of his subscription rights, he will
own approximately 7,000,000 shares of AGCO's common stock. While Mr. McQuinn's
ownership interest will result in him being a significant AGCO stockholder, his
AGCO ownership interest will represent a reduction from his position, which he
has held for over thirty years, as a holder of approximately 58% of Ag-Chem's
outstanding common stock. There can be no assurance that Mr. McQuinn's interests
will be aligned with the interests of other AGCO stockholders. Mr. McQuinn will
be less able to sell any or all of his AGCO stock due to market and, possibly,
securities law restrictions on transfer due to the number of shares of AGCO
stock he will own, and, possibly, based upon his status as a director of AGCO.
See "Stock Ownership of AGCO" on page __.
AGCO'S COSTS OF COMPLIANCE WITH ENVIRONMENTAL LAWS AND REGULATIONS MAY
NEGATIVELY IMPACT AGCO'S RESULTS OF OPERATIONS.
AGCO's operations and products are subject to increasingly stringent
environmental laws and regulations in the countries in which AGCO operates. Such
regulations govern, among other things, emissions into the air, discharges into
water, the use, handling and disposal of hazardous substances, waste disposal
and the remediation of soil and groundwater contamination. To AGCO's knowledge,
it is currently complying in all material respects with applicable environmental
laws and regulations, however if AGCO were to fall out of compliance with any
such regulations, its results of operations may be negatively effected.
AGCO'S LABOR FORCE IS HEAVILY UNIONIZED AND AGCO'S CONTRACTUAL AND LEGAL
OBLIGATIONS UNDER COLLECTIVE BARGAINING AGREEMENTS AND LABOR LAWS MAY IMPAIR
AGCO'S ABILITY TO ACHIEVE COST SAVINGS.
Over 40% of AGCO's employees, principally at its manufacturing
facilities, are represented by collective bargaining agreements with expiration
dates ranging from 2000 to 2002. These collective bargaining agreements could
impair AGCO's flexibility in streamlining existing manufacturing facilities and
in restructuring its combined businesses. The acquisition of Ag-Chem also may
provide the labor unions representing employees at some of AGCO's facilities
with opportunities to expand into currently non-union facilities.
AGCO'S FINANCIAL RESULTS ARE HEAVILY DEPENDENT UPON THE AGRICULTURAL INDUSTRY
AND FACTORS THAT ADVERSELY EFFECT THE AGRICULTURAL INDUSTRY GENERALLY WILL
ADVERSELY EFFECT AGCO'S RESULTS OF OPERATIONS.
AGCO's success is heavily dependent upon the vitality of the
agricultural industry. Historically, the agricultural industry, including the
agricultural equipment business, has been cyclical and subject to a variety of
economic, governmental and weather conditions. Sales of agricultural equipment
generally are related to the health of the agricultural industry, which is
affected by farm income, farm land values, farm cash receipts and farm profits,
all of which reflect levels of commodity prices, acreage planted, crop yields,
demand, government policies and government subsidies. Sales are also influenced
by economic conditions, interest rate and exchange rate levels and the
availability of financing. Weather conditions can also affect farmers' buying
decisions. During previous economic downturns in the farm sector, the
agricultural equipment business experienced a general decline in sales and
profitability, and AGCO expects its business to remain subject to similar market
fluctuation in the future.
THE AGRICULTURAL EQUIPMENT INDUSTRY IS HIGHLY SEASONAL AND SEASONAL FLUCTUATIONS
MAY ADVERSELY EFFECT AGCO'S QUARTERLY RESULTS OF OPERATIONS AND, IN TURN, THE
PRICE OF AGCO'S COMMON STOCK.
The agricultural equipment business is highly seasonal, with farmers
traditionally purchasing agricultural equipment in the Spring and Fall in
conjunction with the major planting and harvesting seasons. AGCO's net sales and
income from operations have historically been the lowest in the first quarter
and have increased in subsequent quarters as dealers increase inventory in
anticipation of increased retail sales in the third and fourth quarters.
16
24
AGCO FACES INTENSE COMPETITION AND ITS RESULTS OF OPERATIONS MAY BE ADVERSELY
EFFECTED BY COMPETITIVE PRESSURES.
The agricultural equipment business is highly competitive, particularly
in North America, Europe and Latin America. AGCO competes with several large
national and international companies which, like AGCO, offer a full line of
agricultural equipment, as well as with numerous short-line and specialty
manufacturers and suppliers of farm equipment products. Some of AGCO's
competitors, including Deere & Co. and CNH Global, are substantially larger than
AGCO and have greater financial and other resources at their disposal. In
addition, in some markets, smaller regional competitors with significant market
share in a single country or group of countries also compete with AGCO. There
can be no assurance that these competitors will not substantially increase the
resources devoted to the development and marketing, including discounting, of
products competitive with those of AGCO.
Competitive pressures in the agricultural equipment business may affect
the market prices of new and used equipment which, in turn, may adversely affect
AGCO's sales margins and results of operations.
AGCO'S OPERATIONS MAY BE ADVERSELY AFFECTED BY DOMESTIC AND FOREIGN GOVERNMENTAL
REGULATION OF AGRICULTURAL PRODUCTS.
Domestic and foreign political developments and government regulations
and policies directly affect the agricultural industry in the United States and
abroad and indirectly affect the agricultural equipment business in which AGCO
operates. The application or modification of existing laws, regulations or
policies or the adoption of new laws, regulations, trade agreements or policies
adversely affecting the agricultural industry could have an adverse effect on
AGCO's business.
AGCO HAS SIGNIFICANT INTERNATIONAL OPERATIONS AND, AS A RESULT, IT IS EXPOSED TO
RISKS RELATED TO LAWS OF OTHER COUNTRIES, TAXES, ECONOMIC CONDITIONS,
FLUCTUATIONS IN CURRENCY RATES, LABOR SUPPLY AND RELATIONS, POLITICAL CONDITIONS
AND POLICIES OF FOREIGN GOVERNMENTS. THESE RISKS MAY DELAY OR REDUCE AGCO'S
REALIZATION OF VALUE FROM ITS INTERNATIONAL OPERATIONS.
AGCO derived $1.9 billion, or 80%, of its revenues for the year ended
December 31, 1999, from sales in foreign countries. The primary foreign
countries in which AGCO does business are Germany, France, Brazil, The United
Kingdom and Ireland. Additionally, AGCO has significant manufacturing operations
in Germany, The United Kingdom, France, Denmark and Brazil. The production
costs, profit margins and competitive position of AGCO are affected by the
strength of the currencies in countries where it manufactures or purchases goods
relative to the strength of the currencies in countries where its products are
sold. In addition, AGCO's results of operations and financial position may be
adversely affected by fluctuations in foreign currencies and by translations of
the financial statements of AGCO's foreign subsidiaries from local currencies
into U.S. dollars. AGCO's international operations are also subject to various
risks that are not present in domestic operations, including restrictions on
dividends and restrictions on the repatriation of funds.
Additionally, trends abroad such as farm consolidations may affect the
agricultural equipment market. Foreign developing markets may present special
risks, such as unavailability of financing, inflation, slow economic growth,
changes in currency relationships or price controls.
SALES OF SIGNIFICANT AMOUNTS OF AGCO SHARES BY AG-CHEM SHAREHOLDERS
FOLLOWING THE MERGER MAY ADVERSELY EFFECT THE MARKET PRICE OF AGCO COMMON STOCK.
Some Ag-Chem shareholders may, shortly after completion of the merger,
liquidate the AGCO shares received by them in the merger, which liquidation may
have a negative impact on the market price for AGCO common stock. If a
significant number of Ag-Chem shareholders do liquidate the AGCO shares received
by them in the merger, such liquidation would likely have a negative effect upon
the market price for AGCO stock.
17
25
CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS
This proxy statement/prospectus contains numerous forward-looking
statements about the financial condition, results of operations, cash flows,
dividends, financing plans, business strategies, operating efficiencies or
capital and other expenditures, competitive positions, growth opportunities for
existing products, plans and objectives of management, markets for stock of AGCO
and other matters. The words "estimate," "project," "intend," "expect,"
"believe," "forecast" and similar expressions are intended to identify these
forward-looking statements, but some of these statements use other phrasing. In
addition, any statement in this proxy statement/prospectus that is not a
historical fact is a "forward-looking statement." Except as required by law,
AGCO and Ag-Chem expressly disclaim any obligation to publicly release any
revisions to these forward-looking statements to reflect events or circumstances
after the date of this proxy statement/prospectus or to reflect the occurrence
of unanticipated events. Such forward-looking statements, wherever they occur in
this proxy statement/prospectus, are necessarily estimates reflecting the best
judgment of the senior management of AGCO and/or Ag-Chem and involve a number of
risks and uncertainties that could cause actual results to differ materially
from those suggested by the forward-looking statements. In addition to the
specific factors described in the section entitled "Risk Factors," important
factors that could cause actual results to differ materially from those
suggested by the forward-looking statements are described in the proxy
statement/prospectus that are incorporated by reference into this proxy
statement/prospectus.
In addition, there can be no assurance that:
- all of the factors affecting AGCO and Ag-Chem's businesses
have been correctly identified and assessed;
- the publicly-available and other information, upon which the
analysis contained in this document is based, is complete or
correct;
- the analysis contained in this document is correct; or
- the strategies, which are based in part on this analysis, will
be successful.
18
26
AG-CHEM SPECIAL MEETING
Ag-Chem is furnishing this proxy statement/prospectus in connection
with the solicitation of proxies by the Ag-Chem board of directors relating to
the merger agreement and the transactions contemplated by the merger agreement.
Ag-Chem is first sending this proxy statement/prospectus to shareholders of
Ag-Chem on or about March 29, 2001. You should read this proxy
statement/prospectus carefully before voting your shares.
DATE, TIME AND PLACE
The special meeting for Ag-Chem is scheduled to be held as follows:
April 13, 2001 1:00 p.m., local time 5720 Smetana Drive,
Minnetonka, Minnesota 55343
MATTERS TO BE CONSIDERED AT THE SPECIAL MEETING
At the meeting, we will ask Ag-Chem shareholders to consider and vote
upon adoption of the merger agreement. Ag-Chem shareholders also will vote upon
any other business that may properly come before the Ag-Chem special meeting or
any adjournment or postponement of that meeting.
RECORD DATE FOR THE SPECIAL MEETING; STOCK ENTITLED TO VOTE; QUORUM
The Ag-Chem board of directors has fixed the close of business on March
19, 2001, as the record date for determining the Ag-Chem shareholders entitled
to notice of and to vote at the Ag-Chem special meeting. On March 19, 2001,
there were 9,579,868 shares of Ag-Chem common stock outstanding held by
approximately 295 holders of record.
APPRAISAL AND DISSENTERS' RIGHTS
Shareholders of Ag-Chem who follow the procedural requirements of
Minnesota law will be entitled to receive cash in the amount of the fair value
of their shares instead of the shares of AGCO common stock and the cash to be
issued and paid pursuant to the merger. The fair value of shares of Ag-Chem
common stock would be determined pursuant to Minnesota law.
Any Ag-Chem shareholder who wishes to exercise dissenters' rights must
not vote in favor of the merger agreement and must comply with all of the
procedural requirements imposed by Minnesota law. A copy of the dissenters'
rights statute, Sections 302A.473 and 302A.471, is attached as Appendix C to
this document. We encourage you to read the statute carefully and to consult
with legal counsel if you desire to exercise your dissenters' rights.
COST OF SOLICITATION
Ag-Chem will pay the expenses incurred in connection with the printing
and mailing of this proxy statement/prospectus. Ag-Chem also will request banks,
brokers and other intermediaries holding shares of Ag-Chem common stock
beneficially owned by others to send this proxy statement/prospectus to, and
obtain proxies from, the beneficial owners and will reimburse the holders for
their reasonable expenses in so doing. Solicitation of proxies by mail may be
supplemented by telephone, telegram and other electronic means, advertisements
and personal solicitation by the directors, officers or employees of Ag-Chem. No
additional compensation will be paid to directors, officers or employees for
such solicitation.
Ag-Chem shareholders should not send in their stock certificates with
their proxy cards and/or voting instructions. For information regarding what to
do with Ag-Chem share certificates, Ag-Chem shareholders should review "Material
Provisions of the Merger Agreement--Exchange of Stock Certificates" on page
____.
19
27
INFORMATION ABOUT OUR COMPANIES
AGCO
AGCO is a manufacturer and distributor of agricultural equipment and
related replacement parts throughout the world. AGCO sells a full range of
agricultural equipment, including tractors, combines, hay tools, sprayers,
forage equipment and implements. AGCO's products are widely recognized in the
agricultural equipment industry and are marketed under the following brand
names: AGCO(R) Allis, Massey Ferguson(R), Hesston(R), White, GLEANER(R), New
Idea(R), AGCOSTAR(R), Tye(R), Farmhand(R), Glencoe(R), Fendt, Spra-Coupe(R) and
Willmar(R). AGCO distributes its products through a combination of approximately
8,200 independent dealers and distributors, associates and licensees. In
addition, AGCO provides retail financing in North America, the United Kingdom,
France, Germany, Spain and Brazil through its finance joint ventures with
Cooperateive Centrale Raiffeisen-Boerenleenbank B.A. AGCO was organized in June
1990 by an investment group formed by management to acquire the successor to the
agricultural equipment business of Allis-Chalmers, a company which began
manufacturing and distributing agricultural equipment in the early 1900's. Since
its formation in June 1990, AGCO has grown substantially through a series of 17
acquisitions for consideration aggregating approximately $1.4 billion. These
acquisitions have allowed AGCO to broaden its product line, expand its dealer
network and establish strong market positions in several new markets throughout
North America, South America, Western Europe and the rest of the world. AGCO has
achieved significant cost savings and efficiencies from its acquisitions by
eliminating duplicate administrative, sales and marketing functions,
rationalizing its dealer network, increasing manufacturing capacity utilization
and engineering common product platforms for certain products. In addition, AGCO
is focusing its efforts on long-term growth and profit improvement initiatives
including developing new and innovative products, expanding and strengthening
its distribution network, reducing product costs, maintaining a flexible
horizontal production strategy, and utilizing efficient asset management.
AG-CHEM
Ag-Chem manufactures and distributes off-road equipment primarily for
use in fertilizing agricultural crops, the application of crop protection
chemicals to crops, and, to a lesser extent, industrial waste treatment
applications and other industrial uses. Ag-Chem was incorporated in Minnesota in
1963.
Ag-Chem's mission is to position itself as a leading, state-of-the-art
manufacturer of agricultural application equipment, with an emphasis on
"Site-Specific Agriculture" through its SOILTEQ products, specifically
SOILECTION(R) and other high-tech hardware and software product offerings.
Ag-Chem's site-specific technology uses computers, satellites and digitized maps
to enable application equipment to selectively apply fertilizers and other
chemicals to specified locations in a single pass. With this process, inputs are
placed only in areas where they can be used by the crop, and excess application
is minimized. The effects of such a process are optimal economic performance and
potentially positive environmental benefits.
In order to achieve this goal, Ag-Chem has implemented a business
strategy that is focused on customer service and training. In addition to its 17
parts and service centers, Ag-Chem provides customers with service by offering
an organization of field service repair personnel who are stationed at various
locations throughout the country. Because Ag-Chem believes customer training in
site-specific technology is of paramount importance, Ag-Chem operates a
Technology & Education Center in Jackson, Minnesota to meet the specialized
training needs of its customers. Unlike most of its competitors which sell
through distributors, Ag-Chem sells a majority of its products directly to
end-users of the equipment, which include fertilizer dealers, farm cooperatives,
large growers, municipalities, waste disposal contractors and mining and
construction companies. This distribution strategy enables Ag-Chem to maintain
close ties with its customers.
20
28
THE MERGER
GENERAL
Ag-Chem is furnishing this proxy statement/prospectus to its
shareholders in connection with the solicitation of proxies by the Ag-Chem board
of directors for use at the Ag-Chem special meeting. At the special meeting,
which will be held on April 12, 2001, Ag-Chem shareholders will be asked to
adopt the merger agreement.
The merger agreement provides that AGCO will acquire all of the
outstanding Ag-Chem common stock in exchange for a combination of cash and AGCO
common stock.
A copy of the merger agreement is attached as Appendix A to this
document. You should read the merger agreement, as it is the legal document that
governs the merger.
BACKGROUND OF THE MERGER
Ag-Chem, prior to May 30, 2000, began exploring the possibility of a
merger with, sale to, or other arrangement with one or more other participants
in the agricultural equipment market. Ag-Chem undertook this exploration based
in part on its belief that aspects of its business, particularly its technology
business, might grow more quickly if owned by, licensed to, or partnered with
others who had greater financial resources, a full equipment line and broader
domestic and international distribution than Ag-Chem. Initially, Ag-Chem had
extensive discussions with a potential candidate, including the possibility of
that first candidate acquiring some or all of Ag-Chem's operations and/or
merging with Ag-Chem. Discussions with the first candidate continued, from time
to time, until the merger agreement with AGCO was signed, and, on a number of
occasions, the first candidate made oral indications of interest which included
possible per share valuations. However, none of these indications of interest
ever met or exceeded the ultimately-agreed-upon price with AGCO.
As discussions with the first candidate proceeded, Ag-Chem engaged
Goldsmith Agio Helms to act as Ag-Chem's financial advisor. In addition to
assisting Ag-Chem in negotiations with the first candidate (and, later, with
AGCO), Goldsmith Agio Helms assisted Ag-Chem in preliminary assessment of
various financial alternatives available to Ag-Chem ranging from a possible
merger with the first candidate, the possible sale of all or a portion of
Ag-Chem's operations, a possible spin-off of SOILTEQ, the possibility of
entering into joint venture arrangements, and others. Although Ag-Chem had, from
time to time, considered the spin-off of SOILTEQ, because of the tax and other
complications regarding the spin-off, as well as the ultimate focus of both the
first candidate and AGCO on acquisition of the entire company, Ag-Chem felt that
a spin off of SOILTEQ operations was not a viable alternative.
In addition to AGCO and the first candidate, Ag-Chem considered third
and fourth candidates to acquire Ag-Chem. Ag-Chem believed that the third
candidate was not likely to have the financial capability for such an
acquisition. Although Goldsmith Agio Helms approached the fourth candidate,
obtained a confidentiality agreement and furnished information to it, the fourth
candidate was not interested in discussing a transaction with Ag-Chem. Ag-Chem
did not solicit or receive bids from other potential acquirors. Ag-Chem, based
upon its knowledge of participants in the agricultural equipment market,
determined that AGCO and the first candidate were the only two potential
acquirors who were likely to be willing to enter into an agreement with Ag-Chem
on terms acceptable to Ag-Chem. In addition to determining that there were only
a limited number of potential candidates, Ag-Chem determined that broader
solicitation of potential candidates for an acquisition transaction would likely
be damaging to Ag-Chem, particularly to employee morale and its ability to
retain key employees and to its ability to continue to market its products to
customers if the fact that it was seeking acquisition candidates were to become
known beyond a limited group of candidates.
In late May 2000, Robert J. Ratliff, Executive Chairman of the board of
directors of AGCO, contacted A.E. McQuinn, Chairman of the Board and Chief
Executive Officer of Ag-Chem and expressed an interest in learning more about
Ag-Chem's business. On May 30, 2000, Ag-Chem made a presentation regarding
Ag-Chem, generally, and regarding SOILTEQ, at its executive offices in
Minnetonka, Minnesota, to Mr. Ratliff, John M. Shumejda, AGCO's President and
Chief Executive Officer, and Norman L. Boyd, AGCO's Vice President for Corporate
Development. This presentation was made by Mr. McQuinn, Mary M. Jetland,
Ag-Chem's Senior Vice President for SOILTEQ, and John C. Retherford, Ag-Chem's
Senior Vice President and Chief Financial Officer, and another employee of
Ag-Chem and was attended by a representative of Goldsmith Agio Helms. This
presentation consisted
21
29
of general information regarding Ag-Chem and, more particularly, regarding
SOILTEQ, a portion of Ag-Chem's business based on computers, satellites and
digitized maps, which is designed to allow the farmer or other applicator to
selectively apply fertilizers and other chemicals in a single pass. Ag-Chem's
presentation included specific discussion of SOILTEQ because Ag-Chem has viewed
its mission, for several years, as positioning itself as a leading,
state-of-the-art manufacturer of agricultural application equipment with an
emphasis on "site-specific agriculture" including SOILTEQ. The presentation
regarding SOILTEQ was similar to presentations made by Ag-Chem to potential
customers, vendors, potential licensees, and potential joint venturers in
site-specific agriculture ventures.
At the same meeting, AGCO made a presentation about its history, growth
strategy, business philosophy, prior acquisitions, operations, locations, and
financial statement information drawn from and available in AGCO's
publicly-available Securities and Exchange Commission filings. In addition, AGCO
provided information regarding its domestic and international market position
and a breakdown of sales by product line. No projections were included in either
Ag-Chem's or AGCO's presentation.
The next day, Messrs. Ratliff, Boyd and Shumejda of AGCO, accompanied
by Mr. McQuinn and Ms. Jetland and the representative of Goldsmith Agio Helms,
toured Ag-Chem's Jackson, Minnesota plant. No merger negotiations resulted
directly from the May meetings although each of Ag-Chem and AGCO was aware that
the other had some interest in a possible transaction or arrangement.
In late July, after Ag-Chem had explored the possible sale of Ag-Chem
to, or merger of Ag-Chem with, the first candidate and determined it unlikely
that the first candidate would be willing to pay an acceptable price or enter
into an acceptable merger agreement, Goldsmith Agio Helms, at Ag-Chem's request,
obtained from AGCO a confidentiality agreement and delivered to AGCO a
confidential memorandum about Ag-Chem. This confidential memorandum contained
information about Ag-Chem's history, management, ownership, products and
operations, as well as historical and projected financial results of Ag-Chem in
the aggregate and by subsidiary, division and selected products. In addition,
the memorandum contained Ag-Chem's perception of the market for agricultural
equipment, factors which Ag-Chem believed potential acquirers should consider in
assessing Ag-Chem's valuation, and opportunities which Ag-Chem had identified
for possible cost savings and revenue enhancements in a possible business
combination.
Between delivery of that memorandum and late August, Goldsmith Agio
Helms had informal discussions by telephone with a representative of AGCO about
the information provided about Ag-Chem and about AGCO's potential valuation of
Ag-Chem.
On August 30, 2000 Messrs. Ratliff and Boyd of AGCO, together with
Stephen D. Lupton, AGCO's Senior Vice President and General Counsel, met with
Messrs. McQuinn and Retherford and Ms. Jetland and representatives of Goldsmith
Agio Helms at Goldsmith Agio Helms's offices in Minneapolis. Ag-Chem presented
information about itself which was more detailed than had been presented at the
late-May meeting and much of which was not publicly available. The presentation
included summary information on Ag-Chem's operations as well as historical
financial information as to Ag-Chem in the aggregate and as to each of Ag-Chem's
subsidiaries and divisions. It also included detailed projections regarding
possible sales increases and cost-savings, both as a result of Ag-Chem's ongoing
cost reduction programs and as a result of a possible business combination with
AGCO. The presentation also included Ag-Chem's views regarding the site-specific
agriculture industry in general and the potential market position of SOILTEQ.
Among the benefits discussed at the August 30th meeting were the
potential benefits that might result from a business combination between AGCO
and Ag-Chem such as the following:
- AGCO's greater purchasing volume;
- the unused capacity in Ag-Chem's Jackson, Minnesota plant;
- the possible reduction of administrative costs;
- the potential use of AGCO's parts distribution system;
- the availability of AGCO's credit company to allow purchasers to
finance purchases of equipment;
22
30
- the potential for Ag-Chem's products to be sold directly to farmers
(Ag-Chem has historically marketed to fertilizer dealers, farm
cooperatives and large growers); and
- the potential for Ag-Chem's products to be sold internationally.
Although there was some discussion about a range of possible valuations for
Ag-Chem, and the nature of consideration which might be given for Ag-Chem's
common stock, there were no negotiations or agreements on price or any terms,
however, AGCO and Ag-Chem did agree to continue discussions.
Over the next month, a number of informal discussions, primarily by
telephone, some through Goldsmith Agio Helms, took place, focusing on a number
of topics, including the price that AGCO might be willing to pay for Ag-Chem,
which portions of Ag-Chem's business might be included in an acquisition and the
nature of consideration that might be given by AGCO.
On September 25, 2000, another meeting took place at the offices of
Goldsmith Agio Helms in Minneapolis. Messrs. McQuinn and Retherford, Ms. Jetland
and DeWalt Willard, a director of Ag-Chem, participated on behalf of Ag-Chem and
Messrs. Ratliff, Boyd, and Lupton participated on behalf of AGCO.
Representatives of Goldsmith Agio Helms also participated in these discussions.
AGCO made a presentation about, among other things, AGCO's financial condition,
debt levels, operating results, and general business outlook. Although AGCO
displayed some projections of its future operations, these projections did not
contain details about the assumptions upon which they were based. AGCO did not,
at that time, give Ag-Chem or Goldsmith Agio Helms a copy of the presentation or
projections. AGCO's presentation also included possible structures for an
acquisition of Ag-Chem, possible benefits that might result from such an
acquisition, possible strategies for integration of Ag-Chem's business into AGCO
and a limited analysis of pro-forma projected financial information related to
the cost savings which might be achieved. AGCO also indicated a willingness to
pursue negotiations regarding a transaction at a price and on terms that were,
at that time, more attractive to Ag-Chem and its shareholders than any other
indication of interest Ag-Chem had received. Although no agreement was reached
regarding price or terms, AGCO and Ag-Chem authorized representatives of AGCO
and AGCO's law firm to conduct "due diligence" inquiries on AGCO's behalf.
During negotiations, AGCO indicated that it was valuing Ag-Chem without
attributing any value to SOILTEQ and that, as a result, it would not object to
Ag-Chem shareholders retaining or otherwise selling SOILTEQ if such retention
would not result in any cost, liability or contingent liability to AGCO.
Discussions at that time about possible alternative structures, including a
possible spin-off or retention by Ag-Chem shareholders of SOILTEQ, were
preliminary in nature and focused on concepts. These concepts were subject to
further research and analysis regarding tax and other structure-related issues.
No satisfactory resolution of such issues was ever reached. As a result, no
agreement, formal or otherwise, was reached regarding any such alternative
structure. As negotiations with the first candidate and AGCO proceeded, both the
first candidate and AGCO indicated that they were interested in acquiring all of
Ag-Chem's business.
During the first week of October, representatives of AGCO visited
Ag-Chem's law firm to conduct inquiries and review information about Ag-Chem,
its business, and other matters. After a couple of days, Ag-Chem discontinued
furnishing due diligence information to AGCO because Ag-Chem had received a
revised indication of interest from the first candidate at a price per Ag-Chem
share of $25, a price that was higher than Ag-Chem believed AGCO would be
willing to pay. No other significant terms were resolved at that time. During
the ensuing two and one half weeks, the first candidate and Ag-Chem continued to
negotiate significant terms. Two of the most significant unresolved terms, which
were never resolved, were the timing of the valuation of the first candidate's
shares for purposes of determining the number of the first candidate's shares to
be delivered to Ag-Chem shareholders and the portion of total consideration to
consist of cash as opposed to shares of the first candidate. These issues, as
well as others, were never agreed upon. Although the first candidate reduced
this indication of interest shortly before an agreement on price was reached
with AGCO, Ag-Chem believes that negotiations with the first candidate would
have continued had an agreement with AGCO not been reached. Because the nature
of such transaction had not been resolved, Ag-Chem had not determined what the
tax consequences of a transaction with such potential acquirer might have been.
While these discussions with the first candidate were ongoing, Mr.
Ratliff of AGCO recontacted A. E. McQuinn. Mr. Ratliff indicated that AGCO had
continued studying the information provided by Ag-Chem and had
23
31
concluded that there was a higher likelihood of achieving benefits than AGCO had
initially contemplated and that, as a result, AGCO would likely be willing to
significantly increase the valuation at which it would be willing to move
forward with negotiations. Mr. Ratliff requested a meeting to discuss valuation.
On October 19, 2000, Mr. McQuinn, Ms. Jetland and representatives of
Goldsmith Agio Helms, on behalf of Ag-Chem, and Messrs. Ratliff, Shumejda and
Boyd, on behalf of AGCO, met at Ag-Chem's offices to discuss price and terms.
During this meeting, there was a general agreement on a price of $26.00 per
Ag-Chem share although the nature of the consideration to be given and several
other material terms, including a potential reduction in price related to
Ag-Chem's anticipated payment of bonuses to some of its employees, were yet to
be resolved. Ultimately, the price per Ag-Chem share was reduced to $25.80 to
allow Ag-Chem to pay bonuses aggregating $1.4 million to Mr. Retherford and Ms.
Jetland related to their efforts negotiating the merger and another $1.6 million
related to past services to some of its still unidentified employees prior to
closing of the merger.
After the October 19 meeting, the first candidate contacted Goldsmith
Agio Helms. Goldsmith Agio Helms, without disclosing the price generally agreed
upon by Ag-Chem and AGCO, encouraged the first candidate to increase its
valuation of Ag-Chem. The first candidate indicated no willingness to proceed
with discussions at a higher price. After the October 19 meeting, AGCO and
Ag-Chem authorized their law firms to begin preparing drafts of the agreements
related to a proposed transaction and, as a result, a first draft of a merger
agreement was distributed to Ag-Chem directors late in the week of November 6th.
During the negotiations, Mr. McQuinn indicated that in the event that
the aggregate purchase price included less than 11,800,000 shares of AGCO common
stock as a result of AGCO's share price being below $8.38 and its election to
substitute cash for the stock portion of the merger consideration, he wanted
Ag-Chem shareholders to have the ability to subscribe to the difference between
the number of shares issued and 11,800,000 shares. In response, AGCO agreed to
grant the subscription rights described under "The Merger--What You Will
Receive; The Merger Consideration-AGCO Subscription Right."
The Ag-Chem board met on Monday, November 13, 2000. At this meeting,
Goldsmith Agio Helms made a presentation regarding the history of negotiations
and pending issues in the negotiations and presented its oral opinion that, as
of the date thereof and subject to the assumptions, procedures and limitations
set forth therein, the proposed merger consideration to be received pursuant to
the merger agreement by the holders of Ag-Chem common stock is fair to the
Ag-Chem shareholders from a financial point of view. The board then appointed a
special committee of the board of directors comprised of G. Waddy Garrett, Al
Giese, and DeWalt Willard, whom the board determined to be all of the
disinterested directors as contemplated by the Minnesota Business Corporation
Act, Section 302A.673. The special committee was given the authority to approve
and authorize Ag-Chem's entering into a merger with AGCO or such other party as
it deemed appropriate, pursuant to such terms and conditions as the special
committee deemed to be in the best interest of Ag-Chem.
On November 13, 2000, the special committee also engaged and met with
independent legal counsel to advise it regarding the negotiations with AGCO and
regarding its responsibilities and met with Goldsmith Agio Helms, to discuss the
proposed merger agreement.
Negotiations between Ag-Chem and AGCO continued, both in person in
Minneapolis and by telephone, and the Ag-Chem special committee continued to
meet, throughout the week of November 13th. Multiple drafts of the proposed
merger agreement were exchanged but there was not final agreement on price and
material terms until November 17th. On that day, the Ag-Chem special committee
met and approved and adopted the merger agreement, subject to the receipt of an
updated fairness opinion from Goldsmith Agio Helms. Goldsmith Agio Helms
delivered an oral opinion to the entire board the next day, which was
subsequently confirmed in writing, and the Ag-Chem board ratified the approval
on that day. Ag-Chem and AGCO executed the merger agreement on Sunday, November
19th, effective as of Monday, November 20th. Ag-Chem and AGCO each issued press
releases before the markets opened on Monday, November 20th announcing the
merger agreement.
AG-CHEM'S REASONS FOR THE MERGER
Ag-Chem's special committee and board of directors have each
unanimously determined that the merger is advisable and in the best interests of
Ag-Chem and its shareholders and have approved and adopted the merger, the
24
32
merger agreement and the transactions contemplated thereby. In reaching the
determination that the merger is advisable and in the best interests of Ag-Chem
and its shareholders, the Ag-Chem special committee and board considered a
number of factors, which included (but did not consist exclusively of) the
following:
- The merger should increase the ability of Ag-Chem, as a subsidiary of
AGCO, to further commercialize its site-specific applications. Ag-Chem
has attempted to position itself as the state-of-the-art manufacturer
of agricultural application equipment, with an emphasis on
site-specific agriculture through its SOILTEQ products, specifically
SOILECTION(R)and other high-tech hardware and software product
offerings. Although the SOILTEQ aspect of Ag-Chem's business has grown
more slowly than Ag-Chem had hoped, Ag-Chem continues to believe in the
future of this product line. Over the past few years, other companies,
some with greater financial, marketing, and other resources than
Ag-Chem, have entered the marketplace for site-specific agriculture.
Ag-Chem has become particularly concerned that Deere & Co. and CNH
Global have begun to market site-specific agricultural equipment. Both
Deere & Co. and CNH Global have greater access to capital, broader name
recognition and larger distribution networks than Ag-Chem, each of
which has placed Ag-Chem at a competitive disadvantage. AGCO has
indicated that it intends to continue to pursue Ag-Chem's site-specific
agriculture strategy and that it views the segments of the agricultural
equipment industry served by Ag-Chem as major growth segments of the
industry. Joining with AGCO will give Ag-Chem the opportunity to more
broadly market its site-specific agricultural products and services to
a wider range of customers.
- Ag-Chem should benefit from increased production efficiencies. Ag-Chem
and AGCO both produce products for various aspects of the agriculture
industry. Many of such products use similar technologies, both in their
design and in their production. The combination of Ag-Chem's and AGCO's
design and production functions should increase Ag-Chem's ability to
efficiently produce its products. AGCO's ability to realize these
efficiencies is uncertain and will depend upon many factors which AGCO
and Ag-Chem will be unable to determine until after the merger is
completed. Further, the ability of AGCO to benefit may be limited by
redundancies in AGCO's and Ag-Chem's operations. For example, both AGCO
and Ag-Chem operate parts and service operations. While Ag-Chem and
AGCO believe that AGCO's service operations will likely increase the
ability to service customers on a more timely basis, the ultimate
determination whether to terminate all or some of Ag-Chem's parts and
service operations will be made by AGCO in the future. If AGCO
determines to terminate Ag-Chem's parts and service operations, AGCO
will incur a cost related to such termination. Secondly, AGCO and
Ag-Chem have not yet assessed the ability to continue to market both
AGCO's and Ag-Chem's post-emergence application equipment. Although the
customers to whom each are currently marketed differ from the other,
both AGCO's and Ag-Chem's equipment have similar capabilities and,
ultimately, AGCO may determine to limit or eliminate one or the other
of such systems from its product line and/or may choose to merge such
product lines. Again, AGCO will not make such determination until after
the merger has been completed.
- AGCO's international distribution network should provide increased
opportunity for marketing of Ag-Chem's products. While Ag-Chem has
traditionally marketed its products in the United States, more
recently, it has expanded its marketing efforts in Europe. European
sales accounted for less than 10% of Ag-Chem's sales in the fiscal year
ended September 30, 2000. Ag-Chem derives little sales revenue from the
sale of its products in South America. AGCO has a well-established
distribution network in Europe and South America, which should provide
new outlets for sales of Ag-Chem's products.
- AGCO's domestic distribution network should provide an increased
ability to compete by marketing Ag-Chem's products to customers to whom
Ag-Chem has not traditionally made significant sales. Ag-Chem's and
AGCO's products have traditionally been marketed to differing segments
of the agriculture industry. The merger should provide an opportunity
to increase sales of Ag-Chem's products because AGCO has access to, and
history with, customers in a portion of the agriculture industry (large
farmers) not traditionally served by Ag-Chem.
- AGCO's ability to finance sales of Ag-Chem's equipment, through AGCO
Finance, should both enhance the ability to market Ag-Chem's products
and to obtain a higher return on sales of such products. Traditionally,
Ag-Chem has provided financing to its customers related to purchases of
Ag-
25
33
Chem's products through financing arrangements with third-party lenders
such as banks. Although such financing has been an essential element of
Ag-Chem's ability to market its products, it has not been a significant
source of revenues for Ag-Chem. AGCO, through its AGCO Finance
subsidiary, obtains financing from the sale of debt securities,
provides such financing and administers such financing arrangements.
AGCO's ability to provide such financing services to purchasers of
Ag-Chem's equipment should provide more revenue after the merger is
completed.
- Use of AGCO's network to distribute parts and service after the
merger is likely to result in lower costs than Ag-Chem's current parts
and service operation. AGCO's parts and service network is more
effective and economical than Ag-Chem's because AGCO has a broader
network of equipment dealers servicing its equipment and AGCO's parts
distribution network is more centrally based. These efficiencies should
allow Ag-Chem, after the merger, to improve the contribution of its
parts and service network to the profitability of the combined
companies.
- The combined purchasing power of Ag-Chem and AGCO should help
lower the cost of production of Ag-Chem's products. AGCO is a much
larger company than Ag-Chem and, as such, is often able to purchase
parts, supplies and services at more competitive prices and rates than
Ag-Chem. Access to such purchasing power should increase the operating
margins of Ag-Chem's products.
- AGCO's financial resources are better able to fund the research and
development for Ag-Chem's site-specific products and other operating
expenses. Although Ag-Chem, from the beginning of its October 1, 1999
fiscal year, through September 30, 2000, has operated with a cumulative
positive cash flow from operations of $46.8 million, a significant
portion of such cash flow has been related to Ag-Chem's reduction in
receivables and inventory. Ag-Chem's focus on, and investment in,
site-specific agriculture has reduced cash flow available to fund
operations and such lower receivables and inventory levels have
hindered Ag-Chem's ability to obtain new financing to fund expansion
and growth. Ag-Chem believes its ability to obtain financing has been
negatively affected by the market for companies engaged in the
agriculture industry. Ag-Chem believes AGCO's access to capital markets
should enhance the ability to fund research and development for
site-specific products and other operating expenses.
- Ag-Chem's shareholders will receive shares of AGCO, a more
broadly-focused participant in the market for agricultural equipment
and will no longer hold shares of a company (Ag-Chem) focused on
equipment used to apply fertilizer and crop protection chemicals.
Although AGCO shares represent a more diversified investment, Ag-Chem
shareholders will no longer hold shares of a company so highly focused
on site-specific agriculture. Further, Ag-Chem shareholders have no
assurance that AGCO will remain committed to, and not abandon,
development and marketing of site-specific agriculture.
- Some Ag-Chem shareholders may, shortly after completion of the merger,
liquidate the AGCO shares to be received by them in the merger, which
liquidation may have a negative impact on the market price for AGCO
common stock. The Ag-Chem board recognized that it could not predict
the number of Ag-Chem shareholders who, upon receiving consideration
partially in freely-tradable AGCO common stock, might choose to
promptly liquidate their holdings of AGCO common stock. If a
significant number of such shareholders do liquidate the AGCO shares
received by them in the merger, such liquidation would likely have a
negative effect upon the market price for AGCO stock.
- Ag-Chem has unused manufacturing capacity in its Jackson, Minnesota,
plant which could be used by AGCO in the event AGCO requires additional
capacity. Ag-Chem built a substantial expansion of its Jackson,
Minnesota plant in 1995 as it was substantially expanding sales of its
RoGator line of equipment. Downturns in the agricultural economy
generally have led to slower expansion of production at such plant than
had been anticipated. During the fiscal year ended September 30, 2000,
such plant operated at approximately 60% of capacity. Ag-Chem believes
that such plant could achieve a much higher percentage of productivity
as a result of increased production of agricultural equipment products
due to the marketing efficiencies related to Ag-Chem described above.
- The combination of AGCO and Ag-Chem should result in administrative
and regulatory cost savings related to being a publicly-held company.
AGCO should be able to reduce and/or eliminate some
26
34
operating costs related to duplicative administrative and regulatory
requirements (e.g. costs of complying with the periodic reporting
requirements of the Securities and Exchange Commission and auditing
costs).
- The fact that the merger will likely be conducted in a manner that will
be partially tax-free to most Ag-Chem shareholders. As discussed in
"The Merger--Material Federal Income Tax Consequences" beginning on
page ___, it is likely that the merger will be conducted in such a
manner that Ag-Chem shareholders will receive both AGCO shares and cash
and, to the extent Ag-Chem shareholders receive AGCO shares, the merger
will likely be tax-free to such shareholders. However, the merger will
be taxable to such shareholders to the extent of the lesser of (i) the
fair market value of the AGCO common stock plus the amount of cash
received, less the shareholder's basis in the Ag-Chem common stock or
(ii) the amount of cash received.
- The merger may be conducted in a manner that will not be partially
tax-free to Ag-Chem shareholders. Both the Ag-Chem special committee
and board of directors recognized that the merger might be conducted in
a manner that is not partially tax-free to Ag-Chem shareholders, even
to the extent Ag-Chem shareholders receive AGCO shares. Although the
Ag-Chem special committee and board of directors considered the
potential for a partially tax-free transaction, each also concluded
that if, ultimately, the merger does not qualify as partially tax-free,
nonetheless, the other factors identified by the Ag-Chem special
committee and board of directors justify completion of the merger on a
taxable basis. The Ag-Chem board of directors' and the special
committee's recommendations that Ag-Chem shareholders vote "For" the
merger are given even if the merger is fully taxable to Ag-Chem
shareholders.
- The opinion of Goldsmith Agio Helms that the merger consideration to be
received pursuant to the merger agreement is fair from a financial
point of view to the shareholders of Ag-Chem. The opinion, dated
November 18, 2000, to the Ag-Chem special committee and the board of
directors, of Goldsmith Agio Helms stated that, as of that date and
based upon and subject to the matters described in the opinion, the per
share consideration which is to be received in the merger by the
Ag-Chem shareholders was fair, from a financial point of view, to such
holders. The Ag-Chem special committee and board of directors
specifically considered that the Goldsmith Agio Helms opinion did not
address the tax consequences of the merger. The full text of Goldsmith
Agio Helms's written opinion, which sets forth the assumptions made,
procedures followed, matters considered and limitations on the review
undertaken by Goldsmith Agio Helms, is attached as Appendix D to this
proxy statement/prospectus. In addition, the opinion is discussed in
more detail below under the caption "The Merger--Opinion of Ag-Chem's
Financial Advisor."
- A. E. McQuinn, who has been a majority shareholder of Ag-Chem since it
went public over 30 years ago, will own less than 10 percent of AGCO's
outstanding common stock after the merger. The Ag-Chem special
committee and board of directors recognized that a number of Ag-Chem
shareholders felt a significant loyalty to Mr. McQuinn based upon the
number of years that he has led Ag-Chem. The special committee and
board of directors recognized that Mr. McQuinn's age might lead to
lesser involvement by him in the management of Ag-Chem if it remained
independent and that he might be less willing to undertake a
significant role in any company acquiring Ag-Chem or its business and
that this change might be considered a negative under either
circumstance. Different directors viewed this factor as either a
positive or a negative aspect of the merger based upon their views of
the merger.
- AGCO's shares were trading at a significant discount from their
historic highs. AGCO's stock, from July 1, 2000 through the date the
merger agreement was signed, traded in a range from $13.875 to $9.625.
Prior thereto, in March 1998, AGCO's stock had traded at a
significantly higher price of $30.00. Although this decline was
consistent with that of other stocks in the agricultural equipment
industry, the Ag-Chem board of directors and special committee each
recognized that there was no assurance this trend would be reversed.
- The cash payments to be made to Ag-Chem shareholders (with or without
any adjustment due to the low price of AGCO common stock), either alone
or in connection with other factors, might place AGCO at risk of not
being in compliance with restrictions pursuant to its debt covenants
and therefore
27
35
negatively impact its ability to complete the merger. Because the
amount of cash to be paid by AGCO to Ag-Chem shareholders is uncertain
and is dependent, in part, upon the market price of AGCO's common stock
prior to closing, and because of the limitation on the number of shares
which AGCO can issue without being required to seek shareholder
approval, the amount of cash to be paid to Ag-Chem shareholders might
be higher than contemplated. The amount of cash required to complete
the merger may place AGCO out of compliance with its debt covenants
and, therefore, AGCO may not be able to raise sufficient cash to pay
the cash portion of the merger price. If this were to occur, there
could be no assurance that AGCO would be able to complete the merger.
- The fact that the price per share to be received by Ag-Chem
shareholders is fixed and is in excess of the price at which Ag-Chem's
common stock has traded in the public market in the recent past and the
fact that the market for AGCO's common stock is larger and better
established. Ag-Chem's common stock has been traded in the Nasdaq
National Market System since April 24, 1995. The highest closing bid
price at which it has traded since that date is $31.75 on October 9,
1995. The volume of Ag-Chem shares has been relatively low since that
date with average weekly trading volumes of 39,909 shares since such
date and 36,496 shares during the 52 weeks prior to entering into the
merger agreement. AGCO's common stock has been traded on the New York
Stock Exchange since April 1992 and its average weekly trading volume
during the 52 weeks prior to entering into the merger agreement has
been 280,000 shares. The agreed-upon price of $25.80 per share of
Ag-Chem common stock was $14.30 (124%) over the price at which Ag-Chem
common stock had closed on Friday, November 17, 2000, the last trading
day before the merger agreement was executed and announced.
The foregoing discussion of the information and factors discussed by
the Ag-Chem special committee and board of directors is not meant to be
exhaustive but includes all material factors considered by the Ag-Chem special
committee and board of directors. Neither the Ag-Chem special committee nor the
Ag-Chem board of directors found it practicable to quantify, rank or otherwise
attach any relative weight to the various factors. In addition, the Ag-Chem
special committee and board of directors did not reach any specific conclusion
with respect to each of the factors considered, or any aspect of any particular
factor, but conducted an overall analysis of these factors, including
discussions with Ag-Chem's management and legal and financial advisors. The
Ag-Chem board of directors did not believe that the negative factors were
sufficient, individually or in the aggregate, to outweigh the potential
advantages of the merger. As a result of its consideration of these factors, the
Ag-Chem special committee and board of directors each determined that the
merger, the merger agreement and the transactions contemplated thereby are
advisable and fair to and in the best interests of Ag-Chem and its shareholders
and approved and adopted the merger, the merger agreement and the transactions
contemplated thereby. In addition, individual members of the Ag-Chem special
committee and board of directors may have given different weight to different
information and factors.
OPINION OF AG-CHEM'S FINANCIAL ADVISOR
On March 3, 2000, Ag-Chem retained Goldsmith, Agio, Helms & Lynner,
Ltd. and its affiliated company Goldsmith, Agio, Helms Securities, Inc.
(collectively, "Goldsmith Agio Helms") to act as its financial advisor to assist
Ag-Chem in its analysis and consideration of various financial alternatives
available to Ag-Chem with respect to a possible sale of Ag-Chem. Goldsmith Agio
Helms is a nationally recognized investment banking firm, which as a customary
part of its business is engaged in the valuation of businesses and securities in
connection with mergers and acquisitions, private placements, and valuations for
corporate and other purposes. Ag-Chem selected Goldsmith Agio Helms based on
Goldsmith Agio Helms's qualifications, expertise, and reputation in investment
banking, and more specifically, in mergers and acquisitions.
On November 13, 2000, Goldsmith Agio Helms presented its oral opinion
to the Ag-Chem board of directors including the directors who were during that
meeting appointed as members of the special committee. After various changes to
the merger agreement were agreed to by AGCO and Ag-Chem, this opinion was
confirmed orally and, thereafter, in writing effective November 18th, to the
effect that, as of the date thereof, and subject to the assumptions, procedures,
and limitations set forth therein, the proposed merger consideration to be
received pursuant to the merger agreement by the holders of Ag-Chem common stock
is fair to the Ag-Chem shareholders from a financial point of view. The merger
agreement, as executed, is in the final form which sets forth the proposed
merger consideration opined upon by Goldsmith Agio Helms.
28
36
The limitations of this opinion are set forth in more detail below.
Among other things, Goldsmith Agio Helms did not opine on, nor did its opinion
consider, the tax consequences of the merger, including tax consequences to any
holder of Ag-Chem common stock.
Pursuant to a letter agreement with Ag-Chem dated March 3, 2000,
Goldsmith Agio Helms was entitled to a fee of $225,000 after delivering its
opinion. Upon consummation of the merger, Goldsmith Agio Helms is entitled to
total cash compensation of one and fifteen hundredths percent (1.15%) of the
merger consideration, or approximately $2,842,347, assuming consideration paid
for Ag-Chem common stock of $247,160,594. Goldsmith Agio Helms received monthly
retainers of $15,000 for a period of six months following its engagement by
Ag-Chem. The aggregate total of the retainers received by Goldsmith Agio Helms
was capped at $90,000. These retainers, but not the $225,000 fee for the
opinion, will be credited against the total fee to be paid at closing. Ag-Chem
has agreed to reimburse Goldsmith Agio Helms for reasonable out-of-pocket
expenses, including, but not limited to, fees and expenses of counsel, and to
indemnify Goldsmith Agio Helms for liabilities and expenses arising out of the
merger or transactions in connection therewith. The fees and expenses of counsel
are not to exceed $15,000, and all fees, disbursements, and expenses are not to
exceed $40,000 without the prior written consent of Ag-Chem. Ag-Chem consented
to allow all fees, disbursements, and expenses to reach not more than $75,000.
The terms of the fee agreement with Goldsmith Agio Helms, which are customary in
transactions of this nature, were negotiated at arm's length between Ag-Chem and
Goldsmith Agio Helms, and the Ag-Chem board of directors and special committee
were aware of the arrangement.
The type and amount of merger consideration payable pursuant to the
merger was determined through negotiation between Ag-Chem and AGCO. Although
Goldsmith Agio Helms provided financial advice to Ag-Chem during the course of
the negotiations, Goldsmith Agio Helms did not recommend the amount of the
merger consideration or the payment or other terms thereof, and the decision to
enter into the merger agreement was solely that of Ag-Chem's special committee
and board of directors. Goldsmith Agio Helms's opinion as to the fairness of the
merger consideration from a financial point of view was only one of many factors
considered by the special committee and the board of directors in making their
determination to recommend adoption of the merger agreement.
A copy of Goldsmith Agio Helms's opinion, which sets forth the
assumptions made, matters considered, and limits on the review taken, is
attached as Appendix D to this proxy statement and is incorporated by reference.
You are urged to, and should, read the Goldsmith Agio Helms opinion in its
entirety. The description of the Goldsmith Agio Helms opinion set forth in this
proxy statement is qualified in its entirety by reference to the full text of
such opinion. Goldsmith Agio Helms's opinion is rendered for the benefit and use
of the special committee and the board of directors of Ag-Chem in connection
with the special committee's and the board of directors' consideration of the
merger and does not constitute a recommendation to any holder of Ag-Chem common
stock as to how such shareholder should vote with respect to the merger.
In arriving at its opinion, Goldsmith Agio Helms undertook such
reviews, analyses and inquiries as it deemed necessary and appropriate under the
circumstances. Among other things, Goldsmith Agio Helms:
- reviewed a draft of the merger agreement in the form provided
to it and assumed that the final form of the merger agreement
would not vary in any regard that would be material to
Goldsmith Agio Helms's analysis;
- analyzed financial and other information that was publicly
available relating to AGCO;
- analyzed financial and other information that was publicly
available relating to Ag-Chem;
- analyzed certain internal financial and operating data of
Ag-Chem that had been made available to Goldsmith Agio Helms
by Ag-Chem;
- visited certain facilities of Ag-Chem and discussed with
management of Ag-Chem the financial condition, operating
results, business outlook, and prospects of Ag-Chem;
- discussed with management of AGCO the financial condition,
operating results, business outlook and prospects of AGCO,
including information relating to certain strategic,
financial, and operational benefits anticipated from the
merger;
29
37
- analyzed the valuations of publicly traded companies that
Goldsmith Agio Helms deemed comparable to Ag-Chem;
- performed a discounted cash flow analysis of Ag-Chem as a
stand-alone entity based on financial projections that Ag-Chem
management provided to Goldsmith Agio Helms;
- analyzed the financial terms of certain transactions Goldsmith
Agio Helms deemed comparable to the merger that recently have
been effected within the agricultural equipment market;
- analyzed the premiums paid in recent mergers and acquisitions
of publicly traded companies with transaction values ranging
from $200 to $500 million;
- analyzed the historical exchange ratios of Ag-Chem and AGCO
common stock over a twelve-month period; and
- reviewed the common stock trading histories of Ag-Chem and
AGCO common stock over the last several years.
In arriving at its opinion, Goldsmith Agio Helms relied upon and
assumed the accuracy, completeness, and fairness of the financial statements and
other information furnished by, or publicly available relating to, Ag-Chem or
AGCO, or otherwise made available to Goldsmith Agio Helms, and relied upon and
assumed that the representations and warranties of Ag-Chem and AGCO contained in
the merger agreement were true and correct. Goldsmith Agio Helms was not engaged
to, and did not attempt to, or assume responsibility to, verify independently
such information. Goldsmith Agio Helms further relied upon assurances by Ag-Chem
that the information provided to Goldsmith Agio Helms had a reasonable basis,
and with respect to projections and other business outlook information,
reflected the best available estimates, and that Ag-Chem was not aware of any
information or fact that would make the information provided to Goldsmith Agio
Helms incomplete or misleading. Goldsmith Agio Helms assumed that Ag-Chem and
AGCO will perform all of the covenants and agreements to be performed by each
under the merger agreement and that the conditions to the merger will be
satisfied and that the merger will be consummated on a timely basis in the
manner contemplated by the merger agreement. In arriving at its opinion,
Goldsmith Agio Helms did not perform any appraisals or valuations of specific
assets or liabilities of Ag-Chem or AGCO and expressed no opinion regarding the
liquidation value of Ag-Chem or AGCO or any of their respective assets. The
Goldsmith Agio Helms opinion is based upon the information available to
Goldsmith Agio Helms and the facts and circumstances as they existed and were
subject to evaluation on the date of the opinion; events occurring after the
date of the opinion could materially affect the assumptions used in preparing
the opinion. However, Goldsmith Agio Helms has no obligation to update, revise,
or reaffirm its opinion.
Goldsmith Agio Helms relied, with respect to legal and accounting
matters related to the merger agreement, on the advice of Ag-Chem's legal and
accounting advisors. Goldsmith Agio Helms made no independent investigation of
any legal or accounting matters that may affect Ag-Chem and assumed the
correctness of the legal and accounting advice provided to Ag-Chem, its board of
directors, and the special committee. Goldsmith Agio Helms did not opine on, nor
did its opinion consider, the tax consequences of the merger, including tax
consequences to any holder of Ag-Chem common stock. Goldsmith Agio Helms was not
asked to, nor did it, express an opinion as to the relative merits of the merger
as compared to any alternative business strategies that might exist for Ag-Chem,
the effect of any other transaction in which Ag-Chem might engage, or the form
of the merger agreement or the terms contained therein. Furthermore, Goldsmith
Agio Helms expressed no opinion as to the prices at which Ag-Chem or AGCO stock
may trade following the date of its opinion or following consummation of the
merger. Goldsmith Agio Helms's opinion was rendered as of the date thereof, and
Goldsmith Agio Helms did not express any opinion as to whether, on or about the
effective time of the merger, the merger consideration will be fair, from a
financial point of view, to Ag-Chem's shareholders.
The preparation of a fairness opinion is a complex process and is not
necessarily susceptible to partial analysis or summary description. The summary
of the Goldsmith Agio Helms analyses set forth below does not purport to be a
complete description of the analyses performed by Goldsmith Agio Helms in
arriving at its opinion or of the presentation by Goldsmith Agio Helms to
Ag-Chem's board of directors and the special committee. In arriving at its
opinion, Goldsmith Agio Helms did not attribute any particular weight to any
analysis or factor
30
38
considered by it, but rather considered the results of its analyses as a whole.
Accordingly, Goldsmith Agio Helms believes that its analyses and the summary set
forth below must be considered as a whole and that selecting portions of its
analyses, or of the summary, without considering all factors and analyses, could
create an incomplete view of the processes underlying its analyses.
The analyses performed by Goldsmith Agio Helms (and summarized below)
are not necessarily indicative of actual values or actual future results, which
may be significantly more or less favorable than suggested by such analyses.
Additionally, analyses relating to the values of businesses do not purport to be
appraisals or to reflect the prices at which businesses or securities actually
may be sold. Although some of the valuation analyses discussed below resulted in
wide valuation ranges, the per share value of the consideration to be received
by Ag-Chem shareholders from AGCO is higher than the high end of each range
discussed.
Discounted Cash Flow Analysis. Goldsmith Agio Helms performed a
discounted cash flow analysis based on the unlevered discounted cash flow of the
projected five-year financial performance of Ag-Chem prepared by Ag-Chem
management. Ag-Chem's weighted average cost of capital for purposes of this
analysis was calculated to be approximately 11.2 percent. Terminal values were
calculated by applying both an earnings before interest, taxes, depreciation and
amortization ("EBITDA") multiple of 6.0x to the projected EBITDA of Ag-Chem in
fiscal year 2005 and by applying a five percent perpetual growth rate to the
projected free cash flow in fiscal year 2005. Based on this analysis, Ag-Chem's
implied per share equity values ranged from $13.60 to $15.75. Discounted cash
flow analysis is a widely-used valuation methodology but it relies on numerous
assumptions, including assets and earnings growth rates, terminal values, and
discount rates. This analysis is not necessarily reflective of the actual value
of Ag-Chem.
Analysis of Publicly Traded Comparable Companies. Goldsmith Agio Helms
analyzed selected historical financial, operating, and stock market data of
Ag-Chem, AGCO, and other publicly traded companies that Goldsmith Agio Helms
deemed to be comparable to Ag-Chem. The four companies (collectively, the
"Comparable Companies") deemed by Goldsmith Agio Helms to be reasonably
comparable to Ag-Chem in terms of products and services offered, markets served,
and business prospects were:
- Deere & Co.;
- Alamo Group, Inc.;
- Gehl Company; and
- CTB International Corporation.
Although Ag-Chem and AGCO were included in the analysis for reference
purposes, they were not included in any calculation of implied multiples for
purposes of Goldsmith Agio Helms's analysis.
No company utilized in Goldsmith Agio Helms's comparable company
analysis is identical to Ag-Chem. Accordingly, an analysis of the results of the
foregoing necessarily involves complex considerations and judgments concerning
the differences in financial and operating characteristics of Ag-Chem and other
factors that could affect the public trading value of the comparable companies
to which they are being compared.
Goldsmith Agio Helms examined certain publicly available financial data
of the Comparable Companies, including the ratio of enterprise value (equity
value plus total debt, including preferred stock, less cash and cash
equivalents) to latest-12-month ("LTM") revenue, EBITDA, and earnings before
interest and taxes ("EBIT"). In addition, Goldsmith Agio Helms examined the
ratio of equity value to LTM net income for each of the Comparable Companies.
This analysis showed that the Comparable Companies had a multiple
represented by the ratio of enterprise value to LTM revenue ranging from 0.4x to
1.5x, with a mean of 0.8x and a median of 0.7x, compared with 1.0x for Ag-Chem
based on a transaction enterprise value of $293,734,594 (equity value of
$247,160,594 at $25.80 per share plus $46,574,000 of outstanding debt); a
multiple represented by the ratio of enterprise value to LTM
31
39
EBIT ranging from 3.6x to 14.6x, with a mean of 8.7x and a median of 8.4x,
compared with 34.7x for Ag-Chem based on a transaction enterprise value of
$293,734,594; a multiple represented by the ratio of enterprise value to LTM
EBITDA ranging from 3.1x to 10.3x, with a mean of 6.3x and a median of 6.0x,
compared with 18.9x for Ag-Chem based on a transaction enterprise value of
$293,734,594; and a multiple represented by the ratio of equity value to net
income ranging from 3.5x to 23.0, with a mean of 12.3x and a median of 11.3x,
compared with 129.0x for Ag-Chem based on a transaction enterprise value of
$293,734,594.
By applying the median ratios derived from Goldsmith Agio Helms's
comparable company analysis to Ag-Chem's estimated operating results for its
fiscal year ended September 30, 2000, Ag-Chem's implied range of equity value
per share was calculated to be $2.32 to $20.41.
Analysis of Selected Merger and Acquisition Transactions. Goldsmith
Agio Helms compared the proposed merger with selected comparable merger and
acquisition transactions. No transaction analyzed in Goldsmith Agio Helms's
comparable transaction analysis is identical to the merger. Accordingly, an
analysis of the results of the foregoing necessarily involves complex
considerations and judgments concerning differences in financial and operating
characteristics of Ag-Chem and other factors that could affect the acquisition
value of the companies to which Ag-Chem is being compared.
Goldsmith Agio Helms performed an analysis of nine merger and
acquisition transactions involving agricultural machinery companies that
occurred between November, 1992 and November, 1999. The nine merger and
acquisition transactions considered were:
- AGCO's acquisition of Massey-Ferguson Ltd. - North American
Distribution Business (Varity Corporation);
- AGCO's acquisition of Allied Products Corporation - White/New
Idea Farm Equipment Division;
- AGCO's acquisition of Massey-Ferguson Group Ltd. (Varity
Corporation);
- M&W Gear Company's acquisition of Alamo Group, Inc.;
- The acquisition of Lindsay Manufacturing Co. by an investor
group;
- Varity Corporation's acquisition of Lucas Industries PLC;
- AGCO's acquisition of Xaver Fendt GmbH and Co.;
- The acquisition of Gehl Company by an investor group; and
- New Holland's acquisition of Case Corp.
For the nine merger and acquisition transactions analyzed, the multiple
represented by the ratio of enterprise value to LTM revenue ranged from 0.4x to
1.7x, with a mean of 0.9x and a median of 0.8x, compared with a multiple
represented by the ratio of enterprise value to revenue of 1.0x for Ag-Chem
based on an enterprise value of $293,734,594. The multiple represented by the
ratio of enterprise value to LTM EBIT ranged from 8.0x to 16.0x, with a mean of
11.9x and a median of 11.8x, compared with a multiple represented by the ratio
of enterprise value to LTM EBIT of 34.7x for Ag-Chem based on an enterprise
value of $293,734,594. The multiple represented by the ratio of enterprise value
to LTM EBITDA ranged from 6.9x to 10.6x with a mean of 8.9x and a median of
9.1x, compared to a multiple represented by the ratio of enterprise value to LTM
EBITDA of 18.9x for Ag-Chem based on an enterprise value of $293,734,594. By
applying the median ratios derived from the Comparable Transaction Analysis to
Ag-Chem's estimated operating results for the fiscal year ended September 30,
2000, Ag-Chem's range of implied equity value per share was calculated to be
$5.55 to $19.75.
Acquisition Premiums Analysis. Goldsmith Agio Helms analyzed the
premiums paid for 270 recent mergers and acquisitions of publicly traded
companies with enterprise values ranging from $200 to $500 million executed
between January 1, 1998 and November 8, 2000. The mean and the median premium
paid over the targets' stock prices four weeks before the announcement date, one
week before the announcement date, and one day before the announcement date were
39.6 percent and 46.9 percent, 31.3 percent and 37.1 percent, and 26.9 percent
and 31.4
32
40
percent, respectively. The per share price to be paid to Ag-Chem shareholders by
AGCO of $25.80 represents a premium of 129.3 percent over Ag-Chem's share price
as of close on November 8, 2000.
Historical Exchange Ratio Analysis. Goldsmith Agio Helms analyzed the
historical exchange ratio determined by comparing Ag-Chem's common stock price
and AGCO's common stock price over a twelve-month period. During the
twelve-month period ended November 8, 2000, the exchange ratio reached a high of
1.23 and a low of 0.48. The mean exchange ratio for this period was 0.79 and the
median was 0.77. This compares to an implied exchange ratio of 2.27, which is
based on the $25.80 share price to be paid to Ag-Chem shareholders and a stock
price of $11.35 for AGCO, which represents the highest of the 5, 10, 15, 20, and
30 day averages of AGCO's closing prices and the 5, 10, 15, 20 and 30 day
averages of the average of AGCO's daily high and low prices for such periods
ending on November 8, 2000.
Common Stock Trading History. Goldsmith Agio Helms's analysis of
Ag-Chem's and AGCO's common stock trading history consisted of historical
analyses of the trading prices and volumes of Ag-Chem and AGCO and the relative
performance of Ag-Chem, AGCO, and the S&P 500 Index. Goldsmith Agio Helms's
analysis considered the high and low closing prices for Ag-Chem and AGCO over
the one-year and three-year periods ended November 8, 2000. On November 15,
1999, Ag-Chem's common stock reached a one-year high closing price of $13.94 and
on June 1, 2000, reached a one-year low closing price of $6.13. On July 1, 1998,
Ag-Chem's common stock reached a three-year high closing price of $19.06 and on
June 1, 2000 reached a three-year low closing price of $6.13. On May 16, 2000,
AGCO's common stock reached a one-year high closing price of $14.16 and on
September 20, 2000, reached a one-year low closing price of $10.06. On January
5, 1998, AGCO's common stock reached a three-year high closing price of $30.47
and on October 5, 1998, reached a three-year low closing price of $6.09.
Goldsmith Agio Helms also analyzed the volume of shares traded at
various prices. For Ag-Chem's common stock, the volume-weighted average price
for the twelve months ending on November 8, 2000 was $9.88. For AGCO, the
volume-weighted average price for the twelve months ending November 8, 2000 was
$11.91.
WHAT YOU WILL RECEIVE; THE MERGER CONSIDERATION
The merger agreement provides for two different possible structures, a
"reverse merger" and a "forward merger." In a reverse merger, a subsidiary of
the acquiring company merges with, and into, the acquired company with the
acquired company being the survivor and ending up as a subsidiary of the
acquiring company. In a forward merger, the acquired company merges with, and
into, a subsidiary of the acquiring company with the survivor being the
subsidiary. Although in either event the acquiring company (AGCO) owns the
business of the acquired company (Ag-Chem) as a subsidiary following the merger,
the tax consequences for the companies and the shareholders of the acquired
company are significantly different for the two structures.
The tax consequences are highly complex and you are urged to carefully
read the section entitled "The Merger--Material Federal Income Tax Consequences"
beginning on page __. However, in general, the most favorable tax treatment is
available when the composition of the cash and stock portions of the purchase
price includes at least 40% stock and the transaction is a forward merger. If
that treatment cannot be obtained, from a tax perspective the composition of the
purchase price is less important but the transaction needs to be structured as a
reverse merger in order to get the most favorable tax treatment for the parties.
Hence, the merger agreement contains provisions that alter the mix of stock and
cash that you will receive as well as the structure of the merger - i.e.,
whether it is a forward merger or a reverse merger - based upon AGCO's share
price and the parties' tax objectives.
REGARDLESS OF THE MERGER STRUCTURE, THE MERGER CONSIDERATION YOU WILL
RECEIVE FOR EACH OF YOUR AG-CHEM SHARES WILL HAVE A VALUE OF $25.80. The
structure of the merger will be determined based upon the closing price of AGCO
shares on the trading day immediately prior to the effective date of the merger
(the "Share Price"). However, the number of shares of AGCO common stock that you
receive will be determined based upon the average closing price of AGCO shares
for the ten trading days immediately prior to the effective date of the merger
(the "Average Price").
- If the Share Price is $10.48 or higher, for each share of
Ag-Chem common stock you will receive a number of AGCO shares
that has a value of $12.90 divided by the
33
41
Average Price. This will result in 1.2317 shares or fewer. The
balance of the $25.80, $12.90, will be paid in cash.
- If the Share Price is between $8.38 and $10.47 for each share
of Ag-Chem common stock you will receive 1.2317 shares of AGCO
common stock. This will be stock with a value of between
$10.32 and $12.90. The balance of the $25.80, between $12.90
and $15.48, will be paid in cash.
Under either of the two scenarios described above, the merger
will be a forward merger and the receipt of AGCO shares
generally will be tax-free.
- If the Share Price is between $6.10 and $8.37, AGCO may elect
to pay you a combination of cash and AGCO common stock in any
ratio AGCO chooses (as long as AGCO does not issue more than
11,800,000 AGCO shares in the merger) that will provide the
value of $25.80. In lieu of either of these options, AGCO may
elect to defer the effective time of the merger for a period
up to thirty days, and if, during that period, the Share Price
goes back up to $8.38 or higher, the merger will be effected
as a forward merger and in exchange for your Ag-Chem shares
you will receive the combination of cash and stock described
above. Under this scenario, the merger will be a reverse
merger and receipt of AGCO shares generally will be taxable.
Under this scenario, the merger will be a reverse merger and
receipt of AGCO shares generally will be taxable.
- If the Average Price is $6.09 or below, AGCO may elect to
terminate the merger agreement, in which case you will
continue to hold your Ag-Chem shares unaffected, or AGCO may
elect to proceed with the merger, in which case you will
receive any portion of cash and stock as AGCO may choose that
will provide a value of $25.80 (as long as AGCO does not issue
more than 11,800,000 shares in the merger). In addition, AGCO
may utilize the issuance election described below. If AGCO
makes an issuance election, or fails to make such an election
within the period provided in the merger agreement, Ag-Chem
may terminate the merger agreement.
Based upon this structure and the various share prices covering the
range between the 52 week low of $9.4375 and the 52 week high of $14.50 for AGCO
common stock, Ag-Chem shareholders will receive the following amounts at the
following prices. Note that as recently as March 15, 2001, the closing price per
share of AGCO common stock was $11.06.
If the AGCO common stock Ag-Chem Shareholders will receive:
price is: ---------------------------------
Shares of AGCO common stock Cash
--------------------------- ----
$9.00 1.2317 $14.71
$9.50 1.2317 $14.10
$10.00 1.2317 $13.48
$10.50 1.2286 $12.90
$11.00 1.1727 $12.90
$11.50 1.1217 $12.90
$12.00 1.0750 $12.90
$12.50 1.0320 $12.90
$13.00 0.9923 $12.90
$13.50 0.9556 $12.90
$14.00 0.9214 $12.90
$14.50 0.8897 $12.90
The $8.38 and $8.37 prices described above are critical thresholds for
the tax treatment of the merger and are subject to adjustment. In addition, the
prices described in the chart are subject to adjustment. In particular,
34
42
because cash issued in lieu of fractional shares and cash paid upon the exercise
of dissenters' rights, if any, will reduce the number of shares issued in the
merger, these two thresholds automatically increase to get the stock portion up
to the level necessary for favorable tax treatment. It is impossible to predict
the exact amount of this adjustment. The adjustment attributable to fractional
shares will depend upon the number of fractional shares, but in all events will
be less than $.005. The adjustment attributable to dissenters will depend upon
the number of shares with respect to which dissenters' rights are exercised--and
frequently there are none--but, for example, if dissenters' rights are exercised
as to 100,000 shares, the resulting adjustment would be less than approximately
$.15. These adjustments will be relevant and material only if the AGCO share
price is slightly above $8.37 and there are dissenters.
Issuance Election. Under New York Stock Exchange rules, AGCO can issue
only approximately 11,800,000 shares of common stock (20% of its outstanding
shares) without obtaining AGCO stockholder approval. As a result, under no
circumstances is AGCO obligated to issue more than 11,800,000 of its shares to
complete the merger. However, if the Average Price is less than $6.10, AGCO may
elect to seek its stockholders' approval to issue more than 11,800,000 shares in
the merger. If AGCO so elects, Ag-Chem has a right to terminate the merger
agreement for a period of three days from the time it receives notice of AGCO's
election. If Ag-Chem does not so terminate, and AGCO obtains the requisite
stockholder approval to issue more than 11,800,000 AGCO shares in the merger,
then AGCO is obligated to issue the minimum number of AGCO shares necessary to
effect the merger as a forward merger, and you will receive for each share of
Ag-Chem common stock a number of AGCO shares equal to $10.32 divided by the
Average Price. Cash will make up any remaining balance, $15.48, owed to you so
that you receive the value of $25.80.
AGCO Subscription Right. If AGCO elects to issue less than 11,800,000
shares of AGCO common stock under the third or fourth scenarios above, you will
have subscription rights to subscribe to your pro rata portion of a number of
AGCO shares equal to the difference between the number of AGCO shares issued in
the merger and 11,800,000 AGCO shares, based on your proportionate ownership of
Ag-Chem shares. The subscription rights may be exercised by indicating the
maximum number of shares that you want to subscribe to, if any, on the
transmittal letter that AGCO sends to you following the merger and returning
that letter within thirty days following the merger. The shares subject to this
AGCO subscription right may be purchased at a price of $8.38 per share or at a
per share price equal to 105% of the average closing price of AGCO common stock
in the ten-day period prior to the effective date of the merger (whichever is
less).
Fractional Shares. Under no circumstances is AGCO obligated to issue
any fractional shares in the merger. Therefore, in place of any fractional AGCO
shares, AGCO will pay an amount in cash (without interest) for each fractional
share determined by multiplying the fraction by the Average Price.
We cannot predict the market prices for the AGCO common stock and we
encourage you to obtain current market quotations of the AGCO common stock,
which is listed on the New York Stock Exchange under the symbol "AG."
Regardless of the structure, upon completion of the merger, Ag-Chem
shareholders who do not exercise appraisal or dissenters' rights under Minnesota
law will receive merger consideration having a value of $25.80 per share in
exchange for their Ag-Chem shares.
RECOMMENDATION OF THE AG-CHEM BOARD OF DIRECTORS REGARDING THE MERGER
The Ag-Chem special committee and the Ag-Chem board of directors have
each unanimously determined that the merger agreement and the transactions
contemplated by the merger agreement, including the merger, are advisable and
fair to and in the best interests of Ag-Chem and its shareholders and both the
special committee and the board of directors recommend that Ag-Chem shareholders
vote to approve and adopt the merger agreement at the Ag-Chem special meeting.
In considering the recommendation of the Ag-Chem special committee and
board of directors with respect to the merger agreement, you should be aware
that some directors, executive officers and shareholders of Ag-Chem may have
interests in the merger that are different from, or are in addition to, the
interests of Ag-Chem shareholders generally. See "The Merger--Interests of
Ag-Chem Directors, Executive Officers and Shareholders," below.
35
43
INTERESTS OF AG-CHEM DIRECTORS, EXECUTIVE OFFICERS AND SHAREHOLDERS
When considering the Ag-Chem board of directors' recommendation that
the Ag-Chem shareholders vote in favor of the merger agreement, Ag-Chem
shareholders should be aware that a number of Ag-Chem directors, executive
officers and shareholders have arrangements that provide them with interests in
the merger that are different from, or in addition to, the interests of Ag-Chem
shareholders as a whole.
Severance for Officers, Directors and Employees. Nothing in the merger
agreement or any document or agreement related to the merger creates a contract
or term of employment for any Ag-Chem employee. As to most employees of Ag-Chem
or its subsidiaries, if their employment is terminated following the merger,
they will be entitled to receive severance in accordance with AGCO's policies
existing at the time. Under the merger agreement, AGCO has agreed to provide
severance payments to some employees equal to one or two times his or her annual
base salary as of the date of the merger agreement, if he or she is terminated
by AGCO without cause or voluntarily resigns for good reason prior to the first
anniversary of the date of the merger. Specifically, AGCO would be required to
make severance payments in the following amounts to the following persons in the
event of such termination. The amount of benefit received by these people has
been limited by so-called "golden parachute" provisions of the tax laws which
would impose a higher tax on such payments and would deny AGCO a deduction for a
portion of these payments.
Mary M. Jetland $195,743
Steve M. Koep $264,481
Donald D. Pottinger $466,000
John C. Retherford $122,450
8 other persons Amounts ranging from $114,400 to $170,000
Although AGCO does not currently intend to terminate the employment of any of
these persons, it has the right to do so based upon its ongoing assessment of
its needs and the value of such persons to its business and operations.
Bonus Plan. Some directors, officers, and employees of Ag-Chem have
been or are being paid bonuses. If the merger is terminated for any reason, no
bonuses that have not already been paid will be given. These bonuses reflect
Ag-Chem's desire to compensate persons for either 1) prior service to Ag-Chem or
2) efforts related to the merger. Ag-Chem has paid or will pay $1.6 million to
employees for their past services to Ag-Chem. Of this amount, $50,000 was paid
to Steve M. Koep and $100,00 was paid to other employees who are not executive
officers. The board of directors has granted Mr. McQuinn, Ag-Chem's CEO and
Chairman, complete discretion to grant bonuses aggregating up to $1.6 million to
employees based upon past services to Ag-Chem without further approval or action
by the board of directors. For their efforts related to negotiating the merger,
John C. Retherford has received $1,000,000 and Mary M. Jetland has received
$400,000. Mr. McQuinn has indicated that he does not intend to grant bonuses to
himself or additional bonuses to Mr. Retherford or Ms. Jetland.
Election to the AGCO Board of A. E. McQuinn. Under the merger
agreement, if A. E. McQuinn acquires an aggregate of 7,000,000 shares of AGCO
common stock in connection with the merger and/or pursuant to the exercise of
any subscription right offered by AGCO to Ag-Chem shareholders, AGCO has agreed
that, at the first meeting of the AGCO board of directors following the merger,
AGCO will use reasonable best efforts to increase the size of its board and to
appoint A. E. McQuinn to any vacancy created thereby. Whether Mr. McQuinn will
acquire an adequate number of shares of AGCO common stock will depend upon the
valuation of AGCO common stock at the time of closing. Based upon an AGCO price
per share of $11.00 (the closing price of AGCO common stock on March 15, 2001
was $11.06), Mr. McQuinn would not exceed the 7,000,000 number. Nevertheless,
AGCO has indicated its willingness to appoint Mr. McQuinn to its board of
directors even if the number of shares held by him is less than 7,000,000.
Phantom Stock Plan Payments. Some Ag-Chem officers, directors and
employees are in possession of "phantom shares" of Ag-Chem stock pursuant to the
Ag-Chem Equipment Co., Inc. 1998 Key Employee Phantom Stock Bonus Plan effective
December 1, 1998. Phantom shares do not represent shares of Ag-Chem's common
stock. Instead, phantom shares are a method of calculating potential bonus
payments to employees. Under the plan, all phantom shares are required to be
redeemed on November 30, 2001 if not sooner called. On the redemption date,
36
44
Ag-Chem is required to make a cash payment to the employee equal to the
difference between the grant price and the price of shares on the date of
redemption. The grant price was $11 15/16, the closing price of Ag-Chem's shares
on the date the plan was adopted. If the market price on the date of redemption
is lower than the grant price, no cash payment is required to be made. If the
price of Ag-Chem's common stock reaches $31 15/16, Ag-Chem has the right to call
and redeem the phantom shares at that time. Under the plan, if a participant's
employment is terminated, all rights under the plan are forfeited unless such
termination is the result of death or permanent total disability, in which case
the participant or his/her estate is entitled to receive a cash payment based
upon the market price of Ag-Chem's common stock on the date of death or
permanent total disability. Pursuant to the merger agreement, Ag-Chem has agreed
that upon or prior to closing of the merger to terminate the Phantom Stock Bonus
Plan and to make cash payments to its employees of approximately $13.86 per
phantom share (the difference between $25.80 and the grant price of $11 15/16),
aggregating $1,188,495 and of which $55,440 has been or will be paid to each of
Donald D. Pottinger, president of Ag-Chem, John C. Retherford, senior vice
president and chief financial officer of Ag-Chem and Mary M. Jetland, senior
vice president, SOILTEQ operations, of Ag-Chem, and $41,580 has been or will be
paid to Steve M. Koep, senior vice president, sales and marketing.
Subscription Rights. In the event that the merger is a reverse merger
and less than 11,800,000 AGCO shares are issued, Ag-Chem shareholders will have
the right to subscribe for the difference between 11,800,000 shares and the
number actually issued. See "The Merger--What You Will Receive; The Merger
Consideration--AGCO Subscription Right." Given the level of liquidity for AGCO
common stock, this right may not be significantly beneficial to most
shareholders who could purchase their pro-rata portion of the difference without
impacting market price, but might be of greater benefit to Mr. McQuinn given the
size of his position and the possibility that a large market purchase by him
might influence the market price.
FINANCING THE MERGER
AGCO anticipates that the total amount of cash necessary to complete
the merger will be approximately $150 million, including expenses related to the
merger and amounts required to pay off some indebtedness of Ag-Chem. AGCO
expects to fund the cash consideration and cash costs of the merger through
borrowings under its revolving credit facility.
AGCO's current credit facility is a 5-year, unsecured revolving credit
facility that expires in January 2002. As of September 30, 2000, the lending
commitment under this facility was $800 million. AGCO's total borrowings under
the revolving credit facility are limited to the sum of 90% of eligible accounts
receivable and 60% of eligible inventory. Interest accrues on borrowings
outstanding under the revolving credit facility primarily at LIBOR plus an
applicable margin, which is based on a rating grid. The revolving credit
facility contains customary covenants, including covenants restricting the
incurrence of indebtedness and the making of restrictive payments, including
dividends. In addition, AGCO must maintain financial covenants including, among
others, a debt to capitalization ratio, a fixed charge coverage ratio and a
ratio of debt to cash flow. As of September 30, 2000, approximately $326.3
million was outstanding under the revolving credit facility and available
borrowings, based on the lending commitment of $800 million, were $473.7
million, subject to the accounts receivable and inventory borrowing base
requirements.
ACCOUNTING TREATMENT OF THE MERGER
The merger will be treated as a purchase for accounting and financial
reporting purposes, which means that AGCO will include Ag-Chem's operating
results in its financial statements only from the consummation of the merger.
MATERIAL FEDERAL INCOME TAX CONSEQUENCES
GENERAL
The following is a summary of federal income tax consequences of the
merger and the exchange by the holders of Ag-Chem common stock of their shares
for the merger consideration. This discussion applies only to those Ag-Chem
shareholders, if any, who hold their shares as a capital asset. This discussion
does not address all aspects of taxation that may be relevant to individual
shareholders in light of their personal investment or tax circumstances, nor
does it discuss any state, local or foreign tax considerations. Further, the
discussion and the tax
37
45
opinions described below do not address all aspects of federal income taxation
that may be applicable to holders covered by special rules, such as:
- insurance companies;
- financial institutions;
- broker-dealers;
- foreign corporations;
- holders who are not United States persons;
- holders who receive stock through the exercise of stock
options or otherwise as compensation for services rendered;
and
- holders who held their stock as part of a hedge, appreciated
financial position, straddle or conversion transaction.
Accordingly, each Ag-Chem shareholder is urged to consult his or her
own tax advisor as to the specific tax consequences of the merger to that
shareholder, including the applicable federal, state, local and foreign tax
consequences of the merger.
Neither AGCO nor Ag-Chem has requested or will receive a ruling from
the Internal Revenue Service (IRS) as to the federal income tax consequences of
the merger. The following discussion is based upon the Internal Revenue Code,
the existing and proposed Treasury regulations thereunder, administrative
rulings and practice by the IRS, and judicial authority, in each case existing
at the time of this discussion, all of which is subject to change, possibly
retroactively.
SUMMARY
The U.S. federal income tax consequences to you of the merger may
differ depending on whether the forward merger structure or the reverse merger
structure is used. See "The Merger--What You Will Receive; The Merger
Consideration" for a description of the forward merger and reverse merger
structures.
As discussed below in "The Merger--Tax Opinions and Tax Consequences of
the Merger," if the forward merger structure is used and other assumptions are
met, the merger will be tax-free to Ag-Chem shareholders to the extent they
receive AGCO common stock in the merger. If the reverse merger structure is
used, the merger will be treated as a taxable sale of Ag-Chem common stock in
exchange for AGCO common stock and cash.
We will not know until the closing of the merger whether the forward
merger structure or the reverse merger structure will be used. As a result, you
will not know the tax consequences of the merger at the time you vote to approve
the merger agreement. However, based on AGCO's current closing common stock
price per share (the closing price was $11.06 on March 15, 2001), Ag-Chem's
management believes the forward merger structure will be used and that the
merger will be tax-free to the Ag-Chem shareholders to the extent they receive
AGCO common stock in the merger, as described below.
One of the requirements that must be satisfied in order for a merger to
qualify as a reorganization under Section 368(a) of the Internal Revenue Code
and therefore be partially tax-free to you, is the continuity of interest
requirement. This requirement will be satisfied if Ag-Chem shareholders exchange
a substantial portion of their proprietary interests in Ag-Chem for proprietary
interests in AGCO.
The IRS takes the position, for advance ruling purposes, that the
continuity of interest requirement is satisfied in a merger if the value of the
acquiring corporation's stock received by the acquired corporation's
shareholders equals or exceeds 50% of the total consideration paid for the stock
of the acquired corporation in the merger. In other words, if at least 50% of
the merger consideration consisted of AGCO common stock, the continuity of
interest requirement would be satisfied. However, the 50% threshold is merely a
safe harbor;
38
46
thresholds as low as 40% have been upheld by the courts. Accordingly, if 40% (by
value) of the merger consideration consisted of AGCO common stock, the
continuity of interest requirement would be satisfied. Unless the continuity of
interest requirement is met, the merger will not qualify as tax-free.
The merger agreement contains a mechanism that is intended to ensure
that the forward merger structure will be used only if the mix of stock and cash
received by the Ag-Chem shareholders satisfies the continuity of interest
requirement. AGCO believes that the continuity of interest requirement will be
satisfied if, on the date of the merger, the fair market value of the AGCO
common stock to be delivered in connection with the merger is greater than or
equal to 40% of the total consideration delivered to Ag-Chem shareholders in the
merger. Whether this requirement will be satisfied depends on certain
conditions, including the closing price of the AGCO common stock on the New York
Stock Exchange at the time of closing, the amount of cash paid in lieu of
fractional shares and the cash received by Ag-Chem shareholders who exercise
dissenters' rights.
The merger agreement also contains a mechanism which, if necessary,
will automatically adjust the AGCO common stock consideration received relative
to cash in order to achieve the 40% stock consideration threshold. However,
there is a limit to the amount of AGCO common stock that can be issued in the
merger (11,800,000 shares) and, if this limit is exceeded, AGCO may structure
the merger as a reverse merger, may seek its stockholders' approval to issue
additional shares or may terminate the merger altogether. This scenario is
likely only in the event of a sudden drop in the AGCO common stock price between
the date of this proxy statement/prospectus and the closing of the merger.
Because these variables will not be determined until the date of the merger, we
will not know at the time of the special meeting whether the merger will qualify
as a reorganization under Section 368(a) of the Internal Revenue Code, and
therefore, whether the forward merger structure or the reverse merger structure
will be used.
TAX OPINIONS AND TAX CONSEQUENCES OF THE MERGER
An opinion of counsel represents counsel's best legal judgment and is
not binding on the IRS, and there can be no assurance that following the merger
the IRS will not challenge the qualification of the merger as a reorganization
within the meaning of Section 368(a) of the Internal Revenue Code.
In connection with the filing of the Registration Statement, Troutman
Sanders LLP, counsel to AGCO, has delivered to AGCO its opinion (the "Tax
Opinion"), that subject to the assumptions, limitations, qualifications and
other considerations described below under "Certain Considerations with Respect
to Opinions," if the forward merger structure is used, the merger will be
treated as a "reorganization" for U.S. federal income tax purposes within the
meaning of Section 368(a) of the Internal Revenue Code, and the U.S. federal
income tax consequences of the merger will be that:
- no gain or loss will be recognized by AGCO, Agri Acquisition
Corp. or Ag-Chem as a result of the merger;
- an Ag-Chem shareholder who receives a combination of AGCO
common stock and cash in exchange for his or her Ag-Chem
common stock in the merger will recognize gain equal to the
lesser of (a) the fair market value of the AGCO common stock
plus the amount of cash received, less his or her basis in the
Ag-Chem common stock surrendered, or (b) the amount of cash
received;
- an Ag-Chem shareholder will not recognize a loss with respect
to his or her Ag-Chem common stock surrendered;
- the tax basis of the AGCO common stock received in the merger
by an Ag-Chem shareholder (including any fractional share
interest) will be the same as the tax basis of the Ag-Chem
common stock exchanged for the AGCO common stock, decreased by
the amount of cash received in the exchange for the Ag-Chem
common stock and increased by the amount of gain recognized by
the Ag-Chem shareholder upon the exchange;
- the holding period for long-term capital gain purposes of the
AGCO common stock received in the merger by an Ag-Chem
shareholder will include the holding period of that
shareholder in the Ag-Chem
39
47
common stock if the Ag-Chem common stock is held as a capital
asset at the effective time of the merger; and
- an Ag-Chem shareholder who exercises dissenters' rights with
respect to Ag-Chem common stock and who receives payment for
that stock in cash will recognize gain or loss measured by the
difference between the amount of cash received and the
shareholders' tax basis in that stock.
If the forward merger structure is used, each party's obligation to
consummate the merger is conditioned upon the receipt by each of AGCO and
Ag-Chem of a tax opinion, dated as of the Effective Time, that subject to the
assumptions, limitations, qualifications and other considerations described
below under "Certain Considerations with Respect to Opinions," the merger will
be treated as a "reorganization" for U.S. federal income tax purposes (the
"Closing Tax Opinions"). If either AGCO or Ag-Chem is unable to obtain its
respective Closing Tax Opinion, the forward merger structure will not be used.
The most likely cause of either AGCO or Ag-Chem not obtaining its respective
Closing Tax Opinion is that the merger consideration lacks sufficient continuity
of interest as described above. In that event, the reverse merger structure will
be used (see "Tax Consequences of a Reverse Merger" below).
Certain Considerations with Respect to Opinions. The Tax Opinion has
been rendered by Troutman Sanders LLP and AGCO expects that its Closing Tax
Opinion will be rendered by Troutman Sanders LLP as well. Ag-Chem expects its
Closing Tax Opinion to be rendered by KPMG LLP. The Tax Opinion, the Closing Tax
Opinions and the foregoing summary of the anticipated U.S. federal income tax
consequences of the merger are based upon, and are subject to certain
assumptions, limitations and qualifications, including certain representations
made by the respective managements of AGCO, Agri Acquisition Corp. and Ag-Chem.
These representations of fact have not and will not be independently verified by
Troutman Sanders LLP or KPMG LLP. If any of these representations or assumptions
are inconsistent with the actual facts, the U.S. federal income tax consequences
of the merger could be adversely affected. The Tax Opinion and Closing Tax
Opinions will also be based upon the Internal Revenue Code, existing and
proposed Treasury regulations thereunder, administrative rulings and practice by
the IRS, and judicial authority, in such case existing at the time each such
opinion is delivered. Any change in applicable law or pertinent facts could
affect the continuing validity of these opinions. In addition, these opinions
will not be binding on the IRS, and there can be no assurance, and none is
hereby given, that the IRS will not take a position which is contrary to one or
more positions reflected in the opinions, or that the opinions will be upheld by
the courts if challenged by the IRS.
Tax Consequences of a Reverse Merger. If the merger is structured as a
reverse merger, it is anticipated that:
- an Ag-Chem shareholder who exchanges his or her Ag-Chem common
stock for AGCO common stock and/or cash will recognize gain or
loss equal to the fair market value of the AGCO common stock
plus cash received, less his or her basis in the Ag-Chem
common stock surrendered;
- the tax basis of the AGCO common stock received by an Ag-Chem
shareholder in the merger will be equal to the fair market
value of the AGCO common stock at the time of the merger;
- the holding period of any stock received will begin at the
time the stock is received. Therefore, if an exchanging
shareholder sells any AGCO common stock received in the merger
less than one year after receiving the AGCO common stock, that
shareholder will not be afforded long-term capital gain or
loss on such a sale; and
- an Ag-Chem shareholder who exercises dissenters' rights with
respect to Ag-Chem common stock and who receives payment for
that stock in cash will recognize gain or loss measured by the
difference between the amount of cash received and the
shareholder's tax basis in that stock.
Reporting Requirements and Backup Withholding. Each shareholder
receiving AGCO common stock as a result of the merger will be required to retain
records and file with the shareholder's federal income tax return a statement
containing facts relating to the merger.
40
48
Backup withholding at the rate of 31% may apply with respect to
payments unless the recipient (a) is a corporation or comes within certain other
exempt categories and, when required, demonstrates this fact or (b) provides a
correct taxpayer identification number, certifies as to no loss of exemption
from backup withholding and otherwise complies with applicable requirements of
the backup withholding rules. A shareholder who does not provide AGCO with his
or her correct taxpayer identification number may have to pay penalties imposed
by the IRS. Any amounts withheld under the backup withholding rules may be
allowed as a refund or a credit against the shareholder's federal income tax
liability provided that any required information is furnished to the IRS. AGCO
will report to shareholders of AGCO and to the IRS the amount of "reportable
payments" and any amount withheld with respect to AGCO common stock received
during each calendar year.
THE DISCUSSION ABOVE AND THE OPINIONS DO NOT ADDRESS THE MATERIAL
FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER TO HOLDERS COVERED BY SPECIAL
RULES (SUCH AS THOSE LISTED ABOVE UNDER THE HEADING "GENERAL"), AND DOES NOT
PURPORT TO BE A COMPLETE ANALYSIS OR DESCRIPTION OF ALL POTENTIAL FEDERAL INCOME
TAX CONSEQUENCES OF THE MERGER. THE DISCUSSION IS BASED ON CURRENTLY EXISTING
PROVISIONS OF THE INTERNAL REVENUE CODE, EXISTING AND PROPOSED TREASURY
REGULATIONS THEREUNDER AND CURRENT ADMINISTRATIVE RULINGS AND COURT DECISIONS.
ALL OF THE FOREGOING ARE SUBJECT TO CHANGE AND ANY SUCH CHANGE COULD AFFECT,
RETROACTIVELY, THE CONTINUING VALIDITY OF THIS DISCUSSION. IN ADDITION, THE
DISCUSSION ABOVE AND THE OPINIONS DO NOT ADDRESS TAX CONSEQUENCES WHICH MAY VARY
WITH, OR ARE CONTINGENT ON, INDIVIDUAL CIRCUMSTANCES. MOREOVER, THIS DISCUSSION
AND THE OPINIONS DO NOT ADDRESS ANY NON-INCOME TAX OR ANY FOREIGN, STATE OR
LOCAL TAX CONSEQUENCES OF THE MERGER. THIS DISCUSSION AND THE OPINIONS DO NOT
ADDRESS THE TAX CONSEQUENCES OF ANY TRANSACTION OTHER THAN THE MERGER. YOU ARE
STRONGLY URGED TO CONSULT WITH YOUR TAX ADVISOR TO DETERMINE THE PARTICULAR
UNITED STATES FEDERAL, STATE, LOCAL OR FOREIGN INCOME OR OTHER TAX CONSEQUENCE
OF THE MERGER TO YOU.
REGULATORY MATTERS
The merger is subject to a number of regulatory filings and/or
approvals that are described below. While AGCO and Ag-Chem believe that they
will be able to obtain any required regulatory approvals, AGCO and Ag-Chem
cannot predict whether such regulatory approvals will be obtained within the
time frame contemplated by the merger agreement or on conditions that would not
be detrimental to AGCO or Ag-Chem, or whether such approvals will be obtained at
all.
Antitrust. Transactions such as the merger are reviewed by the United
States Department of Justice and the United States Federal Trade Commission to
determine whether they comply with applicable antitrust law. Under the
provisions of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (HSR Act), and the rules promulgated thereunder, the merger cannot be
completed until AGCO and Ag-Chem file premerger Notification and Report Forms
with the Antitrust Division of the United States Department of Justice and the
Federal Trade Commission and a required waiting period has expired or been
terminated. In December 2000, AGCO and Ag-Chem filed Notification and Report
Forms but voluntarily withdrew the filings prior to the expiration of the
waiting period as an administrative accommodation to the Federal Trade
Commission. On January 12, 2001, both of AGCO and Ag-Chem resubmitted
Notification and Report Forms. The required waiting period expired at midnight
on February 9, 2001.
At any time before or after the merger is completed, the United States
Department of Justice, the Federal Trade Commission or any state could take
action under the antitrust laws as it deems necessary or desirable in the public
interest, including seeking to enjoin the merger or seeking divestiture of
substantial assets of AGCO or Ag-Chem or their subsidiaries. Private parties may
also seek to take legal action under the antitrust laws under some
circumstances.
Foreign Regulatory Filings. AGCO and Ag-Chem each conduct business in a
number of foreign countries and jurisdictions. In connection with the merger,
the laws of some of those foreign countries and jurisdictions may require the
filing of information with, or the obtaining of the approval of, governmental
authorities in such countries and jurisdictions. On December 11, 2000, AGCO and
Ag-Chem made a premerger notification filing in Brazil. AGCO and Ag-Chem made
regulatory filings in Germany on February 14, 2001 and received clearance on
March 12, 2001. AGCO and Ag-Chem must make regulatory filings in Argentina
within 15 days of closing of the merger.
41
49
AGCO and Ag-Chem can give no assurance that the required regulatory
approvals described above will be received or, if received, the timing and the
terms and conditions of the regulatory approvals or whether conditions will be
imposed.
APPRAISAL AND DISSENTERS' RIGHTS
The following summary of the applicable provisions of sections 302A.473
and 302A.471 of the Minnesota Business Corporation act (the "MBCA") is not
intended to be a complete statement of such provisions and is qualified in its
entirety, by reference to such sections, the full texts of which are attached as
Appendix C to this proxy statement/prospectus. These sections should be reviewed
carefully by any Ag-Chem shareholder who wishes to exercise dissenters' rights
or who wishes to preserve the right to do so, since failure to comply with the
statutory procedures summarized below will result in the loss of dissenters'
rights. Any holder who forfeits his or her dissenters' rights by failure to
follow these procedures will then receive the merger consideration described in
this document upon completion of the merger.
The merger agreement constitutes a plan of merger for which shareholder
approval is required under the MBCA. Under Sections 302A.473 and 302A.471 of the
MBCA, holders of Ag-Chem common stock will have the right, by fully complying
with the applicable provisions of Sections 302A.473 and 302A.471, to dissent
with respect to the merger and to obtain payment in cash of the "fair value" of
their shares of Ag-Chem common stock after the merger is completed. The term
"fair value" means the value of the shares of Ag-Chem common stock immediately
before the effective time.
All references in Sections 302A.473 and 302A.471 and in this summary to
a "shareholder" are to a record holder of the shares of Ag-Chem common stock as
to which dissenters' rights are asserted. A person having beneficial ownership
of shares of Ag-Chem common stock that are held of record in the name of another
person, such as a broker, nominee, trustee or custodian, must act promptly to
cause the record holder to follow the steps summarized below properly and in a
timely manner in order to perfect whatever dissenters' rights such beneficial
owner may have.
Shareholders of record who desire to exercise their dissenters' rights
under the MBCA must satisfy all of the following conditions:
- BEFORE the Ag-Chem special meeting, deliver a written notice
of intent to demand fair value for shares to the Secretary of
Ag-Chem, 5720 Smetana Drive, Minnetonka, Minnesota,
55343-9688, Fax number (952) 933-8799. The written demand
should specify the shareholder's name and mailing address, the
number of shares owned and that the shareholder intends to
demand the value of his or her shares. This written demand
must be in addition to and separate from any proxy or vote
against the merger. Voting against, abstaining from voting or
failing to vote on the merger does not constitute a demand for
appraisal within the meaning of the MBCA.
- Ag-Chem shareholders that elect to exercise their dissenters'
rights under the MBCA must not vote for adoption of the merger
agreement. A shareholder's failure to vote against the merger
agreement will not constitute a waiver of dissenters' rights.
However, if a shareholder returns a signed proxy but does not
specify a vote against adoption of the merger or direction to
abstain, the proxy will be voted for adoption of the merger
agreement, which will have the effect of waiving that
shareholder's dissenters' rights.
- Ag-Chem shareholders may not assert dissenters' rights as to
less than all of the shares registered in such holder's name
except where shares are beneficially owned by another person
but registered in such holder's name. If a record owner, such
as a broker, bank, nominee, trustee or custodian, wishes to
dissent with respect to shares beneficially owned by another
person, such shareholder must dissent with respect to all of
such shares and must disclose the name and address of the
beneficial owner on whose behalf the dissent is made. A
beneficial owner of shares of Ag-Chem common stock who is not
the record owner of such shares may assert dissenters' rights
as to shares held on such person's behalf, provided that such
beneficial owner submits a written consent of the record owner
to Ag-Chem at or before the time such rights are asserted.
42
50
After adoption of the merger agreement by the shareholders at the
Ag-Chem special meeting, the surviving corporation will send a written notice to
each shareholder who filed a written demand for dissenters' rights. The notice
will contain the following information:
- the address to which the shareholder must send a demand for
payment and the shareholder's stock certificates in order to
obtain payment and the date by which they must be received;
- a form to be used to certify the date on which the
shareholder, or the beneficial owner on whose behalf the
shareholder dissents, acquired the shares or an interest in
them and to demand payment; and
- a copy of Section 302A.471 of the MBCA and a copy of this
summary describing the procedures to be followed in asserting
dissenters' rights.
In order to receive fair value for his or her shares, a dissenting
shareholder must, within 30 days after the date the notice from the surviving
corporation was given, send his or her stock certificates, and all other
information specified in the notice, to the address identified in such notice. A
dissenting shareholder will retain all rights as a shareholder until the
effective time of the merger. After a valid demand for payment and the related
stock certificates and other information are received, or after the effective
time of the merger, whichever is later, the surviving corporation will remit to
each dissenting shareholder who has complied with statutory requirements the
amount that the surviving corporation estimates to be the fair value of such
shareholder's shares, with interest commencing five days after the effective
time of the merger at a rate prescribed by statute. Remittance will be
accompanied by the surviving corporation's closing balance sheet and statement
of income for a fiscal year ending not more than 16 months before the effective
time, together with the latest available interim financial data, an estimate of
the fair value of the shareholder's shares and a brief description of the method
used to reach the estimate, a brief description of the procedure to be followed
if such holder is demanding supplemental payment and copies of Sections 302A.473
and 302A.471 of the MBCA. If the dissenting shareholder believes that the amount
remitted by the surviving corporation is less than the fair value of such
holder's shares, plus interest, the shareholder may give written notice to the
surviving corporation of such holder's own estimate of the fair value of the
shares, plus interest, within 30 days after the mailing date of the remittance,
and demand payment of the difference. Such notice must be delivered to the
executive offices of the surviving corporation. A shareholder who fails to give
such written notice within this time period is entitled only to the amount
remitted by the surviving corporation.
Within 60 days after receipt of a demand for supplemental payment, the
surviving corporation must either pay the shareholder the amount demanded or
agreed to by such shareholder after discussion with the surviving corporation or
petition a court for the determination of the fair value of the shares, plus
interest. The petition must name as parties all shareholders who have demanded
supplemental payment and have not reached an agreement with the surviving
corporation. The court, after determining that the shareholder or shareholders
in question have complied with all statutory requirements, may use any valuation
method or combination of methods it deems appropriate to use, whether or not
used by the surviving corporation or the dissenting shareholder, and may appoint
appraisers to recommend the amount of the fair value of the shares. The court's
determination will be binding on all Ag-Chem shareholders who properly exercised
dissenters' rights and did not agree with the surviving corporation as to the
fair value of the shares. Dissenting shareholders are entitled to judgment for
the amount by which the court-determined fair value per share, plus interest,
exceeds the amount per share, plus interest, remitted to the shareholders by the
surviving corporation. The shareholders shall not be liable to the surviving
corporation for any amounts paid by the surviving corporation which exceed the
fair value of the shares as determined by the court, plus interest. The costs
and expenses of such a proceeding, including the expenses and compensation of
any appraisers, will be determined by the court and assessed against the
surviving corporation, except that the court may, in its discretion, assess part
or all of those costs and expenses against any shareholder whose action in
demanding supplemental payment is found to be arbitrary, vexatious or not in
good faith. The court may award fees and expenses to an attorney for the
dissenting shareholders out of the amount, if any, awarded to such shareholders.
Fees and expenses of experts or attorneys may also be assessed against any
person who acted arbitrarily, vexatiously or not in good faith in bringing the
proceeding.
The surviving corporation may withhold the remittance of the estimated
fair value, plus interest, for any shares owned by any person who was not a
43
51
shareholder or who is dissenting on behalf of a person who was not a beneficial
owner on November 20, 2000, the date on which the proposed merger was first
announced to the public. The surviving corporation will forward to any such
dissenting shareholder who has complied with all requirements in exercising
dissenters' rights the notice and all other materials sent after shareholder
approval of the merger to all shareholders who have properly exercised
dissenters' rights, together with a statement of the reason for withholding the
remittance and an offer to pay the dissenting shareholder the amount listed in
the materials if the shareholder agrees to accept that amount in full
satisfaction. The shareholder may decline this offer and demand payment by
following the same procedure as that described for demand of supplemental
payment by shareholders who owned their shares as of such date. Any shareholder
who did not own shares on such date and who fails properly to demand payment
will be entitled only to the amount offered by the surviving corporation. Upon
proper demand by any such shareholder, rules and procedures applicable in
connection with receipt by the surviving corporation of the demand for
supplemental payment given by a dissenting shareholder who owned shares on such
date will also apply to any shareholder properly giving a demand but who did not
own shares of record or beneficially on such date, except that any such
shareholder is not entitled to receive any remittance from the surviving
corporation until the fair value of the shares, plus interest, has been
determined pursuant to such rules and procedures.
Shareholders considering exercising dissenters' rights should bear in
mind that the fair value of their shares determined under Sections 302A.473 and
302A.471 of the MBCA could be more than, the same as or, in some circumstances,
less than the consideration they would receive pursuant to the merger agreement
if they do not seek appraisal of their shares. A dissenting shareholder is
entitled to judgment in cash for the amount, if any, that the court's
determination of the fair value exceeds the amount, if any, remitted by the
surviving corporation. In the event the amount remitted to the dissenting
shareholder exceeds the court's fair-value determination, the dissenting
shareholder is not liable for such difference and is entitled to retain the
greater remitted amount.
Cash received pursuant to the exercise of dissenters' rights may be
subject to federal or state income tax. See "The Merger Agreement--Material
Federal Income Tax Consequences."
FEDERAL SECURITIES LAWS CONSEQUENCES; STOCK TRANSFER RESTRICTIONS
Unless you are an affiliate of AGCO, shares of AGCO common stock
received in the merger will be freely transferable. The definition of affiliate
is complex and depends on specific facts, but generally encompasses directors,
senior officers, 10% shareholders and any other person with the power to direct
the management and policies of AGCO as well as those entities that are
controlled by AGCO and its subsidiaries, including, after the merger, Ag-Chem.
The Securities Act of 1933 and Securities Act Rules 144 and 145 restrict the
ability of affiliates to resell their shares of AGCO common stock. The merger
agreement requires Ag-Chem to use its best efforts to obtain written agreements
with its affiliates to the effect that they will not sell or otherwise dispose
of their AGCO shares in violation of the Securities Act or these rules.
Shareholders who are affiliates of Ag-Chem or AGCO may not sell shares
of AGCO common stock received in the merger except (a) pursuant to an effective
registration statement under the Securities Act, (b) in compliance with an
exemption from the registration requirements of the Securities Act or (c) in
compliance with Rule 144 and Rule 145 of the Securities Act. Generally, those
rules permit resales of stock received in a registered offering by an affiliate
of Ag-Chem or AGCO as long as AGCO has complied with the reporting requirements
and the selling shareholder complies with the volume and manner of sale
restrictions set forth in Rule 144 and Rule 145.
44
52
MATERIAL PROVISIONS OF THE MERGER AGREEMENT AND RELATED AGREEMENTS
The following summarizes the material terms of the merger agreement, a
copy of which is attached as Appendix A to this proxy statement/prospectus and
is incorporated into this proxy statement/prospectus by reference. You should
read the merger agreement in its entirety for a more complete description of the
terms and conditions of the merger.
GENERAL
In the merger, AGCO will acquire all of the outstanding Ag-Chem common
stock in exchange for a combination of shares of AGCO common stock and cash with
a value of $25.80 per share of Ag-Chem common stock.
Forward merger. As long as the closing price of AGCO common stock on
the trading day immediately prior the effective date of the merger is equal to
or greater than $8.38 (or such higher price as may be necessary to obtain
opinions as to the status of the merger as a partially tax-free reorganization),
the merger is intended to qualify as a partially tax-free reorganization for
purposes of Section 368(a) of the Internal Revenue Code and will have a forward
structure. This means that Ag-Chem will merge with and into Agri Acquisition
Corp., a newly-formed wholly-owned subsidiary of AGCO formed solely for this
purpose, and, following the effective time of the merger, the separate corporate
existence of Ag-Chem will cease and Agri Acquisition Corp. will be the surviving
corporation and continue to exist as a Delaware corporation.
Reverse merger. However, if the closing price of shares of AGCO common
stock on the day immediately prior to the effective date of the merger is less
than $8.38 (or such higher price as may be necessary to obtain opinions as to
the status of the merger as a tax-free reorganization), then the merger will not
be a tax-free reorganization and will have a reverse structure. This means that
Agri Acquisition Corp., a newly-formed wholly-owned subsidiary of AGCO formed
solely for this purpose, will merge with and into Ag-Chem and, following the
effective time of the merger, the separate corporate existence of Agri
Acquisition Corp. will cease and Ag-Chem will be the surviving corporation and
continue to exist as a Minnesota corporation.
Measuring Date. The value of the shares of AGCO common stock for
purposes of determining whether the merger will be a forward merger or a reverse
merger will be measured based on the closing price of AGCO common stock on the
trading day immediately prior to the effective date of the merger. Therefore, we
will not know at the time of the Ag-Chem special meeting whether the forward
merger structure or the reverse merger structure will be used. The structure of
the merger will affect the tax consequences of the merger to Ag-Chem
shareholders.
The purpose of this alternate structure is to avoid the substantial
corporate level tax that would result if the merger were to be structured as a
forward merger and were to fail to satisfy the requirements for a Section 368(a)
reorganization.
Tax Consequences to Ag-Chem Shareholders. If the forward merger
structure is used and the merger qualifies as a partially tax-free
reorganization under Section 368(a) of the Internal Revenue Code, you will
recognize gain equal to the lesser of
- the fair market value of the AGCO common stock received, plus
the amount of cash received, less your basis in the Ag-Chem
stock surrendered, and
- the amount of cash received.
You will not be entitled to recognize any loss.
If the reverse merger structure is used, however, you will be taxed on
all gain realized, regardless of the form of consideration that you receive in
exchange for your shares of Ag-Chem stock, and you will be entitled to recognize
any realized loss. Details of the tax consequences of the merger to you are more
fully described under "The Merger--Material Federal Income Tax Consequences."
45
53
Regardless of the structure, upon completion of the merger, Ag-Chem
shareholders who do not exercise their dissenters' rights will receive the
merger consideration in exchange for their Ag-Chem shares (described more fully
under "The Merger--What You Will Receive; The Merger Consideration").
CLOSING; EFFECTIVE TIME
The merger will be effective when both (1) the articles of merger are
filed with the Minnesota Secretary of State and all other filings or recordings
required by the Minnesota Business Corporation Act are made and (2) the
certificate of merger is filed with the Delaware Secretary of State and all
other filings or recordings required by the Delaware General Corporations Law
are made. Alternatively, the merger will be effective at any later date or time
set forth in the articles of merger or in the certificate of merger.
DIRECTORS AND OFFICERS OF SURVIVING CORPORATION AFTER THE MERGER
The directors of the surviving corporation will be determined by AGCO.
The officers of the surviving corporation after the merger will be the
officers of Ag-Chem as comprised immediately before the effective time of the
merger. These officers will remain officers until the earlier of their
resignation, removal or otherwise ceasing to be an officer or until their
respective successors are duly elected and qualified, as the case may be.
CONVERSION OF SHARES
At the effective time of the merger, each share of Ag-Chem common
stock, excluding shares to the extent that dissenters' rights are exercised,
will cease to be outstanding and will be converted into the right to receive the
merger consideration described above.
CONVERSION OF PHANTOM SHARES
In connection with the merger, participants in Ag-Chem's phantom stock
bonus plan will receive $13.86 in cash per phantom stock unit, estimated to be
an aggregate of $1,188,495, including payments already made under this plan.
EXCHANGE OF STOCK CERTIFICATES
Soon after the effective date of the merger, either AGCO or the
exchange agent will mail you a letter of transmittal and instructions for
exchanging your Ag-Chem stock certificates for the merger consideration
described above. Only after you surrender your Ag-Chem stock certificates,
together with the executed letter of transmittal, will you be entitled to
receive the merger consideration described above. The exchange agent is SunTrust
Bank, Atlanta.
If you have not complied with the exchange procedure within six months
after the effective time of the merger, you will have to look to AGCO for
delivery of any AGCO common stock or cash deliverable in exchange for your
Ag-Chem shares.
AGCO will not pay you any cash or any dividends or other distributions
it has declared until you have exchanged your Ag-Chem stock certificates.
Following surrender of any Ag-Chem certificates you may hold, AGCO will pay you,
without interest, any amount of cash owed to you as part of the merger
consideration or for any fractional shares, and any dividends or other
distributions declared by AGCO, to which you are entitled.
If your Ag-Chem stock certificates are lost, stolen, or destroyed
before the closing of the merger, you must submit an affidavit of that fact to
the exchange agent and AGCO and, if required by AGCO, you must post a bond in a
reasonable amount as determined by AGCO as indemnity against any potential claim
regarding the lost certificates. In exchange for lost, stolen or destroyed stock
certificates, after you have made the affidavit and posted the bond, AGCO or the
exchange agent will issue to you any shares of AGCO common stock and cash to
which you are entitled.
46
54
REPRESENTATIONS AND WARRANTIES
In the merger agreement, both Ag-Chem and AGCO make customary
representations and warranties relating to various aspects of their respective
businesses and other matters. These include:
- the valid corporate organization and existence of each party and its
subsidiaries;
- the capitalization of AGCO and Ag-Chem and their subsidiaries;
- the corporate power and authority of each party to enter into the
merger agreement;
- the fact that entry into the merger agreement will not create a
conflict or breach with the certificate or articles of incorporation
and bylaws of each party, applicable law or specified material
agreements;
- third-party consents and governmental approvals relating to the merger;
- each party's compliance with applicable law;
- the timely filing and/or availability and accuracy of required reports
and filings with the Securities and Exchange Commission; and
- that neither party will take any actions that may jeopardize the
qualification of the merger as a reorganization within the meaning of
Section 368(a) of the Internal Revenue Code.
Ag-Chem has given additional representations and warranties including:
- the absence of undisclosed liabilities;
- the absence of undisclosed litigation;
- that there has been complete and correct disclosure of employment
benefit and labor matters;
- that Ag-Chem has no undisclosed intellectual property litigation and
has disclosed the nature of its ownership interests in all of its
intellectual property;
- tax matters, including the filing and accuracy of tax returns;
- the absence of environmental liabilities;
- inapplicability of Minnesota take-over laws;
- insurance coverage compliance; and
- that Ag-Chem has obtained an opinion from its financial advisor that
the merger consideration is fair from a financial point of view to its
shareholders.
AGCO has given additional representations and warranties including:
- issuance and registration of any new stock for the merger;
- procurement of adequate financing for the merger; and
- that no action has been taken that would give rise to a claim against
any party for a brokerage commission or finder's fee with respect to
any of the transactions contemplated by the merger agreement.
47
55
COVENANTS
The following summarizes important pre-closing covenants in the merger
agreement. From the date of the merger agreement until the closing of the
merger, Ag-Chem and its subsidiaries have agreed to continue to operate their
respective businesses according to their ordinary and usual course of business,
conduct its business in material compliance with all applicable laws and
regulations and use its reasonable best efforts to preserve intact its business
and assets and maintain existing relations with its customers, suppliers, and
employees and business associates with limited exceptions. Ag-Chem has also
agreed that it will not, without the prior written consent of AGCO:
- amend its articles of incorporation or bylaws, or adopt a shareholder
rights plan;
- declare, set aside or pay dividends on or make other distributions on
any of its stock, except for intercompany dividends from subsidiaries;
- adjust, split, combine, repurchase, redeem or otherwise acquire, any
shares of its capital stock or other securities of Ag-Chem or its
subsidiaries;
- merge or consolidate with any other entity or make any new acquisition
of assets pursuant to which Ag-Chem shareholders would receive any
consideration in exchange for or in addition to their existing shares
of Ag-Chem stock;
- sell all or substantially all of its assets, business or properties,
other than sales of goods and services to distributors and customers in
the ordinary course of business;
- take any action knowing that it would, or is reasonably likely to,
prevent the merger from qualifying as a reorganization within the
meaning of Section 368(a) of the Internal Revenue Code;
- issue, pledge, dispose of or encumber any capital stock, or issue any
rights or options to acquire capital stock or securities convertible
into or exchangeable for capital stock;
- incur indebtedness outside the ordinary and usual course of business,
consistent with past practice, or incur indebtedness under its short
and long term line of credit loan agreements in excess of $55,000,000
in the aggregate;
- enter into or amend any employment, severance, retention, termination
or similar agreement, other than ordinary course annual salary or wage
rate increases and other than new consulting arrangements not in excess
of $100,000 in the aggregate relating to existing SOILTEQ initiatives;
- enter into, adopt or amend in any material respect any employee benefit
or similar plan;
- pay any special bonus or special remuneration to any of its directors
or officers except for those bonuses described on page __;
- implement or adopt any change in accounting practices, except as
required by accounting principles generally accepted in the United
States or Securities Exchange Commission rules;
- enter into or terminate any contract or agreement, except in the
ordinary course of business, that may involve any amount in excess of
$200,000;
- make any material new tax election, settle any material tax audit or
proceedings or file any material amended tax return;
- pay, discharge, or settle any claims other than settlements with
customers related to Ag-Chem's September 8, 2000 safety recall or
settlements not in excess of $100,000; or
48
56
- make any capital expenditures in excess of $500,000 in the aggregate
in any fiscal quarter.
From the date of the merger agreement until the effective time of the
merger, both Ag-Chem and AGCO have agreed to:
- use their reasonable best efforts to cause the merger to be
consummated;
- obtain any necessary shareholder approvals (Ag-Chem does not currently
intend to amend its proxy statement or to resolicit proxies in the
event that Ag-Chem waives any or all of the conditions to close the
merger);
- prepare and cooperate in the preparation of any filings with the
Securities and Exchange Commission, the New York Stock Exchange, or
other filings associated with the merger;
- agree on the initial press release with respect to the merger, and to
consult the other party prior to the release of any additional releases
or statements;
- give the other access to all of their respective properties, books,
contracts, commitments and records and to furnish information
concerning their businesses, properties and personnel, subject to the
restrictions and for the purposes set forth in the merger agreement;
- give prompt notice to the other of any fact event or circumstance
that would cause or constitute a material breach of any of its
representations, warranties, covenants or agreements;
- use their best efforts to do all things necessary, proper or advisable
to consummate the merger, including obtaining all necessary consents,
governmental approvals and the like; and
- use their best efforts to do all things necessary, proper or advisable
to cause the merger to be a tax-free reorganization.
DIRECTOR AND OFFICER INDEMNIFICATION
ACGO has agreed to indemnify (and advance expenses as incurred) the
present and former directors and officers of Ag-Chem and its subsidiaries
against all costs or expenses (including reasonable attorneys' fees) incurred in
connection with any claim arising out of occurrences at or prior to the
effective time of the merger to the fullest extent that Ag-Chem is permitted to
indemnify its directors and officers under the Ag-Chem bylaws, articles of
incorporation, and the laws of the State of Minnesota. AGCO has further agreed
that for six years after the effective time of the merger, directors' and
officers' liability insurance policies will be maintained covering persons
indemnified by Ag-Chem. AGCO will not be required to incur an annual premium in
excess of 150% of the annual premium paid by Ag-Chem. If equivalent insurance
coverage is not obtainable, AGCO will use reasonable best efforts to obtain the
comparable coverage available for such amount.
AFFILIATE LETTERS
Ag-Chem will provide AGCO with a list of those persons who are or are
likely to be "affiliates" at the time of the Ag-Chem special meeting of
shareholders within the meaning of the rules of the Securities and Exchange
Commission. Ag-Chem will use its best efforts to cause each affiliate to deliver
an executed affiliate letter, substantially in the form of Appendix E attached
to this proxy statement/prospectus, to AGCO prior to the mailing of the proxy
statement/prospectus. Under these letters, each Ag-Chem affiliate will agree not
to dispose of his or her shares of AGCO common stock received in the merger
except pursuant to an effective registration statement or in compliance with the
rules of the Securities and Exchange Commission. AGCO will be entitled to place
appropriate legends on the certificates evidencing any AGCO common stock to be
received by the Ag-Chem affiliates pursuant to the terms of the merger
agreement, and to issue appropriate stop transfer instructions to the transfer
agent for the AGCO common stock, consistent with the terms of the affiliate
letters.
49
57
EMPLOYEE BENEFIT MATTERS
AGCO has agreed to waive most exclusions or waiting periods, to credit
any co-payments and deductibles paid and to recognize service of Ag-Chem
employees for purposes of eligibility to participate in any existing AGCO
benefit plan in which an Ag-Chem employee is eligible to participate after the
merger, but only to the extent that such exclusions, waiting periods,
co-payments and deductibles were recognized under the analogous Ag-Chem benefit
plan and will not result in duplication of benefits. This, however, does not
mean that AGCO is required to provide for the participation of any Ag-Chem
employee in any existing AGCO benefit plan.
APPOINTMENT OF A. E. MCQUINN TO AGCO BOARD OF DIRECTORS
AGCO has agreed to use reasonable best efforts to appoint A. E. McQuinn
to the AGCO board of directors at the first meeting of AGCO's board of directors
following the effective date of the merger, if Mr. McQuinn, in connection with
the merger and/or any AGCO subscription right made available to Ag-Chem
shareholders, acquires an aggregate of 7,000,000 shares of AGCO common stock.
Nevertheless, AGCO has indicated its willingness to appoint Mr. McQuinn to its
board of directors even if the number of AGCO shares held by him is less than
7,000,000.
CONDITIONS TO OBLIGATIONS TO EFFECT THE MERGER
The obligations of Ag-Chem and AGCO to complete the merger are subject
to satisfaction or waiver of the following conditions.
- approval of the merger agreement by the requisite vote of
Ag-Chem shareholders and, if necessary, approval of any
additional share issuance by the requisite vote of AGCO
stockholders;
- the absence of any law, order or other legal restraint
prohibiting completion of the merger;
- the receipt of any required approvals from government entities
or regulatory bodies and the expiration of all related
statutory waiting periods;
- the conditional approval for listing on the New York Stock
Exchange of the shares of AGCO common stock to be issued in
the merger, subject to official notice of issuance; and
- the declaration of the effectiveness of this registration
statement on Form S-4 by the Securities and Exchange
Commission, and the absence of any stop order suspending the
effectiveness.
In addition to the above, the obligation of Ag-Chem to complete the
merger is subject to the satisfaction or waiver of the following conditions:
- material performance by AGCO of all obligations required to be
performed by it under the merger agreement at or prior to the
effective time of the merger;
- the accuracy of the representations and warranties of AGCO in
the merger agreement as of the date of the merger agreement
except as would not have a materially adverse effect on
Ag-Chem or consummation of the merger;
- in the event the merger is a forward merger, the receipt by
Ag-Chem of an opinion of KPMG LLP, dated the effective date of
the merger to the effect that, on the basis of facts,
representations and assumptions set forth in the opinion, the
merger will be treated as a reorganization within the meaning
of Section 368(a) of the Internal Revenue Code and,
accordingly, (1) no gain or loss will be recognized by
Ag-Chem, and (2) no gain or loss will be recognized by any
shareholder of Ag-Chem who receives shares of AGCO stock in
the merger except to the extent of shareholder realized gain
for the cash portion of any merger consideration and cash
received in lieu of fractional share interests;
- the absence of any action by a governmental authority that is
reasonably likely to succeed in seeking to prohibit completion
of the merger or to impose substantial penalties as a result
of the merger; and
50
58
- the receipt by Ag-Chem of a fairness opinion from Ag-Chem's
financial advisor, Goldsmith Agio Helms, in a form acceptable to
Ag-Chem. Goldsmith Agio Helms delivered its fairness opinion dated
November 18, 2000.
In addition to the above, the obligation of AGCO to complete the merger
is subject to the satisfaction or waiver of the following conditions:
- the material performance by Ag-Chem of all obligations required to
be performed by it under the merger agreement at or prior to the
effective time of the merger;
- the accuracy of the representations and warranties of Ag-Chem in
the merger agreement as of the date of the merger agreement except
as would not have a materially adverse effect on AGCO or
consummation of the merger; and
- in the event the merger is a forward merger, the receipt by AGCO
of an opinion of Troutman Sanders LLP, counsel to AGCO and Agri
Acquisition Corp., dated the effective date of the merger to the
effect that, on the basis of the facts, representations and
assumptions set forth in the opinion, the merger will be treated
as a reorganization within the meaning of Section 368(a) of the
Internal Revenue Code and, accordingly, no gain or loss will be
recognized by AGCO, Agri Acquisition Corp. and Ag-Chem.
FRUSTRATION OF CLOSING CONDITIONS
Neither AGCO nor Ag-Chem may rely on the failure to satisfy any of the
above conditions if the failure was caused by such party's failure to use
reasonable best efforts to cause the merger to be consummated.
NO SOLICITATION
Ag-Chem has agreed that it will not, and will not permit any of its
subsidiaries, officers, employees, attorneys, accountants, agents or other
representatives to:
- solicit, initiate or encourage, or take any other actions designed
to facilitate any inquiries or the making of any proposal which
constitutes an acquisition proposal;
- participate in any discussions or negotiations regarding any
acquisition proposal;
- provide any information or data with respect to Ag-Chem to any
person in connection with an acquisition proposal; or
- grant any waiver or release under any standstill or similar
agreement with respect to Ag-Chem's common stock.
Ag-Chem has also agreed to cease any existing discussions or
negotiations with any parties regarding any acquisition proposal or that could
reasonably be expected to lead to any acquisition proposal. An acquisition
proposal excludes the proposed merger with AGCO and includes any offer,
proposal, inquiry or indication of interest regarding:
- a merger, reorganization or consolidation, or any similar business
combination or transaction, involving Ag-Chem (other than mergers,
reorganizations, consolidations or similar business combinations
or transactions involving solely Ag-Chem and/or one or more of
Ag-Chem's wholly-owned subsidiaries);
- a direct or indirect purchase or other acquisition (including by
way of merger, consolidation, share exchange, tender or exchange
offer involving any Ag-Chem subsidiary or securities issued by any
Ag-Chem subsidiary) of more than 15% of the consolidated assets of
Ag-Chem and its subsidiaries;
51
59
- a purchase or other acquisition (including by way of merger,
consolidation, share exchange, tender or exchange offer or
otherwise) of beneficial ownership of securities representing
more than 10% of the voting power of Ag-Chem; or
- any transaction substantially similar to the foregoing
transactions.
Notwithstanding the foregoing, if Ag-Chem's board of directors
reasonably determines, after consultation with its financial advisors and
outside legal counsel, that it has received an acquisition proposal that may
reasonably lead to a superior proposal, Ag-Chem may furnish information and
access to the person submitting the superior proposal pursuant to
confidentiality agreements with terms no less restrictive than its
confidentiality agreement with AGCO, and Ag-Chem may participate in discussions
and negotiate with the person making the superior proposal.
A superior proposal means any bona fide written acquisition proposal
made by a third party that did not result from a violation of the merger
agreement and which a majority of the Ag-Chem board of directors determines in
good faith (based on the advice of its financial advisor and the advice of
outside legal counsel), within 45 days from the date of the merger agreement, to
represent superior value, from a financial point of view, to Ag-Chem's
shareholders as compared to the merger with AGCO (taking into account, among
other things, all legal, financial, regulatory and other aspects of the proposal
and the identity of the person making the proposal).
Ag-Chem has agreed to promptly advise AGCO in writing of the terms of
any acquisition proposal and the identity of the person making the proposal.
Additionally, Ag-Chem has agreed to keep AGCO fully informed on a current basis
of the status of any acquisition proposal and promptly provide AGCO with copies
of all material correspondence and other written material sent or provided to
Ag-Chem from any third party in connection with any acquisition proposal or sent
or provided by Ag-Chem in connection with any acquisition proposal.
TERMINATION OF THE MERGER AGREEMENT
Rights to Terminate. At any time before the effective time of the
merger, the merger agreement may be terminated and the merger abandoned as
follows:
- by the mutual written consent of Ag-Chem and AGCO; or
- by either Ag-Chem or AGCO if:
- the parties have not completed the merger by June 30,
2001, unless the failure to close the merger by that
time has been caused by the knowing action or
inaction of the party seeking to terminate the merger
agreement;
- there has been a material breach by the other party
of any representation, warranty or covenant listed in
the merger agreement, and it is not cured within
thirty calendar days from the time the breaching
party is given written notice of such breach;
- any court or other governmental authority has denied
required approval for completion of the merger by
final non-appealable action;
- any court or other governmental authority has issued
a required approval that contains a final
non-appealable condition, restriction or requirement
that would reasonably be expected to have a material
adverse effect on AGCO or Ag-Chem; or
- Ag-Chem does not obtain the vote of Ag-Chem
shareholders at the Ag-Chem special meeting required
for adoption of the merger agreement; or
- by AGCO if:
- prior to the Ag-Chem special meeting(1) Ag-Chem
enters into a written agreement regarding a superior
proposal (2) Ag-Chem amends, conditions, qualifies,
withdraws or modifies in a
52
60
manner adverse to AGCO its approval and
recommendation of the merger and merger agreement, or
proposes to do so, (3) approves or recommends any
superior proposal or proposes to do so or (4)
resolves to do any of the foregoing; or
- the price of AGCO shares calculated based on the
average closing price for the ten trading days ending
the day before the effective date of the merger falls
to below $6.10 and AGCO does not elect to seek its
stockholders' approval to issue more than 11,800,000
shares to complete the merger; or
- by Ag-Chem if:
- Ag-Chem's board of directors determines, after
consultation with legal counsel, in the exercise of
the Ag-Chem board of directors' good faith judgment
as to fiduciary duties to the Ag-Chem shareholders,
that it is required by applicable law to terminate
the merger agreement because Ag-Chem has received a
superior proposal and AGCO has not responded within
five business days with a written proposal that
matches or is more favorable than the superior
proposal (from a financial point of view);
- for three days after the date Ag-Chem receives notice
from AGCO that AGCO has elected to seek approval from
the AGCO stockholders to issue more than 11,800,000
shares in the merger (Ag-Chem's board of directors
will examine expected benefits and drawbacks of
proceeding with the merger and will likely consider:
tax consequences, delays in completing the merger,
potential alternative transactions, AGCO stock price
issues and anticipated trends in AGCO's business and
the economy in general. Ag-Chem will likely consult
Goldsmith Agio Helms when making its decision.); or
- if all three of the following conditions are met:
(1) the price of AGCO common stock on the trading day
immediately prior to the effective date of the merger
is less than $6.10, (2) AGCO does not terminate the
merger agreement and (3) AGCO does not elect to seek
approval of the AGCO stockholders to issue more than
11,800,000 AGCO shares in the merger within three
days.
Effect of Termination. If the parties terminate the merger agreement
and abandon the merger prior to the effective time of the merger, the merger
agreement will become void and have no effect, without any liability on the part
of any of the parties to the merger agreement or their directors, officers or
agents, except that termination of the merger agreement will not relieve any
party from liability for any termination fees and expenses or for any willful
breach of the merger agreement.
Termination Fee. As a condition to effectiveness of termination of the
merger agreement, Ag-Chem will pay AGCO a termination fee of $10,000,000 on the
same day as termination of the merger agreement if:
- Ag-Chem or AGCO terminates the agreement and abandons the
merger because the approval of the merger by Ag-Chem's
shareholders is not obtained;
- AGCO terminates the agreement and abandons the merger because
Ag-Chem enters into a written agreement, or Ag-Chem's board of
directors resolves to enter into a written agreement or to
pursue an acquisition proposal or a superior proposal from a
party other than AGCO; or
- Ag-Chem terminates the agreement and abandons the merger
because, after consultation with legal counsel and in the good
faith exercise of the Ag-Chem board of directors' fiduciary
duties to Ag-Chem's shareholders, the Ag-Chem board of
directors determines that termination of the merger agreement
is required by law as a result of a superior proposal from a
party other than AGCO.
AGCO may defer its right to payment of the termination fee from time to
time and for any period of time it elects. However, AGCO has the right to
recover any actual costs it may incur if Ag-Chem fails to pay the termination
fee when due under the merger agreement, including fees and expenses of counsel.
53
61
AMENDMENT
The merger agreement may be amended or supplemented in writing before
or after the effective date of the merger by Ag-Chem or by AGCO except as
otherwise provided by law. However, after the Ag-Chem shareholders approve the
merger, there may not be any change to the merger agreement which changes the
amount or type of consideration into which Ag-Chem's common stock would be
converted.
WAIVER
At any time prior to the completion of the merger, either AGCO or
Ag-Chem may:
- extend the time for the performance of any of the obligations
or other acts of the other;
- waive any inaccuracies in the representations and warranties
of the other contained in the merger agreement or other
documents contemplated pursuant to the merger; and
- waive compliance by the other with any of the agreements or
conditions contained in the merger agreement which may legally
be waived.
Any extension or waiver will be valid only if set forth in a written
instrument specifically referring to the merger agreement and signed on behalf
of the party granting the extension or waiver. Ag-Chem does not intend to amend
its proxy statement or resolicit proxies if any material provisions or
conditions are waived or provisions of the merger agreement are amended, or the
termination date is extended.
VOTING AGREEMENT
As a condition to entering into the merger agreement, AGCO required
that, concurrently with the merger agreement, a voting agreement be entered into
by and among A. E. McQuinn, the Alvin E. McQuinn Revocable Trust and AGCO. The
Alvin E. McQuinn Revocable Trust is a trust that is controlled by Mr. McQuinn
and that, as of the date of the merger agreement, held 5,634,148 shares of
Ag-Chem stock, representing approximately 58% of the voting power of the
outstanding Ag-Chem common stock. The voting agreement applies only to 1,906,393
shares of this stock, representing approximately 19.9% of the voting power of
the outstanding Ag-Chem common stock. As to these shares, Mr. McQuinn and the
Alvin E. McQuinn Revocable Trust agreed to:
- revoke any previous proxies relating to the 1,906,393 Ag-Chem
shares subject to the voting agreement;
- vote for the adoption of the merger agreement, the merger and
any transactions contemplated thereby;
- vote against any acquisition proposal or superior proposal or
other action likely to adversely affect the merger; and
- grant AGCO an irrevocable proxy to vote the 1,906,393 Ag-Chem
shares in accordance with the terms of the voting agreement.
Mr. McQuinn and the Alvin E. McQuinn Revocable Trust also agreed that
they will not:
- transfer any of the 1,906,393 Ag-Chem shares;
- grant any proxies with respect to these shares;
- enter into any contract or agreement or take any other action
with respect to these shares which would constitute a
violation of the voting agreement or which would materially
impede the merger and any transactions contemplated thereby;
- enter into any tender or exchange offer or otherwise sell or
encumber or cause to be sold or encumbered any of these shares
of Ag-Chem common stock;
54
62
- acquire any additionalshares of Ag-Chem common stock (with
limited exceptions);
- exercise any rights which may arise in connection with the
merger to demand appraisal of any of these shares; or
- take any other action that would in any way restrict, limit or
interfere with the performance of the obligations under the
voting agreement or which would otherwise diminish the
benefits of the voting agreement to AGCO.
Additional terms to the voting agreement provide:
- In the event that Mr. McQuinn or the Alvin E. McQuinn
Revocable Trust obtains additional shares of Ag-Chem stock in
connection with a stock dividend, stock split,
recapitalization or like transaction, or otherwise becomes the
beneficial owner of any additional shares of Ag-Chem stock,
any such additional shares will be subject to the provisions
of the voting agreement.
- In the event that Mr. McQuinn or the Alvin E. McQuinn
Revocable Trust becomes entitled to, in connection with the
merger, subscribe to a number of AGCO shares, Mr. McQuinn and
the Alvin E. McQuinn Revocable Trust will subscribe to the
maximum number of shares for which they are eligible as long
as the sum of those shares in the aggregate, when combined
with all of the other AGCO shares owned by Mr. McQuinn and the
Alvin E. McQuinn Revocable Trust, does not exceed 7,000,000
shares.
- In the event that the merger agreement is terminated in such a
way that AGCO is entitled to be paid the $10,000,000
termination fee by Ag-Chem, and within twelve months of
termination of the merger agreement Ag-Chem is acquired in a
transaction that would have constituted an acquisition
proposal or superior proposal, then Mr. McQuinn and the Alvin
E. McQuinn Revocable Trust will pay to AGCO 100% of the
consideration received by them in excess of $25.80 for each of
1,906,393 shares of Ag-Chem common stock subject to the voting
agreement.
The voting agreement terminates on the earlier of the effective date of
the merger or the termination of the merger agreement in accordance with its
terms. No party to the voting agreement may terminate the voting agreement
unless the merger is first completed or the merger agreement is terminated
according to its terms. For example, if AGCO's stock price falls below $6.09 and
AGCO elects to solicit its shareholders' approval to issue additional shares and
Ag-Chem elects to terminate the merger agreement under its "walk-away" rights,
the voting agreement will automatically terminate.
The voting agreement is limited to 19.9% of the voting power of the
outstanding shares of Ag-Chem common stock due to limitations imposed by
Minnesota law. The Minnesota Control Share Acquisition Act provides that "shares
of an issuing public corporation acquired by an acquiring person in a control
share acquisition that exceed the threshold of voting power of any of the ranges
specified [20%, 33 1/3% and 50%] shall have only [limited] voting
rights . . . ." Because this provision applies to any acquisition of beneficial
ownership of shares representing 20% or more of the outstanding voting shares of
Ag-Chem, Mr. McQuinn's voting agreement in favor of AGCO is limited to common
stock representing less than 20% of the outstanding voting shares of Ag-Chem in
order to avoid the voting limitations.
Although the voting agreement does not apply to the remaining shares
held by Mr. McQuinn, he has indicated that he intends to vote his remaining
shares in favor of the merger. If he does so, the merger will be approved
regardless of how other shareholders vote.
55
63
UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION
The following unaudited pro forma combined financial information is
based on the historical financial statements of AGCO and Ag-Chem, adjusted to
give effect to the merger.
The pro forma combined financial statements were prepared to illustrate
the estimated effects of the merger, including acquisition-related debt and
equity transactions and other assumptions. The pro forma combined statements of
operations data for the year ended December 31, 1999 and nine months ended
September 30, 2000 give effect to the merger, as if the merger had occurred as
of January 1, 1999. The pro forma combined balance sheet data give effect to the
merger as if it had occurred as of September 30, 2000 and has been computed by
combining AGCO's consolidated balance sheet as of September 30, 2000 and
Ag-Chem's consolidated balance sheet as of December 31, 2000. As Ag-Chem's
year-end of September 30 differs from AGCO's year-end of December 31, we have
updated Ag-Chem's financial information to conform with AGCO's calendar year-end
by adding subsequent interim period results to the most recent fiscal year-end
information and deducting the comparable preceding year interim period results.
The pro forma adjustments are described in the accompanying notes. The pro forma
adjustments are based upon available information and assumptions that AGCO's
management believes are reasonable. The pro forma financial statements do not
purport to represent AGCO's results of operations or financial condition for any
future period or as of any date. The pro forma financial statements should be
read in conjunction with the historical consolidated financial statements of
AGCO and Ag-Chem and the notes thereto and "Management's Discussion and Analysis
of Financial Condition and Results of Operations" contained in AGCO's Form 10-K,
as amended by Form 10-K/A (Amendment No. 1), for the year ended December 31,
1999, and Form 10-Q, as amended by Form 10-Q/A (Amendment No. 1), for the
quarter ended September 30, 2000 and Ag-Chem's Form 10-K, as amended by Form
10-K/A (Amendment No. 1), for the year ended September 30, 2000, and Form 10-Q
for the quarter ended December 31, 2001. All of which are incorporated in this
proxy statement/prospectus by reference and enclosed herewith.
The merger will be accounted for under the purchase method of
accounting. Whether the merger is consummated as a forward or reverse merger,
AGCO will be the accounting acquirer and therefore the pro forma financial
statements are presented with AGCO being the acquirer. Under purchase
accounting, the total purchase cost and fair value of liabilities assumed will
be allocated to the tangible and intangible assets and liabilities of Ag-Chem
based upon their respective fair values as of the closing of the merger based on
preliminary valuations and other studies which are not yet available. A
preliminary allocation of the purchase cost has been made to major categories of
assets and liabilities in the accompanying pro forma consolidated financial
information based on estimates. The actual allocation of purchase cost and the
resulting effect on income from operations may differ materially from the pro
forma amounts included herein. Except as explained in notes 2 and 3 to the
Unaudited Pro Forma Combined Balance Sheet, AGCO has assumed that the current
recorded book value of Ag-Chem's assets, including patents, trademarks, and
property, plant and equipment, and liabilities are equal to their current fair
value. Once AGCO has access to Ag-Chem's detailed asset records, AGCO will make
an allocation of the purchase price to these assets based on detailed valuations
that may change the amount of currently recorded book values of Ag-Chem's assets
and liabilities thereby changing the amount of goodwill reflected in these pro
forma financial statements. In addition, AGCO will review the estimated
remaining lives of the assets, which may affect the resulting depreciation and
amortization relating to these assets, and accordingly, may effect net earnings
and the pro forma results of operations included herein.
56
64
UNAUDITED PRO FORMA COMBINED STATEMENTS OF OPERATIONS
YEAR ENDED DECEMBER 31, 1999
(in millions, except per share data)
PRO FORMA PRO FORMA
AGCO AG-CHEM ADJUSTMENTS COMBINED
------------ ----------- ------------- -------------
Net sales $ 2,413.3 $ 297.9 $ $ 2,711.2
Cost of sales 2,056.9 221.3 2,278.2
------------ ----------- ------------ -------------
Gross profit 356.4 76.6 433.0
Selling, general and administrative expenses 229.6 70.5 (9.0) (1) 291.1
Engineering expenses 44.6 -- 8.3 (1) 52.9
Restructuring and other infrequent expenses 24.5 -- -- 24.5
Amortization of intangibles 14.8 -- 4.1 (3) 19.6
0.7 (1)
------------ ----------- ------------ -------------
Income from operations 42.9 6.1 (4.1) 44.9
Interest and financing expense, net 57.6 6.4 11.3 (2) 75.3
Other expense/(income), net 17.5 (2.7) 0.5 (4) 15.5
0.2 (5)
------------ ----------- ------------ -------------
Income (loss) before income taxes and equity in net
earnings of affiliates (32.2) 2.4 (16.1) (45.9)
Income tax expense (benefit) (10.2) 0.7 (4.8) (6) (14.3)
------------ ----------- ------------ -------------
Income (loss) before equity in net earnings of
affiliates (22.0) 1.7 (11.3) (31.6)
Equity in net earnings of affiliates 10.5 -- 0.1 (5) 10.6
------------ ----------- ------------ -------------
Net income (loss) $ (11.5) $ 1.7 $ (11.2) $ (21.0)
============ =========== ============ =============
Net income (loss) per common share:
Basic $ (0.20) $ 0.18 $ (0.30)
Diluted $ (0.20) $ 0.18 $ (0.30)
Weighted average number of common and common
equivalent shares outstanding:
Basic 58.7 9.6 11.8 (7) 70.5
Diluted 58.7 9.6 11.8 (7) 70.5
57
65
UNAUDITED PRO FORMA COMBINED STATEMENTS OF OPERATIONS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000
(n millions, except per share data)
PRO FORMA PRO FORMA
AGCO AG-CHEM ADJUSTMENTS COMBINED
----------- --------- ----------- -----------
Net sales $ 1,677.0 $ 240.1 $ $ 1,917.1
Cost of sales 1,405.7 187.8 1,593.5
----------- --------- ----------- ----------
Gross profit 271.3 52.3 323.6
Selling, general and administrative expenses 168.3 50.3 (9.6)(1) 209.0
Engineering expenses 33.7 -- 9.2(1) 42.9
Restructuring and other infrequent expenses 19.5 -- -- 19.5
Amortization of intangibles 11.2 -- 3.1(3) 14.7
0.4(1)
----------- --------- ----------- ----------
Income from operations 38.6 2.0 (3.1) 37.5
Interest and financing expense, net 50.8 3.6 8.5(2) 62.9
Other expense/(income), net 11.6 (2.6) 0.4(4) 10.4
1.0(5)
----------- --------- ----------- ----------
Income (loss) before income taxes and equity in net
earnings of affiliates (23.8) 1.0 (13.0) (35.8)
Income tax expense (benefit) (11.5) 0.4 (4.0)(6) (15.1)
----------- --------- ----------- ----------
Income (loss) before equity in net earnings of
affiliates (12.3) 0.6 (9.0) (20.7)
Equity in net earnings of affiliates 8.1 -- 0.6(5) 8.7
----------- --------- ----------- ----------
Net income (loss) $ (4.2) $ 0.6 $ (8.4) $ (12.0)
=========== ========= =========== ==========
Net income (loss) per common share:
Basic $ (0.07) $ 0.06 $ (0.17)
Diluted $ (0.07) $ 0.06 $ (0.17)
Weighted average number of common and common
equivalent shares outstanding:
Basic 59.1 9.6 11.8(7) 70.9
Diluted 59.1 9.6 11.8(7) 70.9
58
66
NOTES TO UNAUDITED PRO FORMA COMBINED STATEMENTS OF OPERATIONS
(1) To reclassify Ag-Chem's engineering expenses and amortization of
intangibles from selling, general, and administrative expenses to a
separate line item to conform with AGCO's presentation.
(2) To reflect the increase in interest expense with respect to borrowings
expected to be incurred in connection with the cash portion of the
merger consideration, assuming that the market price of the AGCO common
stock is $9.9375 (see Note 6 to the Unaudited Pro Forma Combined
Balance Sheet) at an assumed average interest rate of 8.4% which is the
current incremental borrowing rate under AGCO's revolving credit
facility. The actual interest rate related to such debt may differ from
8.4%. Accordingly, for every 0.125% variance in the interest rate,
annual interest expense will vary by approximately $0.2 million.
(3) To reflect the increase in goodwill amortization from the preliminary
purchase price allocation of the net assets acquired in the merger
assuming a 40-year amortization period (see Note 4 to the Unaudited Pro
Form Combined Balance Sheet).
(4) To reflect the increase in depreciation expense from adjusting certain
Ag-Chem office buildings to estimated market value.
(5) To reclassify the equity in net earnings of Ag-Chem's unconsolidated
joint ventures from other income to equity in net earnings in
affiliates on an after-tax basis to conform with AGCO's presentation.
(6) To reflect an income tax provision for the net pro-forma adjustments,
after taking into consideration non-deductible goodwill amortization.
(7) To adjust the weighted average shares outstanding for shares issued in
connection with the common stock portion of the merger consideration.
This adjustment is based on the market price of AGCO common stock of
$9.9375 as of December 15, 2000. In the event the price of AGCO common
stock differs at the closing date, the number of shares issued as
consideration in the merger may differ from the number of shares
included in the pro forma adjustment.
(8) The amounts of cash and common stock merger consideration will vary
depending on the price of AGCO common stock at the closing date. The
preceding Pro Forma Statements of Operations assume a closing common
stock price of $9.9375 per share (closing price as of December 15,
2000). Assuming a common stock price at closing of $8.00 and $12.00 per
share, the resulting interest expense, net loss, net loss per common
share and weighted average shares outstanding, would be as follows (in
millions):
Twelve Months Ended Nine Months Ended
December 31, 1999 September 30, 2000
---------------------- ---------------------
Closing stock price $ 8.00 $12.00 $ 8.00 $12.00
------ ------ ------ ------
Interest expense, net $ 77.3 $ 74.6 $ 64.3 $ 62.3
Net loss (22.2) (20.6) (12.9) (11.7)
Net loss per common share
Basic $(0.31) $(0.30) $(0.18) $(0.17)
Diluted $(0.31) $(0.30) $(0.18) $(0.17)
Weighted average common & common
equivalent shares outstanding
Basic 70.5 69.2 70.9 69.6
Diluted 70.5 69.2 70.9 69.6
59
67
UNAUDITED PRO FORMA COMBINED BALANCE SHEET
AS OF SEPTEMBER 30, 2000
(in millions)
PRO FORMA PRO FORMA
AGCO AG-CHEM (1) ADJUSTMENTS COMBINED
-------- -------- ----------- -----------
Cash and cash equivalents $ 4.0 $ 0.1 $ 4.1
Accounts and notes receivables, net 518.7 16.1 534.8
Inventories, net 604.2 104.7 12.5 (2) 721.4
Other current assets 88.3 8.2 96.5
-------- -------- -------- --------
Total current assets 1,215.2 129.1 12.5 1,356.8
Property, plant and equipment 297.9 37.7 14.2 (3) 349.8
Investments in affiliates 90.1 1.2 91.3
Other assets 165.7 1.6 167.3
Intangible assets, net 287.4 0.6 170.0 (4) 458.0
-------- -------- -------- --------
Total assets 2,056.3 170.2 196.7 2,423.2
======== ======== ======== ========
Accounts payable 221.9 16.9 238.8
Accrued expenses 389.5 16.9 1.3 (5) 407.7
Other current liabilities 19.6 45.0 (22.7) 46.9
5.0 (2)
-------- -------- -------- --------
Total current liabilities 631.0 78.8 (16.4) 693.4
Long-term debt 582.3 23.9 157.6 (6) 763.8
Postretirement health care benefits 28.8 -- 28.8
Other noncurrent liabilities 39.4 -- 5.7 (3) 45.1
-------- -------- -------- --------
Total liabilities 1,281.5 102.7 146.9 1,531.1
-------- -------- -------- --------
Common stock 0.6 0.1 (0.1)(7) 0.7
(0.1)(8)
Additional paid-in capital 427.0 1.1 (1.1)(7) 544.2
117.2 (8)
Retained earnings 615.8 66.7 (66.7)(7) 615.8
Unearned compensation (1.8) -- (1.8)
Accumulated other comprehensive income (266.8) (0.4) 0.4 (7) (266.8)
-------- -------- -------- --------
Total stockholders' equity 774.8 67.5 49.8 892.1
-------- -------- -------- --------
Total liabilities and stockholders' equity $2,056.3 $ 170.2 $ 196.7 $2,423.2
======== ======== ======== ========
60
68
NOTES TO UNAUDITED PRO FORMA COMBINED BALANCE SHEET
(1) Represents the consolidated balance sheet of Ag-Chem as of December 31,
2000. Certain accounts have been reclassified to conform with AGCO's
presentation.
(2) To restate Ag-Chem inventories to its estimated fair value by
eliminating Ag-Chem's LIFO reserves and to establish a deferred tax
liability related to the adjustment.
(3) To adjust certain Ag-Chem office buildings to estimated fair value
based on current appraisals obtained by Ag-Chem and to establish a
deferred tax liability related to the adjustment.
(4) To reflect goodwill from the preliminary purchase price allocation of
the net assets acquired related to the merger as follows:
Purchase cost ($25.80 X 9,579,868 Ag-Chem common
shares outstanding as of December 15, 2000) $247.2
Estimated transaction fees and expenses 5.0
------
Total purchase price 252.2
Actual book value of Ag-Chem net assets at
September 30, 2000 (67.5)
Increase inventory to fair market value (12.5)
Increase property, plant and equipment to estimated
fair market value (14.2)
Recognition of deferred tax liabilities related to
adjustments to inventories and property, plant and
equipment 10.7
Recognition of a liability relating to Ag-Chem
bonuses to be paid prior to and upon closing of
the merger 1.2
Recognition of a liability related to Ag-Chem's
phantom stock bonus plan 0.1
------
Adjusted book value of net assets acquired (82.2)
------
Estimated goodwill $170.0
======
(5) To recognize a liability related to Ag-Chem's phantom stock bonus plan
which is payable upon closing of the merger and Ag-Chem bonuses to be
paid prior to and upon closing of the merger.
(6) To reflect the following:
Repayment of Ag-Chem short-term debt from proceeds
of AGCO's long-term revolving credit facility $ 22.7
Increase in outstanding borrowings on AGCO's revolving
credit facility in connection with the cash portion of the
merger consideration $134.9
------
$157.6
======
This adjustment is based on the stock price of AGCO common stock of
$9.9375 as of December 15, 2000. In the event the price of AGCO common
stock differs at the closing date, the cash portion of the
consideration may differ from the amount included as borrowings in the
pro forma balance sheet. Assuming a closing stock price of $8.00 and
$12.00 per share, the adjustment to long-term debt would change from
$157.6 million to $180.4 million and $148.8 million, respectively.
(7) To reflect the elimination of Ag-Chem's historical stockholders'
equity.
(8) To reflect the issuance of 11,800,000 shares of AGCO common stock in
connection with the common stock portion of the merger consideration.
This adjustment is based on the market price of AGCO common stock of
$9.9375 as of December 15, 2000. In the event the price of AGCO common
stock differs at the closing date, the number of shares issued as
consideration in the merger may differ from the number of shares
included in the pro forma adjustment. Assuming a closing stock price of
$8.00 and $12.00 per share, the pro forma adjustments to stockholder's
equity of $49.8 million would change to $26.9 million and $58.6
million, respectively.
61
69
UNAUDITED COMPARATIVE PER SHARE DATA
Summarized below is the per share information for AGCO and Ag-Chem on a
historical, pro forma combined and pro forma equivalent basis for the periods
and as of the dates indicated below. This data should be read in conjunction
with the Unaudited Pro Forma Combined Financial Information, the Selected
Historical Financial Data for AGCO and Ag-Chem and the Selected Unaudited Pro
Forma Combined Financial Data included elsewhere in this proxy
statement/prospectus. The pro forma information does not purport to represent
AGCO's results of operations or financial position for any future period or as
of any date. The pro forma equivalent data is derived from the product of the
pro forma combined data multiplied by the exchange ratio of the common stock
portion of the merger consideration of 1.2317 shares of AGCO common stock for
each share of Ag-Chem common stock. This exchange ratio is based on the market
price of AGCO common stock as of December 15, 2000 of $9.9375. In the event the
price of AGCO common stock differs at the closing date, the exchange ratio may
differ from the ratio used in the pro forma equivalent data below. The pro forma
equivalent data is derived only from the common stock portion of the merger
consideration, and therefore, is not calculated based on the entire
consideration that Ag-Chem shareholders will receive. In the event the price of
AGCO common stock differs at the closing date, the exchange ratio may differ
from the ratios used in the pro forma equivalent data below. See footnotes 1 and
2 below which show the results assuming the common stock price at closing was
$8.00 and $12.00 per share.
NINE MONTHS
YEAR ENDED ENDED AS OF AS OF
DECEMBER 31, SEPTEMBER 30, SEPTEMBER 30, DECEMBER 31,
1999 (1) 2000 (1) 2000 (2) 2000
Net Income (loss) per common share:
AGCO $(0.20) $(0.07)
AGCO pro forma combined (0.30) (0.17)
Ag-Chem 0.18 0.06
Ag-Chem pro forma equivalent (0.37) (0.21)
Dividends per common share:
AGCO 0.04 0.03
AGCO pro forma combined 0.04 0.03
Ag-Chem -- --
Ag-Chem pro forma equivalent 0.05 0.04
Book value per share:
AGCO $13.00
AGCO pro forma combined 12.50
Ag-Chem 7.48 $ 7.04
Ag-Chem pro forma equivalent 15.40
(1) Assuming AGCO's stock price is $8.00 or $12.00 at the closing date, the
AGCO pro forma combined net loss per common share would be $.31 or $.30
for the twelve months ended December 31, 1999 and $.18 or $.17 for the
nine months ended September 30, 2000 and the Ag-Chem pro forma
equivalent net loss per common share would be $.38 or $.37 for the
twelve months ended December 31, 1999 and $.22 or $.21 for the nine
months ended September 30, 2000.
(2) Assuming AGCO's stock price is $8.00 or $12.00 at the closing date, the
AGCO pro forma combined book value per share as of September 30, 2000
would be $12.18 or $12.62 and the Ag-Chem pro forma equivalent book
value per share as of September 30, 2000 would be $15.00 or $15.54.
62
70
DIRECTORS AND EXECUTIVE OFFICERS OF AGCO FOLLOWING THE MERGER
The executive officers and directors of AGCO will not change as a
result of the merger, except that AGCO has agreed to use its reasonable best
efforts to appoint A. E. McQuinn to its board of directors if Mr. McQuinn
acquires 7,000,000 shares of AGCO common stock in connection with the merger
and/or any subscription right offered by AGCO to Ag-Chem shareholders.
Nevertheless, AGCO has indicated its willingness to appoint A. E. McQuinn to its
board of directors even if A. E. McQuinn does not acquire 7,000,000 shares of
AGCO common stock after the merger.
STOCK OWNERSHIP OF AGCO
The following table contains information about the beneficial ownership
of AGCO common stock, on a pro forma basis as if the transaction has been
completed as a forward merger, by the persons and entities listed based on (1)
their ownership of AGCO common stock as of March 15, 2001 and (2) their
ownership of Ag-Chem common stock as of March 15, 2001. With respect to the
persons and entities listed in the table, the pro forma beneficial ownership of
AGCO common stock listed for each person includes shares of common stock of AGCO
to be issued in exchange for the shares of Ag-Chem common stock held by such
person or entity based upon a price of $11.00 per share of AGCO common stock
(the closing price on March 15, 2001 was $11.06). Unless otherwise indicated, to
our knowledge, each person or entity listed below has sole voting and investment
power over their shares of common stock.
The following table also contains information about the beneficial
ownership of AGCO and Ag-Chem common stock of:
- Each person known to own beneficially more than 5% of the outstanding
shares of each of AGCO or Ag-Chem common stock, based upon such
person's most recently filed Schedule 13D or 13G;
- All executive officers of each of AGCO and Ag-Chem;
- Each director of each of AGCO and Ag-Chem; and
- All directors and executive officers of each of AGCO as a group and of
Ag-Chem as a group.
63
71
PRO FORMA
AGCO AG-CHEM BENEFICIAL OWNERSHIP
BENEFICIAL OWNERSHIP BENEFICIAL OWNERSHIP OF AGCO
--------------------------------------------------------------------------------
COMMON COMMON COMMON
NAME OF BENEFICIAL OWNER STOCK(8)(9)(10) PERCENT(11) STOCK PERCENT(12) STOCK PERCENT
-----------------------------------------------------------------------------------------------------------------------------------
Dimensional Fund Advisors(1)
1299 Ocean Avenue, 11th Floor
Santa Monica, CA 90401 ....................... 3,326,620 5.6% -- -- 3,326,620 4.7%
Massachusetts Financial Services(2)
500 Boylston Street
Boston, MA 02116 ............................ 5,481,175 9.2 -- -- 5,481,175 7.7
Mellon Financial Corporation(3)
One Mellon Center
Pittsburgh, Pennsylvania 15258 ............... 4,973,099 8.3 -- -- 4,973,099 7.0
Forstmann-Leff Associates, LLC(4)
590 Madison Avenue
New York, New York 10022 ..................... 6,352,271 10.7 -- -- 6,352,271 9.0
Same Deutz-Fahr S.p.A(5)
Vidale Francesco Cassani n. 14
24047 Treviglio (Bg), Italy .................. 5,949,000 10.0 -- -- 5,949,000 8.4
University Capital Strategies Group, LLP(6)
408 Saint Peter Street, Suite 444
St. Paul, Minnesota 55102 .................... -- -- 498,600 5.2 584,722 0.8
Wellington Management Company, LLP(7)
State Street
Boston, Massachusetts 02109 ................. -- -- 626,000 6.5 734,127 1.0
AGCO Directors and Executive Officers
Robert J. Ratliff (13) ........................... 791,952 1.3 -- -- 791,952 1.1
W. Wayne Booker .................................. -- * -- -- -- *
Henry J. Claycamp ................................ 23,548 * -- -- 23,548 *
Wolfgang Deml .................................... 1,500 * -- -- 1,500 *
Gerald B. Johanneson ............................. 10,000 * -- -- 10,000 *
Anthony D. Loehnis ............................... 4,500 * -- -- 4,500 *
Curtis E. Moll ................................... 1,000 * -- -- 1,000 *
David E. Momot ................................... -- * -- -- -- *
John M. Shumejda ................................. 362,093 * -- -- 362,093 *
Henk Visser ...................................... 1,000 * -- -- 1,000 *
Wolfgang Sauer ................................... 2,500 * -- -- 2,500 *
Norman L. Boyd ................................... 56,500 * -- -- 56,500 *
Aaron D. Jones ................................... 52,200 * -- -- 52,200 *
Stephen D. Lupton ................................ 30,000 * -- -- 30,000 *
Donald R. Millard ................................ -- * -- -- -- *
Dexter E. Schaible ............................... 39,755 * -- -- 39,755 *
64
72
PRO FORMA
AGCO AG-CHEM BENEFICIAL OWNERSHIP
BENEFICIAL OWNERSHIP BENEFICIAL OWNERSHIP OF AGCO
--------------------------------------------------------------------------------
COMMON COMMON COMMON
NAME OF BENEFICIAL OWNER STOCK(8)(9)(10) PERCENT(11) STOCK PERCENT(12) STOCK PERCENT
-----------------------------------------------------------------------------------------------------------------------------------
Edward R. Swingle ................................ 186,728 * -- -- 186,728 *
Adri Verhagen .................................... 19,900 * -- -- 19,900 *
Ag-Chem Directors and Executive Officers
A. E. McQuinn (14) ............................... -- -- 5,569,148 58.1 6,531,092 9.2
Donald D. Pottinger .............................. -- -- 440 * 516 *
John C. Retherford (15) .......................... -- -- 87,600 * 102,731 *
Mary M. Jetland (16) ............................. -- -- 50,300 * 58,988 *
Steve M. Koep .................................... -- -- 1,800 * 2,111 *
Robert L. Hoffman (17) ........................... -- -- 5,458,498 57.0 6,401,329 9.0
G. Waddy Garrett (18) ............................ -- -- 13,622 * 15,975 *
A.J. (Al) Giese (19) ............................. -- -- 3,300 * 3,870 *
DeWalt J. Willard, Jr ............................ -- -- 10,000 * 11,727 *
Executive officers and directors of AGCO as a
group (18 persons) ............................... 1,583,176 2.7 -- -- 1,583,176 2.2
Executive officers and directors of Ag-Chem as
a group (9 persons) .............................. -- -- 5,736,010 59.9 6,726,775 9.5
----------------
*Less than 1%.
(1) Based upon Schedule 13G filed with the Securities and Exchange
Commission on February 2, 2001. Dimensional Fund Advisors Inc. ("Dimensional")
is an investment advisor registered under Section 203 of the Investment Advisors
Act of 1940 and furnishes investment advice to four investment companies
registered under the Investment Company Act of 1940, and serves as investment
manager to certain other commingled group trusts and separate accounts. These
investment companies, trusts and accounts are the "Funds." All securities
reported in the Schedule 13G filed by Dimensional with the Securities and
Exchange Commission on February 2, 2001 are owned by the Funds. Dimensional
disclaims beneficial ownership of such securities.
(2) Based upon Schedule 13G filed with the Securities and Exchange
Commission on February 9, 2001.
(3) Based upon Schedule 13G filed with the Securities and Exchange
Commission on January 17, 2001.
(4) Based on the Amendment No. 2 to Schedule 13G filed on February 14,
2001. Includes shares beneficially owned by FLA Asset Management, LLC, FLA
Advisers LLC, and Forstmann-Leff International, LLC.
(5) Based upon Schedule 13G filed with the Securities and Exchange
Commission as of February 14, 2001.
(6) Based upon Schedule 13D filed with the Securities and Exchange
Commission on March 8, 2001.
(7) Based on the Schedule 13G filed with the Securities and Exchange
Commission on February 13, 2000, by Wellington Management Company, LLP, an
investment adviser. Represents the total number of shares owned which may be
deemed beneficially held by Wellington in its capacity as an investment adviser
which are held of record by clients of Wellington.
(8) Includes shares of AGCO common stock which may be purchased upon
exercise of options which are exercisable as of February 14, 2001, or become
exercisable within 60 days thereafter, for the following individuals: Mr.
Ratliff -- 9,000; Mr. Claycamp -- 1,000; Mr. Johanneson -- 5,000; Mr. Moll --
1,000; Mr. Visser - 1,000; Dr. Sauer - 1,000; Mr. Boyd -- 5,200; Mr. Jones --
7,200; Mr. Lupton -- 12,000; Mr. Schaible -- 17,255; Mr. Verhagen -- 2,400;
executive officers and directors as a group -- 62,055.
(9) Includes unvested restricted shares of AGCO's common stock earned under
the AGCO Long-Term Incentive Plan by the following individuals: Mr. Shumejda --
42,167; Mr. Boyd -- 14,667; Mr. Jones - 18,333; Mr. Lupton -- 13,333; Mr.
Schaible -- 9,167; Mr. Swingle -- 14,667; Mr. Verhagen -- 11,666; all executive
officers and directors as a group -- 158,833.
(10) Includes restricted shares of AGCO's common stock earned under the AGCO
Director Plan by the following individuals: Mr. Claycamp -- 3,000; Mr. Deml --
1,500; Mr. Johanneson -- 3,000; Mr. Loehnis -- 1,500; Dr. Sauer -- 1,500; all
executive officers and directors as a group -- 10,500.
65
73
(11) Any securities not outstanding which are subject to options which are
exercisable as of March 15, 2001, or become exercisable within 60 days
thereafter are deemed outstanding for the purpose of computing the percentage of
outstanding securities of the class owned by any person holding such securities
but are not deemed outstanding for the purpose of computing the percentage of
the class owned by any other person. Based on 59,591,828 shares of AGCO common
stock outstanding on March 15, 2001.
(12) Based on 9,579,868 shares of Ag-Chem common stock outstanding on March
15, 2001.
(13) Includes 2,742 shares of AGCO common stock owned by Mr. Ratliff's wife,
200,000 shares of Common Stock beneficially owned by Mr. Ratliff as trustee of
the Robert J. Ratliff Charitable Remainder Unitrust and 568,360 shares of Common
Stock owned by a family limited partnership of which Mr. Ratliff controls the
general partner. Mr. Ratliff disclaims beneficial ownership of these shares.
(14) Includes 5,453,298 shares of Ag-Chem common stock owned by the Alvin E.
McQuinn Revocable Trust of which Mr. McQuinn is a co-trustee and 10,000 shares
of Ag-Chem common stock held by Mr. McQuinn as custodian for grandchildren.
(15) Includes 62,450 shares of Ag-Chem common stock owned jointly with Mr.
Retherford's spouse and 16,734 shares held of record by Mr. Retherford's minor
children. Also includes 8,416 shares of Ag-Chem common stock owned of record by
two trusts of which Mr. Retherford is trustee, as to all of which shares Mr.
Retherford disclaims beneficial ownership.
(16) Includes 25,600 shares of Ag-Chem common stock held of record by Ms.
Jetland's spouse and 100 shares of Ag-Chem common stock held of record by Ms.
Jetland's children, as to all of which Ms. Jetland disclaims beneficial
ownership.
(17) Includes 5,453,298 shares of Ag-Chem common stock owned by the Alvin E.
McQuinn Revocable Trust of which Mr. Hoffman is a co-trustee, and 1,200 shares
of Ag-Chem common stock held by Mr. Hoffman's spouse.
(18) Includes 6,000 shares of Ag-Chem common stock held of record by Mr.
Garrett's spouse and 800 shares of Ag-Chem common stock held of record by Mr.
Garrett's children. (19) Includes 3,300 shares of Ag-Chem common stock held
jointly with Mr. Giese's spouse.
66
74
INDEMNIFICATION AND INSURANCE
AGCO has agreed to indemnify the current and former directors and
officers of Ag-Chem and to continue insurance coverage for such persons for a
period of time following the effective time of the merger. For more information,
refer to "Material Provisions of the Merger Agreement and Related
Agreements--Director and Officer Indemnification" on page ___.
COMPARISON OF SHAREHOLDER RIGHTS
This section of the proxy statement/prospectus describes differences
between the rights of holders of Ag-Chem common stock and AGCO common stock.
While the description summarizes the material differences between the two, this
summary may not contain all of the information that is important to you. You
should carefully read this entire proxy statement/prospectus and the other
documents to which it refers for a more complete understanding of the
differences between being a shareholder of Ag-Chem and being a stockholder of
AGCO.
AUTHORIZED SHARES; SHARES OUTSTANDING; TRANSFER AGENT
Ag-Chem's articles of incorporation authorize the issuance of up to
40,000,000 shares of capital stock, no par value per share in the case of common
stock, and a par value as determined by its board of directors in the case of
preferred stock. As of March 15, 2001, 9,579,868 shares of Ag-Chem common stock
were outstanding. Ag-Chem's common stock is the only class or series of Ag-Chem
capital stock issued and outstanding.
AGCO's certificate of incorporation authorizes the issuance of up to
150,000,000 shares of common stock par value $0.01 per share, of which
59,591,828 shares were issued and outstanding as of March 15, 2001, and up to
1,000,000 shares of preferred stock, par value $.0l per share, of which no
shares were issued and outstanding as of March 15, 2001. AGCO's preferred stock
is issuable in series, each series having such rights and preferences as AGCO's
board of directors may fix and determine by resolution. As of March 15, 2001,
like Ag-Chem, AGCO's common stock was the only class or series of AGCO's capital
stock issued and outstanding. The merger agreement does not prohibit, nor is
AGCO otherwise prohibited from, issuing additional shares of common stock or
preferred stock. AGCO's transfer agent is SunTrust Bank, Atlanta.
Minnesota law does not allow shares to be held in treasury. Under
Delaware law, treasury shares may be held, sold, lent, pledged, exchanged,
transferred or otherwise disposed of by AGCO. Treasury shares, however, are not
outstanding shares and therefore do not have voting rights.
DIFFERENCES BETWEEN MINNESOTA AND DELAWARE CORPORATION STATUTES
As a shareholder of Ag-Chem, your rights are currently governed by the
Minnesota Business Corporation Act (MBCA), Ag-Chem's articles of incorporation
and Ag-Chem's bylaws. The rights of AGCO stockholders are currently governed by
the Delaware General Corporation Law (DGCL), AGCO's certificate of incorporation
and AGCO's bylaws. After completion of the merger, you will become a stockholder
of AGCO and your rights will be governed by the DGCL, AGCO's certificate of
incorporation and AGCO's bylaws.
CAPITALIZATION AND VOTING RIGHTS; CUMULATIVE VOTING
Ag-Chem has one class of common stock issued and outstanding. AGCO has
one class of common stock issued and outstanding. Holders of Ag-Chem common
stock and holders of AGCO common stock are each entitled to one vote for each
share held. Neither holders of Ag-Chem common stock nor holders of AGCO common
stock are allowed to cumulate votes for the election of directors.
AGCO's certificate of incorporation also authorizes AGCO to issue
preferred stock in one or more classes or series, with such voting powers,
designations, preferences, rights, qualifications, limitations or restrictions
as AGCO's board of directors may determine.
67
75
APPRAISAL AND DISSENTERS' RIGHTS
Under the MBCA, shareholders have the right to dissent from certain
corporate transactions, principally mergers and consolidations, by demanding
payment in cash for their shares equal to the fair value, as determined by the
corporation or by a court. Under the MBCA, Ag-Chem shareholders would have
dissenters' rights if Ag-Chem amends it articles in such a way that materially
and adversely affects the rights or preferences of the shares of the dissenting
shareholder, enters into a sale, lease, transfer, or other disposition of all or
substantially all of the property and assets of the corporation, a plan of
merger, a plan of exchange or any other action taken pursuant to a shareholder
vote if the articles, bylaws or a resolution approved by the board directs that
dissenting shareholders may obtain payment for their shares. For a discussion of
Ag-Chem shareholders' dissenters' rights in connection with the merger, see "The
Merger--Appraisal and Dissenters' Rights" on page ___.
The DGCL also provides shareholders with the right to dissent from
certain corporate transactions, principally mergers and consolidations, by
demanding payment in cash for their shares equal to the fair value (excluding
any appreciation or depreciation as a consequence or in expectation of the
transaction) as determined by the corporation or by an independent appraiser
appointed by a court in an action timely brought by the dissenters.
Under the DGCL, no dissenters' rights exist for shares of stock of a
constituent corporation in a merger or consolidation that are either listed on a
national securities exchange or designated as a national market system security
on an inter-dealer quotation system by the NASD, or held of record by more than
2,000 shareholders. However, dissenters' rights will exist if the stockholders
receive anything other than: (i) shares of stock (or depositary receipts) of the
corporation surviving or resulting from such merger or consolidation; (ii)
shares of stock (or depositary receipts) of any other corporation which at the
effective date of the merger or consolidation will be either listed on a
national securities exchange or designated as a national market system security
on an inter-dealer quotation system by the NASD, or held of record by more than
2,000 shareholders; (iii) cash in lieu of fractional shares of the corporation
described in clauses (i) and (ii) above, or (iv) any combination of clauses (i),
(ii) or (iii). AGCO's certificate does not provide any appraisal rights. As an
AGCO stockholder, you will not have appraisal rights other than as set forth in
the DGCL.
SHAREHOLDER ACTION
Ag-Chem shareholders may take action at annual or special meetings of
the shareholders, or by unanimous written consent of all Ag-Chem shareholders
entitled to vote. AGCO stockholders may take action at annual or special
meetings of shareholders, but may not take action by written consent.
CONTROL SHARE ACQUISITIONS
The Minnesota Control Share Acquisition Act requires disinterested
shareholder approval for certain transactions. The Minnesota Control Share
Acquisition Act applies only if: (i) the person acquiring the shares is an
"acquiring person" which is a person (whether an individual or an entity) who
acquires, owns or votes the "issuing public corporation's" stock; (ii) the
acquisition constitutes a "control share acquisition" which occurs when the
"acquiring person's" ownership exceeds certain designated percentages; and (iii)
the shares acquired are shares of an "issuing public corporation" which is a
corporation organized under the laws of the State of Minnesota which has at
least 50 shareholders of record. The Minnesota Control Share Acquisition Act
applies unless the "issuing public corporation" opts out of the statute in its
articles of incorporation or bylaws which are approved by its shareholders.
Ag-Chem has not opted out of such provisions.
Under Minnesota law, a "control share acquisition" does not include,
among other things, the following:
- an acquisition under Minnesota Statutes relating to mergers,
statutory share exchanges and sales of substantially all
assets if the issuing public corporation is a party to the
transaction;
- an acquisition from the issuing public corporation; or
- an acquisition, subsequent to January 1, 1991, pursuant to a
cash offer for all of the issuing corporation's voting stock
which has been approved by a majority vote of the members of a
committee comprised of all of the disinterested members of the
board of directors which was formed prior to the commencement
or public announcement of the intent to commence, of the
tender offer and pursuant to
68
76
which the acquiring person will become the owner of over 50%
of the voting stock of the "issuing public corporation"
outstanding at the time of the transaction.
There are no provisions of Delaware law that are comparable to the
Minnesota Control Share Acquisition Act.
AMENDMENT OF CHARTER DOCUMENTS
Articles/Certificate of Incorporation. Ag-Chem's articles of
incorporation may be amended in accordance with the MBCA, which provides that an
amendment to a corporation's articles of incorporation may be approved by a
majority of the voting power of the shares entitled to vote on the proposed
amendment.
AGCO's certificate of incorporation may be amended in accordance with
Delaware law, which provides that an amendment to a corporation's certificate of
incorporation may be approved by a majority of the outstanding shares entitled
to vote on the proposed amendment.
Bylaws. Under the MBCA, shareholders entitled to vote have the power to
amend the corporation's bylaws at any time. In addition, subject to the power of
the shareholders to enact, change or repeal the bylaws by a majority vote of the
shareholders, Ag-Chem's bylaws vest power to amend its bylaws in the board of
directors.
Under the DGCL, stockholders entitled to vote have the power to adopt,
amend or repeal bylaws. A corporation may, in its certificate of incorporation,
confer such power upon the board of directors. The stockholders always have the
power to adopt, amend or repeal bylaws, even though the board of directors may
also be delegated such power.
AGCO's bylaws provide that its bylaws may be amended or repealed (1) by
the affirmative vote of a majority of the voting power of all of the
then-outstanding shares of the voting stock at a duly called meeting of the
shareholders, or (2) by AGCO's board of directors.
BUSINESS COMBINATIONS WITH CERTAIN PERSONS
Ag-Chem is also subject to Section 302A.673 which generally prohibits a
Minnesota public corporation from engaging in a "business combination" with an
"interested shareholder" for a period of four years after the date of the
transaction in which the person became an interested shareholder, unless the
business combination is approved in a prescribed manner. "Business combination"
includes mergers, asset sales, certain issuances of stock and other transactions
resulting in a financial benefit to the interested shareholder. An "interested
shareholder" is a person or an entity who is the beneficial owner, directly or
indirectly, of 10% or more of the voting power of the outstanding shares
entitled to vote of the issuing public corporation or who is an affiliate or
associate of the corporation and at any time within the four years prior to the
date in question was the beneficial owner, directly or indirectly, of 10% or
more of the voting power of the outstanding shares entitled to vote of the
issuing public corporation.
The DGCL requires the approval of the board of directors and the
holders of a majority of the outstanding shares entitled to vote thereon for
mergers or consolidations, and for sales, leases or exchanges of all or
substantially all of its property or assets.
The DGCL, like the MBCA permits a surviving corporation to merge with
another corporation without obtaining the approval of its stockholders if:
- the merger agreement does not amend the surviving
corporation's certificate of incorporation; and
- each share of the surviving common stock outstanding
immediately prior to the effective date of the merger is to be
an identical outstanding or treasury share of the surviving
common stock after the merger; and any authorized but unissued
shares or treasury shares of the surviving common stock to be
issued or delivered under the plan of merger plus those
initially issuable upon conversion of any other securities or
obligations to be issued or delivered under such plan do not
exceed 20% of the shares of the surviving common stock
outstanding immediately prior to the effective date of the
merger.
69
77
Section 203 of the DGCL governs business combinations (e.g. mergers,
sales and leases of assets, issuance of securities) and other similar
transactions between a Delaware public company and an "interested stockholder."
An interested stockholder is a person who beneficially owns or has the right to
vote 15% (unlike 10% in Minnesota) or more of a company's outstanding shares.
Section 203 does not apply if:
- prior to the person or entity becoming an interested
stockholder, the business combination or the transaction
pursuant to which such person or entity became an interested
stockholder was approved by the Corporation's board of
directors,
- upon consummation of the transaction in which he or she became
an interested stockholder, the interested stockholder holds at
least 85% of the Corporation's common stock outstanding at the
time the transaction commenced (excluding shares held by
persons who are both officers and directors and shares held by
employee stock plans); or
- following the transaction in which such person became an
interested stockholder, the business combination is approved
by the Corporation's board of directors and by the holders of
at least two-thirds of the outstanding shares of common stock
(excluding shares owned by the interested stockholder) at an
annual or special meeting of the Corporation's stockholders
(and not by written consent).
The restrictions imposed on interested stockholders under Section 203
do not apply under limited circumstances where a company proposes, with the
approval of the majority of the directors who were directors before any person
became an interested stockholder, a merger or sale of at least 50% of its assets
(as defined under Section 203) or supports (or does not oppose) a tender offer
for at least 50% of its voting stock.
Section 203 only applies to Delaware corporations which have a class of
voting stock that is listed on a national securities exchange, is authorized for
quotation on The Nasdaq Stock Market or is held by record by more than 2,000
stockholders. However, a Delaware corporation may elect not to be governed by
Section 203 in its certificate of incorporation or its bylaws. The authorization
of this provision must be approved by a majority of the shares entitled to vote
and, in the case of a bylaw amendment, may not be further amended by the board
of directors. Currently, Section 203 applies to AGCO.
If Section 203 applies, then for three years after a person becomes an
interested stockholder, the following transactions between the company and the
interested stockholder or persons related to that stockholder are prohibited:
- the sale, lease, exchange, mortgage, pledge, transfer or
acquisition (other than proportionately to stockholders) of
any interest in assets worth more than 10% of the market value
of the company's assets;
- mergers and similar transactions;
- loans or guarantees; and
- subject to certain exceptions, the issuance or transfer of
stock or any rights to acquire stock of the company's
outstanding stock or the stock of its subsidiaries.
DIRECTOR LIABILITY AND INDEMNIFICATION
The MBCA provides that, unless the articles of incorporation or bylaws
otherwise provide, directors and officers will be indemnified against judgments,
penalties, fines, settlements and expenses (including attorneys' fees) incurred
in connection with legal proceedings to which they are made, or threatened to be
made, a party by reason of their present or former status as a director or
officer, if:
- they have not been indemnified by another organization;
70
78
- they acted in good faith;
- they received no improper personal benefit;
- in the case of any criminal proceeding, they had no reasonable
cause to believe their conduct was unlawful; and
- they reasonably believed their conduct to be in the
corporation's best interests.
Ag-Chem's bylaws provide indemnification to directors and officers to
the full extent permitted by the MBCA.
The DGCL permits a corporation to indemnify any director, officer,
employee or agent made or threatened to be made a party to any threatened,
pending or completed proceeding if the person acted in good faith and in a
manner such person reasonably believed to be in the best interests of the
corporation, and, with respect to any criminal proceeding, had no reasonable
cause to believe that his or her conduct was unlawful.
AGCO's bylaws contain provisions which require AGCO to indemnify
directors and officers to the full extent permitted by the DGCL.
AGCO's bylaws also provide, in accordance with the DGCL, that the
corporation may advance expenses incurred by its directors or officers in
defending a civil or criminal action, suit or proceeding because that person is
a director or officer. However, such payment will be made only if the
corporation receives an undertaking by or on behalf of that director or officer
to repay all amounts advanced if it is ultimately determined that he or she is
not entitled to be indemnified by the corporation.
LIMITATION ON DIRECTORS' LIABILITIES
Both the MBCA and the DGCL permit a corporation to include a provision
in its certificate of incorporation eliminating or limiting the personal
liability of a director to the corporation or its shareholders/stockholders for
damages for a breach of the director's fiduciary duty. Ag-Chem's articles of
incorporation include such a provision to the maximum extent permitted by law.
AGCO's certificate of incorporation does not include such a provision.
REMOVAL OF DIRECTORS
Ag-Chem directors may be removed with or without cause by a vote of the
shareholders holding a majority of the shares entitled to vote at an election of
directors except as otherwise provided by law, specifically where shareholders
have the right to cumulate their votes. In addition, Ag-Chem directors who have
been elected by the board of directors to fill a vacancy or to fill a
directorship created by action of the board, and who have not been subsequently
reelected by the shareholders, may be removed by a majority vote of all the
directors.
AGCO directors may be removed for cause only by the affirmative vote of
the holders of at least a majority of the shares entitled to vote at an election
of directors.
SPECIAL MEETINGS OF SHAREHOLDERS
Ag-Chem's bylaws provide that a special meeting may be called by the
chief executive officer, chief financial officer, or such other officer as may
be designated by the board of directors; upon request of a majority of the
members of the board of directors; or upon written request of one or more
shareholders holding 10% or more of the shares entitled to vote on matters to be
presented at the meeting. The MBCA further provides that if an annual meeting of
shareholders has not been held during the immediately preceding 15 months, one
or more shareholders holding three percent or more of the voting power of all
shares entitled to vote may demand an annual meeting by written notice of demand
given to the chief executive officer or chief financial officer of the company.
AGCO's bylaws provide that special meetings of the stockholders may be
called by order of the board of directors or the executive committee. The DGCL
further provides that if an annual meeting is not held within 30 days of the
date designated for the meeting, or is not held for a period of 13 months after
the last annual meeting, the Delaware Court of Chancery may summarily order a
meeting to be held if requested by any stockholder or director.
71
79
NUMBER OF DIRECTORS
Ag-Chem directors are elected for a term of one year and until their
successors are elected and qualified. Ag-Chem's board of directors is not
divided into classes. Ag-Chem's board of directors currently consists of eight
directors. The number of directors on Ag-Chem's board of directors is
determined, from time to time, by the shareholders of Ag-Chem or the board of
directors of Ag-Chem.
AGCO's board of directors is divided into three classes, as permitted
by Delaware law, with one class being elected annually. AGCO directors are
elected for a term of three years and until their successors are elected and
qualified. AGCO's board of directors currently consists of eleven directors. The
number of directors on AGCO's board of directors is determined by a resolution
adopted by a majority vote of the board of directors and may not be less than
three nor more than thirteen.
NEWLY CREATED DIRECTORSHIPS AND VACANCIES
Ag-Chem's bylaws provide that vacancies on the board of directors
resulting from an increase in the number of directors authorized under the
bylaws may be filled by a majority vote of the directors serving at the time of
such increase. All other vacancies on the board of directors shall be filled by
a majority of the remaining directors even though less than a quorum.
AGCO's bylaws provide that any vacancies on the board of directors may
be filled by the affirmative vote of a majority of the remaining directors then
in office, even if less than a quorum. Any director elected in such a manner
shall serve until the election of his successor or until his resignation or
removal as provided in AGCO's bylaws.
COMMITTEES OF THE BOARD OF DIRECTORS
Ag-Chem's bylaws provide that, by the affirmative vote of a majority of
the directors, the board of directors may designate two or more individuals to
constitute a committee having the authority of the board of directors to the
extent provided by the board of directors.
AGCO's bylaws provide for an Executive Committee, Audit Committee,
Compensation Committee and Nominating Committee. AGCO's bylaws also provide that
the board of directors may create any other committee it deems desirable and may
discontinue such other committees at any time.
SHAREHOLDERS' RIGHTS PLAN
In April 1994, AGCO designated 300,000 shares of Junior Cumulative
Preferred Stock in connection with the adoption of a shareholder rights plan.
Under the terms of the rights plan, one-third of a preferred stock purchase
right (a right) is attached to each outstanding share of AGCO common stock. The
rights plan contains provisions that are designed to protect stockholders in the
event of unsolicited attempts to acquire AGCO. Under the terms of the rights
plan, each right entitles the holder to purchase one one-hundredth of a share of
the AGCO junior preferred stock, par value of $0.01 per share, at an exercise
price of $200 per share. The rights are exercisable a specified number of days
following (i) the acquisition by a person or group of persons of 20% or more of
AGCO's common stock or (ii) the commencement of a tender or exchange offer for
20% or more of AGCO's common stock. In the event AGCO is the surviving company
in a merger with a person or group of persons that owns 20% or more of AGCO's
outstanding stock, each right will entitle the holder (other than such 20%
stockholder) to receive, upon exercise, common stock of AGCO having a value
equal to two times the right's exercise price. In addition, in the event AGCO
sells or transfers 50% or more of its assets or earning power, each right will
entitle the holder to receive, upon exercise, common stock of the acquiring
company having a value equal to two times the right's exercise price. The rights
may be redeemed by AGCO at $0.01 per right prior to their expiration on April
27, 2004.
Ag-Chem has no shareholder rights plan.
72
80
NOMINATION PROCEDURES AND SHAREHOLDER PROPOSALS
The MBCA provides that any business appropriate for action by the
shareholders may be transacted at a regular meeting of the shareholders. The
DGCL provides that any business appropriate for action by the stockholders may
be transacted at an annual meeting of the stockholders.
AGCO's bylaws provide that a stockholder who wishes to nominate
directors for election at a stockholder meeting or who wants to bring business
before a stockholder meeting must have given timely notice thereof in writing to
the secretary of the corporation. In order to be timely, the notice must be
received at the corporation's executive offices not less than 60 nor more than
90 days prior to the first anniversary of the preceding year's annual meeting.
Stockholder nominations and proposals will not be brought before any
AGCO shareholder meeting unless the nomination or proposal was made in
accordance with the specific requirements set forth in the bylaws. The chairman
of the AGCO stockholder meeting will have the power to determine whether the
business or nomination set forth by the stockholder was properly brought before
the stockholder meeting. If the chairman determines that the business or
nomination was not properly brought before the stockholder meeting, the chairman
may declare that the business or nomination will be disregarded.
DIVIDENDS
Under the MBCA, Ag-Chem may declare a dividend to its shareholders if
the board of directors determines that Ag-Chem will be able to pay its debts in
the ordinary course of business after making the distribution and the board of
directors does not know before the dividend is made that the determination was
or has become erroneous. A dividend may be made to the holders of a class or
series of shares only if all amounts payable to the holders of shares having a
preference for the payment are paid and the distribution does not reduce the
remaining net assets of Ag-Chem below the aggregate preferential amount payable
in the event of liquidation to the holders of shares having preferential rights,
unless the distribution is made to those shareholders in the order and to the
extent of their respective priorities.
The DGCL provides that, unless restricted by the corporation's
certificate of incorporation, dividends may be declared from the corporation's
surplus (as defined by and computed in accordance with the DGCL) or, if there is
no surplus, from its net profits for the fiscal year in which the dividend is
declared and the preceding fiscal year. However, if the corporation's capital
(as defined by and computed in accordance with the DGCL) has been diminished to
an amount less than the aggregate amount of the capital represented by the
issued and outstanding stock of all classes having a preference upon the
distribution of assets, dividends may not be declared and paid out of net
profits until the deficiency in the capital has been repaired.
INSPECTION OF DOCUMENTS
The MBCA provides that any shareholder or group of shareholders of a
publicly-held corporation have the right, upon written demand stating the
purpose, to examine and copy the corporation's share register and other
corporate records upon demonstrating a proper purpose.
The DGCL provides that a stockholder of a Delaware corporation may
inspect the books and records (including stockholder lists) of the corporation
during normal business hours upon written demand under oath stating the purpose
of the inspection, if such purpose is reasonably related to such person's
interest as a stockholder.
WHERE YOU CAN FIND MORE INFORMATION
statement/prospectus incorporates the following documents by
reference. These documents are being delivered with this proxy
statement/prospectus.
For AGCO (SEC File No. 1-12930), these documents include:
- AGCO's Annual Report on Form 10-K, as amended by Form
10-K/A (Amendment No. 1), for the year ended December
31, 1999;
73
81
- AGCO's Quarterly Report on Form 10-Q, as amended by
Form 10-Q/A (Amendment No. 1), for the quarter ended
March 31, 2000;
- AGCO's proxy statement relating to its Annual Meeting
of Stockholders held on April 26, 2000;
- AGCO's Quarterly Report on Form 10-Q, as amended by
Form 10-Q/A (Amendment No. 1), for the quarter ended
June 30, 2000; and
- AGCO's Quarterly Report on Form 10-Q, as amended by
Form 10-Q/A (Amendment No. 1), for the quarter ended
September 30, 2000.
For Ag-Chem (SEC File No. 0-25360), these documents (excluding
exhibits) include:
- Ag-Chem's Annual Report on Form 10-K, as amended by
Form 10-K/A (Amendment No. 1), for the fiscal year
ended September 30, 2000; and
- Ag-Chem's Quarterly Report on Form 10-Q for the
quarter ended December 31, 2000.
All documents filed by us pursuant to Section 13(a), 13(c), 14 or 15(d)
of the Securities Exchange Act of 1934 after the date of this proxy
statement/prospectus and before the date of the special meeting also are
incorporated by reference into and are made a part of this proxy
statement/prospectus from the date of filing of those documents.
YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROXY
STATEMENT/PROSPECTUS, DELIVERED WITH THIS PROXY STATEMENT/PROSPECTUS OR THAT WE
HAVE REFERRED YOU TO. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH
INFORMATION THAT IS DIFFERENT.
Any statement contained in a document incorporated or deemed to be
incorporated by reference into this proxy statement/prospectus will be deemed to
be modified or superseded for purposes of this proxy statement/prospectus to the
extent that a statement contained in this proxy statement/prospectus or any
other subsequently filed document that is deemed to be incorporated by reference
into this proxy statement/prospectus modifies or supersedes that statement. Any
statement so modified or superseded will not be deemed, except as so modified or
superseded, to constitute a part of this proxy statement/prospectus.
We file reports, proxy statements and other information with the
Securities and Exchange Commission. Copies of our reports, proxy statements and
other information may be inspected and copied at the public reference facilities
maintained by the Securities and Exchange Commission at:
Judiciary Plaza Citicorp Center Seven World Trade Center
Room 1024 500 West Madison Street 13th Floor
450 Fifth Street, NW Suite 1400 New York, NY 10048
Washington, D.C. 20549 Chicago, Illinois 60661
Reports, proxy statements and other information concerning Ag-Chem may
be inspected at:
The National Association of Securities Dealers
1735 K Street, N.W.
Washington, D.C. 20006
Copies of these materials can also be obtained by mail at prescribed
rates from the Public Reference Section of the Securities and Exchange
Commission, 450 Fifth Street, N.W., Washington, D.C. 20549 or by calling the
Securities and Exchange Commission at 1-800-SEC-0330. The Securities and
Exchange Commission maintains a website that contains reports, proxy statements
and other information regarding Ag-Chem and AGCO. The address of the Securities
and Exchange Commission website is http://www.sec.gov.
AGCO has filed a registration statement on Form S-4 under the
Securities Act with the Securities and Exchange Commission with respect to
AGCO's common stock to be issued to Ag-Chem shareholders. This proxy
74
82
statement/prospectus constitutes the prospectus of AGCO filed as part of the
registration statement. This proxy statement/prospectus does not contain all of
the information set forth in the registration statement because parts of the
registration statement are omitted in accordance with the rules and regulations
of the Securities and Exchange Commission. The registration statement and its
exhibits are available for inspection and copying as set forth above.
EXPERTS
The consolidated financial statements and schedule of AGCO as of
December 31, 1999 and 1998, and for each of the three years in the period ended
December 31, 1999, which are incorporated by reference in this proxy
statement/prospectus have been audited by Arthur Andersen LLP, independent
public accountants, as indicated in their reports with respect thereto, and are
incorporated by reference herein in reliance upon the authority of said firm as
experts in accounting and auditing in giving said reports.
The consolidated financial statements and schedules of Ag-Chem as of
September 30, 1999 and 2000, and for each of the years in the three-year period
ended September 30, 2000, have been incorporated by reference in this proxy
statement/prospectus in reliance upon the reports of KPMG LLP, independent
certified public accountants, and upon the authority of said firm as experts in
accounting and auditing.
The discussions under the heading "The Merger--Material Federal Income
Tax Consequences" were reviewed by KPMG LLP, independent certified public
accountants, and have been included herein upon the authority of said firm as
experts in tax accounting.
The financial statements of Redball, LLC as of September 30, 2000, and
for the year then ended, have been incorporated by reference in this proxy
statement/prospectus in reliance upon the report of KPMG LLP, independent
certified public accountants, and upon authority of said firm as experts in
accounting and auditing.
The financial statements of Agricredit Acceptance LLC, as of December
31, 1999 and 1998, have been incorporated by reference in this proxy
statement/prospectus in reliance upon the report of KPMG LLP, independent
certified public accountants, and upon authority of said firm as experts in
accounting and auditing.
Ag-Chem anticipates that one or more representatives of KPMG LLP will
be present at the special meeting with an opportunity to make a statement, if
desired, and will be available to answer appropriate questions from shareholders
who are present.
LEGAL MATTERS
Troutman Sanders LLP, counsel to AGCO, will deliver an opinion to AGCO
pursuant to the merger agreement, relating to material federal income tax
matters. Troutman Sanders LLP also will deliver an opinion as to the validity of
the AGCO common stock and the subscription rights issued in the merger. Larkin,
Hoffman, Daly & Lindgren, Ltd. has represented Ag-Chem in connection with the
merger agreement and matters related to the merger.
FUTURE SHAREHOLDER PROPOSALS
Ag-Chem will hold its annual meeting of Ag-Chem shareholders only if
the merger is not consummated. Shareholder proposals sought to be included in
the proxy statement for the 2001 annual meeting of Ag-Chem shareholders if the
merger is not completed should have been received by Ag-Chem at its principal
executive offices on or before ________, 2001. Pursuant to Rule 14a-4(c)(1), as
promulgated under the Securities Exchange Act of 1934 if a proponent of a
proposal fails to notify Ag-Chem of a shareholder proposal at least 45 days
prior to the date of mailing of the prior year's proxy statement (i.e., January
8, 2000), the management proxies will be allowed to use their discretionary
voting authority when the proposal is raised at the meeting, without any
discussion of the matter in the proxy statement.
OTHER MATTERS
75
83
The Ag-Chem board of directors knows of no other matters that are
likely to be brought before the special meeting. If any other matters are
properly brought before the meeting, A. E. McQuinn and John C. Retherford, as
the proxy agents named in the enclosed proxy, will vote on those matters in
accordance with their best judgment.
APPENDICES
You should rely only on the information contained or incorporated by
reference in this proxy statement/prospectus to vote on the proposal to adopt
the merger agreement. Neither AGCO nor Ag-Chem has authorized anyone to provide
you with information that is different from that which is contained in this
proxy statement/prospectus. You should not assume that the information contained
in this proxy statement/prospectus is accurate as of any date other than the
date set forth on the cover page, and neither the mailing of this proxy
statement/prospectus to shareholders nor the issuance of AGCO common stock in
the merger shall create any implication to the contrary.
Appendix A - Agreement and Plan of Merger
Appendix B - Voting Agreement
Appendix C - Sections 302A.473 and 302A.471 of the Minnesota Business
Corporation Act
Appendix D - Opinion of Goldsmith, Agio, Helms Securities, Inc.
Appendix E - Form of Affiliate Letter
76
84
APPENDIX A
AGREEMENT AND PLAN OF MERGER
by and among
AGCO CORPORATION,
AGRI ACQUISITION CORP.
and
AG-CHEM EQUIPMENT CO., INC.
Dated as of November 20, 2000
85
AGREEMENT AND PLAN OF MERGER, dated as of November 20, 2000
(this "Agreement"), by and among AGCO CORPORATION, a corporation organized under
the laws of the State of Delaware ("Parent"), AGRI ACQUISITION CORP., a
corporation organized under the laws of the State of Delaware ("Sub"), and
AG-CHEM EQUIPMENT CO., INC., a corporation organized under the laws of the State
of Minnesota (the "Company").
WITNESSETH:
WHEREAS, the Boards of Directors of each of Parent, Sub and
the Company have determined that it is advisable and in the best interests of
their respective companies and their stockholders to consummate the transaction
provided for herein in which, upon the terms and subject to the conditions set
forth herein, the Company will merge (the "Merger") with Sub;
WHEREAS, the parties intend that for U.S. federal income tax
purposes, the Merger qualify as a "reorganization" within the meaning of Section
368(a) of the Code (in the event that it is a merger under Section 2.01(a)(i)
hereof);
WHEREAS, as a condition and as an inducement to Parent's
willingness to enter into this Agreement, Parent is entering into a Voting
Agreement (the "Voting Agreement") with a certain substantial Company
shareholder (the "Specified Stockholder"); and
WHEREAS, the parties desire to make certain representations,
warranties and agreements in connection with the Merger and also to prescribe
certain conditions to the Merger.
NOW, THEREFORE, in consideration of the mutual
representations, warranties, covenants and agreements contained herein, and
intending to be legally bound hereby, the parties agree as follows:
ARTICLE I
CERTAIN DEFINITIONS
1.01. Certain Definitions. As used in this Agreement, the
following terms shall have the meanings set forth below:
"Acquisition Proposal" shall mean any offer, proposal, inquiry
or indication of interest with respect to any of the following, in each case
other than the transactions contemplated by this Agreement (a) a merger,
reorganization or consolidation, or any similar business combination or
transaction, involving the Company (other than mergers, reorganizations,
consolidations or similar business combinations or transactions involving solely
the Company and/or one or more wholly-owned Subsidiaries of the Company), (b) a
direct or indirect purchase or other acquisition (including by way of merger,
consolidation, share exchange, tender or exchange offer involving any Subsidiary
of the Company or securities issued by any Subsidiary of the Company, as the
case may be) of greater than 15% of the consolidated assets of the Company and
its Subsidiaries, (c) a purchase or other acquisition (including by way of
merger, consolidation, share exchange, tender or exchange offer or otherwise) of
beneficial ownership of securities representing more than 10% of the voting
power of the Company, (d) any substantially similar transaction.
"Agreement" shall have the meaning set forth in the first
paragraph of this Agreement.
"Arthur Andersen" shall have the meaning set forth in Section
6.13.
"Articles of Merger" shall have the meaning set forth in
Section 2.01(b).
"Business Day" shall mean each day on which banking
institutions in New York, New York are not authorized or required to close.
A-1
86
"Capitalization Date" shall have the meaning set forth in
Section 5.01(b).
"Cash Portion" shall mean (i) $25.80 minus (ii) the product of
(A) the Stock Portion multiplied by (B) the Parent Price.
"Certificate of Merger" shall have the meaning set forth in
Section 2.01(b).
"Code" shall mean the U.S. Internal Revenue Code of 1986, as
amended.
"Company" shall have the meaning set forth in the first
paragraph of this Agreement.
"Company Affiliate" shall have the meaning set forth in
Section 6.07(a).
"Company Board" shall mean the Board of Directors of the
Company.
"Company By-Laws" shall mean the By-Laws of the Company.
"Company Certificate" shall mean the Articles of Incorporation
of the Company, as amended.
"Company Common Stock" shall have the meaning set forth in
Section 3.01(b).
"Company Disclosure Schedule" shall have the meaning set forth
in the opening paragraph of Section 5.01.
"Company Employees" shall have the meaning set forth in
Section 6.12(a).
"Company Equity Interests" shall have the meaning set forth in
Section 5.01(c).
"Company Filed SEC Documents" shall mean the forms, reports
and documents filed or to be filed by the Company with the SEC since January 1,
1996.
"Company Financial Advisor" shall have the meaning set forth
in Section 5.01(j).
"Company Intellectual Property" shall have the meaning set
forth in Section 5.01(n).
"Company Meeting" shall have the meaning set forth in Section
6.02.
"Company Plan" shall mean any Plan entered into or currently
maintained, sponsored, or contributed to by the Company or any of its
Subsidiaries or to which the Company or any such Subsidiary has any obligation
to contribute or with respect to which the Company or any of its Subsidiaries
may have any liability.
"Company Proxy Statement" shall have the meaning set forth in
Section 6.03(a).
"Confidentiality Agreement" shall mean that certain
confidentiality agreement, dated July 27, 2000, by and between the Company's
Financial Advisor and Parent (of which the Company is a third party beneficiary)
and the confidentiality agreement between the Company and Parent dated May 30,
2000.
"Copyrights" shall have the meaning set forth in the
definition of Intellectual Property Rights.
"Costs" shall have the meaning set forth in Section 6.11(a).
"Designated Price" shall mean the greater of (i) $8.38 or (ii)
the lowest amount necessary, as a result of any amounts required to be paid out
to dissenting shareholders of the Company or for fractional shares, in order for
the opinions set forth in Sections 7.02(c) and 7.03(c) to be provided.
A-2
87
"DGCL" shall mean the General Corporation Law of the State of
Delaware.
"Effective Date" shall have the meaning set forth in Section
2.02.
"Effective Time" shall have the meaning set forth in Section
2.02.
"Environmental Claim" shall mean any claim, demand, action,
suit, complaint, investigation, or notice of noncompliance, violation, or
liability, by any person or entity asserting liability or potential liability
(including without limitation liability or potential liability for enforcement,
investigatory costs, cleanup costs, governmental response costs, natural
resource damages, property damage, personal injury, fines or penalties) arising
out of, based on or resulting from (i) the presence, discharge, emission,
release or threatened release of any Hazardous Materials at or from any
location, (ii) circumstances forming the basis of any violation or alleged
violation of any Environmental Laws or Environmental Permits, or (iii) otherwise
relating to obligations or liabilities under any Environmental Law.
"Environmental Laws" shall mean any and all laws, rules,
orders, regulations, statutes, ordinances, guidelines, codes, decrees, or other
legally enforceable requirements (including, without limitation, common law) of
any foreign government, the United States, or any state, local, municipal or
other governmental authority, regulating, relating to or imposing liability or
standards of conduct concerning protection of the environment (including without
limitation indoor air, ambient air, surface water, groundwater, land surface,
subsurface strata, or plant or animal species) or human health as affected by
the environment or Hazardous Materials (including without limitation employee
health and safety).
"Environmental Permits" shall mean all permits, licenses,
registrations, approvals, exemptions and other filings with or authorizations by
any Governmental Authority under any Environmental Law.
"Environmental Report" shall mean any report, study,
assessment, audit, or other similar document that addresses any issue of actual
or potential noncompliance with, actual or potential liability under or cost
arising out of, or actual or potential impact on business in connection with,
any Environmental Law or any proposed or anticipated change in or addition to
Environmental Law, that may affect the Company or any of its Subsidiaries.
"ERISA" shall mean the Employee Retirement Income Security Act
of 1974, as amended, and the regulations promulgated thereunder and published
interpretations of any Governmental Authority with respect thereto.
"Exchange Act" shall mean the Securities Exchange Act of 1934,
as amended, and the rules and regulations promulgated thereunder.
"Exchange Agent" shall have the meaning set forth in Section
3.05(a).
"Exchange Fund" shall have the meaning set forth in Section
3.05(a).
"Expenses" shall mean out-of pocket expenses (including,
without limitation, all fees and expenses of counsel, accountants, investment
bankers, experts and consultants to a party hereto and its affiliates) incurred
by a party or on its behalf in connection with or related to the authorization,
preparation, negotiation, execution and performance of this Agreement, the
preparation, printing, filing and mailing of the Company Proxy Statement, the
solicitation of shareholder approvals and all other matters related to the
consummation of the Merger.
"GAAP" shall mean accounting principles generally accepted in
the respective country where a Party, or its Subsidiaries operate, as
applicable.
A-3
88
"Governmental Authority" means any foreign or domestic
federal, state, county, provincial or local court, tribunal, judicial or
arbitral body, administrative agency or commission or other governmental or
regulatory authority or instrumentality.
"HSR Act" shall have the meaning set forth in Section 5.01(p).
"Hazardous Materials" shall mean all hazardous or toxic
substances, wastes, materials or chemicals, petroleum (including crude oil or
any fraction thereof), petroleum products, asbestos, asbestos-containing
materials, pollutants, contaminants, radioactivity and all other materials,
whether or not defined as such, that are regulated pursuant to or that could
result in liability under any applicable Environmental Laws.
"Indemnified Party" shall have the meaning set forth in
Section 6.11(a).
"Insurance Amount" shall have the meaning set forth in Section
6.11(b).
"Intellectual Property Rights" shall mean all proprietary,
license and other rights anywhere in the United States in and to: (A)
trademarks, service marks, brand names, trade dress, trade names and any and all
other indications of origin whether registered or at common law, domain names
and the goodwill associated with the foregoing ("Trademarks"); (B) patents,
patent applications (together, "Patents"), inventors' certificates and invention
disclosures; (C) trade secrets and other confidential or non-public business
information, including ideas, formulas, compositions, discoveries and
improvements, know-how, manufacturing and production processes and techniques,
and research and development information; drawings, specifications, plans,
proposals and technical data; analytical models, investment and lending
strategies and records, financial and other products; financial, marketing and
business data, pricing and cost information; business and marketing plans and
customer and supplier lists and information; in each case whether patentable,
copyrightable or not ("Trade Secrets"); (D) computer programs and databases, in
each case whether patentable, copyrightable or not (collectively, "Software"),
and all documentation therefor; (E) writings and other works of authorship,
including marketing materials, brochures, training materials, including all
copyrights and moral rights related to each of the foregoing ("Copyrights"); (F)
rights to limit the use or disclosure of confidential information by any Person;
(G) registrations of, and applications to register, any of the foregoing with
any Governmental Authority and any renewals or extensions thereof; and (I) any
claims or causes of action arising out of or related to any infringement or
misappropriation of any of the foregoing and the right to recover damages and
lost profits therefrom.
"Issuance Election" shall mean an election by Parent pursuant
to Section 3.02(b).
"KPMG" shall have the meaning set forth in Section 6.13.
"Knowledge" or "knowledge" with respect to a party shall mean
to the knowledge of its directors and the individuals listed on Schedule A
hereto.
"Law" shall mean the common law and any statute, ordinance,
code or other law, rule, regulation, order, requirement or procedure enacted,
adopted, promulgated, applied or followed by any Governmental Authority.
"Liens" shall mean any charge, mortgage, pledge, security
interest, material restriction, claim, lien, or encumbrance.
"MBCA" shall mean the Minnesota Business Corporation Act.
"Material Adverse Effect" shall mean with respect to the
Company or Parent, any event, change, occurrence, fact or circumstance which (i)
is or which would reasonably be expected to lead to an adverse change in the
consolidated balance sheet of the Company or any of the Company's Subsidiaries,
or Parent or any of Parent's Subsidiaries, which is material to the Company and
its Subsidiaries, taken as a whole, or Parent and its Subsidiaries taken as a
whole, as the case may be, or (ii) would materially impair the ability of Parent
or the Company, as the case may be, to perform its obligations under this
Agreement or to consummate the transactions contemplated hereby,
A-4
89
other than (in the case of (i) or (ii)) an event, change, occurrence, fact or
circumstance (A) arising out of general U.S. or global economic conditions, (B)
arising with respect to the industry in which Parent and the Company compete, so
long as such change does not specifically relate to or disproportionately affect
Parent or the Company, as the case may be, (C) arising out of facts or events
specifically set forth in the Company Disclosure Schedule or the Parent
Disclosure Schedule, as the case may be or (D) arising out of the public
announcement of the transactions contemplated by this Agreement.
"Maximum Share Amount" shall mean 11,800,000 Parent Common
Shares.
"Merger" shall have the meaning set forth in the recitals to
this Agreement.
"Merger Consideration" shall mean the Cash Portion plus the
Stock Portion.
"NASD" shall mean the National Association of Securities
Dealers, Inc. or, if the context so requires, the Nasdaq Stock Market, Inc.
"New Certificates" shall have the meaning set forth in Section
3.05(a).
"NYSE" shall mean the New York Stock Exchange, Inc.
"Old Certificates" shall have the meaning set forth in Section
3.05(a).
"Parent" shall have the meaning set forth in the first
paragraph of this Agreement.
"Parent Board" shall mean the Board of Directors of Parent.
"Parent By-Laws" shall mean the By-Laws of Parent.
"Parent Certificate" shall mean the Certificate of
Incorporation of Parent, as amended.
"Parent Common Shares" shall mean shares of common stock, par
value $0.01 per share, of Parent.
"Parent Disclosure Schedule" shall have the meaning set forth
in the opening paragraph of Section 5.02.
"Parent Filed SEC Documents" shall mean the forms, reports and
documents filed or to be filed by the Parent with the SEC since January 1, 1996.
"Parent Plan" shall have the meaning set forth in Section
6.12(a).
"Parent Price" shall mean the average (rounded to the nearest
1/100th) of the closing price of Parent Common Shares on the NYSE Composite
Transaction Reporting System, as reported in The Wall Street Journal (for
trading during regular trading hours, not extended trading), for the 10
consecutive Trading Days ending on the Trading Day immediately preceding the
Effective Date.
"Parent Rights" shall mean the Rights issued pursuant to the
Parent Rights Plan.
"Parent Rights Plan" shall mean the shareholder rights plan
established pursuant to the Rights Agreement dated as of April 27, 1994, between
Parent and SunTrust Bank, as such plan may from time to time be amended.
"Parent Trigger Price" shall mean the closing price of Parent
Common Shares on the NYSE Composite Transactions Reporting System (for trading
during regular trading hours, not extended trading) on the
A-5
90
Trading Day immediately preceding the Effective Date. For purposes of this
definition, the Effective Date shall be determined without reference to the
conditions set forth in Sections 7.02(c) and 7.03(c).
"Party" shall mean Parent, Company and/or Sub, as applicable.
"Patents" shall have the meaning set forth in the definition
of Intellectual Property Rights.
"Person" or "person" shall mean any individual, bank,
corporation, limited liability company, partnership, association, joint-stock
company, business trust or unincorporated organization.
"Plan" shall mean any employee benefit plan, including,
without limitation, any "employment benefit plan" within the meaning of Section
3(3) of ERISA, whether or not subject to ERISA, and any employment, consulting,
termination, severance, retention, change in control, deferred or incentive
compensation, bonus, phantom stock, restricted stock, stock option, stock bonus,
stock purchase or other equity based, vacation or other fringe benefit plan,
program, policy, arrangement, agreement or commitment.
"Previously Disclosed" by a party shall mean set forth in the
related section of its Disclosure Schedule.
"Registration Statement" shall have the meaning set forth in
Section 6.03(a).
"Regulatory Law" shall mean the Sherman Act, as amended, the
Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as
amended, and all other federal, state and foreign, if any, statutes, rules,
regulations, orders, decrees, administrative and judicial doctrines and other
laws that are designed or intended to prohibit, restrict or regulate actions
having the purpose or effect of monopolization or restraint of trade or
lessening of competition through merger or acquisition.
"Rights" shall mean, with respect to any person, securities or
obligations convertible into or exercisable or exchangeable for, or giving any
person any right to subscribe for or acquire, or any options, warrants, calls,
agreements, arrangements or commitments of any character relating to, or any
stock appreciation right, phantom stock option or other instrument the value of
which is determined in whole or in part by reference to the market price or
value of, shares of capital stock of such person.
"SEC" shall mean the United States Securities and Exchange
Commission.
"Securities Act" shall mean the Securities Act of 1933, as
amended, and the rules and regulations promulgated thereunder.
"Specified Stockholder" shall have the meaning set forth in
the recitals to this Agreement.
"Software" shall have the meaning set forth in the definition
of Intellectual Property Rights.
"Stock Portion" shall mean:
(A) if the Parent Trigger Price is greater than or equal to
the Designated Price, a number of Parent Common Shares
equal to the lesser of (i) the quotient obtained by
dividing (x) $12.90 by (y) the Parent Price or (ii)
1.2317;
(B) if the Parent Trigger Price is less than the Designated
Price but no Issuance Election has been made, zero or
such other number elected by Parent pursuant to Section
3.02(a); or
(C) if the Parent Trigger Price is less than the Designated
Price and an Issuance Election has been made, a number
of Parent Common Shares equal to the quotient obtained
by dividing (x) $10.32 by (y) the Parent Price.
A-6
91
Notwithstanding the foregoing, in the event one or more shareholders of the
Company have properly exercised their dissenters rights pursuant to the MBCA,
(i) the number set forth in clause (A)(ii) above shall automatically be
increased to the maximum amount allowed such that no more than the Maximum Share
Amount of Parent Common Shares are issued and (ii) the amount set forth in
clause (C) above shall automatically be increased by the minimum amount
necessary in order for the opinions set forth in Sections 7.02(c) and 7.03(c) to
be provided.
"Sub" shall have the meaning set forth in the first paragraph
of this Agreement.
"Sub Common Stock" shall have the meaning set forth in Section
3.01(a).
"Subsidiary" and "Significant Subsidiary" shall have the
meanings ascribed to them in Rule 1-02 of Regulation S-X of the SEC.
"Superior Proposal" shall have the meaning set forth in
Section 6.06(a).
"Surviving Corporation" shall mean the surviving corporation
in the Merger as provided in Section 2.01(a).
"Takeover Laws" shall mean any "control share," "fair price,"
or other anti-takeover laws or regulations of any state or jurisdiction that are
applicable to the Merger or the other transactions contemplated by this
Agreement or the Voting Agreement.
"Tax" means any federal, state, local, or foreign income,
gross receipts, license, payroll, employment, excise, severance, stamp,
occupation, premium, windfall profits, environmental (including taxes under
Section 59A of the Code), customs duties, capital stock, franchise, profits,
withholding, social security (or similar), unemployment, disability, real
property, personal property, sales, use, transfer, registration, value added,
alternative or add-on minimum, estimated, or other tax of any kind whatsoever,
including any interest, penalty, or addition thereto, whether disputed or not.
"Tax Return" shall mean any report, return, document,
declaration, claim for refund, information return, or other information or
filing relating to Taxes, including any schedule or attachment thereto, and
including any amendment thereof.
"Termination Fee" shall have the meaning set forth in Section
8.02(b).
"Trade Secrets" shall have the meaning set forth in the
definition of Intellectual Property Rights.
"Trademarks" shall have the meaning set forth in the
definition of Intellectual Property Rights.
"Trading Day" shall mean any day on which the NYSE is open for
trading.
"Voting Agreement" shall mean the agreement defined as such in
the recitals hereto, as such agreement may from time to time be amended.
ARTICLE II
THE MERGER; EFFECTS OF THE MERGER
2.01. The Merger. (a) Surviving Corporation. Upon the terms
and subject to the conditions set forth in this Agreement, and in accordance
with the DGCL and the MBCA, at the Effective Time:
(i) if the Parent Trigger Price is greater than or equal
to the Designated Price or in the event of an
Issuance Election (where the Company has not
terminated this Agreement pursuant to Section
8.01(g)), the Company will merge with and into Sub
pursuant to the Merger and, following
A-7
92
the Effective Time of the Merger, the separate
corporate existence of the Company shall cease and
Sub shall survive and continue to exist as a Delaware
corporation; or
(ii) if the Parent Trigger Price is less than the
Designated Price (unless there is an Issuance
Election), Sub will merge with and into the Company
pursuant to the Merger and, following the Effective
Time of the Merger, the separate corporate existence
of Sub shall cease and the Company shall survive and
continue to exist as a Minnesota corporation.
(b) Effectiveness and Effects of the Merger. Subject to the
satisfaction or waiver of the conditions set forth in Article VII in accordance
with this Agreement, the Merger shall become effective upon the occurrence of
(i) the filing in the office of the Secretary of State of the State of Minnesota
of articles of merger ("Articles of Merger") in accordance with Sections
302A.615 of the MBCA executed in accordance with the relevant provisions of the
MBCA and the making of all other filings and recordings required under the MBCA
to effect the Merger and (ii) the filing in the office of the Secretary of State
of the State of Delaware of a certificate of merger ("Certificate of Merger") in
accordance with Section 251 of the DGCL and the making of all other filings or
recordings required under the DGCL to effect the Merger, or at such later date
and time as may be set forth in the Articles of Merger and the Certificate of
Merger. The Merger shall have the effects prescribed in the MBCA and the DGCL.
Without limiting the generality of the foregoing, and subject thereto, at the
Effective Time all the property, rights, privileges, powers and franchises of
the Company and Sub shall be vested in the Surviving Corporation, and all debt,
liabilities and duties of the Company and Sub shall become the debt, liabilities
and duties of the Surviving Corporation.
(c) Certificate of Incorporation and By-Laws. The certificate
of incorporation and by-laws of the corporation that continues in existence, as
in effect immediately prior to the Effective Time, shall be those of the
Surviving Corporation until thereafter changed or amended as provided therein or
by applicable law.
(d) Name. The name of the Surviving Corporation shall be
Ag-Chem Equipment Co., Inc.
(e) Officers and Directors of Surviving Corporation. The
officers of the Company as of the Effective Time shall be the officers of the
Surviving Corporation, until the earlier of their resignation or removal or
otherwise ceasing to be an officer or until their respective successors are duly
elected and qualified, as the case may be. The directors of Sub as of the
Effective Time shall be the directors of the Surviving Corporation until the
earlier of their resignation or removal or otherwise ceasing to be a director or
until their respective successors are duly elected and qualified, as the case
may be.
2.02. Effective Date and Effective Time. (a) Subject to the
satisfaction or waiver (subject to applicable law) of the conditions set forth
in Article VII in accordance with this Agreement, the parties shall cause the
effective date of the Merger (the "Effective Date") to occur on the earliest of:
(i) the first Business Day that the Parent Trigger Price
is greater than or equal to the Designated Price,
provided that the last of the conditions set forth in
Sections 7.01, 7.02 and 7.03 has been satisfied or
waived (other than conditions that, by their terms,
cannot be satisfied until the Effective Date so long
as it is reasonably apparent that such conditions
will be satisfied on the Effective Date);
(ii) the first Business Day following the thirty (30) day
period from and including the date upon which the
last of the conditions set forth in Sections 7.01,
7.02 and 7.03 has been satisfied or waived (other
than the conditions set forth in Sections 7.02(c) and
7.03(c) and other than conditions that, by their
terms, cannot be satisfied until the Effective Date
so long as it is reasonably apparent that such
conditions will be satisfied on the Effective Date),
provided that, Parent may, in its sole discretion,
elect by providing written notice to the Company at
any time during such thirty (30) day period to cause
the Effective Time to occur on the first Business Day
following such election; or
A-8
93
(iii) such other date to which the Parties may agree in
writing.
(b) The time on the Effective Date when the Merger shall
become effective pursuant to (i) the filing of the Articles of Merger with the
Secretary of State of the State of Minnesota in the form required by and
executed in accordance with the applicable provisions of the MBCA and (ii) the
filing of the Certificate of Merger with the Secretary of State of the State of
Delaware in the form required by and executed in accordance with the applicable
provisions of the DGCL is referred to as the "Effective Time."
2.03. Tax Consequences. In the event the Merger is effected
pursuant to Section 2.01(a)(i), it is intended that the Merger shall qualify as
a reorganization under Section 368(a) of the Code. The parties agree to use
their reasonable best efforts, not inconsistent with the terms of this
Agreement, to have this Merger effectuated pursuant to Section 368(a) of the
Code, and agree to work with each other and their respective counsel in order to
determine the lowest possible Designated Price which will allow the transaction
to be treated as tax-free reorganization pursuant to Section 368(a) of the Code.
ARTICLE III
CONVERSION OF SHARES; EXCHANGE PROCEDURES
3.01. Conversion of Shares. Subject to the provisions of this
Agreement, at the Effective Time, automatically by virtue of the Merger and
without any action on the part of any party or shareholder of the Company or
Sub:
(a) Conversion of Sub Common Stock. If the Merger is effected
pursuant to Section 2.01(a)(i) each share of common stock of Sub, no
par value per share (the "Sub Common Stock"), issued and outstanding
immediately prior to the Effective Time, shall remain issued and
outstanding after the Merger as fully-paid and non-assessable share of
common stock, no par value per share, of the Surviving Corporation.
(b) Conversion of Company Common Stock. Subject to Section
3.04, each share of common stock, par value $0.01 per share, of the
Company (the "Company Common Stock") issued and outstanding immediately
prior to the Effective Time (other than any Dissenting Shares) shall
become and be converted into the right to receive, upon surrender of
the certificate formerly representing such Company Common Stock (or
compliance with the procedures set forth in Section 3.05(f) hereof
relating to lost certificates), the Merger Consideration, without
interest thereon, together, if the Parent Rights Plan is then in
effect, with the related Parent Rights. All of the shares of Company
Common Stock converted into the right to receive the Merger
Consideration pursuant to this Article III shall no longer be
outstanding and shall automatically be canceled and retired and shall
cease to exist as of the Effective Time.
(c) If the Merger shall be effected pursuant to Section
2.01(a)(ii), at the Effective Time, the Surviving Corporation shall
issue to Parent 1,000 shares of newly issued, fully-paid and
non-assessable common stock of the Surviving Corporation.
3.02 Election. (a) In the event that the Parent Trigger Price
is less than Designated Price on the Trading Day of such determination and the
Merger is to be consummated pursuant to Section 2.01(a)(ii), Parent shall give
written notice to the Company of Parent's election as to the number of Parent
Common Shares, if any, that shall constitute the Stock Portion, but in no event
shall such number of Parent Common Shares to be issued, if any, be more than the
Maximum Share Amount.
(b) In lieu of the election set forth in Section 3.02(a), in
the event that the Parent Price is less than $6.10, Parent may give written
notice to the Company prior to the otherwise expected Effective Time of (i) its
determination to terminate the Agreement pursuant to Section 8.01(f) or (ii) its
election (an "Issuance Election") to seek approval from its shareholders for the
issuance of a number of Parent Common Shares in connection with the
A-9
94
Merger in excess of the Maximum Share Amount, in which event the Effective Time
shall be deferred as contemplated by Section 7.01(a).
(c) In the event that Parent makes an election pursuant to
Section 3.02(a), each Company shareholder may elect to purchase such number of
Parent Common Shares from the Parent equal to or less than the difference
between the Maximum Share Amount and the number of Parent Common Shares issued
in the Merger, at a per share price equal to the lesser of (i) the Designated
Price and (ii) 105% of the Parent Price. In the event that elections made by
Company shareholders to purchase Parent Common Shares, when added to the number
of Parent Common Shares issued in the Merger, are more than the Maximum Share
Amount or such greater number as Parent may consent to, the number available to
be purchased by each Company shareholder shall be determined on a pro rata basis
based upon the number of shares of Company Common Stock held by each holder
making an election to purchase Parent Common Shares. Each election by a
shareholder of the Company must be made not more than thirty days after the
Effective Time in connection with the submission of transmittal materials
pursuant to Section 3.05.
3.03. Rights as Shareholders; Stock Transfers. At the
Effective Time, holders of Company Common Stock shall cease to be, and shall
have no rights as, shareholders of the Company, other than the right to receive
any dividend or other distribution with respect to such Company Common Stock
with a record date occurring prior to the Effective Time and the consideration
provided under this Article III. After the Effective Time, there shall be no
transfers on the stock transfer books of the Company or the Surviving
Corporation of shares of Company Common Stock.
3.04. Fractional Shares. Notwithstanding any other provision
hereof, no fractional Parent Common Shares (or related Parent Rights) and no
certificates or scrip therefor, or other evidence of ownership thereof, will be
issued in the Merger; instead, Parent shall pay to each holder of Company Common
Stock who would otherwise be entitled to a fractional share of Parent Common
Shares (after taking into account all Old Certificates delivered by such holder)
an amount (in U.S. dollars) in cash (without interest) determined by multiplying
such fraction by the Parent Price. As promptly as practicable after the
determination of the amount of cash, if any, to be paid to holders of fractional
interests, Parent shall so notify the Exchange Agent, and Parent shall cause the
Surviving Corporation to deposit such amount with the Exchange Agent and shall
cause the Exchange Agent to forward payments to such holders of fractional
interests subject to and in accordance with the terms hereof.
3.05. Exchange Procedures. (a) At or prior to the Effective
Time, Parent shall deposit, or shall cause to be deposited, with a bank or trust
company to act as exchange agent (the "Exchange Agent"), for the benefit of the
holders of certificates formerly representing shares of Company Common Stock
("Old Certificates") and for exchange in accordance with this Article III, the
Merger Consideration (including a sufficient number of Parent Common Shares, the
"New Certificates") and an estimated amount of cash payable pursuant to Section
3.04 (such Merger Consideration and estimated amount of cash, without any
interest thereon, being hereinafter referred to as the "Exchange Fund") to be
paid pursuant to this Article III in exchange for outstanding shares of Company
Common Stock.
(b) As promptly as practicable after the Effective Date,
Parent shall send or cause the Exchange Agent to send or cause to be sent to
each former holder of record of shares (other than any Dissenting Shares) of
Company Common Stock immediately prior to the Effective Time transmittal
materials for use in exchanging such shareholder's Old Certificates for the
Merger Consideration with respect to such Old Certificates as set forth in this
Article III. In the event that an election is made pursuant to Section 3.02(a),
the transmittal materials shall provide for the purchase of Parent Common Shares
provided for in Section 3.02(c). Parent shall cause the Merger Consideration
into which shares of a shareholder's Company Common Stock are converted at the
Effective Time and/or any check in respect of any fractional share interests or
dividends or distributions which such person shall be entitled to receive
pursuant to this Article III, to be delivered to such shareholder upon delivery
to the Exchange Agent of Old Certificates representing such shares of Company
Common Stock (or, pursuant to Section 3.05(f), a surety bond reasonably
satisfactory to Parent and the Exchange Agent, if any of such certificates are
lost, stolen or destroyed) owned by such shareholder. No interest will be paid
or accrued on the Cash Portion of the Merger Consideration or any cash to be
paid in lieu of fractional share interests or in respect of dividends or
distributions which any such person shall be entitled to receive pursuant to
this Article III upon such delivery. Notwithstanding
A-10
95
anything to the contrary contained herein, Old Certificates surrendered for
exchange by any Person constituting a Company Affiliate for purposes of Section
6.07 shall not be exchanged until Parent has received from such Person an
agreement in the form attached hereto as Exhibit A.
(c) Notwithstanding the foregoing, neither the Exchange Agent
nor any party hereto shall be liable to any Person for any amount properly
delivered to a public official pursuant to applicable abandoned property,
escheat or similar laws.
(d) No dividends or other distributions with respect to Parent
Common Shares with a record date occurring after the Effective Time shall be
paid to the holder of any unsurrendered Old Certificate representing shares of
Company Common Stock converted in the Merger into the right to receive the
Merger Consideration and cash in lieu of fractional Parent Common Shares
pursuant to Section 3.04, until the holder thereof shall be entitled to receive
the Merger Consideration and such amount of cash in exchange therefor in
accordance with this Article III. After becoming so entitled in accordance with
this Article III, the record holder thereof also shall be entitled to receive
any such dividends or other distributions, without any interest thereon, which
theretofore had become payable with respect to Parent Common Shares such holder
had the right to receive upon surrender of the Old Certificate, and payment
thereof shall be made promptly following the later of (i) the date on which such
holder shall become entitled to receive New Certificates and (ii) the payment
date with respect to such dividend or other distribution.
(e) Any portion of the Exchange Fund that remains unclaimed by
the shareholders of the Company for six months after the Effective Time shall,
upon demand by Parent, be paid or delivered to Parent. Any shareholders of the
Company who have not theretofore complied with this Article III shall thereafter
look only to Parent for payment of the Merger Consideration, cash in lieu of any
fractional shares and unpaid dividends and distributions on the Parent Common
Shares deliverable in respect of each share of Company Common Stock such
shareholder holds, as determined pursuant to this Agreement, in each case,
without any interest thereon.
(f) If any Old Certificate shall have been lost, stolen or
destroyed, upon the making of an affidavit of that fact by the person claiming
such Old Certificate to be lost, stolen or destroyed and the posting by such
person of a bond in such reasonable amount as Parent may direct as indemnity
against any claim that may be made against it or the Surviving Corporation with
respect to such Old Certificate, Parent shall, in exchange for such lost, stolen
or destroyed Old Certificate, deliver or cause the Exchange Agent to deliver a
New Certificate and cash payment in respect thereof pursuant to this Article
III.
(g) The Exchange Agent shall invest any cash included in the
Exchange Fund as directed by the Surviving Corporation on a daily basis. Any
interest or other income resulting from such investments shall promptly be paid
to the Surviving Corporation.
3.06. Anti-Dilution Provisions. In the event Parent changes
(or establishes a record date for changing) the number of Parent Common Shares
issued and outstanding prior to the Effective Time as a result of a stock split,
stock dividend, recapitalization, subdivision, reclassification, combination,
exchange of shares or similar transaction with respect to the outstanding Parent
Common Shares then (a) if the record and payment dates therefor shall be prior
to the Effective Time, the Stock Portion and references to $6.10 and Designated
Price shall be proportionately adjusted to reflect such stock split, stock
dividend, recapitalization, subdivision, reclassification, combination, exchange
of shares or similar transaction; and (b) if the record date therefor shall be
prior to the Effective Time but the payment date therefor shall be subsequent to
the Effective Time, Parent shall take such action as shall be required so that
on such payment date any former holder of Old Certificates who shall have
received or become entitled to receive New Certificates pursuant to this Article
III shall be entitled to receive such additional Parent Common Shares as such
holder would have received as a result of such event if the record date therefor
had been immediately after the Effective Time.
3.07. Stock Plans. Pursuant to the terms of the Company's 1998
Key Employee Phantom Stock Bonus Plan, at the Effective Time, the Company shall
terminate such plan, and pay to each individual then entitled to receive payment
immediately prior to the termination of such plan the difference between $25.80
and eleven and
A-11
96
15/16ths dollars ($11 15/16) multiplied by the number of Phantom Shares (as
defined in such plan) granted to such individual. The Company shall use its
reasonable best efforts to cause the Compensation Committee of the Company Board
to take any and all such action necessary in order to accelerate the timing and
vesting of such payment pursuant to the terms and conditions of such plan.
3.08. Dissenting Shares. Notwithstanding anything in this
Agreement to the contrary, each share of Company Common Stock that is issued and
outstanding immediately prior to the Effective Time and that is held by a
shareholder who has properly demanded and perfected such shareholder's rights to
dissent from the Merger and to be paid the fair value of such shares in
accordance with Sections 302A.471 and 302A.473 of the MBCA (the "Dissenting
Shares"), shall not be converted into or exchangeable for the right to receive
the Merger Consideration, but the holder thereof shall be entitled to such
rights as are granted by the MBCA and the Surviving Corporation shall make all
payments to the holders of such Dissenting Shares with respect to such demands
in accordance with the MBCA; provided, however, that if any such holder shall
have failed to perfect or shall have lost the right to dissent and obtain
payment for such holder's Dissenting Shares under the MBCA, each share of
Company Common Stock held by such holder shall thereupon be deemed to have been
converted into and to have become exchangeable for, as of the Effective Time,
solely the right to receive the Merger Consideration. The Company shall give
prompt written notice to Parent and Sub of any demands received by the Company
for payment under Sections 302A.471 and 302A.473 of the MBCA, and Parent and Sub
shall have the right to participate in all negotiations and proceedings with
respect to such demands. The Company shall not, except with the prior written
consent of Parent and Sub, make any payment with respect to, settle or offer to
make any payment or settle, any such demands.
ARTICLE IV
ACTIONS PENDING MERGER
4.01. Forbearances of the Company. From the date hereof until
the Effective Time, except as expressly contemplated by this Agreement,
including, without limitation, Section 6.06 below, or as set forth in Section
4.01 of the Company's Disclosure Schedule, without the prior written consent of
Parent (which consent will not be unreasonably withheld with respect to Sections
4.01(i), 4.01(l) and 4.01(n)), the Company will not, and will cause each of its
Subsidiaries not to:
(a) Ordinary Course. (i) Conduct its business and the business
of its Subsidiaries other than in the ordinary and usual course
consistent with past practice in all material respects and in material
compliance with applicable laws and regulations or (ii) to the extent
consistent with subsection (i) above, fail to use reasonable best
efforts to preserve intact their business organizations and assets and
maintain their rights, franchises and existing relations with
customers, suppliers, employees and business associates.
(b) Capital Stock. (i) Except as set forth in Section 4.01(b)
of the Company Disclosure Schedule, issue, sell, pledge, dispose of or
encumber, or authorize or propose the issuance, sale, pledge,
disposition or encumbrance of, any shares of its capital stock or any
other securities or any Rights, (ii) enter into any agreement with
respect to the foregoing or (iii) permit any additional shares of
capital stock to become subject to new grants of employee or director
stock options, other Rights or similar stock-based employee rights,
other than issuances by a wholly owned Subsidiary of the Company of
capital stock to the Company.
(c) Dividends; Adjustments. (i) Make, declare, pay or set
aside for payment any dividend (other than dividends from the Company's
Subsidiaries to the Company or another Subsidiary of the Company) on or
in respect of, or declare or make any distribution on any shares of its
capital stock or (ii) except for any such transaction by a wholly owned
Subsidiary of the Company which remains a wholly owned Subsidiary after
consummation of such transaction, directly or indirectly adjust, split,
combine, redeem, reclassify, purchase, repurchase or otherwise acquire,
any shares of the capital stock of the Company or any of its
Subsidiaries.
(d) Compensation; Employment Agreements. Except as set forth
in Section 4.01(d) of the Company Disclosure Schedule, enter into or
amend any employment, consulting, severance, retention,
A-12
97
termination, change in control or similar agreements or arrangements
with, or make any severance, retention, termination, change of control
or similar payments to, any of its or its Subsidiaries' directors,
officers, employees or consultants or former directors, officers,
employees or consultants, or grant any salary, wage or other
compensation increase, make any award or grant under any Plan or
increase or modify any employee benefit (including any incentive or
bonus payments or perquisite), except for (i) increases in annual
salary or hourly wage rates granted to current employees (other than
officers) in the ordinary course of business consistent with past
practice, (ii) consulting arrangements with new consultants in
connection with Soiltec initiatives existing as of the date of this
Agreement (provided that such consulting arrangements do not involve in
excess of $100,000 in the aggregate), and (iii) changes required to be
implemented in accordance with the current terms of any Company Plan
set forth in Section 4.01(d) of the Company Disclosure Schedule.
(e) Benefit Plans. Enter into, adopt, implement or amend in
any material respect (except to the extent required to comply with
applicable law) any Plan.
(f) Acquisitions and Dispositions. Except as set forth in
Section 4.01(f) of the Company Disclosure Schedule, acquire all or any
portion of the assets, business or properties of any other entity or
sell, transfer, mortgage, encumber or otherwise dispose of or
discontinue any material portion of its assets, business or properties
or agree to enter into any merger, reorganization, share exchange,
business combination or similar transaction pursuant to which
shareholders of the Company would receive any consideration in exchange
for or in addition to their existing shares of Company Common Stock.
(g) Amendments. Amend the Company Certificate or the Company
By-Laws, or adopt a shareholder rights plan.
(h) Accounting Methods. Implement or adopt any change in its
accounting principles, practices or methods, other than as may be
required by GAAP or SEC regulation.
(i) Contracts. Except in the ordinary course of business or as
set forth in Section 4.01(i) of the Company Disclosure Schedule, enter
into or terminate any contract, agreement or lease potentially
involving in excess of $200,000, or terminate, amend or modify in any
material respect any of its existing contracts, agreements or leases
(including any licensing agreement) in excess of $200,000 or involving
any non-competition or similar obligation by the Company or its
affiliates.
(j) Claims. Pay, discharge, satisfy or settle any claim,
liability, obligation (whether absolute, accrued, asserted or
unasserted, contingent or otherwise), action or proceeding, except (i)
in the ordinary course of business consistent with past practice, (ii)
as reflected or reserved against in the consolidated financial
statements in the Company Filed SEC Documents as of the date hereof
(iii) settlements with customers consistent with past practices in
connection with the Company's September 8, 2000, safety recall, or (iv)
in an additional amount not to exceed $100,000 in the aggregate. In the
event Parent determines not to consent to any proposed settlement with
Valmet related to the Company's September 8, 2000, safety recall, the
parties hereto agree that any change or event arising out of such
determination shall not constitute a Material Adverse Effect with
respect to the Company.
(k) Adverse Actions. (i) Unless the Merger shall be effected
pursuant to Section 2.01(a)(ii), take any action while knowing that
such action would, or is reasonably likely to, prevent or impede the
Merger from qualifying as a reorganization within the meaning of
Section 368(a) of the Code; or (ii) knowingly take any action that is
intended or is reasonably likely to result in (A) any of its
representations and warranties set forth in this Agreement being or
becoming untrue at any time at or prior to the Effective Time, (B)
except as otherwise permitted by Section 6.06, any of the conditions to
the Merger set forth in Article VII not being satisfied or satisfaction
of any such condition being materially delayed or (C) a violation of
any provision of this Agreement except, in each case, as may be
required by applicable law.
A-13
98
(l) Incurrence of Indebtedness. Other than (i) indebtedness
incurred in the ordinary course of business consistent with past
practice under its short and long term line of credit loan agreements
but in no event to exceed an aggregate of $55,000,000 of indebtedness
and (ii) indebtedness of the Company or any of its Subsidiaries to the
Company or any of its Subsidiaries in the ordinary course of business
consistent with past practice, incur any indebtedness for borrowed
money, assume, guarantee, endorse or otherwise as an accommodation
become responsible for the obligations of any other individual,
corporation or other entity, or make any loan or advance.
(m) Derivatives. Enter into (i) leveraged derivative contracts
(defined as contracts that use a factor to multiply the underlying
index exposure), or (ii) other derivative contracts except for the
purpose of hedging known interest rate and foreign exchange exposures
or otherwise reducing the Company's cost of financing.
(n) Capital Expenditures. Except as set forth in Section
4.01(n) of the Company Disclosure Schedule, make any capital
expenditures in excess of $500,000 in the aggregate in any quarter of
the year.
(o) Tax Elections. Make any new or different material Tax
election, or revoke any material Tax election, file any material
amended Tax Returns, settle any material Tax audits or other
proceedings, other than in connection with currently pending
proceedings or subsequent related proceedings, or change in any
material respect (i) its method of tax accounting or tax practice, or
(ii) its accounting policies, methods, or procedures, except as
required by GAAP.
(p) Confidentiality Agreements. Waive any confidentiality or
"standstill" provisions entered into with any third party in connection
with its consideration of an Acquisition Proposal.
(q) Agreements. In writing or otherwise, agree or commit to do
anything prohibited by the above paragraphs (a) through (o).
4.02. Forbearances of Parent. From the date hereof until the
Effective Time, except as expressly contemplated by this Agreement or as set
forth in Section 4.02 of Parent's Disclosure Schedule, without the prior written
consent of the Company, Parent will not, and will cause each of its Subsidiaries
not to (i) unless the Merger shall be effected pursuant to Section 2.01(a)(ii),
take any action while knowing that such action would, or is reasonably likely
to, prevent or impede the Merger from qualifying as a reorganization within the
meaning of Section 368(a) of the Code; or (ii) knowingly take any action that is
intended or is reasonably likely to result in (A) any of its representations and
warranties set forth in this Agreement being or becoming untrue at any time at
or prior to the Effective Time, (B) any of the conditions to the Merger set
forth in Article VII not being satisfied or satisfaction of any such condition
being materially delayed or (C) a violation of any provision of this Agreement
except, in each case, as may be required by applicable law.
ARTICLE V
REPRESENTATIONS AND WARRANTIES
5.01. Representations and Warranties of the Company. Except as
set forth in the disclosure schedule delivered by the Company to Parent prior to
the execution of this Agreement, with specific reference to the section of this
Agreement to which the information stated in such disclosure relates (the
"Company Disclosure Schedule"), the Company hereby represents and warrants to
each of Parent and Sub as follows:
(a) Organization, Standing and Authority. The Company is a
corporation duly organized, validly existing and in good standing under
the laws of the State of Minnesota. It is duly qualified to do business
and is in good standing in the states of the United States and foreign
jurisdictions where its ownership, leasing or operation of property or
assets or the conduct of its business requires it to be so qualified
and it has in effect all federal, state, local and foreign governmental
authorizations necessary for it to own, lease and operate its
properties and assets and to carry on its business as it is now
conducted, except where the
A-14
99
failure to be so duly qualified and in good standing or to have in
effect all federal, state, local, and foreign governmental
authorizations does not have, and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on
the Company. The Company has, prior to the date of this Agreement, made
available to Parent complete and correct copies of the Company
Certificate and the Company By-Laws, in each case as amended and in
full force and effect as of the date of this Agreement, and the Company
is not in violation of any provision thereof.
(b) Shares.
(i) The authorized capital stock of the Company
consists of 40,000,000 shares of Company Common Stock of which
9,579,868 shares were outstanding as of July 31, 2000 (the
"Capitalization Date"). Since the Capitalization Date, there
have been no issuances of shares of the capital stock of the
Company or any other securities of the Company.
(ii) All issued and outstanding shares of Company
Common Stock have been duly authorized and validly issued, and
are fully paid and nonassessable, and no class of capital
stock of the Company is entitled to, rights nor have any
shares of Company Common Stock been issued in violation of,
nor are they subject to, any preemptive rights. There are no
voting trusts or other agreements or understandings to which
the Company is a party with respect to the voting of the
capital stock of the Company or any of its Subsidiaries.
(iii) There were outstanding at the Capitalization
Date no Rights to acquire capital stock from the Company. No
Rights to acquire capital stock from the Company have been
issued or granted since the Capitalization Date.
(iv) Neither the Company nor any of its Subsidiaries
has any authorized or outstanding bonds, debentures, notes or
other indebtedness or obligations the holders of which have
the right to vote (or convertible or exchangeable into or
exercisable for securities the holders of which would have the
right to vote) with the shareholders of the Company on any
matter. There are no outstanding obligations of the Company or
any of its Subsidiaries to repurchase, redeem or otherwise
acquire any shares of the Company Common Stock.
(c) Subsidiaries.
(i) Section 5.01(c)(i) of the Company Disclosure
Schedule sets forth a list as of the date hereof of all of the
Company's Subsidiaries, together with their jurisdiction of
organization or incorporation. Unless otherwise described
therein, the Company owns, directly or indirectly,
beneficially and of record 100% of the issued and outstanding
voting securities of each such Subsidiary (other than
directors' qualifying shares, if any, described in Section
5.01(c)(i) of the Company Disclosure Schedule). Except as
described in Section 5.01(c)(i) of the Company Disclosure
Schedule, no equity securities of any of the Company's
Subsidiaries are or may become required to be issued (other
than to the Company or its wholly owned Subsidiaries) by
reason of any Rights and there are no contracts, commitments,
understandings or arrangements by which any of such
Subsidiaries is bound to sell or otherwise transfer any shares
of capital stock of any such Subsidiaries (other than to the
Company or its wholly owned Subsidiaries). In addition,
Section 5.01(c)(i) of the Company Disclosure Schedule lists as
of the date of this Agreement each corporation, partnership,
limited liability company or similar entity with respect to
which, as of the date of this Agreement, the Company or any
Subsidiary of the Company owns more than 5% but less than a
majority of the voting equity or similar voting interest or
any interest convertible into, or exchangeable or exercisable
for, more than 5% but less than a majority of the voting
equity or similar voting interest and which interest is
carried on the Company's most recent financial statements (or
if not held as of the date thereof, would be carried on the
Company's financial statements if prepared as of the date
hereof) at a value in excess of $100,000 (collectively, the
"Company Equity Interests"). Except as set forth in Section
5.01(c)(i) of the Company Disclosure
A-15
100
Schedule, all of the shares of capital stock of each of the
Subsidiaries of the Company and all the Company Equity
Interests held by the Company and each Subsidiary of the
Company are fully paid and nonassessable and are owned by the
Company or such Subsidiary free and clear of any Liens and are
not subject to, and were not issued in violation of, any
preemptive rights. Except as set forth in Section 5.01(c)(i)
of the Company Disclosure Schedule, there are no outstanding
contractual obligations of the Company or any of its
Subsidiaries to provide funds to, or make any investment (in
the form of a loan, capital contribution or otherwise) in any
Subsidiary or in any entity in which the Company or any
Subsidiary of the Company owns a Company Equity Interest.
(ii) Each of the Company's Subsidiaries has been duly
organized and is validly existing and in good standing under
the laws of the jurisdiction of its incorporation. Each of
such Subsidiaries is duly qualified to do business and is in
good standing in the states or jurisdictions where its
ownership, leasing or operation of property or assets or the
conduct of its business requires it to be so qualified and
each has in effect all federal, state, local and foreign
governmental authorizations necessary for it to own, lease and
operate its properties and assets and to carry on its business
as it is now conducted, except where the failure to be so
qualified and in good standing or to have in effect all
federal, state, local, and foreign governmental authorizations
does not have, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on
the Company. The Company has, prior to the date of this
Agreement, made available to Parent complete and correct
copies of the articles or certificate of incorporation,
by-laws or other governing or organizational documents of each
of its Subsidiaries, in each case as amended and in full force
and effect as of the date of this Agreement, and neither the
Company nor any such Subsidiary is in violation of any
provision thereof.
(d) Corporate Power. The Company and each of its Subsidiaries
has all necessary corporate power and authority to carry on its
business as it is now being conducted and to own, lease and operate all
its properties and assets; and it has all requisite corporate power and
authority to execute and deliver this Agreement and perform its
obligations hereunder and to consummate the transactions contemplated
hereby.
(e) Corporate Authority.
(i) Subject, in the case of the consummation of the
Merger, only to receipt of the requisite approval and adoption
of this Agreement and the Merger by the holders of a majority
of the outstanding shares of Company Common Stock entitled to
vote thereon, the special committee of the Company Board
having unanimously adopted a resolution approving this
Agreement and the Merger, and the Company Board having
ratified such approval, this Agreement and the transactions
contemplated hereby have been authorized and approved by all
necessary corporate action of the Company, the special
committee of the Company Board and the Company Board.
(ii) This Agreement is a legal, valid and binding
obligation of the Company, enforceable in accordance with its
terms.
(f) No Defaults. Except as set forth in Section 5.01(f) of the
Company Disclosure Schedule and subject to (i) receipt of the
regulatory approvals, and expiration of the waiting periods, referred
to in Section 5.01(p), (ii) any required filings under federal and
state securities laws, the execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated hereby
by the Company do not and will not (i) constitute a breach or violation
of, or a default under, any law, rule or regulation or any judgment,
decree, order, governmental permit or license, or agreement, indenture
or instrument of the Company or of any of its Subsidiaries or to which
the Company or any of its Subsidiaries or any of their respective
properties or assets are subject or bound, (ii) constitute a breach or
violation of, or a default under, the articles or certificate of
incorporation or by-laws or other organizational or governing documents
of the Company or any of its Subsidiaries or (iii) require any consent
or approval under any such law, rule, regulation, judgment, decree,
order, governmental permit or license, agreement, indenture or
instrument, except in the case of (i) and (iii), where such breach,
violation or default or the failure to obtain
A-16
101
such consents or approvals would not in the aggregate have a Material
Adverse Effect on the Company, the Surviving Corporation or Parent and
would not prevent or materially impair the Company's ability to
consummate the transactions contemplated by this Agreement. Section
5.01(f) of the Company Disclosure Schedule contains a list of all
consents of third parties required to be obtained by the Company or its
Subsidiaries prior to, or as a result of, the consummation of the
Merger.
(g) Financial Reports and SEC Documents.
(i) Company Filed SEC Reports. Since January 1, 1996,
the Company has filed, and will file after the date hereof,
all forms, reports and documents with the SEC required to be
filed by it pursuant to all applicable federal securities
laws, all of which complied, or will comply, as of the date
filed (or, with respect to a document filed prior to the date
of this Agreement and amended or superseded by a subsequent
filing prior to the date of this Agreement, then on the date
of such filing as so amended or superseded), in all material
respects as to form with all applicable requirements of the
Securities Act or the Exchange Act, as applicable, and the
rules and regulations promulgated thereunder. None of the
Company Filed SEC Reports, at the time filed (or, with respect
to a document filed prior to the date of this Agreement and
amended or superseded by a subsequent filing prior to the date
of this Agreement, then on the date of such filing as so
amended or superseded), contained, or will contain, any untrue
statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances
under which they were made, not misleading.
(ii) Financial Statements, Accounting Matters. The
consolidated balance sheets and the related consolidated
statements of earnings, stockholders' equity and cash flows
(including the related notes thereto) of the Company included
in or incorporated by reference in the Company Filed SEC
Reports complied, or will comply, as to form in all material
respects with the published rules and regulations of the SEC
with respect thereto, were prepared, or will be prepared, in
accordance with GAAP applied on a basis consistent with prior
periods (except as otherwise noted therein), and presented
fairly, or will present fairly, the financial position of the
Company and its Subsidiaries as of their respective dates, and
the consolidated results of its operations and its cash flows
for the periods presented therein (subject, in the case of the
unaudited interim financial statements, to normal year-end
adjustments and except that the unaudited interim financial
statements do not contain all of the footnote disclosure
required by GAAP). Notwithstanding the foregoing, no
representations or warranties are made regarding any forecast,
projections or budgets relating to the Company or its
Subsidiaries.
(iii) Since September 30, 1999, neither the Company
nor any of its Subsidiaries has incurred any material
liabilities (whether absolute, accrued, contingent or
otherwise) except (x) liabilities as set forth on the face of
the consolidated balance sheet of the Company as of September
30, 1999 in the Company Filed SEC Documents, (y) other
liabilities incurred since September 30, 1999 in the ordinary
course of business consistent with past practice or (z) as set
forth in Section 5.01(g)(iii) of the Company Disclosure
Schedule.
(iv) Unless the Merger shall be effected pursuant to
Section 2.01(a)(ii), to the knowledge of the Company, neither
the Company nor any of the Company Affiliates has taken or
agreed to take any action that would jeopardize the
qualification of the Merger as a reorganization within the
meaning of Section 368(a) of the Code.
(h) Litigation. Section 5.01(h) of the Company Disclosure
Schedule sets forth all litigation, claims, actions or proceedings
before any Governmental Authority as of the date hereof pending or, to
the knowledge of the Company, threatened against or affecting the
Company or any of its Subsidiaries or their respective property, assets
or businesses which (i) could reasonably be expected to result,
individually or in the aggregate, in judgment against the Company or
its Subsidiaries in excess of $100,000 if determined adversely to the
Company or its Subsidiaries or (ii) could reasonably be expected to
have, individually or in
A-17
102
the aggregate, a Material Adverse Effect. Neither the Company nor any
of its Subsidiaries nor any of their respective properties, assets or
businesses is subject to any outstanding order writ, judgment,
stipulation, award, injunction or decree or, to the knowledge of the
Company, any investigation or inquiry by any Governmental Authority
issued against or affecting the Company or any of its Subsidiaries or
naming the Company or any of its Subsidiaries which has had or would
have a Material Adverse Effect on the Company.
(i) Compliance with Laws. As of the date hereof, the business
of the Company and its Subsidiaries is not being conducted in violation
of any Law, except for possible violations which, individually or in
the aggregate, would not have a Material Adverse Effect.
(j) No Brokers. No action has been taken by the Company, its
officers, directors or employees that would give rise to any valid
claim against any party hereto for a brokerage commission, finder's fee
or other like payment with respect to the transactions contemplated by
this Agreement, other than fees to be paid to Goldsmith, Agio, Helms &
Lynner, Ltd. (the "Company Financial Advisor") pursuant to the
Company's written agreement with such firm, a true and complete copy of
which has been furnished to Parent prior to the date of this Agreement.
(k) Employee Benefits; Employee Relations.
(i) Section 5.01(k) of the Company Disclosure
Schedule contains a complete and correct list of each written
Company Plan and each material oral Company Plan. With respect
to each such Company Plan, true and complete copies have been
made available to Parent of: (A) the plan document or
agreement or, with respect to any Company Plan that is not in
writing, a written description of the terms thereof; (B) the
trust agreement, insurance contract or other documentation of
any related funding arrangement; (C) the summary plan
description; (D) the most recent required Internal Revenue
Service Form 5500, including all schedules thereto, and
actuarial report; and (E) any material communication within
the past two years to or from any Governmental Authority,
including a written description of any oral communication.
(ii) Neither the Company nor any Subsidiary thereof
has disseminated in writing or otherwise broadly or generally
notified employees of any intent or commitment (whether or not
legally binding) to create or implement any additional Plan or
to amend, modify or terminate any Company Plan, except for
immaterial amendments to any Company Plan that will not result
in an increase in the annual costs in respect of such plan
incurred or to be incurred by the Company or any of its
Subsidiaries.
(iii) Each Company Plan has been operated and
administered, and is, in compliance with its terms and all
applicable Laws, except as would not, individually or in the
aggregate, have a Material Adverse Effect on the Company.
(iv) No Company Plan is, and neither the Company nor
any Subsidiary thereof contributes to or has any liability or
obligation with respect to any Plan that is, (A) a
multiemployer plan within the meaning of Section 4001(a)(3) of
ERISA, (B) any single employer plan or other pension plan
subject to Title IV or Section 302 of ERISA or Section 412 of
the Code or (C) a multiple employer plan within the meaning of
Section 4063 or 4064 of ERISA.
(v) Each Company Plan that is intended to qualify
under Section 401(a) and/or 401(k) of the Code so qualifies
and its trust is exempt from taxation under Section 501(a) of
the Code. The Company and its Subsidiaries have timely paid
all contributions, premiums and expenses payable to or in
respect of each Company Plan under the terms thereof and in
accordance with applicable law, including ERISA and the Code,
and, to the extent any such contributions, premiums or
expenses are not yet due, the liability therefor has been
properly and adequately accrued to the
A-18
103
extent required by GAAP on the Company's financial statements
included in its Quarterly Report on Form 10-Q for the period
ended June 30, 2000.
(vi) Neither the Company nor any of its Subsidiaries
has incurred or will incur, either directly or indirectly
(including as a result of an indemnification obligation), any
liability under or pursuant to any provision of Title I or IV
of ERISA or the penalty, excise tax or joint and several
liability provisions of the Code relating to employee benefit
plans, and to the Knowledge of the Company, no event,
transaction or condition has occurred, exists or is expected
to occur which could reasonably be expected to result in any
such liability to the Company, any of its Subsidiaries or,
after the Effective Time, Parent or any of its affiliates.
(vii) Except as set forth in Section 5.01(k)(vii) of
the Disclosure Schedule, neither the execution and delivery of
this Agreement, nor the consummation of the transactions
contemplated hereby, either alone or in combination with
another event (whether contingent or otherwise) will (A)
entitle any current or former employee, consultant, officer or
director of the Company or any of its Subsidiaries to any
increased or modified benefit or payment; (B) increase the
amount of compensation due to any such employee, consultant,
officer or director; (C) accelerate the vesting, payment or
funding of any compensation, stock-based benefit, incentive or
other benefit; (D) result in any "parachute payment" under
Section 280G of the Code (whether or not such payment is
considered to be reasonable compensation for services
rendered); or (E) cause any compensation to fail to be
deductible under Section 162(m), or any other provision of the
Code or any similar foreign Law.
(l) Takeover Laws. A special committee of the Company Board
has approved this Agreement and the transactions contemplated hereby,
such approval has been ratified by the Company Board and such approval
constitutes approval of the Merger and transactions contemplated hereby
under the provisions of Section 302A.613 of the MBCA such that Section
302A.671 of the MBCA does not apply to the shares of the Company or of
the Sub as a result of this Agreement and the transactions hereby.
There are no other Takeover Laws applicable to this Agreement or the
Voting Agreement and the transactions contemplated hereby and thereby;
provided that, no representation is made hereunder as to any Takeover
Laws under the Georgia Business Corporation Code or the DGCL.
A-19
104
(m) Environmental Matters.
Except as disclosed in Section 5.01(m) of the Company
Disclosure Schedule or in the Company Filed SEC Documents, as of the
date hereof: (i) (A) the Company and each of its Subsidiaries are, and
within the period of all applicable statutes of limitation have been,
in material compliance with all applicable Environmental Laws; and (B)
the Company and each of its Subsidiaries believes that each of them
will, and will not incur material expense to, timely attain or maintain
compliance with any Environmental Laws applicable to any of their
current operations or properties or to any of their planned operations
with respect to properties currently or formerly owned, leased or
otherwise occupied by the Company or any of its Subsidiaries; (ii) the
Company and its Subsidiaries hold all material Environmental Permits
(each of which is in full force and effect) required for any of their
current operations and for any property owned, leased, or otherwise
operated by any of them, and are, and within the period of all
applicable statutes of limitation have been, in material compliance
with all such Environmental Permits; and (iii) neither the Company nor
any of its Subsidiaries has received any material Environmental Claim
against any of them, and neither the Company nor any of its
Subsidiaries has knowledge of any material Environmental Claim being
threatened; and to the knowledge of the Company, no Hazardous Materials
or other conditions are present on any property formerly or currently
owned, leased, occupied or operated by the Company or any of its
Subsidiaries, or at any other location, that are reasonably likely to
form the basis of any material Environmental Claim against any of them
or against any person or entity (including without limitation any
predecessor of the Company or any of its Subsidiaries) whose liability
the Company or any of its Subsidiaries retained or assumed either
contractually or by operation of law.
(n) Intellectual Property.
(i) Except as set forth in Section 5.01(n)(i) of the
Company Disclosure Schedule, as of the date hereof the Company
and its Subsidiaries own or are licensed to use all material
Intellectual Property Rights as currently used in the business
of the Company or its Subsidiaries or necessary to conduct the
business of the Company and its Subsidiaries as currently
conducted or, in the case of Soiltec, currently anticipated to
be conducted (the "Company Intellectual Property Rights").
(ii) Section 5.01(n)(ii) of the Company Disclosure
Schedule contains an accurate and complete list as of the date
of this Agreement of the following categories of Company
Intellectual Property Rights owned by the Company or any of
its Subsidiaries: (A) Trademarks that are registered or for
which an application for registration is pending; (B) Patents;
(C) Software; and (D) material Copyrights that are registered
or for which an application for registration is pending.
(iii) Section 5.01(n)(iii) of the Company Disclosure
Schedule contains an accurate and complete list as of the date
of this Agreement of (A) all licenses and agreements under
which the Company and its Subsidiaries are licensed to use
third party Intellectual Property Rights, other than licenses
that are readily available on commercially reasonable terms
(such as routine accounting systems, CAD systems and the like)
and (B) all licenses and sublicenses under which the Company
and its Subsidiaries have granted material rights to third
parties to use the Company Intellectual Property Rights.
Except as set forth in Section 5.01(n)(iii) of the Company
Disclosure Schedule, the Company and its Subsidiaries are not
required to pay any royalties, fees or other amounts to any
Person in connection with the use of the Company Intellectual
Property Rights.
(iv) Except as set forth in Section 5.01(n)(iv),
within the past two years and prior to the date hereof,
neither the Company nor any of its Subsidiaries: (A) has been
notified or is otherwise aware of any actual or threatened
adverse proceeding or claims of any Person pertaining to any
challenge to the Company Intellectual Property Rights; (B) to
the knowledge of the Company, is the subject of any claim of
infringement or misappropriation by the Company or any of its
Subsidiaries of any third party Intellectual Property Rights;
or (C) to the knowledge of the Company, has any claim for
infringement or misappropriation of, or breach of any license
or agreement involving, any of the Company Intellectual
Property Rights.
A-20
105
(o) Tax Matters.
(i) Each of the Company and its Subsidiaries has
filed all Tax Returns that it was required to file. All such
Tax Returns were correct and complete in all material
respects. All material Taxes due and owing by any of the
Company and its Subsidiaries (whether or not shown on any Tax
Return) have been paid. Except as set forth in Section
5.01(o)(i) of the Company Disclosure Schedule, none of the
Company and its Subsidiaries currently is the beneficiary of
any extension of time within which to file any Tax Return. To
the knowledge of the Company, no claim has been made within
the past five years by a Governmental Authority in a
jurisdiction where any of the Company and its Subsidiaries
does not file Tax Returns that it is or may be subject to
taxation by that jurisdiction.
(ii) Except as set forth in Section 5.01(o)(ii) of
the Company Disclosure Schedule, as of the date hereof, there
is no dispute or claim concerning any Tax liability of any of
the Company and its Subsidiaries either claimed or raised by
any Governmental Authority in writing. No audit of any Tax or
Tax Return of the Company or any of its Subsidiaries is being
conducted by any Governmental Authority as of the date of this
Agreement, except as set forth in Section 5.01(o)(ii) of the
Company Disclosure Schedule.
(iii) Except as set forth in Section 5.01(o)(iii) of
the Company Disclosure Schedule, none of the Company and its
Subsidiaries has waived any statute of limitations in respect
of Taxes or agreed to any extension of time with respect to a
Tax assessment or deficiency, which waiver or agreement is
currently in effect.
(iv) None of the Company and its Subsidiaries has
filed a consent under Section 341(f) of the Code concerning
collapsible corporations. None of the Company and its
Subsidiaries has made any payments, is obligated to make any
payments, or is a party to any agreement that under certain
circumstances could obligate it to make any payments that will
not be deductible under Section 280G of the Code. Each of the
Company and its Subsidiaries has disclosed on its federal
income Tax Returns all positions taken therein that could give
rise to a substantial understatement of federal income Tax
within the meaning of Section 6662 of the Code. None of the
Company and its Subsidiaries is a party to any Tax allocation
or sharing agreement. None of the Company and its Subsidiaries
(A) has been a member of an "affiliated group" (as defined in
Section 1504(a) of the Code, or any similar group defined
under a similar provision of state, local or foreign law)
filing a consolidated federal income Tax Return (other than a
group the common parent of which was the Company) or (B) has
any liability for the Taxes of any person (other than any of
the Company and its Subsidiaries) under Treasury Regulation
Section 1.1502-6 (or any similar provision of state, local, or
foreign law), as a transferee or successor, by contract, or
otherwise.
(p) Regulatory Approvals. No consents or approvals of, or
filings or registrations with, any Governmental Authority or
instrumentality are necessary to consummate the Merger except (i) as
may be required under, and other applicable requirements of, the
Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended (the
"HSR Act"); (ii) as may be required by the by-laws, rules, regulations
or policies of the NYSE in respect of the Parent Common Shares to be
issued in the Merger; (iii) the filing with the SEC of the Company
Proxy Statement and the filing and declaration of effectiveness of the
Registration Statement; (iv) the filing of the Articles of Merger with
the Secretary of State of the State of Minnesota pursuant to the MBCA
and the filing of the Certificate of Merger with the Secretary of State
of the State of Delaware pursuant to the DGCL, each as provided in
Section 3.01(b); and (v) such filings as are required to be made or
approvals as are required to be obtained under the securities or "Blue
Sky" laws of various states in connection with the issuance of Parent
Common Shares in the Merger.
(q) Title to Properties; Encumbrances. As of June 30, 2000,
the Company and each of its Subsidiaries had good and marketable title
to all properties, interests in properties and assets (real and
personal) reflected in the consolidated balance sheet of the Company as
of June 30, 2000 and continues to
A-21
106
have good and marketable title thereto except for properties, interests
in properties and assets sold or otherwise disposed of in the ordinary
course of business since the respective dates of such balance sheets
free and clear of all Liens of any kind or character, except for (i)
Liens of public record (ii) rights of lessors or licensors pursuant to
lease or license agreements with the Company and/or its Subsidiaries
(iii) current taxes not yet due and payable and (iv) such Liens which
would not, individually or in the aggregate, have a Material Adverse
Effect.
(r) Insurance. The Company and its Subsidiaries have obtained
and currently maintain in full force and effect insurance with
responsible and reputable insurance companies or associations in such
amounts, on such terms and covering such risks, including fire and
other risks insured against by extended coverage, as is reasonably
prudent, and each is maintaining in full force and effect public
liability insurance, insurance against claims for personal injury or
death or property damage occurring in connection with the activities of
the Company or its Subsidiaries or any properties owned, occupied or
controlled by the Company or its Subsidiaries, in such amounts as
reasonably deemed necessary by the Company or its Subsidiaries.
(s) Fairness Opinion. The Company Financial Advisor has
delivered its opinion to the Company Board that the Merger
Consideration is fair, from a financial point of view, to the holders
of Company Common Stock (other than Parent) and such opinion has not
been withdrawn.
5.02. Representations and Warranties of Parent and Sub. Except
as set forth in the disclosure schedule delivered by Parent to the Company prior
to the execution of this Agreement (the "Parent Disclosure Schedule") (each
section of which qualifies the correspondingly numbered representation and
warranty or covenant to the extent specified therein), Parent and Sub hereby
represent and warrant to the Company as follows:
(a) Organization, Standing and Authority. Each of Parent and
Sub (x) is a corporation duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization and (y)
is duly qualified to do business and is in good standing in the states
of the United States and foreign jurisdictions where its ownership,
leasing or operation of property or assets or the conduct of its
business requires it to be so qualified, except where the failure to be
duly organized, validly existing, in good standing, or duly qualified
does not have and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on Parent
or Sub. Each of Parent and Sub has in effect all federal, state, local
and foreign governmental authorizations necessary for it to own, lease
and operate its properties and assets and to carry on its business as
it is now conducted, except where failure to have in effect such
authorizations does not have and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect on
Parent. Each of Parent and Sub has made available to the Company a
complete and correct copy of its certificate of incorporation and
by-laws, each as amended to date and in full force and effect and the
Parent is not in violation of any provision thereof.
(b) Shares.
(i) As of the date hereof, the authorized capital
stock of Parent consists of 150,000,000 Parent Common Shares,
of which 59,592,961 shares were outstanding as of July 31,
2000 and 1,000,000 shares of $.01 par value preferred stock,
of which no shares were outstanding as of July 31, 2000.
(ii) The authorized capital stock of Sub consists of
1,000 shares of common stock, no par value per share, which
shares are outstanding and is owned directly by Parent. Sub
has not conducted any business prior to the date hereof and
has no Subsidiaries and no assets, liabilities or obligations
of any nature other than incident to its formation and
incident to this Agreement.
(iii) The outstanding shares of Parent's and Sub's
capital stock have been duly authorized and are validly issued
and outstanding, fully paid and nonassessable, and subject to
no preemptive rights (and were not issued in violation of any
preemptive rights). As of the date hereof, there are
A-22
107
no shares of capital stock of Sub authorized and reserved for
issuance pursuant to, and Sub does not have, any Rights issued
or outstanding with respect to its capital stock or any
commitment to authorize, issue or sell any such shares or
Rights, except pursuant to this Agreement.
(iv) The Parent Common Shares to be issued in
exchange for shares of Company Common Stock in the Merger,
when issued will be duly authorized, validly issued,
fully-paid and non-assessable and will not have been issued in
violation of, nor will they be subject to, any preemptive
rights.
(c) Corporate Power. Each of Parent and Sub has all necessary
corporate power and authority to carry on its business as it is now
being conducted and to own, lease and operate all its properties and
assets; and each of Parent and Sub has all requisite corporate power
and authority to execute and deliver this Agreement and perform its
obligations under this Agreement and to consummate the transactions
contemplated hereby.
(d) Corporate Authority. (i) This Agreement and the
transactions contemplated hereby, including the issuance of Parent
Common Shares in the Merger (except for any issuance of Parent Common
Shares in excess of the Maximum Share Amount in connection with the
Merger and/or pursuant to Section 3.02(c), which issuance shall be
subject to approval by Parent's shareholders), have been authorized and
approved by all necessary corporate action of Parent, Sub, the Parent
Board and the Board of Directors of Sub prior to the date hereof (which
action has not been rescinded or modified in any way) and (ii) this
Agreement is a legal, valid and binding obligation of each of Parent
and Sub, enforceable in accordance with its terms. This Agreement and
the transactions contemplated hereby, including the issuance of Parent
Common Shares (up to the Maximum Share Amount) in the Merger do not
require the approval of the shareholders of Parent.
(e) No Defaults. Subject to (i) receipt of the regulatory
approvals, and expiration of the waiting periods, referred to in
Section 5.02(i) and (ii) any required filings under federal and state
securities laws, the execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated hereby
by Parent and Sub do not and will not (i) constitute a breach or
violation of, or a default under, any law, rule or regulation or any
judgment, decree, order, governmental permit or license, or agreement,
indenture or instrument of Parent or of any of Parent's Subsidiaries or
to which it or any of its Subsidiaries or any of their respective
properties or assets are subject or bound, (ii) constitute a breach or
violation of, or a default under, the certificate of incorporation or
by-laws of either Parent or Sub, or (iii) require any consent or
approval under any such law, rule, regulation, judgment, decree, order,
governmental permit or license, agreement, indenture or instrument,
except in the case of (i) and (iii), where such breach, violation or
default or the failure to obtain such consents or approvals would not
in the aggregate have a Material Adverse Effect on the Company, the
Surviving Corporation or Parent and would not prevent or materially
impair Parent's or Sub's ability to consummate the transactions
contemplated by this Agreement.
(f) Financial Reports and SEC Documents.
(i) Parent SEC Reports. Since January 1, 1996, the
Parent has filed, and will file after the date hereof, all
forms, reports and documents with the SEC required to be filed
by it pursuant to all applicable federal securities laws, all
of which complied, or will comply, as of date filed (or, with
respect to a document filed prior to the date of this
Agreement and amended or superseded by a subsequent filing
prior to the date of this Agreement, then on the date of such
filing as so amended or superseded), in all material respects
with all applicable requirements of the Securities Act or the
Exchange Act, as applicable, and the rules and regulations
promulgated thereunder. None of the Parent Filed SEC Reports,
at the time filed (or, with respect to a document filed prior
to the date of this Agreement and amended or superseded by a
subsequent filing prior to the date of this Agreement, then on
the date of such filing as so amended or superseded),
contained, or will contain, any untrue statement of a material
fact or omitted to state a material fact
A-23
108
required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under
which they were made, not misleading.
(ii) Financial Statements, Accounting Matters. The
consolidated balance sheets and the related consolidated
statements of earnings, stockholders' equity and cash flows
(including the related notes thereto) of the Parent included
in or incorporated by reference in the Parent Filed SEC
Reports complied, or will comply, as to form in all material
respects with the published rules and regulations of the SEC
with respect thereto, were prepared, or will be prepared, in
accordance with GAAP applied on a basis consistent with prior
periods (except as otherwise noted therein), and presented
fairly, or will present fairly, the financial position of the
Parent and its Subsidiaries as of their respective dates, and
the consolidated results of its operations and its cash flows
for the periods presented therein (subject, in the case of the
unaudited interim financial statements, to normal year-end
adjustments and except that the unaudited interim financial
statements do not contain all of the footnote disclosure
required by GAAP). Notwithstanding the foregoing, no
representations or warranties are made regarding any forecast,
budgets or projections of the Parent or the Sub.
(iii) Unless the Merger shall be effected pursuant to
Section 2.01(a)(ii), to the knowledge of the Parent, neither
the Parent nor any of the Parent Affiliates, has taken or
agreed to take any action that would jeopardize the
qualification of the Merger as a reorganization within the
meaning of Section 368(a) of the Code.
(g) Litigation. Except as Previously Disclosed, no litigation,
claim or other proceeding before any court or governmental agency that
is pending or, to Parent's Knowledge, threatened against Parent or any
of its Subsidiaries would reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on Parent.
(h) No Brokers. No action has been taken by it that would give
rise to any valid claim against any party hereto for a brokerage
commission, finder's fee or other like payment with respect to the
transactions contemplated by this Agreement, excluding fees to be paid
to Donaldson, Lufkin and Jenrette.
(i) Regulatory Approvals. No consents or approvals of, or
filings or registrations with, any Governmental Authority or with any
third party are necessary to consummate the Merger except for (i) as
may be required under, and other applicable requirements of, the HSR
Act; (ii) as may be required by the by-laws, rules, regulations or
policies of the NYSE in respect of the Parent Common Shares to be
issued in the Merger; (iii) the filing with the SEC of the Company
Proxy Statement in definitive form and the filing and declaration of
effectiveness of the Registration Statement; (iv) the filing of the
Articles of Merger with the Secretary of State of the State of
Minnesota pursuant to the MBCA and the filing of the Certificate of
Merger with the Secretary of State of the State of Delaware pursuant to
the DGCL, each as provided in Section 3.01(b); and (v) such filings as
are required to be made or approvals as are required to be obtained
under the securities or "Blue Sky" laws of various states in connection
with the issuance of Parent Common Shares in the Merger.
(j) Parent Common Stock. Prior to the Effective Time, Parent
will have taken all necessary action required to permit it to issue the
number of shares of Parent Common Stock required to be issued pursuant
to Article III. Parent Common Stock issued pursuant to Article III
will, when issued, be validly issued, fully paid and nonassessable, and
no Person will have any preemptive or subscription or purchase right in
respect thereof. Such Parent's Common Stock will, when issued, be
registered under the Securities Act and the Exchange Act, and will be
registered or exempt from registration under any applicable state
securities laws and will be listed on the Exchange, subject to notice
of official issuance.
(k) Adequate Financing. Parent has obtained all financing
required of it in order to consummate the transactions contemplated by
this Agreement.
A-24
109
(l) Interim Operations of Sub. Sub was formed solely for the
purpose of engaging in the Merger and transactions contemplated
thereby, and has not engaged in any business activities or conducted
any operations other than in connection with the Merger. Sub has no
Subsidiaries.
ARTICLE VI
COVENANTS
The Company hereby covenants to and agrees with Parent, and
each of Parent and Sub hereby covenants to and agrees with the Company, that:
6.01. Reasonable Best Efforts. Subject to the terms and
conditions of this Agreement, each Party shall use its reasonable best efforts
in good faith to take, or cause to be taken, all actions, and to do, or cause to
be done, all things necessary, proper or desirable (including, without
limitation, obtaining any regulatory approvals and obtaining any consents of
third parties required under any agreement to be obtained by it or its
subsidiaries prior to, or as a result of, the consummation of the Merger so that
such agreement is not terminable as a result of the Merger, or advisable under
applicable laws, so as to permit consummation of the Merger) as promptly as
practicable and otherwise to enable consummation of the transactions
contemplated hereby and shall cooperate fully with the other party hereto to
that end. In case at any time after the Effective Time any further action is
necessary or desirable to carry out the purpose of this Agreement or to vest the
Surviving Corporation with full title to all properties, assets, rights,
approvals, immunities and franchises of any of the parties to the Merger, the
proper officers and directors of each party to this Agreement and their
respective Subsidiaries shall take all such necessary action as may be
reasonably requested by Parent.
6.02. Shareholder Approvals. The Company shall take, in
accordance with this Agreement, applicable law, applicable NASD rules and the
Company Certificate and Company By-Laws, all action necessary to duly call, give
notice of, convene and hold a meeting of shareholders of the Company to consider
and vote upon the approval and adoption of this Agreement, the Merger and the
transactions contemplated hereby and thereby and any other matters required to
be approved by the Company's shareholders for consummation of the Merger
(including any adjournment or postponement, the "Company Meeting") as promptly
as practicable after the date hereof.
6.03. Registration Statement. (a) As soon as practicable after
the date hereof, each of Parent and the Company agrees to prepare, and to
cooperate in the preparation of, a registration statement on Form S-4 (the
"Registration Statement") to be filed by Parent with the SEC in connection with
the issuance of Parent Common Shares in the Merger or pursuant to Section
3.02(c) (including the proxy statement and prospectus and other proxy
solicitation materials of the Company constituting a part thereof (the "Company
Proxy Statement") and all related documents). The Registration Statement and the
Company Proxy Statement shall comply as to form in all material respects with
the applicable provisions of the Securities Act and the Exchange Act and the
rules and regulations thereunder. The Company agrees to file the Company Proxy
Statement in preliminary form with the SEC as promptly as practicable, and
Parent agrees to file the Registration Statement with the SEC as promptly as
practicable after any SEC comments with respect to the preliminary Company Proxy
Statement are resolved or at such earlier time as Parent may elect. Each of
Parent and the Company shall, as promptly as practicable after receipt thereof,
provide copies of any written comments received from the SEC with respect to the
Registration Statement and the Company Proxy Statement, as the case may be, to
the other party, and advise the other party of any oral comments with respect to
the Registration Statement or the Company Proxy Statement received from the SEC.
Each of Parent and the Company agrees to use reasonable best efforts to cause
the Registration Statement to be declared effective under the Securities Act as
promptly as practicable after filing thereof, and the Company agrees to mail the
Company Proxy Statement to its shareholders as promptly as practicable after the
Registration Statement is declared effective. Each Party shall furnish to the
other Parties all information concerning such Party, and its officers, directors
and shareholders as may be necessary in connection with the preparation and
filing of the Registration statement and any amendments or supplements thereto.
(b) Each of Parent and the Company agrees, as to itself and
its Subsidiaries, that none of the information supplied or to be supplied by it
for inclusion or incorporation by reference in (i) the Registration
A-25
110
Statement will, at the time the Registration Statement and each amendment or
supplement thereto, if any, becomes effective under the Securities Act, contain
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading and (ii)
the Company Proxy Statement and any amendment or supplement thereto will, at the
date of mailing to shareholders and at the time of the Company Meeting, contain
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading. The
Company agrees promptly to advise Parent if at any time during which the Company
Proxy Statement is required to be delivered any information provided by the
Company, its subsidiaries, officers, directors or shareholders in the Company
Proxy Statement becomes incorrect or incomplete in any material respect and to
provide Parent with the information necessary to correct such inaccuracy or
omission.
(c) Parent agrees to advise the Company, promptly after Parent
receives notice thereof, of the time when the Registration Statement has become
effective or any supplement or amendment has been filed, of the issuance of any
stop order or the suspension of the qualification of the Parent Common Shares
for offering or sale in any jurisdiction, of the initiation or threat of any
proceeding for any such purpose, or of any request by the SEC for the amendment
or supplement of the Registration Statement or for additional information.
(d) As promptly as practicable after the date of an Issuance
Election and provided that the Company has not terminated this Agreement
pursuant to Section 8.01(g) hereof, Parent agrees to take, in accordance with
this Agreement, applicable law, applicable NYSE rules and the Parent Certificate
and Parent By-Laws, all action necessary to duly call, give notice of, convene
and hold a meeting of shareholders of Parent to consider and vote upon the
approval of the issuance of Parent Common Shares in excess of the Maximum Share
Amount pursuant to the Merger and/or Section 3.02(c) (including any adjournment
or postponement, the "Parent Meeting"), and Parent agrees to prepare a proxy
statement and other proxy solicitation materials of Parent constituting a part
thereof (the "Parent Proxy Statement") and all related documents for use in
connection therewith and promptly provide Company with a copy of all documents
and filings. The Parent Proxy Statement shall comply as to form in all material
respects with the applicable provisions of the Securities Act and the Exchange
Act and the rules and regulations thereunder. Parent agrees to file the Parent
Proxy Statement in preliminary form with the SEC as promptly as practicable
after the date of an Issuance Election. Parent shall, as promptly as practicable
after receipt thereof, provide copies of any written comments received from the
SEC with respect to the Parent Proxy Statement to the Company, and advise the
Company of any oral comments with respect to the Parent Proxy Statement received
from the SEC. Parent agrees to mail the Parent Proxy Statement to its
shareholders as promptly as practicable after the resolution of any comments
with the SEC. The Company shall furnish to Parent all information concerning the
Company, and its officers, directors and shareholders as may be necessary in
connection with the preparation and filing of the Parent Proxy Statement and any
amendments or supplements thereto. Parent agrees that none of the information
included or incorporated by reference in the Parent Proxy Statement and any
amendment or supplement thereto will, at the date of mailing to Parent's
shareholders and at the time of the Parent Meeting, contain any untrue statement
of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading. The Company agrees
promptly to advise Parent if at any time during which the Parent Proxy Statement
is required to be delivered any information provided by the Company, its
subsidiaries, officers, directors or shareholders in the Parent Proxy Statement
becomes incorrect or incomplete in any material respect and to provide Parent
with the information necessary to correct such inaccuracy or omission.
(e) Parent will use its reasonable best efforts to obtain
state securities law or "Blue Sky" permits and approvals required to carry out
the transactions contemplated by this Agreement.
6.04. Press Releases. Parent and the Company shall jointly
agree on an initial press release with respect to the Merger. Neither Party
will, without the prior approval of the other Party, issue any other press
release or written statement for general circulation (including any written
statement circulated to employees, customers or other third parties) relating to
the transactions contemplated hereby, except, based on the advice of counsel, as
otherwise required by applicable law or regulation or NYSE or NASD rules and
only after consulting with the other Party and, prior to the issuance of any
such release or statement, providing written copies of any such proposed press
A-26
111
release or written statement to the other Party and providing the other Party
with a reasonable opportunity to review and comment upon such proposed press
release or written statement.
6.05. Access; Information. (a) Upon reasonable notice and
subject to applicable laws relating to the exchange of information, the Parties
shall afford to the officers, employees, counsel, accountants and other
authorized representatives of the other Party, reasonable access, during normal
business hours throughout the period prior to the Effective Date, to all of the
Parties' employees, properties, books, contracts, commitments and records in
order for the other Party to make such investigations as it shall reasonably
require and, during such period, it shall furnish promptly to the other Party
(i) a copy of each material report, schedule and other document filed by it or
any of its Subsidiaries pursuant to the requirements of federal, state or
foreign securities laws, and (ii) all other information concerning its or any of
its Subsidiaries' business, properties and personnel as a party may reasonably
request; provided, that such information may not be used for any purpose
unrelated to the consummation of the transactions contemplated by this
Agreement. The Parties shall promptly inform the other Party of any litigation,
claim or other proceeding before any court or other governmental authority that
arises following the date of this Agreement and any material development in any
such existing litigation, claim or other proceeding. The Parties shall not be
required to provide access to or to disclose information where such access or
disclosure would contravene any law, rule, regulation, order, judgment, decree
or agreement. Parent and the Company shall make appropriate substitute
disclosure arrangements under circumstances in which the restrictions of the
preceding sentence apply.
(b) Subject to the requirements of applicable law, pending
consummation of the Merger, all non-public information provided by the Company
to Parent and Parent to the Company pursuant to this Agreement or otherwise will
remain subject to the obligations of Parent and the Company under the
Confidentiality Agreement.
(c) No investigation by a party, pursuant to this Section 6.05
or otherwise, shall affect or be deemed to modify any representation or warranty
of the other party contained herein.
6.06. Acquisition Proposals. (a) Subject to Section 6.06(d) of
this Agreement, the Company shall not, nor shall it permit any of its
Subsidiaries to, nor shall it authorize or permit any of its directors, officers
or employees or any investment banker, financial advisor, attorney, accountant
or other representative retained by it or any of its Subsidiaries to, directly
or indirectly through another person, (i) solicit, initiate or encourage, or
take any other actions designed to facilitate, any inquiries or the making of
any proposal which constitutes an Acquisition Proposal, (ii) participate in any
discussions or negotiations regarding any Acquisition Proposal, (iii) provide
any information or data with respect to the Company or its Subsidiaries to any
Person in connection with an Acquisition Proposal or (iv) grant any waiver or
release under any standstill or similar agreement with respect to the Company
Common Stock. The Company and its officers and directors will cease any existing
discussions or negotiations, if any, with any parties conducted heretofore with
respect to, or that could reasonably be expected to lead to, any Acquisition
Proposal. Notwithstanding the foregoing, if the Board of Directors of the
Company reasonably determines, after consultation with its financial advisors
and outside legal counsel, that it has received an Acquisition Proposal that may
reasonably lead to a Superior Proposal (as defined herein), the Company may
furnish information and access to the Person who has submitted such Superior
Proposal pursuant to confidentiality agreements with terms no less restrictive
than the Confidentiality Agreement (July 27, 2000 version), and may participate
in discussions and negotiate with such Person concerning any proposed merger,
sale of assets, sale of shares of capital stock or similar transaction involving
the Company. For the purposes of this Agreement, "Superior Proposal" shall mean
any bona fide written Acquisition Proposal made by a third party that did not
result from a violation of this Agreement and which a majority of the Company
Board determines in good faith (based on the advice of its financial advisor and
the advice of outside legal counsel), within 45 days from the date hereof, to
represent superior value, from a financial point of view, to the shareholders of
the Company as compared to the transactions contemplated by this Agreement
(taking into account, among other things, all legal, financial, regulatory and
other aspects of the proposal and the identity of the offeror).
(b) If the Company receives an Acquisition Proposal, the
Company shall promptly advise Parent in writing of the terms of the Acquisition
Proposal and the identity of the Person making the Acquisition Proposal. The
Company shall keep Parent fully informed on a current basis of the status,
including any change to the
A-27
112
details, of such Acquisition Proposal and promptly provide to Parent after
receipt or delivery thereof with copies of all material correspondence and other
written material sent or provided to the Company from any third party in
connection with any Acquisition Proposal or sent or provided by the Company in
connection with any Acquisition Proposal. The Company agrees that it shall
simultaneously provide to Parent any non-public information concerning the
Company or its Subsidiaries provided to any other person or group in connection
with any Acquisition Proposal that was not previously provided to Parent.
Notwithstanding the foregoing, the Company shall not be required to provide
Parent with (i) non-public analyses prepared for a Person who has made an
Acquisition Proposal with respect to business or financial synergies unique to
such Person, or (ii) non-public financial or similar information of a Person who
has made an Acquisition Proposal.
(c) The Company agrees that neither the Company Board nor any
committee thereof shall (i) amend, condition, qualify, withdraw or modify, or
propose to amend, condition, qualify, withdraw or modify, in a manner adverse to
Parent, the approval and declaration of advisability by the Company Board of
this Agreement or the Merger, (ii) approve or recommend, or propose to approve
or recommend, any Acquisition Proposal, (iii) approve or cause the Company or
any of its Subsidiaries to enter into any letter of intent, agreement in
principle, acquisition or merger agreement or other similar agreement with
respect to any Acquisition Proposal or (iv) other than in accordance with
subsection (a) above, withdraw or modify, in a manner adverse to Parent, or fail
to make, the recommendation to Company shareholders of this Agreement and the
Merger.
(d) Notwithstanding the foregoing, nothing herein shall
require the Company's Board of Directors on behalf of the Company (a) to act, or
refrain from acting, in any manner which, in the opinion of such Board of
Directors after consultation with its legal counsel, would violate its fiduciary
duties to the Company's shareholders under applicable Law or (b) to fail to
comply with Rule 14d-9 or Rule 14e-2 promulgated under the Exchange Act with
regard to an Acquisition Proposal.
6.07. Affiliate Agreements. (a) Not later than the mailing of
the Company Proxy Statement, the Company shall deliver to Parent a schedule of
each person that, to the best of its knowledge, is or is reasonably likely to
be, as of the date of the Company Meeting, deemed to be an "affiliate" of it
(each, a "Company Affiliate") as that term is used in Rule 145 under the
Securities Act. Thereafter, the Company shall promptly notify Parent upon
becoming aware of any other person that is or is reasonably likely to be, as of
the date of the Company Meeting, deemed to be a Company Affiliate.
(b) The Company shall use its best efforts to cause each
person who may be deemed to be a Company Affiliate to execute and deliver to
Parent on or before the date of mailing of the Company Proxy Statement (or, in
the case of any person identified as a possible Company Affiliate after such
date, as promptly thereafter as possible) an agreement in the form attached
hereto as Exhibit A.
6.08. Takeover Laws. Subject to Section 6.06, no party shall
take any action that would cause the transactions contemplated by this Agreement
or the Voting Agreement to be subject to requirements imposed by any Takeover
Law and each of them shall take all necessary steps within its control to exempt
(or ensure the continued exemption of) or minimize the effect on, the
transactions contemplated by this Agreement and the Voting Agreement from, or if
necessary challenge the validity or applicability of, any applicable Takeover
Law, as now or hereafter in effect, that purports to apply to this Agreement,
the Voting Agreement or the transactions contemplated hereby or thereby.
6.09. Shares Listed. Parent shall use its reasonable best
efforts to list, prior to the Effective Date, on the NYSE, subject to official
notice of issuance, the Parent Common Shares to be issued to the holders of
Company Common Stock in the Merger or pursuant to Section 3.02(c).
6.10. Regulatory Applications. (a) Parent and the Company and
their respective Subsidiaries shall cooperate and use their respective
reasonable best efforts (i) to prepare all documentation, to effect all filings
(including, without limitation, filings under the HSR Act) and to obtain all
permits, consents, approvals and authorizations of all third parties and
Governmental Authorities necessary to consummate the transactions contemplated
by this Agreement and (ii) to cause the Merger to be consummated as
expeditiously as reasonably
A-28
113
practicable. Each of Parent and the Company shall have the right to review in
advance, and to the extent practicable each will consult with the other, in each
case subject to applicable laws relating to the exchange of information, with
respect to, all material written information submitted to any third party or any
Governmental Authority in connection with the transactions contemplated by this
Agreement. In exercising the foregoing right, each of the parties hereto agrees
to act reasonably and as promptly as practicable. Each party hereto agrees that
it will consult with the other party hereto with respect to the obtaining of all
material permits, consents, approvals and authorizations of all third parties
and Governmental Authorities necessary or advisable to consummate the
transactions contemplated by this Agreement and each party will keep the other
party apprised of the status of material matters relating to completion of the
transactions contemplated hereby.
(b) Each party agrees, upon request, to furnish the other
party with all information concerning itself, its Subsidiaries, directors,
officers and stockholders and such other matters as may be reasonably necessary
or advisable in connection with any filing, notice or application made by or on
behalf of such other party or any of its Subsidiaries to any third party or
Governmental Authority.
(c) In furtherance and not in limitation of the covenants of
the parties contained in Sections 6.10(a) and (b), if any objections are
asserted with respect to the transactions contemplated by this Agreement under
any Regulatory Law or if any suit is instituted or threatened by any
Governmental Authority or any private party challenging any of the transactions
contemplated by this Agreement as violative of any Regulatory Law, each of
Parent and the Company shall use its reasonable best efforts to resolve any such
objections or challenge as such Governmental Authority or private party may have
to such transactions under such Regulatory Law so as to permit consummation of
the transactions contemplated by this Agreement, and if any administrative or
judicial action or proceeding, including any proceeding by a private party, is
instituted (or threatened to be instituted) challenging any transaction
contemplated by this Agreement as violative of any Regulatory Law, each of
Parent and the Company shall cooperate in all respects with each other and use
its respective reasonable best efforts to contest and resist any such action or
proceeding and to have vacated, lifted, reversed or overturned any decree,
judgment, injunction or other order, whether temporary, preliminary or
permanent, that is in effect and prohibits, prevents or restricts consummation
of the transactions contemplated by this Agreement. Notwithstanding the
foregoing or any other provision of this Agreement, nothing in this Section 6.10
shall limit a party's rights under Sections 7.01(b) and 8.01(d) so long as such
party has theretofore complied in all respects with its obligations under this
Section 6.10.
6.11. Indemnification. (a) Following the Effective Date and
until the expiration of any applicable statutory limitations period, the Parent
and the Surviving Corporation shall, jointly and severally, indemnify, defend
and hold harmless the present and former directors and officers of the Company
and its Subsidiaries (each, an "Indemnified Party") against all costs or
expenses (including reasonable attorneys' fees), judgments, fines, losses,
claims, damages or liabilities (collectively, "Costs") incurred in connection
with any claim, action, suit, proceeding or investigation, whether civil,
criminal, administrative or investigative, arising out of actions or omissions
occurring at or prior to the Effective Time (including, without limitation, the
transactions contemplated by this Agreement and the Voting Agreement) to the
fullest extent that the Company is permitted to indemnify its directors and
officers under the laws of the State of Minnesota, the Company Certificate and
the Company By-Laws as in effect on the date hereof (and the Surviving
Corporation shall also advance expenses as incurred to the fullest extent
permitted under applicable law).
(b) For a period of six years from the Effective Time, Parent
shall provide a "runoff" policy with respect to that portion of director's and
officer's liability insurance that serves to cover the present and former
officers and directors of the Company and its Subsidiaries (determined as of the
Effective Time) with respect to claims against such directors and officers
arising from facts or events which occurred at or before the Effective Time,
which "runoff" insurance shall contain substantially the same coverage and
amounts to such officers and directors, and contain terms and conditions
substantially the same, as that coverage currently provided by the Company;
provided, however, that in no event shall Parent be required to expend to
maintain or obtain the insurance called for by this Section 6.11(b) more than
150 percent of the current annual amount expended by the Company to maintain or
procure such directors and officers insurance coverage for the current year (the
"Insurance Amount"); provided, further, that if Parent is unable to maintain or
obtain the insurance called for by this Section 6.11(b), Parent shall use its
reasonable best efforts to obtain as much comparable insurance as is available
for the Insurance Amount;
A-29
114
provided, further, that officers and directors of the Company or any Subsidiary
of the Company may be required to make application and provide customary
representations and warranties to Parent's insurance carrier for the purpose of
obtaining such insurance.
(c) Any Indemnified Party wishing to claim indemnification
under Section 6.11(a), upon learning of any claim, action, suit, proceeding or
investigation described above, shall promptly notify Parent thereof; provided,
that the failure so to notify shall not affect the obligations of Parent under
Section 6.11(a) unless and to the extent such failure materially increases
Parent's liability under such subsection (a).
(d) If Parent or any of its successors or assigns shall
consolidate with or merge into any other entity and shall not be the continuing
or surviving entity of such consolidation or merger or shall transfer all or
substantially all of its assets to any entity, then and in each case, proper
provision shall be made so that the successors and assigns of Parent shall
assume the obligations set forth in this Section 6.11.
6.12. Certain Employee Benefit Matters. (a) With respect to
the Plans, if any, of Parent or Parent's Subsidiaries in which employees of the
Company or its Subsidiaries ("Company Employees") become eligible to participate
after the Effective Time (the "Parent Plans"), Parent shall, or shall cause its
Subsidiaries or the Surviving Corporation to: (i) with respect to each Parent
Plan that is a medical or health plan, (x) waive any exclusions for pre-existing
conditions under such Parent Plan that would result in a lack of coverage for
any condition for which the applicable Company Employee would have been entitled
to coverage under the corresponding Company Plan in which such Company Employee
was an active participant immediately prior to his or her transfer to the Parent
Plan; (y) waive any waiting period under such Parent Plan to the extent that
such period exceeds the corresponding waiting period under the corresponding
Company Plan in which such Company Employee was an active participant
immediately prior to his or her transfer to the Parent Plan (after taking into
account the service credit provided for herein for purposes of satisfying such
waiting period); and (z) provide each Company Employee with credit for any
co-payments and deductibles paid by such Company Employee prior to his or her
transfer to the Parent Plan (to the same extent such credit was given under the
analogous Company Plan prior to such transfer) in satisfying any applicable
deductible or out-of-pocket requirements under such Parent Plan for the plan
year that includes such transfer; and (ii) recognize service of the Company
Employees with the Company or any of its Subsidiaries for purposes of
eligibility to participate and vesting credit, and, solely with respect to
vacation benefits, benefit accrual in any Parent Plan in which the Company
Employees are eligible to participate after the Effective Time to the extent
that such service was recognized for that purpose under the analogous Company
Plan prior to such transfer; provided that the foregoing shall not apply to the
extent it would result in duplication of benefits. While Parent agrees to
provide the aforesaid benefits, nothing in this paragraph shall be interpreted
to require Parent to provide for the participation of any Company Employee in
any existing Parent Plan.
(b) To the extent applicable, Parent and the Company shall
each take such reasonable steps as are required to cause the disposition and
acquisition of equity securities (including derivative securities) pursuant to
Article III of this Agreement in connection with the consummation of the Merger
by each individual who is an officer or director of the Company to qualify for
exemption from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e)
promulgated under the Exchange Act.
6.13. Accountants' Letters. The Company shall use its
reasonable best efforts to cause to be delivered to Parent a letter of KPMG LLP,
certified public accountants ("KPMG"), and Parent shall use its reasonable best
efforts to cause to be delivered to the Company a letter of Arthur Andersen LLP,
independent auditors ("Arthur Andersen"), each dated a date within two Business
Days of the date on which the Registration Statement shall become effective and
addressed to such other party, and in form and substance customary for "Agreed
Upon Procedures" letters delivered by independent accountants and certified
public accountants in accordance with Statement of Accounting Standards No. 72
for similar transactions.
6.14. Notification of Certain Matters. (a) Each of the Company
and Parent shall give prompt notice to the other of any fact, event or
circumstance known to it that would cause or constitute a material breach of any
of its representations, warranties, covenants or agreements contained herein.
A-30
115
(b) Parent shall promptly notify the Company, and the Company
shall promptly notify Parent, in writing, of any notice or other communication
from any regulatory authority or self-regulatory organization in connection with
the transactions contemplated by this Agreement or the Voting Agreement.
(c) Each of Parent and the Company shall promptly notify the
other of any fact, event or circumstance known to it that could reasonably be
expected to, individually or taken together with all other facts, events and
circumstances known to it, cause the Merger to fail to qualify as a
"reorganization" within the meaning of Section 368(a) of the Code (unless the
Merger shall be effected pursuant to Section 2.01(a)(ii).
6.15. Certain Tax Matters. Unless the Merger shall be effected
pursuant to Section 2.01(a)(ii), each of Parent and the Company will use its
reasonable best efforts to cause the Merger to constitute a reorganization
within the meaning of Section 368(a) of the Code, and to timely satisfy, or
cause to be timely satisfied, all applicable tax reporting and filing
requirements contained in the U.S. Code and Treasury Regulations with respect to
the Merger.
6.16. Withholding. To the extent required by applicable United
States, state, local or foreign laws, the parties to this Agreement agree and
acknowledge that Parent and Sub shall withhold Taxes from the amounts otherwise
required to be paid or delivered to Company, its shareholders or their
affiliates. If Company, its shareholders or their affiliates desire to avail
themselves of an exemption from the otherwise applicable withholding laws, or a
reduced withholding rate, then Company, its shareholders or their affiliates, as
the case may be, shall be obligated to obtain and furnish to Parent and Sub such
appropriate certificates, affidavits, rulings from Governmental Authorities, or
other documents necessary to establish or qualify for such exemption or reduced
rate. Parent and Sub shall reasonably cooperate with Company, its shareholders
and their affiliates in this regard. Company, its shareholders and their
affiliates hereby agree to indemnify Parent and Sub for any Costs that arise
from a failure to withhold Taxes, which failure was based on a good faith
interpretation of the law.
6.17. Election to Board. If A. E. McQuinn shall have acquired
an aggregate of 7,000,000 Parent Common Shares either in connection with the
Merger or pursuant to Section 3.02(c) hereof, at the first meeting of Parent's
Board of Directors following the Effective Time, Parent shall use reasonable
best efforts to increase the size of its Board of Directors and shall take such
other action as may be necessary to appoint A. E. McQuinn to the vacancy created
thereby.
6.18. Reorganization. Unless the Merger shall be effected
pursuant to Section 2.01(a)(ii), neither Party shall take any action that would
jeopardize the qualification of the Merger as a reorganization within the
meaning of Section 368(a) of the Code.
6.19. Severance for Employees. Each of the employees of the
Company listed on Schedule B1 hereto whose employment is terminated by Parent or
Surviving Corporation prior to the first anniversary of the Effective Time for
reasons other than "Cause" (as defined on Schedule B3) or such employee's
voluntary resignation for "Good Reason" (as defined on Schedule B3) shall
receive severance in an amount equal to two times such employee's annual base
salary as of the date of this Agreement. Each of the employees of the Company
listed on Schedule B2 hereto whose employment is terminated by Parent or
Surviving Corporation prior to the first anniversary of the Effective Time for
reasons other than "Cause" (as defined on Schedule B3) or such employee's
voluntary resignation for "Good Reason" (as defined on Schedule B3) shall
receive severance in an amount equal to such employee's annual base salary as of
the date of this Agreement. All other employees of the Company or any of its
Subsidiaries whose employment is terminated by Parent or Surviving Corporation
following the Effective Time shall receive severance in accordance with Parent's
policies existing at the time of such termination. Nothing in this Section 6.19
shall be construed as creating a contract or term of employment.
A-31
116
ARTICLE VII
CONDITIONS TO CONSUMMATION OF THE MERGER
7.01. Conditions to Each Party's Obligation to Effect the
Merger. The respective obligation of each of Parent, Sub and the Company to
consummate the Merger is subject to the fulfillment or written waiver by Parent,
Sub and the Company prior to the Effective Time of each of the following
conditions:
(a) Stockholder Approvals. This Agreement and the Merger shall
have been duly adopted by the requisite vote of the shareholders of the
Company. In the event Parent shall have made an Issuance Election and
the Company shall not have terminated this Agreement pursuant to
Section 8.01(g) hereof, the issuance of Parent Common Shares in excess
of the Minimum Share Amount shall have been duly approved by the
requisite vote of the shareholders of Parent.
(b) Regulatory Approvals. All regulatory approvals required to
consummate the transactions contemplated hereby shall have been
obtained and shall remain in full force and effect and all statutory
waiting periods in respect thereof shall have expired and (in the case
of Parent's obligation to consummate the Merger) no such approvals
shall contain any conditions, restrictions or requirements which would
reasonably be expected to, following the Effective Time, have a
Material Adverse Effect on Parent, the Company or the Surviving
Corporation.
(c) No Injunction. No Governmental Authority of competent
jurisdiction shall have enacted, issued, promulgated, enforced or
entered any statute, rule, regulation, judgment, decree, injunction or
other order (whether temporary, preliminary or permanent) which is in
effect and enjoins or prohibits consummation of the Merger.
(d) Registration Statement. The Registration Statement shall
have become effective under the Securities Act and no stop order
suspending the effectiveness of the Registration Statement shall have
been issued and be in effect and no proceedings for that purpose shall
have been initiated or threatened by the SEC and not concluded or
withdrawn.
(e) Listing. The Parent Common Shares to be issued in the
Merger or pursuant to Section 3.02(c) shall have received conditional
approval for listing on the NYSE, subject to official notice of
issuance, and Parent shall have received all state securities and Law
or "blue sky" permits and authorizations necessary to issue the Parent
Common Shares in exchange for the Company Shares in the Merger or
pursuant to Section 3.02(c).
7.02. Conditions to Obligation of the Company. The obligation
of the Company to consummate the Merger is also subject to the fulfillment or
written waiver by the Company prior to the Effective Time of each of the
following conditions:
(a) Representations and Warranties. The representations and
warranties of Parent and Sub shall be true and correct, in each such
case as of the date of this Agreement and as of the Effective Time as
though made on the Effective Time (except that the representations and
warranties that speak as of a specific date shall be true and correct
as of such date), provided that for purposes of determining the
satisfaction of the foregoing, such representations and warranties
shall be deemed true and correct if the failure or failures of such
representations and warranties to be so true and correct (excluding the
effect of any qualifications set forth therein relating to
"materiality" or "Material Adverse Effect") have not had and could not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, and the Company shall have received a
certificate, dated the Effective Date, signed on behalf of Parent by
the Chief Executive Officer and the Chief Financial Officer of Parent
to such effect.
(b) Performance of Obligations. Parent shall have performed in
all material respects all obligations required to be performed by it
under this Agreement at or prior to the Effective Time, and the
A-32
117
Company shall have received a certificate, dated the Effective Date,
signed on behalf of Parent by the Chief Executive Officer and the Chief
Financial Officer of Parent to such effect.
(c) Opinion of the Company's Counsel. Unless the Merger shall
be effected pursuant to Section 2.01(a)(ii), the Company shall have
received an opinion of Larkin, Hoffman, Daly & Lindgren, Ltd., counsel
to the Company, and/or KPMG, dated the Effective Date, to the effect
that, on the basis of facts, representations and assumptions set forth
in such opinion, (a) the Merger constitutes a reorganization within the
meaning of Section 368(a) of the Code, and (b) that, accordingly, (i)
no gain or loss will be recognized by the Company as a result of the
Merger and (ii) no gain or loss will be recognized by a shareholder of
the Company who receives the Merger Consideration in exchange for
shares of Company Common Stock, except to the extent of shareholder
realized gain for the Cash Portion of the Merger Consideration and cash
received in lieu of fractional share interests. In rendering its
opinion, such counsel may require and rely upon customary
representations contained in letters from the Company, Parent, Sub and
shareholders of the Company.
(d) Fairness Opinion. The Company shall have received a
fairness opinion from the Company's Financial Advisor in form
acceptable to the Company.
7.03. Conditions to Obligation of Parent and Sub. The
obligations of Parent and Sub to consummate the Merger are also subject to the
fulfillment or written waiver by Parent and Sub prior to the Effective Time of
each of the following conditions:
(a) Representations and Warranties. The representations and
warranties of Company shall be true and correct, in each such case as
of the date of this Agreement and as of the Effective Time as though
made on the Effective Time (except that the representations and
warranties that speak as of a specific date shall be true and correct
as of such date), provided that for purposes of determining the
satisfaction of the foregoing, such representations and warranties
shall be deemed true and correct if the failure or failures of such
representations and warranties to be so true and correct (excluding the
effect of any qualifications set forth therein relating to
"materiality" or "Material Adverse Effect") have not had and could not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, and Parent and Sub shall have received a
certificate, dated the Effective Date, signed on behalf of the Company
by the Chief Executive Officer and the Chief Financial Officer of the
Company to such effect.
(b) Performance of Obligations of the Company. The Company
shall have performed in all material respects all obligations required
to be performed by it under this Agreement at or prior to the Effective
Time, and Parent and Sub shall have received a certificate, dated the
Effective Date, signed on behalf of the Company by the Chief Executive
Officer and the Chief Financial Officer of the Company to such effect.
(c) Opinion of Parent and Sub's Counsel. Unless the Merger
shall be effected pursuant to Section 2.01(a)(ii), Parent shall have
received an opinion of Troutman Sanders LLP, counsel to Parent and Sub
dated the Effective Date, to the effect that, on the basis of facts,
representations and assumptions set forth in such opinion, (a) the
Merger constitutes a reorganization under Section 368(a) of the Code,
and (b) that, accordingly, (i) no gain or loss will be recognized by
Parent, Sub and the Company as a result of the Merger. In rendering its
opinion, Troutman Sanders LLP may require and rely upon customary
representations contained in letters from the Company, Parent, Sub and
shareholders of the Company.
7.04. Frustration of Closing Conditions. Neither Parent nor
the Company may rely on the failure of any condition set forth in Sections 7.01,
7.02 or 7.03, as the case may be, to be satisfied if such failure was caused by
such party's failure to use reasonable best efforts to consummate the Merger and
the other transactions contemplated by this Agreement.
A-33
118
ARTICLE VIII
TERMINATION
8.01. Termination. This Agreement may be terminated, and the
Merger may be abandoned:
(a) Mutual Consent. At any time prior to the Effective Time,
by the mutual written consent of Parent and the Company by action taken
by their respective Boards of Directors.
(b) Breach. At any time prior to the Effective Time, by Parent
or the Company, in the event of either: (i) a breach by the other party
of any representation or warranty contained herein which would result
in the non-satisfaction of the conditions set forth in Sections 7.02(a)
and 7.03(a), as the case may be, which breach is not capable of being
cured or has not been cured within 30 calendar days after the giving of
written notice to the breaching party of such breach; or (ii) a
material breach by the other party of any of the covenants or
agreements contained herein, which breach is not capable of being cured
or has not been cured within 30 calendar days after the giving of
written notice to the breaching party of such breach.
(c) Delay. At any time prior to the Effective Time, by Parent
or the Company, if its Board of Directors so determines, in the event
that the Merger is not consummated by June 30, 2001, except to the
extent that the failure of the Merger then to be consummated arises out
of or results from the knowing action or inaction of the party seeking
to terminate pursuant to this Section 8.01(c) which action or inaction
is in violation of its obligations under this Agreement.
(d) No Approval.
(i) By the Company or Parent, by action taken by its Board of
Directors, in the event the approval of any Governmental Authority
required for consummation of the Merger and the other transactions
contemplated by this Agreement shall have been denied by final
nonappealable action of such Governmental Authority, or in the event
any Governmental Authority of competent jurisdiction shall have issued
an order, decree or ruling or taken any other action to permanently
enjoining or otherwise prohibiting consummation, or requiring the
unwinding, of the Merger, or imposing substantial penalties as a result
of the Merger, and such action shall have become final and
nonappealable.
(ii) By Parent, by action taken by its Board of Directors, in
the event any required approval of a Governmental Authority contains
any final nonappealable conditions, restrictions or requirements which
would reasonably be expected to, following the Effective Time, have a
Material Adverse Effect on Parent or the Company as the Surviving
Corporation.
(iii) By the Company, by action taken by its Board of
Directors, in the event any required approval of a Governmental
Authority contains any final, nonappealable conditions, restrictions or
requirements which would reasonably be expected to, following the
Effective Time, have a Material Adverse Effect on Parent and its
Subsidiaries taken as a whole, unless within 30 days following receipt
by Parent of written notice of the Company's intent to terminate this
Agreement under this clause (iii) Parent notifies the Company that it
waives its right to terminate this Agreement under clause (ii) above.
(iv) By Parent or the Company, if its Board of Directors so
determines, in the event the approval of the Company's shareholders
required by Section 7.01(a) herein is not obtained at the Company
Meeting by reason of the failure to obtain the requisite vote required
by Section 7.01(a).
(e) Withdrawal of Recommendation.
(i) By Parent, if at any time after the date hereof and prior
to the Company Meeting, (A) the Company, or its Board of Directors, as
the case may be, shall have (1) entered into any written letter of
intent, written agreement in principle, written acquisition or written
merger agreement or other written agreement with respect to any
Superior Proposal (other than a confidentiality agreement contemplated
by
A-34
119
Section 6.06), (2) amended, conditioned, qualified, withdrawn or
modified, or if the Company Board shall have proposed to do so, in a
manner adverse to Parent, its approval and recommendation of the Merger
and this Agreement, or (3) approved or recommended, or if the Company
Board shall have proposed to approve or recommend, any Superior
Proposal other, or (B) the Company or the Company's Board of Directors
or any committee thereof shall have resolved to do any of the
foregoing;
(ii) By the Company, if (A) after consultation with legal
counsel, in the exercise of the Company Board's good faith judgment as
to fiduciary duties to the Company's shareholders, the Company Board
determines that such termination is required by applicable Law as a
result of a Superior Proposal being made and (B) after written notice
is given to Parent of the intent to accept a Superior Proposal, Parent
has not communicated in writing, within five (5) Business Days after
receipt of such notice, a proposal that, in the good faith judgment of
the Company Board, matches or is more favorable than the third-party
Superior Proposal from a financial point of view.
(f) By Parent, if the Parent Price calculated pursuant to
Section 3.02(b) hereof is less than $6.10 and Parent has determined not
to make an Issuance Election in accordance with Section 3.02(b).
(g) By the Company, within three (3) Business Days following
Company's receipt of an Issuance Election.
(h) By the Company, if Parent fails to make an Issuance
Election by the date specified in Section 3.02(b).
8.02. Effect of Termination and Abandonment. (a) In the event
of termination of this Agreement and the abandonment of the Merger pursuant to
this Article VIII, no party to this Agreement (nor any of their respective
officers, directors or agents) shall have any liability or further obligation to
any other party hereunder except as set forth in subsections (b) and (c) below
and in Section 9.01, and except that termination shall not relieve a party from
liability for any willful breach of this Agreement. In the event of termination
of this Agreement by either Parent or Company pursuant to Section 8.01 hereof,
the terminating party shall give prompt written notice thereof to the
non-terminating party.
(b) Parent and the Company agree that the Company shall pay to
Parent the sum of $10,000,000 (the "Termination Fee") solely if the Company or
Parent terminates this Agreement pursuant to: (i) Section 8.01(d)(iv) or (ii)
Section 8.01(e).
(c) The Termination Fee required to be paid pursuant to
Section 8.02(b) shall be payable by the Company to Parent on the same day as the
termination referred to therein and payment of such Termination Fee shall be a
condition precedent to the effectiveness of any termination by the Company.
Notwithstanding the foregoing, (i) in no event shall more than one Termination
Fee be payable and (ii) Parent may elect, by notice to the Company, to defer the
payment of the Termination Fee from time to time for a period or periods of up
to an aggregate of twelve months after the date such fee would otherwise be
payable. In the event that the Company shall fail to pay any Termination Fee
when due in accordance with this Article VIII, the amount of any such
Termination Fee shall be increased to include the costs and expenses actually
incurred (including, without limitation, fees and expenses of counsel) in
connection with the collection under and enforcement of this Section 8.02. All
payments under this Section 8.02 shall be made by wire transfer of immediately
available funds to an account designated by Parent.
(d) Upon termination of this Agreement, except for any amounts payable
by the Company pursuant to this Section 8.02 and except as otherwise
contemplated by this Section 8.02, this Agreement shall become void and have no
effect, without any liability on the part of any party hereto or its Affiliates,
directors, officers or stockholders; provided that, notwithstanding the
foregoing, this shall not relieve a breaching Party from liability for an
uncured willful breach of a representation, warranty or covenant or agreement
giving rise to such termination. In the event a claim is made against a party
under this Section 8.02(d), the non-prevailing party shall reimburse the
prevailing party for its reasonable costs and expenses incurred in connection
with a claim made against the other party under this Section 8.02(d).
A-35
120
ARTICLE IX
MISCELLANEOUS
9.01. Survival. All representations, warranties, agreements
and covenants contained in this Agreement shall not survive the Effective Time
or termination of this Agreement if this Agreement is terminated prior to the
Effective Time; provided, however, if the Effective Time occurs, the agreements
of the parties in Sections 6.01, 6.03, 6.04, 6.09, 6.11, 6.12, 6.15, 6.16, 6.17,
6.18 and 6.19 and this Article IX shall survive the Effective Time, and if this
Agreement is terminated prior to the Effective Time, the agreements of the
parties in the proviso to Section 6.05(a), Sections 6.05(b) and 8.02 and Article
IX and the Confidentiality Agreement shall survive such termination.
9.02. Amendment; Extension; Waiver. (a) Subject to compliance
with applicable law, this Agreement may be amended by the parties hereto, by
action taken or authorized by their respective Boards of Directors, at any time
before or after approval of the matters presented in connection with the Merger
by the shareholders of the Company; provided, however, that after any approval
of the transactions contemplated by this Agreement by the shareholders of the
Company, there may not be, without further approval of such shareholders, any
amendment of this Agreement which by law requires such further approval by such
shareholders. This Agreement may not be amended except by an instrument in
writing signed on behalf of each of the parties hereto.
(b) Prior to the Effective Time, the parties hereto, by action
taken or authorized by their respective Boards of Directors, may, to the extent
legally allowed, (i) extend the time for the performance of any of the
obligations or other acts of the other parties hereto, (ii) waive any
inaccuracies in the representations and warranties contained herein or in any
document delivered pursuant hereto and (iii) waive compliance with any of the
agreements or conditions contained herein. Any agreement on the part of a party
hereto to any such extension or waiver shall be valid only if set forth in a
written instrument signed on behalf of such party, but such extension or waiver
or failure to insist on strict compliance with an obligation, covenant,
agreement or condition shall not operate as a waiver of, or estoppel with
respect to, any subsequent or other failure.
9.03. Counterparts. This Agreement may be executed in one or
more counterparts, each of which when executed shall be deemed to constitute an
original but all of which when taken together shall constitute one and the same
instrument.
9.04. Governing Law. This Agreement shall be governed by, and
interpreted in accordance with, the laws of the State of Delaware (except
insofar as mandatory provisions of the MBCA are applicable), without regard to
the conflict of law principles thereof.
9.05. Expenses. Subject to Sections 8.02(b) and 8.02(c) and
except as otherwise provided herein, each party hereto will bear all Expenses
incurred by it in connection with this Agreement and the transactions
contemplated hereby, except that printing and mailing expenses and SEC
registration and filing fees shall be shared equally between the Company and
Parent.
9.06. Notices. All notices, requests and other communications
hereunder to a party shall be in writing and shall be deemed given if personally
delivered, telecopied (with confirmation) or three Business Days after being
mailed by registered or certified mail (return receipt requested) or one
Business Day after being delivered by overnight courier to such party at its
address set forth below or such other address as such party may specify by
notice to the parties hereto.
A-36
121
If to Parent or to Sub, to:
AGCO Corporation
4205 River Green Parkway
Duluth, Georgia 30096-2568
Attention: Stephen D. Lupton, Senior Vice President and
General Counsel
Fax: (770) 813-6599
Phone: (770) 813-6094
With a copy to:
Troutman Sanders LLP
Bank of America Plaza
Suite 5200
600 Peachtree St., N.E.
Atlanta, Georgia 30308-2216
Attention: Robert W. Grout, Esq.
Fax: (404) 962-6789
Phone: (404) 885-3152
If to the Company, to:
Ag-Chem Equipment Co., Inc.
5720 Smetana Drive
Minnetonka, Minnesota 55343-9688
Attention: A. E. McQuinn
Fax: (952) 933-8799
Phone: (952) 933-9006
With a copy to:
Larkin, Hoffman, Daly & Lindgren, Ltd.
1500 Wells Fargo Plaza
7900 Xerxes Avenue South
Bloomington, Minnesota 55431-1194
Attention: Frank I. Harvey
Fax: (952) 896-3333
Phone: (952) 896-3291
9.07. Entire Understanding. This Agreement (including the
Disclosure Schedules), the Voting Agreement and the Confidentiality Agreement
represent the entire understanding of the parties hereto with reference to the
transactions contemplated hereby and thereby and this Agreement supersedes any
and all other oral or written agreements (other than the Voting Agreement and
the Confidentiality Agreement) heretofore made.
9.08. Assignment; No Third Party Beneficiaries. Neither this
Agreement, nor any of the rights, interests or obligations shall be assigned by
any of the parties hereto (whether by operation of law or otherwise) without the
prior written consent of the other parties. Subject to the preceding sentence,
this Agreement will be binding upon, inure to the benefit of and be enforceable
by the parties and their respective successors and assigns. Except for Section
6.19, nothing in this Agreement expressed or implied, is intended to confer upon
any person, other than the parties hereto or their respective successors, any
rights, remedies, obligations or liabilities under or by reason of this
Agreement.
A-37
122
9.09. Interpretation. When a reference is made in this
Agreement to Sections, Exhibits or Disclosure Schedules, such reference shall be
to a Section of, or Exhibit or Disclosure Schedule to, this Agreement unless
otherwise indicated. The table of contents and headings contained in this
Agreement are for reference purposes only and are not part of this Agreement.
Whenever the words "include", "includes" or "including" are used in this
Agreement, they shall be deemed to be followed by the words "without
limitation". Any reference to "herein" or "hereof" or similar terms shall refer
to the agreement as a whole rather than to the individual paragraph, section or
article.
9.10. Severability. Any term or provision of this Agreement
which is invalid or unenforceable in any jurisdiction shall, as to that
jurisdiction, be ineffective to the extent of such invalidity or
unenforceability without rendering invalid or unenforceable the remaining terms
and provisions of this Agreement or affecting the validity or enforceability of
any of the terms or provisions of this Agreement in any other jurisdiction. If
any provision of this Agreement is so broad as to be unenforceable, the
provision shall be interpreted to be only so broad as it is enforceable.
9.11. Immunity of Officers. No recourse shall be had for any
claims arising under this Agreement against (excluding any claims resulting from
fraud) any past, present or future officer, director, incorporator, employee or
shareholder of a Party, or any of them, either directly or indirectly, under any
rule of law or equity, statute or constitution, and all such liability of any
such officer, director, incorporator, employee, or shareholder is hereby
expressly waived and released as a condition of and in consideration for the
execution of this Agreement.
* * *
A-38
123
IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be executed in counterparts by their duly authorized officers, all
as of the day and year first above written.
AGCO CORPORATION
By: /s/ Robert J. Ratliff
------------------------------------
Name: Robert J. Ratliff
Title: Chairman of the Board
AGRI ACQUISITION CORP.
By: /s/ Robert J. Ratliff
------------------------------------
Name: Robert J. Ratliff
Title: President
AG-CHEM EQUIPMENT CO., INC.
By: /s/ A. E. McQuinn
------------------------------------
Name: A. E. McQuinn
Title: Chairman and Chief Executive
Officer
A-39
124
APPENDIX B
VOTING AGREEMENT
VOTING AGREEMENT, dated as of November 20, 2000, by and among AGCO
Corporation, a Delaware corporation ("Parent"), The A. E. McQuinn Revocable
Trust (the "Trust"), a trust created pursuant to that certain Trust Agreement
(the "Trust Agreement") dated July 19, 1973, as amended, by and between A. E.
McQuinn and Robert L. Hoffman ("Hoffman") , and A. E. McQuinn, a resident of the
State of Minnesota ("McQuinn" or individually a "Shareholder" and together with
the Trust, the "Shareholders").
WHEREAS, concurrently herewith, Parent and Ag-Chem Equipment Co., Inc.,
a Minnesota corporation ("Company"), are entering into an Agreement and Plan of
Merger (as amended or supplemented from time to time, the "Merger Agreement")
(capitalized terms used without definition herein having the meanings ascribed
thereto in the Merger Agreement);
WHEREAS, as of the date hereof, the Shareholders own and/or have the
power to vote, as applicable, 5,634,148 shares of Company Common Stock (the
"Shares");
WHEREAS, the parties hereto desire that this Agreement apply only to
1,906,393 Shares, representing approximately 19.9% of the voting capital stock
of the Company (the "Subject Shares", as such number of Subject Shares may be
increased pursuant to Section 2(b) hereof);
WHEREAS, approval of the Merger Agreement by the Company's shareholders
is a condition to the consummation of the Merger;
WHEREAS, the Company Board has established a special committee of its
disinterested directors determined pursuant to Section 302A.673 of the MBCA, who
have affirmatively voted pursuant to Section 302A.673 of the MBCA, to approve
the Merger Agreement and the transactions contemplated thereby; and
WHEREAS, as a condition to its entering into the Merger Agreement,
Parent has required that the Shareholders agree, and the Shareholders have so
agreed, to enter into this Agreement;
NOW THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements set forth herein, the parties hereto agree as follows:
Section 1. Agreement to Vote. (a) Each of the Shareholders, by this
Agreement, hereby (i) agree to appear at any annual, special, postponed or
adjourned meeting of the shareholders of the Company or otherwise cause the
Subject Shares such Shareholder beneficially owns on the record date of any such
meeting to be counted as present thereat for purposes of establishing a quorum
and to vote or consent, and (ii) constitute and appoint Parent, or any nominee
thereof, with full power of substitution, during and for the term of this
Agreement, as each such Shareholder's true and lawful attorney and proxy for and
in each such Shareholder's name, place and stead, to vote all the Subject Shares
such Shareholder beneficially owns at the time of the record date for such vote,
at any annual, special, postponed or adjourned meeting of the shareholders of
the Company (and this appointment will include the right to sign the name of
each of the Shareholders (as shareholders) to any consent, certificate or other
document relating to the Company that laws of the State of Minnesota may require
or permit, in the case of both (i) and (ii) above, (x) in favor of approval of
the Merger Agreement and approval of the Merger and the transactions
contemplated thereby, (y) against any action, transaction or agreement that
would result in a breach in any respect of any covenant, representation or
warranty or any other obligation or agreement of the Company under the Merger
Agreement (including, without limitation, any Acquisition Proposal or Superior
Proposal), and (z) except as otherwise agreed to in writing in advance by
Parent, against the following actions (other than the Merger and the
transactions contemplated by the Merger Agreement): (A) any extraordinary
corporate transaction, such as a merger, consolidation or other business
combination involving the Company or any of its Subsidiaries; (B) a sale, lease
or transfer of a material amount of assets of the Company or any of its
Subsidiaries, or a reorganization, recapitalization, dissolution or liquidation
of the Company or any of its Subsidiaries; (C) (1) any change in a majority of
the Persons who constitute the Company Board; (2) any change in the present
capitalization of the
B-1
125
Company or any amendment of the Company Certificate or Company By-Laws; (3) any
other material change in the Company's corporate structure or business; or (4)
any other action involving the Company or any of its Subsidiaries which is
intended, or could reasonably be expected, to impede, interfere with, delay,
postpone or materially adversely affect the Merger or any of the transactions
contemplated by this Agreement or the Merger Agreement. This proxy and power of
attorney is a proxy and power coupled with an interest, and each Shareholder
declares that it is irrevocable until this Agreement shall terminate in
accordance with its terms. Each Shareholder hereby revokes all and any other
proxies with respect to the Subject Shares that such Shareholder may have
heretofore made or granted. For Subject Shares as to which a Shareholder is the
beneficial but not the record owner, such Shareholder shall use his or its
reasonable best efforts to cause any record owner of such Subject Shares to
grant to Parent a proxy to the same effect as that contained herein. Each
Shareholder hereby agrees to permit Parent to publish and disclose in the
Registration Statement, any related filings under the securities laws and any
press release or announcement issued in accordance with the Merger Agreement,
such Shareholder's identity, intent in and ownership of the Subject Shares and
the nature of the commitments, arrangements and understandings under this
Agreement.
(b) Nothing herein contained shall (i) restrict, limit or prohibit
McQuinn or Hoffman from exercising (in his capacity as a director or officer)
his fiduciary duties to the shareholders of the Company under applicable law, or
(ii) require McQuinn or Hoffman, in his capacity as an officer of the Company,
to take any action in contravention of, or omit to take any action pursuant to,
or otherwise take or refrain from taking any actions which are inconsistent
with, instructions or directions of the Board of Directors of the Company
undertaken in the exercise of his fiduciary duties, provided that nothing in
this Section 1(b) shall relieve or be deemed to relieve McQuinn or Hoffman from
his obligations under Sections 1 or 2 of this Agreement.
Section 2. Disposition of Subject Shares. (a) During the term of this
Agreement, except as otherwise expressly provided herein, each Shareholder
agrees that such Shareholder will not (i) tender into any tender or exchange
offer or otherwise sell, offer for sale, transfer, pledge, assign, hypothecate
or otherwise dispose of, or encumber with any security interest, lien, claim,
pledge, option, right of first refusal, agreement, charge or other encumbrance
or restriction or limitation on such Shareholder's right to vote or dispose of,
whether directly or indirectly, any of the Subject Shares, (ii) acquire any
shares of Company Common Stock or other securities of the Company (otherwise
than in connection with a transaction of the type described in Section 2(b)),
(iii) deposit the Subject Shares into a voting trust, enter into a voting
agreement or arrangement with respect to the Subject Shares or grant any proxy
or power of attorney with respect to the Subject Shares, (iv) enter into any
contract, commitment, arrangement, understanding or relationship (including any
profit sharing arrangement) with respect to the direct or indirect acquisition
or sale, transfer, pledge, assignment, hypothecation, disposition or encumbrance
with any security interest, lien, claim, pledge, option, right of first refusal,
agreement, charge or other encumbrance or restriction or limitation, or other
disposition of any interest in or the voting of any Subject Shares or any other
securities of the Company, (v) exercise any rights (including, without
limitation, under Sections 302A.471 and 302A.473 of the MBCA) to demand
appraisal of any Subject Shares which may arise with respect to the Merger, or
(vi) take any other action that would in any way restrict, limit or interfere
with the performance of such Shareholder's obligations hereunder or the
transactions contemplated hereby or which would otherwise diminish the benefits
of this Agreement to Parent.
(b) In the event (i) of any stock dividend, stock split,
recapitalization, reclassification, combination or exchange of shares of capital
stock or other securities of the Company on, of or affecting the Subject Shares
or the like or any other action that would have the effect of changing a
Shareholder's ownership of the Company's capital stock or other securities or
(ii) a Shareholder becomes the beneficial owner of any additional shares of
Company Common Stock or other securities of the Company, then, except as
provided otherwise in this Section 2(b), the terms of this Agreement will apply
to the shares of capital stock held by such Shareholder immediately following
the effectiveness of the events described in clause (i) or such Shareholder
becoming the beneficial owner thereof, as described in clause (ii), as though
they were Subject Shares hereunder.
(c) Each Shareholder hereby agrees, while this Agreement is in effect,
to promptly notify Parent of the number of any new Shares acquired by such
Shareholder, if any, after the date hereof.
B-2
126
(d) Each Shareholder agrees with and covenants to Parent that such
Shareholder shall not request that the Company register the transfer (book-entry
or otherwise) of any certificate or uncertificated interest representing any of
the Subject Shares, unless such transfer is made in compliance with this
Agreement.
Section 3. Other Covenants and Agreements. (a) Each party shall execute
and deliver such additional instruments and other documents and shall take such
further actions as may be reasonably necessary or appropriate to effectuate,
carry out and comply with all of their respective obligations under this
Agreement. Without limiting the generality of the foregoing, neither party shall
enter into any agreement or arrangement (or alter, amend or terminate any
existing agreement or arrangement) or take any other action (or fail to take any
other action) if such action (or failure) would materially impair the ability of
any party to effectuate, carry out or comply with all the terms of this
Agreement. Parent agrees to cooperate with each Shareholder in connection with
any filings required to be made by a Shareholder in connection with the Merger
and the transactions contemplated thereby. McQuinn agrees and covenants that he
will not, without the prior written consent of Parent, directly or indirectly,
take any action, or authorize or direct any action to be taken, that would cause
the Trust to be amended, modified, dissolved, revoked or terminated in any
manner that would be adverse to Parent.
(b) In the event a subscription election is made available to the
shareholders of the Company under Section 3.02(c) of the Merger Agreement, the
Shareholders jointly and severally agree and covenant to exercise such
subscription election to subscribe to the maximum number of Parent Common Shares
for which such Shareholders are eligible to subscribe pursuant to such Section
3.02(c); provided that, such Shareholders shall only be obligated to subscribe
for such number of Parent Common Shares that, when added to the aggregate number
of Parent Common Shares received by the Shareholders in the Merger, would equal
7,000,000 Parent Common Shares in the aggregate.
Section 4. Representations and Warranties of Shareholder. Each
Shareholder represents and warrants to Parent as follows:
(a) The Shares constitute all of the securities (as defined in Section
3(a)(10) of the Exchange Act), of the Company beneficially owned, directly or
indirectly, by such Shareholder.
(b) Except for the Shares, each Shareholder does not, directly or
indirectly, beneficially own or have any option, warrant or other right to
acquire any securities of the Company that are or may by their terms become
entitled to vote or any securities that are convertible or exchangeable into or
exercisable for any securities of the Company that are or may by their terms
become entitled to vote, nor is such Shareholder subject to any contract,
commitment, arrangement, understanding, restriction or relationship (whether or
not legally enforceable), other than this Agreement, that provides for a
Shareholder to vote or acquire any securities of the Company. Such Shareholder
holds exclusive power to vote and dispose of the Shares free and clear of any
security interests, liens, claims, pledges, options, rights of first refusal,
agreement, charge, encumbrance or any other restriction or limitation on their
right to vote or dispose of the Shares, and neither Shareholder has granted a
proxy to any other Person to vote the Shares, subject to the limitations set
forth in this Agreement.
(c) Each Shareholder has all necessary power and authority to execute
and deliver this Agreement and to consummate the transactions contemplated
hereby. This Agreement has been duly executed and delivered by each Shareholder
and, assuming due authorization, execution and delivery of this Agreement by
Parent, is a valid and binding obligation of each Shareholder enforceable
against each of them in accordance with its terms.
(d) None of the execution and delivery of this Agreement by such
Shareholder, the consummation by such Shareholder of the transactions
contemplated hereby or compliance by such Shareholder with any of the provisions
hereof shall (i) result in violation or breach of, or constitute (with or
without notice or lapse of time or both) a default (or give rise to any third
party right of termination, cancellation, material modification or acceleration)
under any of the terms, conditions or provisions of any note, loan agreement,
bond mortgage, indenture, license, contract, commitment, lease, permit,
franchise, arrangement, understanding, agreement or other instrument or
obligation of any kind to which such Shareholder is a party or by which such
Shareholder or any of his or its properties or assets may be bound, or (ii)
violate any order, writ, injunction, decree, judgment, law, statute, rule or
regulation applicable to such Shareholder or any of his or its properties or
assets, excluding from the foregoing
B-3
127
such violations, breaches or defaults which would not, individually or in the
aggregate, have a material adverse effect on such Shareholder or which would
materially impair the ability of such Shareholder to consummate the transactions
contemplated hereby.
(e) The execution and delivery of this Agreement by such Shareholder
does not, and the performance of this Agreement by such Shareholder shall not,
require any consent, approval, authorization or permit of, or filing with or
notification to, any court or arbitrator or any governmental body, agency or
official except for applicable requirements, if any, of the Exchange Act, and
except where the failure to obtain such consents, approvals, authorizations or
permits, or to make such filings or notifications, would not prevent or delay
the performance by such Shareholder of his or its obligations under this
Agreement.
(f) Each Shareholder understands and acknowledges that Parent is
entering into the Merger Agreement in reliance upon such Shareholder's execution
and delivery of this Agreement.
(g) There are no Takeover Laws that are applicable to this Agreement or
the transactions contemplated hereby.
Section 5. Effectiveness. It is a condition precedent to the
effectiveness of this Agreement that the Merger Agreement shall have been duly
executed and delivered by the parties thereto.
Section 6. Termination. The termination of this Agreement will occur
upon the first to occur of (a) the Effective Time or (b) termination of the
Merger Agreement. In the event (i) a Termination Fee is payable by the Company
pursuant to Section 8.02(b)(i) or 8.02(b)(ii) of the Merger Agreement and (ii)
within 12 months of the termination of the Merger Agreement, the Company
consummates an Acquisition Proposal or Superior Proposal, the Shareholders shall
pay to Parent in cash simultaneously with the consummation of such Acquisition
Proposal or Superior Proposal an amount equal to the product of (x) the excess
of the per share consideration paid in connection with such Acquisition Proposal
or Superior Proposal over $25.80 multiplied by (y) the number of Subject Shares.
The foregoing calculation shall be adjusted appropriately to reflect any stock
split, stock dividend, recapitalization, reclassification, combination or
exchange of shares of capital stock or other securities of the Company after the
date hereof.
Section 7. Miscellaneous.
(a) Notices, Etc. All notices, requests, demands or other communications
required by or otherwise with respect to this Agreement shall be in
writing and shall be deemed to have been duly given to any party when
delivered personally (by courier service or otherwise), when delivered
by telecopy and confirmed by return telecopy, or three days after being
mailed by courier service that guarantees overnight delivery, in each
case to the applicable addresses set forth below:
If to Parent:
AGCO Corporation
4205 River Green Parkway
Duluth, Georgia 30096-2568
Attention: Stephen D. Lupton, Senior Vice President and
General Counsel
Fax: (770) 813-6599
Phone: (770) 813-6094
B-4
128
with a copy to:
Troutman Sanders LLP
Bank of America Plaza
Suite 5200
600 Peachtree St., N.E.
Atlanta, Georgia 30308-2216
Attention: Robert W. Grout, Esq.
Fax: (404) 962-6789
Phone: (404) 885-3152
If to either Shareholder:
Ag-Chem Equipment Co., Inc.
5720 Smetana Drive
Minnetonka, Minnesota 55343-9688
Attention: A. E. McQuinn
Fax: (952) 933-8799
Phone: (952) 933-9006
with a copy to:
Larkin, Hoffman, Daly & Lindgren, Ltd.
1500 Wells Fargo Plaza
7900 Xerxes Avenue South
Bloomington, Minnesota 55431-1194
Attention: Frank I. Harvey
Fax: (952) 896-3333
Phone: (952) 896-3291
or to such other address as such party shall have designated by notice so given
to each other party.
(b) Amendments, Waivers, Etc. This Agreement may not be amended,
changed, supplemented, waived or otherwise modified or terminated except by an
instrument in writing signed by Parent and Shareholder.
(c) Successors and Assigns. This Agreement shall be binding upon and
shall inure to the benefit of and be enforceable by the parties and their
respective heirs, successors and assigns, including without limitation any party
succeeding to the ownership of (or power to vote) the Shares. The foregoing
sentence shall be deemed to be an amendment to the Trust Agreement.
(d) Entire Agreement. This Agreement and the Merger Agreement embodies
the entire agreement and understanding between the parties relating to the
subject matter hereof and supersedes all prior agreements and understandings
relating to such subject matter. There are no representations, warranties or
covenants by the parties hereto relating to such subject matter other than those
expressly set forth in this Agreement and the Merger Agreement.
(e) Severability. If any term of this Agreement or the application
thereof to any party or circumstance shall be held invalid or unenforceable to
any extent, the remainder of this Agreement and the application of such term to
the other party or circumstances shall not be affected thereby and shall be
enforced to the greatest extent permitted by applicable law, provided that in
such event the parties shall negotiate in good faith in an attempt to agree to
another provision (in lieu of the term or application held to be invalid or
unenforceable) that will be valid and enforceable and will carry out the
parties' intentions hereunder.
B-5
129
(f) Specific Performance. The parties acknowledge that money damages
are not an adequate remedy for violations of this Agreement and that any party
may, in its sole discretion, apply to a court of competent jurisdiction for
specific performance or injunctive or such other relief as such court may deem
just and proper in order to enforce this Agreement or prevent any violation
hereof and, to the extent permitted by applicable law, each party waives any
objection to the imposition of such relief.
(g) Remedies Cumulative. All rights, powers and remedies provided under
this Agreement or otherwise available in respect hereof at law or in equity
shall be cumulative and not alternative, and the exercise or beginning of the
exercise of any thereof by any party shall not preclude the simultaneous or
later exercise of any other such right, power or remedy by such party.
(h) No Waiver. The failure of any party hereto to exercise any right,
power or remedy provided under this Agreement or otherwise available in respect
hereof at law or in equity, or to insist upon compliance by any other party
hereto with its obligations hereunder, and any custom or practice of the parties
at variance with the terms hereof, shall not constitute a waiver by such party
of its right to exercise any such or other right, power or remedy or to demand
such compliance.
(i) Third Party Beneficiaries. This Agreement is not intended to be for
the benefit of and shall not be enforceable by any person or entity who or which
is not a party hereto, except the parties hereto acknowledge that Company is a
third party beneficiary with respect to Section 1(b) of this Agreement.
(j) Jurisdiction. Each party hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts located in the State of
Minnesota in any action arising in connection with this Agreement, and agrees
that any such action shall be brought only in such court (and waives any
objection based on forum non conveniens or any other objection to venue
therein); provided, however, that such consent to jurisdiction is solely for the
purpose referred to in this paragraph (j) and shall not be deemed to be a
general submission to the jurisdiction of said courts or in the State of
Minnesota other than for such purposes; provided, further, that if any action
arises in connection with the Merger Agreement in a state or federal court other
than a state or federal court located in the State of Minnesota, each party
hereto agrees to submit to the jurisdiction of such other court with respect to
any action arising in connection with this Agreement. Each party hereto hereby
waives any right to a trial by jury in connection with any such action.
(k) Governing Law. This Agreement and all disputes hereunder shall be
governed by and construed and enforced in accordance with the laws of the State
of Minnesota to the fullest extent possible.
(l) Name, Captions, Gender. The name assigned this Agreement and the
section captions used herein are for convenience of reference only and shall not
affect the interpretation or construction hereof. Whenever the context may
require, any pronoun used herein shall include the corresponding masculine,
feminine or neuter forms.
(m) Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one instrument. Each counterpart may consist of a
number of copies each signed by less than all, but together signed by all, the
parties hereto.
(n) Expenses. Each party shall bear its or his own expenses incurred in
connection with this Agreement and the transactions contemplated hereby.
(o) Applicability. Notwithstanding anything herein to the contrary, the
provisions of Section 1 and 2 hereof shall be deemed to apply only to such
number of Subject Shares representing 19.9% of the Company's outstanding voting
capital stock.
B-6
130
IN WITNESS WHEREOF, the parties have duly executed this Agreement as of
the date first above written.
/s/ A. E. McQuinn
---------------------------------------
A. E. McQuinn
TRUST
By:/s/ A. E. McQuinn
------------------------------------
Name: A. E. McQuinn
Title: Co-Trustee
By: /s/ Robert L. Hoffman
-----------------------------------
Name: Robert L. Hoffman
Title: Co-Trustee
PARENT
By:/s/ Robert J. Ratliff
-------------------------------------
Name: Robert J. Ratliff
Title: Chairman of the Board
B-7
131
APPENDIX C
MINNESOTA BUSINESS CORPORATION ACT SECTION 302A.473
SUBDIVISION 1. DEFINITIONS. (a) For purposes of this section, the terms defined
in this subdivision have the meanings given them.
(b) "Corporation" means the issuer of the shares held by a dissenter before the
corporate action referred to in section 302A.471, subdivision 1 or the successor
by merger of that issuer.
(c) "Fair value of the shares" means the value of the shares of a corporation
immediately before the effective date of the corporate action referred to in
section 302A.471, subdivision 1.
(d) "Interest" means interest commencing five days after the effective date of
the corporate action referred to in section 302A.471, subdivision 1, up to and
including the date of payment, calculated at the rate provided in section 549.09
for interest on verdicts and judgments.
SUBD. 2. NOTICE OF ACTION. If a corporation calls a shareholder meeting at
which any action described in section 302A.471, subdivision 1 is to be voted
upon, the notice of the meeting shall inform each shareholder of the right to
dissent and shall include a copy of section 302A.471 and this section and a
brief description of the procedure to be followed under these sections.
SUBD. 3. NOTICE OF DISSENT. If the proposed action must be approved by the
shareholders, a shareholder who is entitled to dissent under section 302A.471
and who wishes to exercise dissenters' rights must file with the corporation
before the vote on the proposed action a written notice of intent to demand the
fair value of the shares owned by the shareholder and must not vote the shares
in favor of the proposed action.
SUBD. 4. NOTICE OF PROCEDURE; DEPOSIT OF SHARES. (a) After the proposed action
has been approved by the board and, if necessary, the shareholders, the
corporation shall send to all shareholders who have complied with subdivision 3
and to all shareholders entitled to dissent if no shareholder vote was required,
a notice that contains:
(1) The address to which a demand for payment and certificates of certificated
shares must be sent in order to obtain payment and the date by which they must
be received;
(2) Any restrictions on transfer of uncertificated shares that will apply after
the demand for payment is received;
(3) A form to be used to certify the date on which the shareholder, or the
beneficial owner on whose behalf the shareholder dissents, acquired the shares
or an interest in them and to demand payment; and
(4) A copy of section 302A.471 and this section and a brief description of the
procedures to be followed under these sections.
(b) In order to receive the fair value of the shares, a dissenting shareholder
must demand payment and deposit certificated shares or comply with any
restrictions on transfer of uncertificated shares within 30 days after the
notice required by paragraph (a) was given, but the dissenter retains all other
rights of a shareholder until the proposed action takes effect.
SUBD. 5. PAYMENT; RETURN OF SHARES. (a) After the corporate action takes
effect, or after the corporation receives a valid demand for payment, whichever
is later, the corporation shall remit to each dissenting shareholder who has
complied with subdivisions 3 and 4 the amount the corporation estimates to be
the fair value of the shares, plus interest, accompanied by:
C-1
132
(1) The corporation's closing balance sheet and statement of income for a
fiscal year ending not more than 16 months before the effective date of the
corporate action, together with the latest available interim financial
statements;
(2) An estimate by the corporation of the fair value of the shares and a brief
description of the method used to reach the estimate; and
(3) A copy of section 302A.471 and this section, and a brief description of the
procedure to be followed in demanding supplemental payment.
(b) The corporation may withhold the remittance described in paragraph (a) from
a person who was not a shareholder on the date the action dissented from was
first announced to the public or who is dissenting on behalf of a person who was
not a beneficial owner on that date. If the dissenter has complied with
subdivisions 3 and 4, the corporation shall forward to the dissenter the
materials described in paragraph (a), a statement of the reason for withholding
the remittance, and an offer to pay to the dissenter the amount listed in the
materials if the dissenter agrees to accept that amount in full satisfaction.
The dissenter may decline the offer and demand payment under subdivision 6.
Failure to do so entitles the dissenter only to the amount offered. If the
dissenter makes demand, subdivisions 7 and 8 apply.
(c) If the corporation fails to remit payment within 60 days of the deposit of
certificates or the imposition of transfer restrictions on uncertificated
shares, it shall return all deposited certificates and cancel all transfer
restrictions. However, the corporation may again give notice under subdivision 4
and require deposit or restrict transfer at a later time.
SUBD. 6. SUPPLEMENTAL PAYMENT; DEMAND. If a dissenter believes that the amount
remitted under subdivision 5 is less than the fair value of the shares plus
interest, the dissenter may give written notice to the corporation of the
dissenter's own estimate of the fair value of the shares, plus interest, within
30 days after the corporation mails the remittance under subdivision 5, and
demand payment of the difference. Otherwise, a dissenter is entitled only to the
amount remitted by the corporation.
SUBD. 7. PETITION; DETERMINATION. If the corporation receives a demand under
subdivision 6, it shall, within 60 days after receiving the demand, either pay
to the dissenter the amount demanded or agreed to by the dissenter after
discussion with the corporation or file in court a petition requesting that the
court determine the fair value of the shares, plus interest. The petition shall
be filed in the county in which the registered office of the corporation is
located, except that a surviving foreign corporation that receives a demand
relating to the shares of a constituent domestic corporation shall file the
petition in the county in this state in which the last registered office of the
constituent corporation was located. The petition shall name as parties all
dissenters who have demanded payment under subdivision 6 and who have not
reached agreement with the corporation. The corporation shall, after filing the
petition, serve all parties with a summons and copy of the petition under the
rules of civil procedure. Nonresidents of this state may be served by registered
or certified mail or by publication as provided by law. Except as otherwise
provided, the rules of civil procedure apply to this proceeding. The
jurisdiction of the court is plenary and exclusive. The court may appoint
appraisers, with powers and authorities the court deems proper, to receive
evidence on and recommend the amount of the fair value of the shares. The court
shall determine whether the shareholder or shareholders in question have fully
complied with the requirements of this section, and shall determine the fair
value of the shares, taking into account any and all factors the court finds
relevant, computed by any method or combination of methods that the court, in
its discretion, sees fit to use, whether or not used by the corporation or by a
dissenter. The fair value of the shares as determined by the court is binding on
all shareholders, wherever located. A dissenter is entitled to judgment in cash
for the amount by which the fair value of the shares as determined by the court,
plus interest, exceeds the amount, if any, remitted under subdivision 5, but
shall not be liable to the corporation for the amount, if any, by which the
amount, if any, remitted to the dissenter under subdivision 5 exceeds the fair
value of the shares as determined by the court, plus interest.
SUBD. 8. COSTS; FEES; EXPENSES. (a) The court shall determine the costs and
expenses of a proceeding under subdivision 7, including the reasonable expenses
and compensation of any appraisers appointed by the court, and
C-2
133
shall assess those costs and expenses against the corporation, except that the
court may assess part or all of those costs and expenses against a dissenter
whose action in demanding payment under subdivision 6 is found to be arbitrary,
vexatious, or not in good faith.
(b) If the court finds that the corporation has failed to comply substantially
with this section, the court may assess all fees and expenses of any experts or
attorneys as the court deems equitable. These fees and expenses may also be
assessed against a person who has acted arbitrarily, vexatiously, or not in good
faith in bringing the proceeding, and may be awarded to a party injured by those
actions.
(c) The court may award, in its discretion, fees and expenses to an attorney
for the dissenters out of the amount awarded to the dissenters, if any.
C-3
134
MINNESOTA BUSINESS CORPORATION ACT SECTION 302A.471
SUBDIVISION 1. ACTIONS CREATING RIGHTS. A shareholder of a corporation may
dissent from, and obtain payment for the fair value of the shareholder's shares
in the event of, any of the following corporate actions:
(a) An amendment of the articles that materially and adversely affects the
rights or preferences of the shares of the dissenting shareholder in that it:
(1) alters or abolishes a preferential right of the shares;
(2) creates, alters, or abolishes a right in respect of the redemption of the
shares, including a provision respecting a sinking fund for the redemption or
repurchase of the shares;
(3) alters or abolishes a preemptive right of the holder of the shares to
acquire shares, securities other than shares, or rights to purchase shares or
securities other than shares;
(4) excludes or limits the right of a shareholder to vote on a matter, or to
cumulate votes, except as the right may be excluded or limited through the
authorization or issuance of securities of an existing or new class or series
with similar or different voting rights; except that an amendment to the
articles of an issuing public corporation that provides that section 302A.671
does not apply to a control share acquisition does not give rise to the right to
obtain payment under this section;
(b) A sale, lease, transfer, or other disposition of all or substantially all
of the property and assets of the corporation, but not including a transaction
permitted without shareholder approval in section 302A.661, subdivision 1, or a
disposition in dissolution described in section 302A.725, subdivision 2, or a
disposition pursuant to an order of a court, or a disposition for cash on terms
requiring that all or substantially all of the net proceeds of disposition be
distributed to the shareholders in accordance with their respective interests
within one year after the date of disposition;
(c) A plan of merger, whether under this chapter or under chapter 322B, to
which the corporation is a constituent organization, except as provided in
subdivision 3;
(d) A plan of exchange, whether under this chapter or under chapter 322B, to
which the corporation is a party as the corporation whose shares will be
acquired by the acquiring corporation, except as provided in subdivision 3; or
(e) Any other corporate action taken pursuant to a shareholder vote with
respect to which the articles, the bylaws, or a resolution approved by the board
directs that dissenting shareholders may obtain payment for their shares.
SUBD. 2. BENEFICIAL OWNERS. (a) A shareholder shall not assert dissenters'
rights as to less than all of the shares registered in the name of the
shareholder, unless the shareholder dissents with respect to all the shares that
are beneficially owned by another person but registered in the name of the
shareholder and discloses the name and address of each beneficial owner on whose
behalf the shareholder dissents. In that event, the rights of the dissenter
shall be determined as if the shares as to which the shareholder has dissented
and the other shares were registered in the names of different shareholders.
(b) A beneficial owner of shares who is not the shareholder may assert
dissenters' rights with respect to shares held on behalf of the beneficial
owner, and shall be treated as a dissenting shareholder under the terms of this
section and section 302A.473, if the beneficial owner submits to the corporation
at the time of or before the assertion of the rights a written consent of the
shareholder.
SUBD. 3. RIGHTS NOT TO APPLY. (a) Unless the articles, the bylaws, or a
resolution approved by the board otherwise provide, the right to obtain payment
under this section does not apply to a shareholder of (1) the surviving
corporation in a merger with respect to shares of the shareholder that are not
entitled to be voted on the merger and
C-4
135
are not canceled or exchanged in the merger or (2) the corporation whose shares
will be acquired by the acquiring corporation in a plan of exchange with respect
to shares of the shareholder that are not entitled to be voted on the plan of
exchange and are not exchanged in the plan of exchange.
(b) If a date is fixed according to section 302A.445, subdivision 1, for the
determination of shareholders entitled to receive notice of and to vote on an
action described in subdivision 1, only shareholders as of the date fixed, and
beneficial owners as of the date fixed who hold through shareholders, as
provided in subdivision 2, may exercise dissenters' rights.
SUBD. 4. OTHER RIGHTS. The shareholders of a corporation who have a right under
this section to obtain payment for their shares do not have a right at law or in
equity to have a corporate action described in subdivision 1 set aside or
rescinded, except when the corporate action is fraudulent with regard to the
complaining shareholder or the corporation.
C-5
136
APPENDIX D
GOLDSMITH, AGIO, HELMS SECURITIES, INC.
Member: National Association Securities Dealers
U.S. BANK PLACE - THE FORTY-SIXTH FLOOR
TEL 612 339 0500 601 Second Avenue South, Minneapolis, Minnesota 55402 FAX
612 339 0507
18 November 2000
PERSONAL AND CONFIDENTIAL
Members of the Special Committee of the Board of Directors and the
Board of Directors
Ag-Chem Equipment Co., Inc.
5720 Smetana Drive
Minnetonka, Minnesota 55343
Re: Fairness Opinion
Members of the Special Committee of the Board of Directors and the
Board of Directors:
In connection with the proposed merger (the "Merger") of Ag-Chem
Equipment Co., Inc. ("Ag-Chem" or the "Company") with AGRI Acquisition
Corp., a wholly-owned subsidiary ("Sub") of AGCO Corporation ("AGCO"
or "Parent"), pursuant to the Agreement and Plan of Merger to be dated
November 20, 2000 (the "Agreement"), by and among AGCO, Sub, and
Ag-Chem, you have requested our opinion as to the fairness, from a
financial point of view, to the Company's shareholders of the
consideration to be received by such shareholders for their common
stock in the proposed Merger pursuant to the Agreement. Capitalized
terms used herein, unless otherwise defined herein, will have the
meanings ascribed to them in the Agreement.
Subject to the provisions of the Agreement, at the effective time of
the Merger (the "Effective Time"), each share of Ag-Chem common stock
("Company Common Stock") issued and outstanding immediately prior to
the Effective Time (other than any dissenting shares) shall become and
be converted, by virtue of the Merger, into the right to receive, upon
surrender of the certificate formerly representing such Company Common
Stock, as consideration in the Merger, $25.80 composed of the Cash
Portion and the Stock Portion as defined and described in the Merger
Agreement. The Cash Portion plus the Stock Portion are hereinafter
referred to as the "Merger Consideration."
As a customary part of its investment banking business, Goldsmith,
Agio, Helms Securities, Inc. is engaged in the valuation of businesses
and securities in connection with mergers and acquisitions, private
placements, and valuations for corporate and other purposes. In return
for our services in connection with providing this opinion, the
Company will pay us a fee, which fee is not contingent upon the
consummation of the Merger, and indemnify us against certain
liabilities. We also are acting as a financial advisor to the Company
in connection with the Merger for which we will receive certain other
fees, a significant portion of which is contingent upon the
consummation of the Merger.
In arriving at our opinion, we have undertaken such reviews, analyses
and inquiries as we deemed necessary and appropriate under the
circumstances. Among other things, we have (i) reviewed the latest
draft of the Agreement; (ii) analyzed financial and other information
that is
D-1
137
publicly available relating to AGCO; (iii) analyzed financial and
other information that is publicly available relating to the Company;
(iv) analyzed certain internal financial and operating data of the
Company that has been made available to us by the Company; (v) visited
certain facilities of the Company and discussed with management of the
Company the financial condition, operating results, business outlook
and prospects of the Company; (vi) discussed with management of AGCO
the financial condition, operating results, business outlook and
prospects of AGCO; (vii) analyzed the valuations of publicly traded
companies that we deemed comparable to the Company; (viii) performed a
discounted cash flow analysis of the Company based on financial
projections that the Company's management provided to us; and (ix)
analyzed the financial terms of certain transactions we deemed similar
to the Merger that recently have been effected.
We have relied upon and assume the accuracy, completeness, and
fairness of the financial statements and other information furnished
by, or publicly available relating to, the Company or AGCO, or
otherwise made available to us, and relied upon and assumed that the
representations and warranties of the Company and AGCO contained in
the Agreement are true and correct. We were not engaged to, and did
not attempt to or assume responsibility to, verify independently such
information. We have further relied upon assurances by the Company
that the information provided to us has a reasonable basis, and with
respect to projections and other business outlook information,
reflects the best currently available estimates, and that the Company
is not aware of any information or fact that would make the
information provided to us incomplete or misleading. We also assumed
that the Company and AGCO each will perform all of the covenants and
agreements to be performed by it under the Agreement and that the
conditions to the Merger as set forth in the Agreement would be
satisfied and that the Merger would be consummated on a timely basis
in the manner contemplated by the Agreement. In arriving at our
opinion, we have not performed any appraisals or valuations of
specific assets or liabilities of the Company or AGCO and express no
opinion regarding the liquidation value of the Company or AGCO or any
of their respective assets. Our opinion is based upon the information
available to us and the facts and circumstances as they exist and are
subject to evaluation on the date hereof; events occurring after the
date hereof could materially affect the assumptions used in preparing
this opinion. However, we do not have any obligation to update,
revise, or reaffirm this opinion.
We have relied, with respect to legal and accounting matters related
to the Agreement, on the advice of the Company's and AGCO's legal and
accounting advisors. We have made no independent investigation of any
legal or accounting matters that may affect the Company or AGCO and
have assumed the correctness of the legal and accounting advice
provided to the Company and AGCO, their respective Boards of
Directors, and the Special Committee of the Company's Board of
Directors.
Our opinion is rendered for the benefit and use of the Board of
Directors of the Company and the Special Committee in connection with
the Board's and the Special Committee's consideration of the Merger
and does not constitute a recommendation to any holder of Company
Common Stock as to how such shareholder should vote with respect to
the Merger. We do not opine on, nor does our opinion consider, the tax
consequences of the Merger, including tax consequences to any holder
of Company Common Stock. We have not been asked to, nor do we, express
an opinion as to the relative merits of the Merger as compared to any
alternative business strategies that might exist for the Company, the
effect of any other transaction in which the Company might engage, or
the form of the Agreement or the terms contained therein. Furthermore,
we express no opinion as to the prices at which Ag-Chem or AGCO stock
may trade following the date of this opinion or following consummation
of the Merger. Our opinion is rendered as of the date hereof, and we
do not express any opinion as to whether, on or about the Effective
Time, the Merger Consideration will be fair, from a financial point of
view, to the Company's shareholders; such opinion can only be rendered
as
D-2
138
of such time. This opinion may not be published or otherwise used or
referred to publicly without our written consent; provided, however,
that this opinion may be included in its entirety in any filing with
the Securities and Exchange Commission with respect to the Merger.
Based upon and subject to the foregoing, and based upon such other
facts as we consider relevant, it is our opinion that, as of the date
hereof, the Merger Consideration to be received by the Company's
shareholders for their common stock in the proposed Merger pursuant to
the Agreement is fair to such shareholders from a financial point of
view.
Sincerely,
/s/ Goldsmith, Agio, Helms Securities, Inc.
Goldsmith, Agio, Helms Securities, Inc.
D-3
139
APPENDIX E
FORM OF AFFILIATE LETTER
Parent Corporation
Ladies and Gentlemen:
I have been advised that as of the date of this letter I may
be deemed to be an "affiliate" of Ag-Chem Equipment Co., Inc., a Minnesota
corporation (the "Company"), as the term "affiliate" is defined for purposes of
paragraphs (c) and (d) of Rule 145 of the rules and regulations (the "Rules and
Regulations") of the Securities and Exchange Commission (the "Commission") under
the Securities Act of 1933, as amended (the "Act"). Pursuant to the terms of the
Agreement and Plan of Merger dated as of November 20, 2000 (the "Agreement"), by
and between AGCO Corporation, a Delaware corporation ("Parent"), Agri
Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent
("Sub") and the Company, the Company will merge with Sub (the "Merger").
As a result of the Merger, I may receive common shares,
without par value, of Parent (the "Parent Common Shares") in exchange for shares
owned by me of common stock, par value $0.01 per share, of the Company.
I represent, warrant and covenant to Parent that in the event
I receive any Parent Common Shares as a result of the Merger:
A. I shall not make any sale, transfer or other disposition of
Parent Common Shares in violation of the Act or the Rules and Regulations.
B. I have carefully read this letter and the Agreement and
discussed the requirements of such documents and other applicable limitations
upon my ability to sell, transfer or otherwise dispose of the Parent Common
Shares, to the extent I felt necessary, with my counsel or counsel for Parent.
C. I have been advised that the issuance of Parent Common
Shares to me pursuant to the Merger has been registered with the Commission
under the Act on a Registration Statement on Form S-4. However, I have also been
advised that, since at the time the Merger was submitted for a vote of the
shareholders of the Company, I may be deemed to have been an affiliate of the
Company and the distribution by me of the Parent Common Shares has not been
registered under the Act, I may not sell, transfer or otherwise dispose of the
Parent Common Shares issued to me in the Merger unless (i) such sale, transfer
or other disposition has been registered under the Act, (ii) such sale, transfer
or other disposition is made in conformity with Rule 145 promulgated by the
Commission under the Act or (iii) in the opinion of counsel reasonably
acceptable to Parent, or pursuant to a "no action" letter obtained by the
undersigned from the staff of the Commission, such sale, transfer or other
disposition is otherwise exempt from registration under the Act.
D. I understand that, except as may be provided in any
registration rights agreement entered into by Parent and the undersigned, Parent
is under no obligation to register the sale, transfer or other disposition of
the Parent Common Shares by me or on my behalf under the Act or to take any
other action necessary in order to make compliance with an exemption from such
registration available.
E-1
140
Execution of this letter should not be considered an admission
on my part that I am an "affiliate" of the Company as described in the first
paragraph of this letter or as a waiver of any rights I may have to object to
any claim that I am such an affiliate on or after the date of this letter.
Very truly yours,
_______________________________
Agreed to and Accepted this
____ day of _________, 2000
AGCO CORPORATION
By: _________________________________
Name:
Title:
E-2
141
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 20. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Section 145 of the Delaware General Corporation Law empowers a Delaware
corporation to indemnify any person who was or is a party or is threatened to be
made a party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action
by or in the right of such corporation) by reason of the fact that such person
is or was a director, officer, employee or agent of such corporation, or is or
was serving at the request of such corporation as a director, officer, employee
or agent of another corporation or enterprise. A corporation may indemnify such
person against expenses (including attorneys' fees), judgments, fines and
amounts paid in settlement actually and reasonably incurred by such person in
connection with such action, suit or proceeding if such person acted in good
faith and in a manner such person reasonably believed to be in or not opposed to
the best interests of the corporation, and, with respect to any criminal action
or proceeding, had no reasonable cause to believe such person's conduct was
unlawful. A Delaware corporation may indemnify officers and directors in an
action by or in the right of the corporation to procure a judgment in its favor
under the same conditions, except that no indemnification is permitted without
judicial approval if the officer or director is adjudged to be liable to the
corporation. Where a present or former officer or director is successful on the
merits or otherwise in the defense of any action referred to above, the
corporation must indemnify such person against the expenses (including
attorneys' fees) which such person actually and reasonably incurred in
connection therewith. The indemnification provided is not deemed to be exclusive
of any other rights to which an officer or director may be entitled under any
corporation's bylaws, agreement, vote or otherwise.
ITEM 21. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) Exhibits:
A list of the exhibits included as part of this registration statement
is set forth on the Exhibit Index immediately preceding such exhibits and is
incorporated herein by reference.
(b) Financial Statement Schedules:
All schedules for which provision is made in the applicable accounting
regulations of the Securities and Exchange Commission have been omitted because
they are not required, amounts which would otherwise be required to be shown
with respect to any item are not material, are inapplicable or the required
information has already been provided elsewhere in the registration statement.
(c) Opinions of Financial Advisors:
Opinion of Goldsmith, Agio, Helms Securities, Inc., advisors to Ag-Chem
(see Appendix D to proxy statement/prospectus).
ITEM 22. UNDERTAKINGS
The undersigned registrant hereby undertakes:
(1) That prior to any public reoffering of the securities registered
hereunder through use of a prospectus which is a part of this registration
statement, by any person or party who is deemed to be an underwriter within the
meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus
will contain the information called for by the applicable registration form with
respect to reofferings by persons who may be deemed underwriters, in addition to
the information called for by the other items of the applicable form.
II-1
142
(2) That every prospectus (i) that is filed pursuant to paragraph (1)
immediately preceding, or (ii) that purports to meet the requirements of Section
10(a)(3) of the Securities Act of 1933 and is used in connection with an
offering of securities subject to Rule 415, will be filed as a part of an
amendment to the registration statement and will not be used until such
amendment is effective, and that, for purposes of determining any liability
under the Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(3) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
(4) To respond to requests for information that is incorporated by
reference into the prospectus pursuant to Item 4, 10(b), 11 or 13 of this Form,
within one business day of receipt of such request, and to send the incorporated
documents by first class mail or other equally prompt means. This includes
information contained in documents filed subsequent to the effective date of the
Registration Statement through the date of responding to the request.
(5) To supply by means of a post-effective amendment all information
concerning a transaction, and the company being acquired or involved therein,
that was not the subject of and included in the registration statement when it
became effective.
(6) For purposes of determining any liability under the Securities Act
of 1933, each filing of the registrant's annual report pursuant to Section 13(a)
or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each
filing of an employee benefit plan's annual report pursuant to Section 15(d) of
the Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
(7) To file, during any period in which offers or sales are being made,
a post-effective amendment to this registration statement; (i) To include any
prospectus required by Section 10(a)(3) of the Securities Act of 1933; (ii) To
reflect in the prospectus any facts or events arising after the effective date
of the registration statement (or the most recent post-effective amendment
thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate
offering price set forth in the "Calculation of Registration Fee" table in the
effective registration statement. (iii) To include any material information with
respect to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration
statement. (2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof; and (3) To remove from registration by means of a
post-effective amendment any of the securities being registered which remain
unsold at the termination of the offering.
II-2
143
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in Atlanta, Georgia on the
20th day of March, 2001.
AGCO Corporation
By: /s/ John M. Shumejda
--------------------------------------
John M. Shumejda
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by or on behalf of the following persons
in the capacities and on the dates indicated.
Signature Title Date
--------- ----- ----
/s/ Robert J. Ratliff Chairman of the Board **
---------------------------------------
Robert J. Ratliff
/s/ John M. Shumejda President, Chief Executive Officer and Director **
---------------------------------------
John M. Shumejda
Donald R. Millard* Senior Vice President and Chief Financial Officer **
---------------------------------------
Donald R. Millard
W. Wayne Booker* Director **
---------------------------------------
W. Wayne Booker
Henry J. Claycamp* Director **
---------------------------------------
Henry J. Claycamp
Wolfgang Deml* Director **
---------------------------------------
Wolfgang Deml
Gerald B. Johanneson* Director **
---------------------------------------
Gerald B. Johanneson
144
Anthony D. Loehnis* Director **
---------------------------------------
Anthony D. Loehnis
David E. Momot* Director **
---------------------------------------
David E. Momot
Curtis E. Moll* Director **
---------------------------------------
Curtis E. Moll
Wolfgang Sauer* Director **
---------------------------------------
Wolfgang Sauer
Henk Visser* Director **
---------------------------------------
Henk Visser
*By /s/ John M Shumejda March 20, 2001
---------------------------------------
John M. Shumejda
Attorney-in-Fact Pursuant to
Previously Filed Power of Attorney
145
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION PAGE NO.
----------- ----------- --------
2.1 Agreement and Plan of merger dated as of November 20, 2000. Included as Appendix A
to proxy statement/
prospectus
3.1 Certificate of Incorporation of AGCO. **
3.2 Bylaws of AGCO. **
4.1 Rights Agreement, as amended between AGCO and SunTrust Bank. ****
4.2 Form of Affiliate Letter. Included as Appendix E
to proxy
statement/prospectus
5.1 Form of opinion of Troutman Sanders LLP regarding legality of the shares of +
common stock being offered.
8.1 Form of opinion of Troutman Sanders LLP regarding certain tax matters.
10.1 Voting Agreement dated as of November 20, 2000. Included as Appendix B
to proxy
statement/prospectus
23.1 Consent of Troutman Sanders LLP. Included in Exhibit 5.1
23.2 Consent of Arthur Andersen LLP. *
23.3 Consent of KPMG LLP for financial statements of Ag-Chem Equipment Co., Inc. and *
Redball, LLC.
23.4 Consent of KPMG LLP for financial statements of Agricredit Acceptance LLC. *
24 Power of Attorney. +
99.1 Form of Proxy Card.
99.2 Consent of Goldsmith Agio Helms Securities, Inc. +
---------------
* To be filed by amendment.
** Incorporated by reference to the Quarterly Report on Form 10-Q for the
quarter ended March 31, 1996.
*** Incorporated by reference to the Annual Report on Form 10-K for the
year ended December 31, 1997.
**** Incorporated by reference to the Quarterly Report on Form 10-Q for the
quarter ended March 31, 1994 and the Form 8-A/A dated August 8, 1999.
+ Previously filed.